<SEC-DOCUMENT>0001558370-22-005265.txt : 20220411
<SEC-HEADER>0001558370-22-005265.hdr.sgml : 20220411
<ACCEPTANCE-DATETIME>20220411083050
ACCESSION NUMBER:		0001558370-22-005265
CONFORMED SUBMISSION TYPE:	DEF 14A
PUBLIC DOCUMENT COUNT:		4
CONFORMED PERIOD OF REPORT:	20220518
FILED AS OF DATE:		20220411
DATE AS OF CHANGE:		20220411

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			GLYCOMIMETICS INC
		CENTRAL INDEX KEY:			0001253689
		STANDARD INDUSTRIAL CLASSIFICATION:	PHARMACEUTICAL PREPARATIONS [2834]
		IRS NUMBER:				000000000
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		DEF 14A
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-36177
		FILM NUMBER:		22818538

	BUSINESS ADDRESS:	
		STREET 1:		9708 MEDICAL CENTER DRIVE
		CITY:			ROCKVILLE
		STATE:			MD
		ZIP:			20850
		BUSINESS PHONE:		240-243-1201

	MAIL ADDRESS:	
		STREET 1:		9708 MEDICAL CENTER DRIVE
		CITY:			ROCKVILLE
		STATE:			MD
		ZIP:			20850
</SEC-HEADER>
<DOCUMENT>
<TYPE>DEF 14A
<SEQUENCE>1
<FILENAME>tmb-20220518xdef14a.htm
<DESCRIPTION>DEF 14A
<TEXT>
<!--Enhanced HTML document created with Toppan Merrill Bridge  9.14.0.96--><!--Created on: 4/8/2022 08:39:17 PM (UTC)--><!DOCTYPE HTML PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN" "http://www.w3.org/TR/html4/loose.dtd"><html><head><meta charset="UTF-8"><title></title></head><body><div style="margin-top:30pt;"></div><div style="max-width:100%;padding-left:4.47%;padding-right:4.47%;position:relative;"><div style="clear:both;max-width:100%;position:relative;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><a name="_DV_C790"></a><b style="font-weight:bold;">SCHEDULE 14A </b><a name="_DV_M1"></a></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;">Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><a name="_DV_M2"></a>(Amendment No.__)</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><font style="text-decoration-line:underline;text-decoration-style:solid;visibility:hidden;">&#8203;</font></p><div align="left"><table style="border-collapse:collapse;font-size:16pt;height:max-content;padding-left:0pt;padding-right:0pt;table-layout:auto;width:100%;"><tr style="height:1pt;"><td colspan="2" style="vertical-align:top;width:33.92%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="position:absolute;top:0pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;"><font style="font-size:1pt;text-decoration-line:underline;text-decoration-style:solid;visibility:hidden;">&#8203;</font></p></div></div></td><td style="vertical-align:top;width:66.07%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="position:absolute;top:0pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;"><font style="font-size:1pt;text-decoration-line:underline;text-decoration-style:solid;visibility:hidden;">&#8203;</font></p></div></div></td></tr><tr><td colspan="2" style="vertical-align:top;width:33.92%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;">Filed by the Registrant</p></td><td style="vertical-align:top;width:66.07%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;"><b style="font-family:'Times New Roman';font-weight:bold;">&#8999;</b></p></td></tr><tr><td colspan="2" style="vertical-align:top;width:33.92%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;">Filed by a Party other than the Registrant</p></td><td style="vertical-align:top;width:66.07%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;"><b style="font-family:'Times New Roman';font-weight:bold;">&#9723;</b></p></td></tr><tr><td colspan="2" style="vertical-align:top;width:33.92%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:top;width:66.07%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></td></tr><tr><td colspan="3" style="vertical-align:top;width:100%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;">Check the appropriate box:</p></td></tr><tr><td colspan="3" style="vertical-align:top;width:100%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></td></tr><tr><td style="vertical-align:top;width:3.22%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;"><b style="font-family:'Times New Roman';font-weight:bold;">&#9723;</b></p></td><td colspan="2" style="vertical-align:top;width:96.77%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;">Preliminary Proxy Statement</p></td></tr><tr><td style="vertical-align:top;width:3.22%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;"><b style="font-family:'Times New Roman';font-weight:bold;">&#9723;</b></p></td><td colspan="2" style="vertical-align:top;width:96.77%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;">Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2))</p></td></tr><tr><td style="vertical-align:top;width:3.22%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;"><b style="font-family:'Times New Roman';font-weight:bold;">&#8999;</b></p></td><td colspan="2" style="vertical-align:top;width:96.77%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;">Definitive Proxy Statement</p></td></tr><tr><td style="vertical-align:top;width:3.22%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;"><b style="font-family:'Times New Roman';font-weight:bold;">&#9723;</b></p></td><td colspan="2" style="vertical-align:top;width:96.77%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;">Definitive Additional Materials</p></td></tr><tr style="height:3.4pt;"><td style="vertical-align:top;width:3.22%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;"><b style="font-family:'Times New Roman';font-weight:bold;">&#9723;</b></p></td><td colspan="2" style="vertical-align:top;width:96.77%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;">Soliciting Material Pursuant to &#167; 240.14a-12</p></td></tr><tr><td style="vertical-align:top;width:3.22%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;"><font style="font-family:'Wingdings';text-decoration-line:underline;text-decoration-style:solid;visibility:hidden;">&#8203;</font></p></td><td colspan="2" style="vertical-align:top;width:96.77%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;"><font style="text-decoration-line:underline;text-decoration-style:solid;visibility:hidden;">&#8203;</font></p></td></tr><tr><td colspan="3" style="vertical-align:top;width:100%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><b style="font-size:20pt;font-weight:bold;text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">GlycoMimetics, Inc.</b></p></td></tr><tr><td colspan="3" style="vertical-align:top;width:100%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;">(Name of Registrant as Specified In Its Charter)</p></td></tr><tr><td colspan="3" style="vertical-align:top;width:100%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></td></tr><tr><td colspan="3" style="vertical-align:top;width:100%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></td></tr><tr><td colspan="3" style="vertical-align:top;width:100%;border-top:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;">(Name of Person(s) Filing Proxy Statement if other than the Registrant)</p></td></tr><tr><td colspan="3" style="vertical-align:top;width:100%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></td></tr><tr><td colspan="3" style="vertical-align:top;width:100%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></td></tr><tr><td colspan="3" style="vertical-align:top;width:100%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;">Payment of Filing Fee (Check all boxes that apply):</p></td></tr><tr><td colspan="3" style="vertical-align:top;width:100%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></td></tr><tr><td style="vertical-align:top;width:3.22%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;"><b style="font-family:'Times New Roman';font-weight:bold;">&#8999;</b></p></td><td colspan="2" style="vertical-align:top;width:96.77%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;">No fee required</p></td></tr><tr><td style="vertical-align:top;width:3.22%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;"><b style="font-family:'Times New Roman';font-weight:bold;">&#9723;</b></p></td><td colspan="2" style="vertical-align:top;width:96.77%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;">Fee paid previously with preliminary materials</p></td></tr><tr><td style="vertical-align:top;width:3.22%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;"><b style="font-family:'Times New Roman';font-weight:bold;">&#9723;</b></p></td><td colspan="2" style="vertical-align:top;width:96.77%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;">Fee computed on table in exhibit required by Item 25(b) per Exchange Act Rules 14a-6(i)(1) and 0-11</p></td></tr><tr><td style="vertical-align:top;width:3.22%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;"><font style="font-family:'Wingdings';font-size:9pt;text-decoration-line:underline;text-decoration-style:solid;visibility:hidden;">&#8203;</font></p></td><td colspan="2" style="vertical-align:top;width:96.77%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;"><font style="font-size:9pt;text-decoration-line:underline;text-decoration-style:solid;visibility:hidden;">&#8203;</font></p></td></tr></table></div><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;"><font style="font-size:1pt;visibility:hidden;">&#8203;</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;"><font style="font-size:2pt;visibility:hidden;">&#8203;</font></p><p style="display:none;line-height:0pt;text-align:center;margin:0pt;"><font style="font-family:'Times New Roman','Times','serif';font-size:0pt;text-decoration-line:underline;text-decoration-style:solid;visibility:hidden;">&#8203;</font></p></div></div><hr style="background-color:#000000;clear:both;color:#000000;height:2pt;line-height:0;margin-bottom:30pt;margin-left:4.47%;margin-right:4.47%;margin-top:30pt;page-break-after:always;width:91.06%;border-width:0;"><div style="max-width:100%;padding-left:11.76%;padding-right:11.76%;position:relative;"><div style="margin-top:27.35pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;"> <font style="visibility:hidden;">&#8203;</font></p></div><div style="clear:both;max-width:100%;position:relative;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><a name="_DV_M38"></a><a name="_DV_M41"></a><b style="font-weight:bold;">GLYCOMIMETICS, INC.</b></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><a name="_DV_M42"></a>9708 Medical Center Drive</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;">Rockville, Maryland 20850</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><font style="font-size:6pt;visibility:hidden;">&#8203;</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><a name="_DV_M43"></a><b style="font-weight:bold;">NOTICE OF ANNUAL MEETING OF STOCKHOLDERS</b></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><font style="font-size:6pt;visibility:hidden;">&#8203;</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><a name="_DV_M44"></a><b style="font-weight:bold;">To Be Held On May 18, 2022</b></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><font style="font-size:6pt;visibility:hidden;">&#8203;</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;"><a name="_DV_M45"></a><font style="visibility:hidden;">&#8203;</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;">Dear Stockholder:</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;"><font style="font-size:6pt;visibility:hidden;">&#8203;</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:0pt;margin:0pt;"><a name="_DV_M46"></a>You are cordially invited to attend the virtual Annual Meeting of Stockholders of GlycoMimetics, Inc., a Delaware corporation. In light of public health concerns regarding the COVID-19 pandemic, to protect the health and safety of our stockholders and employees and to facilitate stockholder participation, the Annual Meeting will again be held through a live webcast at www.virtualshareholdermeeting.com/GLYC2022<a name="_DV_M47"></a>. You will not be able to attend the meeting in person. The meeting will be held on Wednesday, May 18, 2022 at 9:00 a.m. Eastern Time for the following purposes: </p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt;"><font style="font-size:6pt;margin-bottom:12pt;visibility:hidden;">&#8203;</font></p><table border="0" cellpadding="0" cellspacing="0"><tr><td style="width:18pt;padding:0pt;"></td><td style="vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:0pt;margin-top:0pt;"><a name="_DV_M48"></a>1.</p></td><td style="padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:0pt;margin-top:0pt;"><font style="white-space:pre-wrap;">To elect the three nominees for director named herein to hold office until the 2025 Annual Meeting of Stockholders.  </font></p></td></tr></table><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;padding-left:18pt;text-indent:-18pt;margin:0pt 0pt 0pt 18pt;"><font style="margin-bottom:12pt;margin-left:0pt;visibility:hidden;">&#8203;</font></p><table border="0" cellpadding="0" cellspacing="0"><tr><td style="width:18pt;padding:0pt;"></td><td style="vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:0pt;margin-top:0pt;">2.</p></td><td style="padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:0pt;margin-top:0pt;">To ratify the selection by the Audit Committee of the Board of Directors of Ernst &amp; Young LLP as the independent registered public accounting firm of GlycoMimetics, Inc. for its fiscal year ending December 31, 2022. </p></td></tr></table><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;padding-left:18pt;text-indent:-18pt;margin:0pt 0pt 0pt 18pt;"><font style="margin-bottom:12pt;margin-left:0pt;visibility:hidden;">&#8203;</font></p><table border="0" cellpadding="0" cellspacing="0"><tr><td style="width:18pt;padding:0pt;"></td><td style="vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:0pt;margin-top:0pt;">3.</p></td><td style="padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:0pt;margin-top:0pt;">To approve the Amended and Restated 2013 Equity Incentive Plan.<font style="display:inline-block;width:18.07pt;"></font></p></td></tr></table><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;padding-left:18pt;text-indent:-18pt;margin:0pt 0pt 0pt 18pt;"><font style="margin-bottom:12pt;margin-left:0pt;visibility:hidden;">&#8203;</font></p><table border="0" cellpadding="0" cellspacing="0"><tr><td style="width:18pt;padding:0pt;"></td><td style="vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:0pt;margin-top:0pt;">4.</p></td><td style="padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:0pt;margin-top:0pt;">To approve, on an advisory basis, the compensation of the Company&#8217;s named executive officers as disclosed in the proxy materials.</p></td></tr></table><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;padding-left:18pt;text-indent:-18pt;margin:0pt 0pt 0pt 18pt;"><font style="margin-bottom:12pt;margin-left:0pt;visibility:hidden;">&#8203;</font></p><table border="0" cellpadding="0" cellspacing="0"><tr><td style="width:18pt;padding:0pt;"></td><td style="vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:0pt;margin-top:0pt;"><a name="_DV_M52"></a><a name="OLE_LINK14"></a><a name="OLE_LINK15"></a>5.</p></td><td style="padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:0pt;margin-top:0pt;">To conduct any other business properly brought before the meeting.</p></td></tr></table><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;padding-left:18pt;text-align:justify;text-indent:-18pt;margin:0pt 0pt 0pt 18pt;"><font style="font-size:6pt;margin-bottom:12pt;margin-left:0pt;visibility:hidden;">&#8203;</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:0pt;margin:0pt;"><a name="_DV_M53"></a>These items of business are more fully described in the Proxy Statement accompanying this Notice.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:0pt;margin:0pt;"><font style="margin-bottom:12pt;visibility:hidden;">&#8203;</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:0pt;margin:0pt;">You will be able to attend the virtual Annual Meeting, submit questions, and vote during the live webcast by visiting www.virtualshareholdermeeting.com/GLYC2022 and entering the 16-digit Control Number found on your proxy card or in the instructions that you received via email. We encourage our stockholders to retain their control numbers from proxy cards or voting instruction forms in order to be able to access the virtual Annual Meeting. Please refer to the additional logistical details and recommendations in the accompanying proxy statement. You may log in beginning at 8:30 a.m. Eastern Time on Wednesday, May 18, 2022.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:18pt;margin:0pt;"><font style="font-size:6pt;margin-bottom:12pt;visibility:hidden;">&#8203;</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:0pt;margin:0pt;"><a name="_DV_M54"></a>The record date for the Annual Meeting is April 7, 2022. Only stockholders of record at the close of business on that date may vote at the meeting or any adjournment thereof. </p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:0pt;margin:0pt;"><font style="margin-bottom:12pt;visibility:hidden;">&#8203;</font></p><div align="left"><table style="border-collapse:collapse;font-size:16pt;height:max-content;padding-left:0pt;padding-right:0pt;table-layout:auto;width:100%;"><tr><td style="vertical-align:top;width:100%;border-bottom:1px solid #000000;border-left:1px solid #000000;border-right:1px solid #000000;border-top:1px solid #000000;margin:0pt;padding:1.45pt 1.2pt 1.45pt 1.2pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;text-indent:0pt;margin:2pt 0pt 0pt 0pt;"><a name="_DV_M55"></a><a name="_DV_M56"></a><a name="_DV_M57"></a><b style="font-weight:bold;">Important Notice Regarding the Availability of Proxy Materials for the Stockholders&#8217; Meeting to Be Held on May 18, 2022 at 9:00 a.m. Eastern Time at www.virtualshareholdermeeting.com/GLYC2022.</b></p><p style="font-family:'Times New Roman','Times','serif';font-size:6pt;text-align:center;text-indent:0pt;margin:0pt;"><b style="font-weight:bold;"> </b><font style="font-weight:bold;margin-bottom:12pt;visibility:hidden;">&#8203;</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;text-indent:0pt;margin:0pt;">The proxy statement and annual report to stockholders</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;text-indent:0pt;margin:0pt 0pt 2pt 0pt;">are available at http://materials.proxyvote.com/38000Q. </p></td></tr></table></div><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;"><font style="font-size:1pt;visibility:hidden;">&#8203;</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;"><font style="font-size:6pt;visibility:hidden;">&#8203;</font></p><div align="left"><table style="border-collapse:collapse;font-size:16pt;height:max-content;padding-left:0pt;padding-right:0pt;width:100%;"><tr style="height:1pt;"><td style="vertical-align:top;width:50.91%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="position:absolute;top:0pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;"><a name="_DV_M59"></a><a name="_DV_M63"></a><a name="_DV_M64"></a><font style="font-size:1pt;visibility:hidden;">&#8203;</font></p></div></div></td><td style="vertical-align:top;width:49.08%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="position:absolute;top:0pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;"><font style="font-size:1pt;visibility:hidden;">&#8203;</font></p></div></div></td></tr><tr><td style="vertical-align:top;width:50.91%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:0pt;margin:0pt;"><font style="margin-bottom:12pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:top;width:49.08%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:0pt;margin:0pt;">By Order of the Board of Directors</p></td></tr><tr><td style="vertical-align:top;width:50.91%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:0pt;margin:0pt;"><font style="margin-bottom:12pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:top;width:49.08%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:0pt;margin:0pt;"><font style="margin-bottom:12pt;visibility:hidden;">&#8203;</font></p></td></tr><tr><td style="vertical-align:top;width:50.91%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:top;width:49.08%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;"><a name="_DV_M60"></a><a name="_DV_M61"></a><img src="tmb-20220518xdef14a001.jpg" alt="Graphic" style="display:inline-block;height:21.6pt;left:0%;padding-bottom:0pt;position:relative;top:0pt;width:107.55pt;"></p></td></tr><tr><td style="vertical-align:top;width:50.91%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:top;width:49.08%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></td></tr><tr><td style="vertical-align:top;width:50.91%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:top;width:49.08%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;">Christian B. Dinneen-Long</p></td></tr><tr><td style="vertical-align:top;width:50.91%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:top;width:49.08%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;"><a name="_DV_M62"></a>Secretary</p></td></tr></table></div><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;">Rockville, Maryland </p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;">April 11, 2022</p></div><div style="clear:both;margin-bottom:27.35pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></div></div><hr style="background-color:#000000;clear:both;color:#000000;height:2pt;line-height:0;margin-bottom:30pt;margin-left:11.76%;margin-right:11.76%;margin-top:30pt;page-break-after:always;width:76.47%;border-width:0;"><div style="max-width:100%;padding-left:11.76%;padding-right:11.76%;position:relative;"><div style="margin-top:27.35pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"><font style="font-weight:bold;visibility:hidden;">&#8203;</font></p></div><div style="clear:both;max-width:100%;position:relative;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;"><font style="font-size:6pt;visibility:hidden;">&#8203;</font></p><div align="left"><table style="border-collapse:collapse;font-size:16pt;height:max-content;padding-left:0pt;padding-right:0pt;table-layout:auto;width:100%;"><tr style="height:1pt;"><td style="vertical-align:top;width:100%;border-left:1px solid #000000;border-right:1px solid #000000;border-top:1px solid #000000;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="position:absolute;top:0pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:18pt;margin:0pt 7.2pt 0pt 7.2pt;"><font style="font-size:1pt;font-weight:bold;margin-left:0pt;margin-right:0pt;visibility:hidden;">&#8203;</font></p></div></div></td></tr><tr><td style="vertical-align:top;width:100%;border-bottom:1px solid #000000;border-left:1px solid #000000;border-right:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:2pt 3.6pt 2pt 3.6pt;"><b style="font-weight:bold;">You are cordially invited to attend the meeting of GlycoMimetics, Inc. online. Whether or not you expect to access the meeting, please complete, date, sign and return the enclosed proxy, or vote over the telephone or on the Internet as instructed in these materials, as promptly as possible in order to ensure your representation at the meeting. A return envelope (which is postage prepaid if mailed in the United States) has been provided for your convenience. Even if you have voted by proxy, you may still vote online on the virtual meeting website. Please retain your Control Number from your proxy card or voting instruction form in order to be able to access the meeting. Please note, however, that if your shares are held of record by a broker, bank or other nominee and you wish to vote at the meeting, you should follow the instructions provided by your broker, bank or other nominee to be able to participate at the meeting.</b></p></td></tr></table></div><p style="border-bottom-style:none;font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;padding-bottom:0pt;text-align:justify;text-indent:0pt;margin:0pt;"><font style="font-size:1pt;margin-bottom:12pt;visibility:hidden;">&#8203;</font></p><p style="border-top-style:none;font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;text-align:justify;text-indent:0pt;margin:0pt;"><a name="_DV_M149"></a><a name="_DV_M147"></a><a name="_DV_M68"></a><a name="_DV_M67"></a><a name="_DV_M65"></a><a name="_DV_M66"></a><font style="margin-bottom:12pt;visibility:hidden;">&#8203;</font></p><p style="display:none;font-weight:bold;line-height:0pt;text-align:justify;text-indent:0pt;margin:0pt;"><font style="font-family:'Times New Roman','Times','serif';font-size:0pt;margin-bottom:12pt;visibility:hidden;">&#8203;</font></p></div><div style="clear:both;margin-bottom:27.35pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;min-height:12.0pt;text-align:center;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></div></div><hr style="background-color:#000000;clear:both;color:#000000;height:2pt;line-height:0;margin-bottom:30pt;margin-left:11.76%;margin-right:11.76%;margin-top:30pt;page-break-after:always;width:76.47%;border-width:0;"><div style="max-width:100%;padding-left:11.76%;padding-right:11.76%;position:relative;"><div style="margin-top:27.35pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;"> <font style="visibility:hidden;">&#8203;</font></p></div><div style="clear:both;max-width:100%;position:relative;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">GLYCOMIMETICS, INC.</b></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;">9708 Medical Center Drive</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;">Rockville, Maryland 20850</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><font style="font-size:8pt;visibility:hidden;">&#8203;</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">PROXY STATEMENT</b></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><a name="_DV_M150"></a><b style="font-weight:bold;">FOR THE 2022 ANNUAL MEETING OF STOCKHOLDERS</b></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><font style="font-size:8pt;visibility:hidden;">&#8203;</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><a name="_DV_M151"></a>To be held on May 18, 2022</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><a name="_DV_M152"></a><b style="font-weight:bold;">QUESTIONS AND ANSWERS ABOUT THESE PROXY MATERIALS AND VOTING</b></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p><p style="font-family:'Times New Roman Bold';font-size:10pt;font-weight:bold;line-height:1.19;margin:0pt;"><a name="_DV_M153"></a><a name="_DV_M154"></a><b style="font-family:'Times New Roman','Times','serif';font-weight:bold;">Why am I receiving these materials?</b></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:0pt;margin:0pt;"><a name="_DV_M155"></a><a name="_DV_M156"></a>We have sent you these proxy materials because the Board of Directors (the &#8220;Board&#8221;) of GlycoMimetics, Inc. (sometimes referred to as the &#8220;Company&#8221; or &#8220;GlycoMimetics&#8221;) is soliciting your proxy to vote at the 2022 Annual Meeting of Stockholders, including at any adjournments or postponements thereof (the &#8220;Annual Meeting&#8221;). You are invited to attend the Annual Meeting virtually to vote on the proposals described in this proxy statement. However, you do not need to attend the virtual meeting to vote your shares. Instead, you may simply complete, sign and return the enclosed proxy card, or follow the instructions below to submit your proxy over the telephone or on the Internet<a name="_DV_M157"></a>.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:0pt;margin:0pt;">We intend to mail these proxy materials on or about April 11, 2022 to all stockholders of record entitled to vote at the Annual Meeting.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p><p style="font-family:'Times New Roman Bold';font-size:10pt;font-weight:bold;line-height:1.19;margin:0pt;"><a name="_DV_M158"></a><a name="_DV_M164"></a><b style="font-family:'Times New Roman','Times','serif';font-weight:bold;">How do I attend the Annual Meeting?</b></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><a name="_DV_M165"></a>In light of public health concerns regarding the COVID-19 pandemic, to protect the health and safety of our stockholders and employees and to facilitate stockholder participation, the Annual Meeting will be held through a live webcast on Wednesday, May 18, 2022 at 9:00 a.m. Eastern Time. Online access to the Annual Meeting will begin at 8:30 a.m. ET. Stockholders will not be able to attend the Annual Meeting in person. </p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">To participate in and/or vote at the virtual Annual Meeting, stockholders should go to www.virtualshareholdermeeting.com/GLYC2022. Stockholders must enter the 16-digit Control Number found on their proxy card. Stockholders may still vote prior to the Annual Meeting by internet, telephone or by mail per the instructions on their proxy card. The webcast of the Annual Meeting will be archived for one year after the date of the Annual Meeting at www.virtualshareholdermeeting.com/GLYC2022. Instructions on how to connect to the Annual Meeting and participate via the internet, including how to demonstrate proof of stock ownership, are posted at www.virtualshareholdermeeting.com/GLYC2022.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><b style="font-weight:bold;">What if I cannot find my Control Number?</b></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Please note that if you do not have your Control Number and you are a stockholder of record as of the record date, you can call (240) 243-1201 prior to the day of the Annual Meeting and request that your Control Number be provided to you. If you do not have a Control Number, you will still be able to log in as a guest to the meeting webcast by visiting www.virtualshareholdermeeting.com/GLYC2022 and registering as a guest. However, if you log in as a guest you will not be able to vote your shares or ask questions during the Annual Meeting.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><b style="font-weight:bold;">How do I ask questions of management or the Board?</b></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Questions may be submitted during the Annual Meeting through www.virtualshareholdermeeting.com/GLYC2022. &#8202;We will post answers to stockholders&#8217; questions received during the Annual Meeting that are relevant to our business on our Investor Relations website shortly after the meeting.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></div><div style="clear:both;display:table;margin-bottom:27.35pt;min-height:44.65pt;width:100%;"><div style="display:table-cell;vertical-align:bottom;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;min-height:12.0pt;text-align:center;margin:0pt;">1</p></div></div></div><hr style="background-color:#000000;clear:both;color:#000000;height:2pt;line-height:0;margin-bottom:30pt;margin-left:11.76%;margin-right:11.76%;margin-top:30pt;page-break-after:always;width:76.47%;border-width:0;"><div style="max-width:100%;padding-left:11.76%;padding-right:11.76%;position:relative;"><div style="margin-top:27.35pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"><font style="font-weight:bold;visibility:hidden;">&#8203;</font></p></div><div style="clear:both;max-width:100%;position:relative;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><b style="font-weight:bold;">Where can I get technical assistance?</b></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:0pt;margin:0pt;">If you encounter any difficulties accessing the virtual meeting during the check-in time or meeting time, or you have any questions regarding how to use the virtual meeting platform, please call the technical support number that will be posted on the virtual stockholder meeting log-in page. &#160;</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p><p style="font-family:'Times New Roman Bold';font-size:10pt;font-weight:bold;line-height:1.19;margin:0pt;"><a name="_DV_M166"></a><b style="font-family:'Times New Roman','Times','serif';font-weight:bold;">Who can vote at the Annual Meeting?</b></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:0pt;margin:0pt;"><a name="_DV_M167"></a>Only stockholders of record at the close of business on April 7, 2022 will be entitled to vote at the Annual Meeting. </p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><a name="_DV_M168"></a><i style="font-style:italic;white-space:pre-wrap;">Stockholder of Record:  Shares Registered in Your Name</i></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:0pt;margin:0pt;"><a name="_DV_M169"></a>If, on April 7, 2022, your shares were registered directly in your name with our transfer agent, American Stock Transfer &amp; Trust Company, LLC, then you are a stockholder of record. As a stockholder of record, you may vote online during the virtual meeting or vote by proxy. Whether or not you plan to attend the virtual meeting, we urge you to fill out and return the enclosed proxy card or vote by proxy over the telephone or on the internet as instructed below to ensure your vote is counted. </p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><a name="_DV_M170"></a><i style="font-style:italic;white-space:pre-wrap;">Beneficial Owner:  Shares Registered in the Name of a Broker or Bank</i></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:0pt;margin:0pt;"><a name="_DV_M171"></a><a name="_DV_M172"></a>If, on April 7, 2022, your shares were not held in your name but rather in an account at a brokerage firm, bank or other similar intermediary, then you are the beneficial owner of shares held in &#8220;street name&#8221; and these proxy materials are<b style="font-weight:bold;"> </b>being forwarded to you by that intermediary. The intermediary holding your account is considered to be the stockholder of record for purposes of voting at the Annual Meeting. As a beneficial owner, you have the right to direct your broker, bank or other intermediary regarding how to vote the shares in your account. You are also invited to attend the virtual Annual Meeting. </p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:8pt 0pt 8pt 0pt;"><a name="_Hlk37169063"></a><b style="font-weight:bold;">Will a list of stockholders of record be available?</b></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;line-height:1.19;margin:0pt;"><font style="font-weight:normal;">A list of our stockholders of record as of the close of business on the record date will be made available to stockholders during the meeting at</font><font style="color:#7030a0;font-weight:normal;"> </font><font style="font-weight:normal;">www.virtualshareholdermeeting.com/GLYC2022</font><i style="color:#7030a0;font-style:italic;font-weight:normal;">. </i><font style="font-weight:normal;">In addition, for the ten days prior to the Annual Meeting, the list will be available for examination by any stockholder of record for a legally valid purpose.</font><font style="font-weight:normal;"> To access the list of stockholders of record beginning on May 6, 2022 and until the Annual Meeting, stockholders should email ir@glycomimetics.com.</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;line-height:1.19;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;line-height:1.19;margin:0pt;">What am I voting on?</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p><p style="font-family:'Times New Roman Bold';font-size:10pt;font-weight:bold;line-height:1.19;margin:0pt;"><font style="font-family:'Times New Roman','Times','serif';font-weight:normal;">There are four matters scheduled for a vote: </font></p><p style="font-family:'Times New Roman Bold';font-size:10pt;font-weight:bold;line-height:1.19;margin:0pt;"><font style="font-family:'Times New Roman','Times','serif';font-size:8pt;font-weight:normal;margin-bottom:12pt;visibility:hidden;">&#8203;</font></p><table border="0" cellpadding="0" cellspacing="0" style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"></td><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><font style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;"><a name="_DV_M174"></a></font><font style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">Election of three</font><font style="color:#800080;font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;"> </font><font style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">directors (Proposal 1); </font></td></tr></table><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;padding-left:18pt;text-indent:-18pt;margin:0pt 0pt 0pt 18pt;"><font style="font-size:8pt;margin-bottom:12pt;margin-left:0pt;visibility:hidden;">&#8203;</font></p><table border="0" cellpadding="0" cellspacing="0" style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"></td><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><font style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;"><a name="_DV_M175"></a></font><font style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">Ratification of the selection by the </font><font style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">Audit Committee of the</font><font style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;"> Board of Directors of Ernst &amp; Young LLP as independent registered public accounting firm of the Company for its fiscal year ending December 31, 2022 (Proposal&#160;2); </font></td></tr></table><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt 0pt 0pt 36pt;"><font style="margin-left:0pt;visibility:hidden;">&#8203;</font></p><table border="0" cellpadding="0" cellspacing="0" style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"></td><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><font style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">Approval of the Company&#8217;s Amended and Restated 2013 Equity Incentive Plan (Proposal 3); and </font></td></tr></table><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><font style="font-size:8pt;visibility:hidden;">&#8203;</font></p><table border="0" cellpadding="0" cellspacing="0" style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"></td><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><font style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">Approval, on an advisory basis, of the compensation of the Company&#8217;s named executive officers as disclosed in the proxy materials (Proposal 4).</font></td></tr></table><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;line-height:1.19;margin:0pt;"><a name="_DV_M178"></a>What if another matter is properly brought before the meeting?</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:0pt;margin:0pt;"><a name="_DV_M179"></a>The Board knows of no other matters that will be presented for consideration at the Annual Meeting. If any other matters are properly brought before the meeting, it is the intention of the persons named in the accompanying proxy to vote on those matters in accordance with their best judgment.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></div><div style="clear:both;display:table;margin-bottom:27.35pt;min-height:44.65pt;width:100%;"><div style="display:table-cell;vertical-align:bottom;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;min-height:12.0pt;text-align:center;margin:24pt 0pt 0pt 0pt;">2</p></div></div></div><hr style="background-color:#000000;clear:both;color:#000000;height:2pt;line-height:0;margin-bottom:30pt;margin-left:11.76%;margin-right:11.76%;margin-top:30pt;page-break-after:always;width:76.47%;border-width:0;"><div style="max-width:100%;padding-left:11.76%;padding-right:11.76%;position:relative;"><div style="margin-top:27.35pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"><font style="font-weight:bold;visibility:hidden;">&#8203;</font></p></div><div style="clear:both;max-width:100%;position:relative;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;line-height:1.19;margin:0pt;"><a name="_DV_M180"></a>How do I vote?</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:0pt;margin:0pt;"><a name="_DV_M181"></a>You may either vote &#8220;For&#8221; all the nominees to the Board of Directors or you may &#8220;Withhold&#8221; your vote for any nominee you specify. For each of the other matters to be voted on, you may vote &#8220;For&#8221; or &#8220;Against&#8221; or abstain from voting.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:0pt;margin:0pt;">The procedures for voting are as follows:</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><a name="_DV_M182"></a><i style="font-style:italic;">Stockholder of Record: Shares Registered in Your Name</i></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:0pt;margin:0pt;"><a name="_DV_M183"></a>If you are a stockholder of record, you may vote online at the virtual Annual Meeting, vote by proxy using the enclosed proxy card, vote by proxy over the telephone or vote by proxy on the internet. Whether or not you plan to attend the virtual meeting online, we urge you to vote by proxy to ensure your vote is counted. You may still attend virtually and vote during the Annual Meeting even if you have already voted by proxy.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:0pt;margin:0pt;"><font style="font-size:8pt;margin-bottom:12pt;visibility:hidden;">&#8203;</font></p><table border="0" cellpadding="0" cellspacing="0" style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"></td><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><font style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;"><a name="_DV_M184"></a></font><font style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">To vote on the internet before the meeting, go to http://www.proxyvote.com to complete an electronic proxy card. You will be asked to provide the company number and Control Number from the enclosed proxy card. Your internet vote must be received by 11:59 p.m. Eastern Time on May 17, 2022 to be counted. </font></td></tr></table><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;padding-left:18pt;text-indent:-18pt;margin:0pt 0pt 0pt 18pt;"><font style="font-size:8pt;margin-bottom:12pt;margin-left:0pt;visibility:hidden;">&#8203;</font></p><table border="0" cellpadding="0" cellspacing="0" style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"></td><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><font style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">To vote over the telephone, dial toll-free 1-800-690-6903 using a touch-tone phone and follow the recorded instructions. You will be asked to provide the company number and Control Number from the enclosed proxy card. Your telephone vote must be received by 11:59 p.m.</font><font style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;"><a name="_DV_M188"></a></font><font style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;"> Eastern Time on May 17, 2022 to be counted.</font></td></tr></table><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;padding-left:18pt;text-indent:-18pt;margin:0pt 0pt 0pt 18pt;"><font style="font-size:8pt;margin-bottom:12pt;margin-left:0pt;visibility:hidden;">&#8203;</font></p><table border="0" cellpadding="0" cellspacing="0" style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"></td><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><font style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">To vote using the proxy card, simply complete, sign and date the enclosed proxy card</font><b style="color:#0000ff;font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:bold;"> </b><font style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;"><a name="_DV_M186"></a><a name="_DV_M187"></a><a name="_DV_M189"></a>and return it promptly in the envelope provided. If you return your signed proxy card to us before the Annual Meeting, we will vote your shares as you direct. You should mail your signed proxy card sufficiently in advance for it to be received by May 17, 2022.</font></td></tr></table><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;padding-left:18pt;text-indent:-18pt;margin:0pt 0pt 0pt 18pt;"><font style="font-size:8pt;margin-bottom:12pt;margin-left:0pt;visibility:hidden;">&#8203;</font></p><table border="0" cellpadding="0" cellspacing="0" style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"></td><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><font style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;"><a name="_DV_M191"></a></font><font style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;"><a name="_DV_M185"></a>To vote online during the Annual Meeting, stockholders of record will be able to vote their shares electronically during the Annual Meeting by using their 16-digit Control Number. Instructions on how to vote while participating in the Annual Meeting live via the internet are posted at www.virtualshareholdermeeting.com/GLYC2022. </font></td></tr></table><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><a name="_DV_M192"></a><i style="font-style:italic;white-space:pre-wrap;">Beneficial Owner:  Shares Registered in the Name of Broker or Bank</i></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:0pt;margin:0pt;"><a name="_DV_M193"></a><a name="_DV_M194"></a><a name="OLE_LINK7"></a><a name="_DV_M195"></a>If you are a beneficial owner of shares registered in the name of your broker, bank, or other similar intermediary, you should have received a voting instruction form with these proxy materials from that intermediary rather than from GlycoMimetics. Simply complete and mail the voting instruction form to ensure that your vote is counted. Alternatively, you may vote by telephone or on the internet as instructed by your broker or bank. To vote online at the virtual Annual Meeting, you should follow the instructions provided by your broker, bank or other intermediary, or contact that intermediary to request a proxy form.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:0pt;margin:0pt;"><font style="margin-bottom:12pt;visibility:hidden;">&#8203;</font></p><div align="left"><table style="border-collapse:collapse;font-size:16pt;height:max-content;padding-left:0pt;padding-right:0pt;table-layout:auto;width:100%;"><tr style="height:1pt;"><td style="vertical-align:top;width:100%;border-left:1px solid #000000;border-right:1px solid #000000;border-top:1px solid #000000;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="position:absolute;top:0pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 7.2pt 0pt 7.2pt;"><font style="font-size:1pt;font-weight:bold;margin-left:0pt;margin-right:0pt;visibility:hidden;">&#8203;</font></p></div></div></td></tr><tr><td style="vertical-align:top;width:100%;border-bottom:1px solid #000000;border-left:1px solid #000000;border-right:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:2pt 7.2pt 2pt 7.2pt;"><b style="font-weight:bold;">I</b><a name="_DV_M196"></a><b style="font-weight:bold;">nternet proxy voting will be provided to allow you to vote your shares online, with procedures designed to ensure the authenticity and correctness of your proxy vote instructions. However, please be aware that you must bear any costs associated with your internet access, such as usage charges from internet access providers and telephone companies.</b></p></td></tr></table></div><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;"><a name="_DV_M197"></a><font style="visibility:hidden;">&#8203;</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;line-height:1.19;margin:0pt;">How many votes do I have?</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:0pt;margin:0pt;"><a name="_DV_M198"></a><a name="_DV_M205"></a>On each matter to be voted upon, you have one vote for each share of common stock you owned as of April 7, 2022.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></div><div style="clear:both;display:table;margin-bottom:27.35pt;min-height:44.65pt;width:100%;"><div style="display:table-cell;vertical-align:bottom;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;min-height:12.0pt;text-align:center;margin:24pt 0pt 0pt 0pt;">3</p></div></div></div><hr style="background-color:#000000;clear:both;color:#000000;height:2pt;line-height:0;margin-bottom:30pt;margin-left:11.76%;margin-right:11.76%;margin-top:30pt;page-break-after:always;width:76.47%;border-width:0;"><div style="max-width:100%;padding-left:11.76%;padding-right:11.76%;position:relative;"><div style="margin-top:27.35pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"><font style="font-weight:bold;visibility:hidden;">&#8203;</font></p></div><div style="clear:both;max-width:100%;position:relative;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;line-height:1.19;margin:0pt;"><a name="_DV_M206"></a>If I am a stockholder of record and I do not vote, or if I return a proxy card or otherwise vote without giving specific voting instructions, what happens?</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p><p style="font-family:'Times New Roman Bold';font-size:10pt;font-weight:bold;line-height:1.19;margin:0pt;"><font style="font-family:'Times New Roman','Times','serif';font-weight:normal;">If you are a stockholder of record and do not vote by completing your proxy card, by telephone, on the internet or online at the virtual Annual Meeting, your shares will not be voted. </font></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:0pt;margin:0pt;"><a name="_DV_M207"></a>If you return a signed and dated proxy card or otherwise vote without marking voting selections, your shares will be voted, as applicable, &#8220;For&#8221; the election of the three nominees for director, &#8220;For&#8221; the ratification of the selection of Ernst&#160;&amp; Young LLP as our registered public accounting firm for the fiscal year ending December&#160;31, 2022, &#8220;For&#8221; the approval of the Amended and Restated 2013 Equity Incentive Plan and &#8220;For&#8221; the advisory approval of executive compensation. If any other matter is properly presented at the meeting, your proxyholder (one of the individuals named on your proxy card) will vote your shares using his or her best judgment.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;line-height:1.19;margin:0pt;">If I am a beneficial owner of shares held in street name and I do not provide my broker or bank with voting instructions, what happens?</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:0pt;margin:0pt;">If you are a beneficial owner of shares held in street name and you do not instruct your broker, bank or other similar intermediary how to vote your shares, your broker, bank or other intermediary may still be able to vote your shares in its discretion. Under the rules of the New York Stock Exchange (NYSE), brokers, banks and other securities intermediaries that are subject to NYSE rules may use their discretion to vote your &#8220;uninstructed&#8221; shares with respect to matters considered to be &#8220;routine&#8221; under NYSE rules, but not with respect to &#8220;non-routine&#8221; matters. In this regard, Proposals 1, 3 and 4 are considered to be &#8220;non-routine&#8221; under NYSE rules, meaning that your broker may not vote your shares on those proposals in the absence of your voting instructions. However, Proposal 2 is considered to be a &#8220;routine&#8221; matter under NYSE rules, meaning that if you do not return voting instructions to your broker by its deadline, your shares may be voted by your broker in its discretion on Proposal 2. </p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:0pt;margin:0pt;"><font style="font-style:italic;font-weight:bold;">If you are a beneficial owner of shares held in street name, in order to ensure your shares are voted in the way you would prefer, you must provide voting instructions to your broker, bank or other intermediary</font> <font style="font-style:italic;font-weight:bold;">by the deadline provided in the materials you receive from your broker, bank or other intermediary.</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:0pt;margin:0pt;"><a name="_DV_M208"></a><b style="font-weight:bold;">Who is paying for this proxy solicitation?</b></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:0pt;margin:0pt;"><a name="_DV_M209"></a>We will pay for the entire cost of soliciting proxies. In addition to these proxy materials, our directors and employees may also solicit proxies in person, by telephone, or by other means of communication. Directors and employees will not be paid any additional compensation for soliciting proxies. We may also reimburse brokerage firms, banks and other agents for the cost of forwarding proxy materials to beneficial owners.<b style="font-weight:bold;"> </b>In addition, we have engaged Alliance Advisors, LLC to assist in the solicitation of proxies and provide related advice and information support for a services fee and reimbursement of customary disbursements that are not expected to exceed $25,000 in total.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;line-height:1.19;margin:0pt;"><a name="_DV_M210"></a>What does it mean if I receive more than one set of proxy materials?</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:0pt;margin:0pt;"><a name="_DV_M211"></a>If you receive more than one set of proxy materials, your shares may be registered in more than one name or in different accounts. Please follow the voting instructions on the proxy cards in the proxy materials to ensure that all of your shares are voted.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;"><a name="_DV_M212"></a><font style="visibility:hidden;">&#8203;</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><b style="font-weight:bold;">Can I change my vote after submitting my proxy?</b></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><a name="_DV_M213"></a><i style="font-style:italic;">Stockholder of Record: Shares Registered in Your Name</i></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:0pt;margin:0pt;">Yes. You can revoke your proxy at any time before the final vote at the Annual Meeting. If you are the record holder of your shares, you may revoke your proxy in any one of the following ways:</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p><table border="0" cellpadding="0" cellspacing="0" style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"></td><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><font style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;"><a name="_DV_M214"></a></font><font style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">You may submit another properly completed proxy card with a later date.</font></td></tr></table><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;padding-left:18pt;text-indent:-18pt;margin:0pt 0pt 0pt 18pt;"><font style="font-size:8pt;margin-bottom:12pt;margin-left:0pt;visibility:hidden;">&#8203;</font></p><table border="0" cellpadding="0" cellspacing="0" style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"></td><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><font style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;"><a name="_DV_M215"></a></font><font style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">You may submit a subsequent proxy by telephone or on the internet.</font></td></tr></table></div><div style="clear:both;display:table;margin-bottom:27.35pt;min-height:44.65pt;width:100%;"><div style="display:table-cell;vertical-align:bottom;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;min-height:12.0pt;text-align:center;margin:24pt 0pt 0pt 0pt;">4</p></div></div></div><hr style="background-color:#000000;clear:both;color:#000000;height:2pt;line-height:0;margin-bottom:30pt;margin-left:11.76%;margin-right:11.76%;margin-top:30pt;page-break-after:always;width:76.47%;border-width:0;"><div style="max-width:100%;padding-left:11.76%;padding-right:11.76%;position:relative;"><div style="margin-top:27.35pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"><font style="font-weight:bold;visibility:hidden;">&#8203;</font></p></div><div style="clear:both;max-width:100%;position:relative;"><table border="0" cellpadding="0" cellspacing="0" style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"></td><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><font style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;"><a name="_DV_M216"></a></font><font style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">You may send a timely written notice that you are revoking your proxy to our Corporate Secretary at 9708 Medical Center Drive, Rockville, Maryland 20850.</font><b style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:bold;"> </b></td></tr></table><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;padding-left:18pt;text-indent:-18pt;margin:0pt 0pt 0pt 18pt;"><font style="font-size:8pt;margin-bottom:12pt;margin-left:0pt;visibility:hidden;">&#8203;</font></p><table border="0" cellpadding="0" cellspacing="0" style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"></td><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><font style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;"><a name="_DV_M217"></a></font><font style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">You may attend and vote online at the virtual Annual Meeting. Simply attending the meeting will not, by itself, revoke your proxy.</font></td></tr></table><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:0pt;margin:0pt;"><a name="_DV_M218"></a><font style="white-space:pre-wrap;">Your most current proxy card or telephone or internet proxy is the one that is counted.  </font></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><a name="_DV_M219"></a><i style="font-style:italic;white-space:pre-wrap;">Beneficial Owner:  Shares Registered in the Name of Broker or Bank</i></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:0pt;margin:0pt;">If your shares are held by your broker, bank or other similar intermediary, you should follow the instructions provided by that intermediary.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;line-height:1.19;margin:0pt;"><a name="_DV_M220"></a>When are stockholder proposals due for next year&#8217;s annual meeting?</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><a name="_DV_M221"></a>To be considered for inclusion in next year&#8217;s proxy materials, your proposal must be submitted in writing by December 12, 2022, to our Corporate Secretary at 9708 Medical Center Drive, Rockville, Maryland 20850. If you wish to nominate an individual for election as a director at, or bring business other than through a stockholder proposal before, the 2023 Annual Meeting of Stockholders, you must deliver your notice to our Corporate Secretary at the foregoing address between January 18, 2023, and February 17, 2023. In the event that next year&#8217;s annual meeting is scheduled to be held before April 18, 2023, or after June 17, 2023, then you must deliver your notice to our Corporate Secretary at the foregoing address at least 90 days, but not more than 120 days, prior to the date of next year&#8217;s annual meeting, or not more than 10 days following the day on which public announcement of the date of next year&#8217;s annual meeting is made. Your notice to the Corporate Secretary must set forth information specified in our amended and restated bylaws, including your name and address and the class and number of shares of our stock that you beneficially own. </p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> <font style="visibility:hidden;">&#8203;</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">If you propose to bring business before an annual meeting other than a director nomination, your notice must also include, as to each matter proposed, the following: 1) a brief description of the business desired to be brought before the annual meeting and the reasons for conducting that business at the annual meeting; and 2) any material interest you have in that business. If you propose to nominate an individual for election as a director, your notice must also include, as to each person you propose to nominate for election as a director, the following: 1) the name, age, business address and residence address of the person; 2) the principal occupation or employment of the person; 3)&#160;the class and number of shares of our stock that are owned of record and beneficially owned by the person; 4) the date or dates on which the shares were acquired and the investment intent of the acquisition; and 5) any other information concerning the person as would be required to be disclosed in a proxy statement soliciting proxies for the election of that person as a director in an election contest (even if an election contest is not involved), or that is otherwise required to be disclosed pursuant to Section 14 of the Securities Exchange Act of 1934 (the &#8220;Exchange Act&#8221;), and the rules and regulations promulgated under the Exchange Act, including the person&#8217;s written consent to being named as a nominee and to serving as a director if elected. We may require any proposed nominee to furnish other information as we may reasonably require to determine the eligibility of the proposed nominee to serve as an independent director or that could be material to a reasonable stockholder&#8217;s understanding of the independence, or lack of independence, of the proposed nominee.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">For more information, and for more detailed requirements, please refer to our amended and restated bylaws, filed as an exhibit to our most recent Annual Report on Form&#160;10-K, filed with the Securities and Exchange Commission (the &#8220;SEC&#8221;) on March 3, 2022.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;line-height:1.19;margin:0pt;"><a name="_DV_M224"></a>How are votes counted?</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:0pt;margin:0pt;"><a name="_DV_M225"></a>Votes will be counted by the inspector of election appointed for the Annual Meeting, who will separately count, for Proposal 1, votes &#8220;For,&#8221; &#8220;Withhold&#8221; and broker non-votes for each nominee; and with respect to Proposals 2, 3 and 4, votes &#8220;For,&#8221; &#8220;Against,&#8221; abstentions and, if applicable, broker non-votes.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></div><div style="clear:both;display:table;margin-bottom:27.35pt;min-height:44.65pt;width:100%;"><div style="display:table-cell;vertical-align:bottom;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;min-height:12.0pt;text-align:center;margin:24pt 0pt 0pt 0pt;">5</p></div></div></div><hr style="background-color:#000000;clear:both;color:#000000;height:2pt;line-height:0;margin-bottom:30pt;margin-left:11.76%;margin-right:11.76%;margin-top:30pt;page-break-after:always;width:76.47%;border-width:0;"><div style="max-width:100%;padding-left:11.76%;padding-right:11.76%;position:relative;"><div style="margin-top:27.35pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"><font style="font-weight:bold;visibility:hidden;">&#8203;</font></p></div><div style="clear:both;max-width:100%;position:relative;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:0pt;margin:0pt;">Abstentions will be counted towards the vote total for Proposals 2, 3 and 4, and will have the same effect as &#8220;Against&#8221; votes. Broker non-votes on Proposals 1, 3 and 4 will have no effect and will not be counted towards the vote total for any of those proposals. </p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;"><a name="_DV_M227"></a><a name="_DV_M229"></a><font style="visibility:hidden;">&#8203;</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;line-height:1.19;margin:0pt;">What are &#8220;broker non-votes&#8221;? </p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:0pt;margin:0pt;"><a name="_DV_X92"></a><a name="_DV_C120"></a><a name="_DV_C121"></a><a name="_DV_X94"></a>As discussed above, when a beneficial owner of shares held in &#8220;street name&#8221; does not give any voting instructions to such beneficial owner&#8217;s broker, bank or other securities intermediary holding such beneficial owner&#8217;s shares under NYSE rules, the broker, bank or other such intermediary cannot vote the shares on matters deemed to be &#8220;non-routine&#8221; matters. These un-voted shares are counted as &#8220;broker non-votes.&#8221; Proposals 1, 3 and 4 are considered to be &#8220;non-routine&#8221; under NYSE rules, and we therefore expect broker non-votes to exist in connection with these proposals. </p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:0pt;margin:0pt;"><font style="margin-bottom:12pt;visibility:hidden;">&#8203;</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:0pt;margin:0pt 0pt 12pt 0pt;"><font style="font-style:italic;font-weight:bold;">As a reminder, if you are a beneficial owner of shares held in street name, in order to ensure your shares are voted in the way you would prefer, you must provide voting instructions to your broker, bank or other intermediary</font> <font style="font-style:italic;font-weight:bold;">by the deadline provided in the materials you receive from your broker, bank or other intermediary.</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;line-height:1.19;margin:0pt;"><a name="_DV_M230"></a>How many votes are needed to approve each proposal? </p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 6pt 0pt;"><a name="_DV_M231"></a><a name="_DV_M232"></a>The following table summarizes the minimum vote needed to approve each proposal and the effect of abstentions and broker non-votes. </p><div style="margin-left:-0.5pt;" align="left"><table style="border-collapse:collapse;font-size:16pt;height:max-content;padding-left:0.5pt;padding-right:0.5pt;table-layout:auto;width:100%;"><tr style="height:1pt;"><td style="vertical-align:bottom;width:7.79%;margin:0pt;padding:0pt 0.5pt 0pt 0.5pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;width:27.88%;margin:0pt;padding:0pt 0.5pt 0pt 0.5pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;width:36.53%;margin:0pt;padding:0pt 0.5pt 0pt 0.5pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;width:13.46%;margin:0pt;padding:0pt 0.5pt 0pt 0.5pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;width:14.31%;margin:0pt;padding:0pt 0.5pt 0pt 0.5pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td></tr><tr><td style="vertical-align:bottom;width:7.79%;border-bottom:1px solid #000000;margin:0pt;padding:0pt 0.5pt 0pt 0.5pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:9pt;line-height:1.27;text-align:center;border-bottom:1px solid #000000;margin:6pt 0pt 0pt 0pt;"><b style="font-weight:bold;">Proposal Number</b></p></td><td style="vertical-align:bottom;width:27.88%;border-bottom:1px solid #000000;margin:0pt;padding:0pt 0.5pt 0pt 0.5pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:9pt;line-height:1.27;text-align:center;border-bottom:1px solid #000000;margin:6pt 0pt 0pt 0pt;"><b style="font-weight:bold;">Proposal Description</b></p></td><td style="vertical-align:bottom;width:36.53%;border-bottom:1px solid #000000;margin:0pt;padding:0pt 0.5pt 0pt 0.5pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:9pt;line-height:1.27;text-align:center;border-bottom:1px solid #000000;margin:6pt 0pt 0pt 0pt;"><b style="font-weight:bold;">Vote Required for Approval</b></p></td><td style="vertical-align:bottom;width:13.46%;border-bottom:1px solid #000000;margin:0pt;padding:0pt 0.5pt 0pt 0.5pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:9pt;line-height:1.27;text-align:center;border-bottom:1px solid #000000;margin:6pt 0pt 0pt 0pt;"><b style="font-weight:bold;">Effect of Abstentions</b></p></td><td style="vertical-align:bottom;width:14.31%;border-bottom:1px solid #000000;margin:0pt;padding:0pt 0.5pt 0pt 0.5pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:9pt;line-height:1.27;text-align:center;border-bottom:1px solid #000000;margin:6pt 0pt 0pt 0pt;"><b style="font-weight:bold;">Effect of Broker Non-Votes</b></p></td></tr><tr><td style="vertical-align:top;width:7.79%;background:#cceeff;border-top:1px solid #000000;margin:0pt;padding:0pt 0.5pt 0pt 0.5pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:9pt;line-height:1.27;text-align:center;margin:6pt 0pt 0pt 0pt;">1</p></td><td style="vertical-align:top;width:27.88%;background:#cceeff;border-top:1px solid #000000;margin:0pt;padding:0pt 0.5pt 0pt 0.5pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:9pt;line-height:1.27;margin:6pt 8.5pt 0pt 0pt;">Election of Directors</p></td><td style="vertical-align:top;width:36.53%;background:#cceeff;border-top:1px solid #000000;margin:0pt;padding:0pt 0.5pt 0pt 0.5pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:9pt;line-height:1.27;margin:6pt 4.4pt 0pt 4pt;">The three nominees receiving the most &#8220;For&#8221; votes will be elected; withheld votes will have no effect</p></td><td style="vertical-align:top;width:13.46%;background:#cceeff;border-top:1px solid #000000;margin:0pt;padding:0pt 0.5pt 0pt 0.5pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:9pt;line-height:1.27;text-align:center;margin:6pt 4pt 0pt 3.6pt;">Not applicable</p></td><td style="vertical-align:top;width:14.31%;background:#cceeff;border-top:1px solid #000000;margin:0pt;padding:0pt 0.5pt 0pt 0.5pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:9pt;line-height:1.27;text-align:center;margin:6pt 0pt 0pt 0pt;">No effect</p></td></tr><tr><td style="vertical-align:top;width:7.79%;margin:0pt;padding:0pt 0.5pt 0pt 0.5pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:9pt;line-height:1.27;text-align:center;margin:6pt 0pt 0pt 0pt;">2</p></td><td style="vertical-align:top;width:27.88%;margin:0pt;padding:0pt 0.5pt 0pt 0.5pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:9pt;line-height:1.27;margin:6pt 8.5pt 0pt 0pt;">Ratification of the selection of Ernst &amp; Young LLP as the Company&#8217;s independent registered public accounting firm for fiscal 2022</p></td><td style="vertical-align:top;width:36.53%;margin:0pt;padding:0pt 0.5pt 0pt 0.5pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:9pt;line-height:1.27;margin:6pt 4.4pt 0pt 4pt;">&#8220;For&#8221; votes from the holders of a majority of shares present virtually at the meeting or represented by proxy and entitled to vote on the matter</p></td><td style="vertical-align:top;width:13.46%;margin:0pt;padding:0pt 0.5pt 0pt 0.5pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:9pt;line-height:1.27;text-align:center;margin:6pt 4pt 0pt 3.6pt;">Against</p></td><td style="vertical-align:top;width:14.31%;margin:0pt;padding:0pt 0.5pt 0pt 0.5pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:9pt;line-height:1.27;text-align:center;margin:6pt 0pt 0pt 0pt;">Not applicable*</p></td></tr><tr><td style="vertical-align:top;width:7.79%;background:#cceeff;margin:0pt;padding:0pt 0.5pt 0pt 0.5pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:9pt;line-height:1.27;text-align:center;margin:6pt 0pt 0pt 0pt;">3</p></td><td style="vertical-align:top;width:27.88%;background:#cceeff;margin:0pt;padding:0pt 0.5pt 0pt 0.5pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:9pt;line-height:1.27;margin:6pt 8.5pt 0pt 0pt;">Approval of the Company&#8217;s Amended and Restated Equity Incentive Plan</p></td><td style="vertical-align:top;width:36.53%;background:#cceeff;margin:0pt;padding:0pt 0.5pt 0pt 0.5pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:9pt;line-height:1.27;margin:6pt 4.4pt 0pt 4pt;">&#8220;For&#8221; votes from the holders of a majority of shares present virtually at the meeting or represented by proxy and entitled to vote on the matter</p></td><td style="vertical-align:top;width:13.46%;background:#cceeff;margin:0pt;padding:0pt 0.5pt 0pt 0.5pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:9pt;line-height:1.27;text-align:center;margin:6pt 4pt 0pt 3.6pt;">Against</p></td><td style="vertical-align:top;width:14.31%;background:#cceeff;margin:0pt;padding:0pt 0.5pt 0pt 0.5pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:9pt;line-height:1.27;text-align:center;margin:6pt 0pt 0pt 0pt;">No effect</p></td></tr><tr><td style="vertical-align:top;width:7.79%;background:#ffffff;margin:0pt;padding:0pt 0.5pt 0pt 0.5pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:9pt;line-height:1.27;text-align:center;margin:6pt 0pt 0pt 0pt;">4</p></td><td style="vertical-align:top;width:27.88%;background:#ffffff;margin:0pt;padding:0pt 0.5pt 0pt 0.5pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:9pt;line-height:1.27;margin:6pt 8.5pt 0pt 0pt;">Advisory approval of the compensation of the Company&#8217;s named executive officers</p></td><td style="vertical-align:top;width:36.53%;background:#ffffff;margin:0pt;padding:0pt 0.5pt 0pt 0.5pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:9pt;line-height:1.27;margin:6pt 4.4pt 0pt 4pt;">&#8220;For&#8221; votes from the holders of a majority of shares present virtually at the meeting or represented by proxy and entitled to vote on the matter</p></td><td style="vertical-align:top;width:13.46%;background:#ffffff;margin:0pt;padding:0pt 0.5pt 0pt 0.5pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:9pt;line-height:1.27;text-align:center;margin:6pt 4pt 0pt 3.6pt;">Against</p></td><td style="vertical-align:top;width:14.31%;background:#ffffff;margin:0pt;padding:0pt 0.5pt 0pt 0.5pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:9pt;line-height:1.27;text-align:center;margin:6pt 0pt 0pt 0pt;">No effect</p></td></tr><tr style="height:1pt;"><td style="vertical-align:top;width:7.79%;margin:0pt;padding:0pt 0.5pt 0pt 0.5pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="position:absolute;top:0pt;width:100%;"></div></div></td><td style="vertical-align:top;width:27.88%;margin:0pt;padding:0pt 0.5pt 0pt 0.5pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="position:absolute;top:0pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;"><font style="font-size:1pt;visibility:hidden;">&#8203;</font></p></div></div></td><td style="vertical-align:top;width:36.53%;margin:0pt;padding:0pt 0.5pt 0pt 0.5pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="position:absolute;top:0pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;"><font style="font-size:1pt;visibility:hidden;">&#8203;</font></p></div></div></td><td style="vertical-align:top;width:13.46%;margin:0pt;padding:0pt 0.5pt 0pt 0.5pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="position:absolute;top:0pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;"><font style="font-size:1pt;visibility:hidden;">&#8203;</font></p></div></div></td><td style="vertical-align:top;width:14.31%;margin:0pt;padding:0pt 0.5pt 0pt 0.5pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="position:absolute;top:0pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;"><font style="font-size:1pt;visibility:hidden;">&#8203;</font></p></div></div></td></tr></table></div><div style="font-family:'Times New Roman','Times','serif';font-size:10.0pt;margin-bottom:0pt;margin-top:0pt;min-height:1.19em;position:relative;width:100%;"><hr noshade="true" color="#000000" size="1" width="25.0%" style="background-color:#000000;color:#000000;height:1pt;position:relative;top:0.6em;border:none;margin:0pt;" align="left"></div><p style="font-family:'Times New Roman','Times','serif';font-size:9pt;text-indent:0pt;margin:0pt;">*This proposal is considered to be a &#8220;routine&#8221; matter under NYSE rules. Accordingly, if you hold your shares in street name and do not provide voting instructions to your broker, bank or other intermediary that holds your shares, your broker, bank or other intermediary has discretionary authority under NYSE rules to vote your shares on this proposal.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;line-height:1.19;margin:0pt;"><a name="_DV_M240"></a>What is the quorum requirement? </p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:0pt;margin:0pt;"><a name="_Hlk37446516"></a><a name="_Hlk37446565"></a><a name="_DV_C28"></a>A quorum of stockholders is necessary to hold a valid meeting. A quorum will be present if stockholders holding at least a majority of the outstanding shares entitled to vote are present online at the Annual Meeting or represented by proxy. On the record date, there were 52,392,444 shares outstanding and entitled to vote.<sup style="font-size:7.5pt;vertical-align:top;"> </sup>Thus, the holders of 26,196,223 shares must be present online or represented by proxy at the Annual Meeting to have a quorum.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:0pt;margin:0pt;"><a name="_DV_M243"></a>Your shares will be counted towards the quorum only if you submit a valid proxy (or one is submitted on your behalf by your broker, bank or other intermediary) or if you vote online at the Annual Meeting. Abstentions and </p></div><div style="clear:both;display:table;margin-bottom:27.35pt;min-height:44.65pt;width:100%;"><div style="display:table-cell;vertical-align:bottom;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;min-height:12.0pt;text-align:center;margin:24pt 0pt 0pt 0pt;">6</p></div></div></div><hr style="background-color:#000000;clear:both;color:#000000;height:2pt;line-height:0;margin-bottom:30pt;margin-left:11.76%;margin-right:11.76%;margin-top:30pt;page-break-after:always;width:76.47%;border-width:0;"><div style="max-width:100%;padding-left:11.76%;padding-right:11.76%;position:relative;"><div style="margin-top:27.35pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"><font style="font-weight:bold;visibility:hidden;">&#8203;</font></p></div><div style="clear:both;max-width:100%;position:relative;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">broker non-votes will be counted towards the quorum requirement. If there is no quorum, the holders of a majority of shares present at the Annual Meeting or represented by proxy may adjourn the meeting to another date.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;"><a name="_DV_M244"></a><font style="font-weight:bold;visibility:hidden;">&#8203;</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;"><b style="font-weight:bold;">If I miss the Annual Meeting, will there be a copy posted online?</b></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;line-height:1.19;margin:0pt;"><font style="font-weight:normal;">Yes, a replay of the virtual meeting webcast will be available at </font><font style="font-weight:normal;">www.virtualshareholdermeeting.com/GLYC2022</font><font style="color:#7030a0;font-weight:normal;"> </font><font style="font-weight:normal;">and remain available for at least one year from the date of the Annual Meeting.</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;line-height:1.19;margin:0pt;"><font style="font-weight:normal;visibility:hidden;">&#8203;</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;line-height:1.19;margin:0pt;">How can I find out the results of the voting at the Annual Meeting?</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:0pt;margin:0pt;"><a name="_DV_M245"></a>Preliminary voting results will be announced at the Annual Meeting. In addition, final voting results will be published in a Current Report on Form 8-K that we expect to file within four business days after the Annual Meeting. If final voting results are not available to us in time to file a Current Report on Form&#160;8-K within four business days after the Annual Meeting, we intend to file a Current Report on Form&#160;8-K to publish preliminary results and, within four business days after the final results are known to us, file an additional Current Report on Form&#160;8-K to publish the final results.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;line-height:1.19;margin:0pt;"><a name="_DV_M248"></a>What proxy materials are available on the internet? </p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:0pt;margin:0pt;"><a name="_DV_M249"></a>The<font style="color:#800080;"> </font>proxy statement and annual report to stockholders<font style="color:#1f497d;"> </font>are available at http://materials.proxyvote.com/38000Q. </p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;"><a name="_DV_M250"></a><a name="_DV_M251"></a><font style="visibility:hidden;">&#8203;</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></div><div style="clear:both;display:table;margin-bottom:27.35pt;min-height:44.65pt;width:100%;"><div style="display:table-cell;vertical-align:bottom;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;min-height:12.0pt;text-align:center;margin:24pt 0pt 0pt 0pt;">7</p></div></div></div><hr style="background-color:#000000;clear:both;color:#000000;height:2pt;line-height:0;margin-bottom:30pt;margin-left:11.76%;margin-right:11.76%;margin-top:30pt;page-break-after:always;width:76.47%;border-width:0;"><div style="max-width:100%;padding-left:11.76%;padding-right:11.76%;position:relative;"><div style="margin-top:27.35pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"><font style="font-weight:bold;visibility:hidden;">&#8203;</font></p></div><div style="clear:both;max-width:100%;position:relative;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-variant:small-caps;font-weight:bold;line-height:1.19;text-align:center;margin:0pt;"><b style="font-size:12pt;font-variant:normal;font-weight:bold;">PROPOSAL 1</b></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-variant:small-caps;font-weight:bold;line-height:1.19;text-align:center;margin:0pt;"><font style="font-size:12pt;font-variant:normal;line-height:12pt;margin-bottom:12pt;margin-top:12pt;visibility:hidden;">&#8203;</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-variant:small-caps;font-weight:bold;line-height:1.19;text-align:center;margin:0pt;"><a name="_DV_M252"></a><b style="font-size:12pt;font-variant:normal;font-weight:bold;">ELECTION OF DIRECTORS</b></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-variant:small-caps;font-weight:bold;line-height:1.19;margin:0pt;"><font style="font-size:12pt;font-variant:normal;line-height:12pt;margin-bottom:12pt;margin-top:12pt;visibility:hidden;">&#8203;</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:0pt;margin:0pt;"><a name="_DV_M253"></a><a name="_DV_M262"></a><a name="_DV_M263"></a>Our Board is divided into three classes. Each class consists, as nearly as possible, of one-third of the total number of directors, and each class has a three-year term. Vacancies on the Board may be filled only by persons elected by a majority of the remaining directors. A director elected by the Board to fill a vacancy in a class, including vacancies created by an increase in the number of directors, shall serve for the remainder of the full term of that class and until that director&#8217;s successor is duly elected and qualified. </p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:0pt;margin:0pt;"><font style="margin-bottom:12pt;visibility:hidden;">&#8203;</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:0pt;margin:0pt;"><a name="_DV_M264"></a>The Board presently has eight members. There are three directors in the class whose term of office expires in 2022. If elected at the Annual Meeting, each of the nominees would serve until the 2025 annual meeting of stockholders and until his successor has been duly elected and qualified, or, if sooner, until his death, resignation or removal. </p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:0pt;margin:0pt;"><font style="margin-bottom:12pt;visibility:hidden;">&#8203;</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:0pt;margin:0pt;">It is our policy to invite and encourage directors and nominees for director to attend each annual meeting of stockholders. All directors serving as of the date of the 2021 annual meeting of stockholders were in attendance at that meeting. </p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:0pt;margin:0pt;"><font style="margin-bottom:12pt;visibility:hidden;">&#8203;</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:0pt;margin:0pt;"><a name="_DV_M267"></a>Directors are elected by a plurality of the votes of the holders of shares present virtually or represented by proxy and entitled to vote on the election of directors. Accordingly, the three nominees receiving the highest number of affirmative votes will be elected.<b style="font-weight:bold;"> </b>Shares represented by executed proxies will be voted, if authority to do so is not withheld, for the election of the three nominees named below. If any nominee becomes unavailable for election as a result of an unexpected occurrence, shares that would have been voted for that nominee will instead be voted for the election of a substitute nominee that we will propose. Each person nominated for election has agreed to serve if elected. Our management has no reason to believe that any nominee will be unable to serve. </p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:0pt;margin:0pt;"><font style="margin-bottom:12pt;visibility:hidden;">&#8203;</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:0pt;margin:0pt;"><a name="_DV_M269"></a><a name="_DV_M270"></a>The Nominating and Corporate Governance Committee seeks to assemble a board that, as a whole, possesses the appropriate balance of professional and industry knowledge, financial expertise and high-level management experience necessary to oversee and direct our business. To that end, the Nominating and Corporate Governance Committee has identified and evaluated nominees in the broader context of the Board&#8217;s overall composition, with the goal of recruiting members who complement and strengthen the skills of other members and who also exhibit integrity, collegiality, sound business judgment and other qualities that the Committee views as critical to the effective functioning of the Board. In an effort to provide a variety of experience and perspective on the Board, the Committee considers criteria for nominees to require the highest personal integrity and ethics and an ability to read and understand financial statements, and also takes into account the relevant expertise, availability, commitment, demonstrated excellence and diversity of its members. The brief biographies below include information, as of the date of this proxy statement, regarding the specific and particular experience, qualifications, attributes or skills of each nominee that led the Nominating and Corporate Governance Committee<b style="font-weight:bold;"> </b>to believe that the nominee should continue to serve on the Board. However, each of the members of the Nominating and Corporate Governance Committee may have a variety of reasons why a particular person would be an appropriate nominee for the Board, and these views may differ from the views of other members.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:0pt;margin:0pt;"><font style="margin-bottom:12pt;visibility:hidden;">&#8203;</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-variant:small-caps;font-weight:bold;line-height:1.19;margin:0pt;"><a name="_DV_M309"></a><b style="font-variant:normal;font-weight:bold;">NOMINEES FOR ELECTION TO THE BOARD OF DIRECTORS FOR A THREE-YEAR TERM EXPIRING AT THE 2025 ANNUAL MEETING</b></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:0pt;margin:0pt;"><b style="font-weight:bold;">Scott Jackson, age 57</b></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:0pt;margin:0pt;">Mr. Jackson has served as a member of our Board since November 2018. Mr. Jackson served as the chief executive officer and as a member of the board of directors of Celator Pharmaceuticals, Inc. from 2008 until 2016, when the company was acquired by Jazz Pharmaceuticals plc. Mr. Jackson&#160;has more than 30 years of experience in the pharmaceutical and biotechnology industries and has held positions of increasing responsibility in sales, marketing and commercial development at Eli Lilly &amp; Co., SmithKline Beecham,&#160;ImClone Systems Inc.,&#160;Centocor Inc. (a division of Johnson &amp; Johnson), Eximias Pharmaceutical and&#160;YM BioSciences.&#160; Mr. Jackson currently serves on the board of directors of MacroGenics, Inc. and Spero Therapeutics, Inc., both of which are publicly traded pharmaceutical companies. He holds a B.S. in pharmacy from the&#160;Philadelphia College of Pharmacy&#160;and Science </p></div><div style="clear:both;display:table;margin-bottom:27.35pt;min-height:44.65pt;width:100%;"><div style="display:table-cell;vertical-align:bottom;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;min-height:12.0pt;text-align:center;margin:24pt 0pt 0pt 0pt;">8</p></div></div></div><hr style="background-color:#000000;clear:both;color:#000000;height:2pt;line-height:0;margin-bottom:30pt;margin-left:11.76%;margin-right:11.76%;margin-top:30pt;page-break-after:always;width:76.47%;border-width:0;"><div style="max-width:100%;padding-left:11.76%;padding-right:11.76%;position:relative;"><div style="margin-top:27.35pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"><font style="font-weight:bold;visibility:hidden;">&#8203;</font></p></div><div style="clear:both;max-width:100%;position:relative;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><font style="white-space:pre-wrap;">and an M.B.A. from the&#160;University of Notre Dame.&#160;</font>We believe Mr.&#160;Jackson&#8217;s extensive experience in the pharmaceutical and biotechnology industries, including service as an executive officer and board member, as well as his management expertise and significant background in business and commercial development, sales and marketing and clinical development, make him highly qualified to serve as a member of our Board.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;line-height:1.19;margin:0pt;">Scott Koenig, M.D., Ph.D., age 69</p><p style="font-family:'Times New Roman Bold';font-size:10pt;font-weight:bold;line-height:1.19;margin:0pt;"><font style="font-family:'Times New Roman','Times','serif';font-weight:normal;margin-bottom:12pt;visibility:hidden;">&#8203;</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:0pt;margin:0pt;">Dr. Koenig has served as a member of our Board since March 2017. Dr. Koenig is the co-founder of and has been the president and chief executive officer and a director of MacroGenics, Inc., a publicly held pharmaceutical company, since 2001. Previously, Dr. Koenig served as a senior vice president at MedImmune, Inc., where he participated in the selection and maturation of their product pipeline. From 1984 to 1990, he worked in the Laboratory of Immunoregulation at the National Institute of Allergy and Infectious Diseases at the National Institutes of Health, where he investigated the immune response to retroviruses and studied the pathogenesis of AIDS. Dr. Koenig currently serves as chairman of the board of directors of Applied Genetic Technologies Corporation, or AGTC, a publicly held pharmaceutical company. He is also a member of the board of directors of the Biotechnology Innovation Organization (BIO) and the International Biomedical Research Alliance. Dr. Koenig received his A.B. and Ph.D. from Cornell University and his M.D. from the University of Texas Health Science Center in Houston. </p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:0pt;margin:0pt;"><font style="margin-bottom:12pt;visibility:hidden;">&#8203;</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:0pt;margin:0pt;">Based on Dr. Koenig&#8217;s deep experience in the biopharmaceutical industry, and specifically in the BioHealth Capital Region of Maryland, Virginia, and Washington, DC, and his service on committees and boards of local institutions and organizations, we believe that Dr. Koenig brings valuable strategic and operational expertise and leadership skills to the Board. The Board believes that Dr. Koenig is able to perform his duties as a director of our company while also serving as an officer and director of MacroGenics and as chairman of AGTC. Dr. Koenig&#8217;s service on our Board is not meaningfully impacted by any travel requirements related to his service on the MacroGenics board, as the executive offices of GlycoMimetics and MacroGenics are located in adjacent buildings. Dr. Koenig maintained a perfect attendance record at all Board and committee meetings during 2021. His local presence also enhances his accessibility for other informal interactions as may be requested by management from time to time. In addition to Dr. Koenig&#8217;s directly-relevant leadership, strategic and operational skills, we believe his extensive experience in research and clinical development further uniquely qualify him to serve on our Board.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:0pt;margin:0pt;"><font style="margin-bottom:12pt;visibility:hidden;">&#8203;</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:0pt;margin:0pt;"><b style="font-weight:bold;">Harout Semerjian, age 51</b></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:0pt;margin:0pt;"><font style="font-weight:bold;margin-bottom:12pt;visibility:hidden;">&#8203;</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:0pt;margin:0pt;"><font style="white-space:pre-wrap;">Mr. Semerjian has served as our President and Chief Executive Officer and as a member of our Board since August 2021. Prior to joining our company, he was an independent advisor to private equity firms focused on investments in healthcare companies. He previously served as president and chief executive officer of Immunomedics, Inc., a pharmaceutical company, during April and May of 2020. From March 2018 to April 2020, he served as an executive vice president and chief commercial officer at Ipsen Pharma, where he was accountable for that company&#8217;s worldwide commercialization and portfolio strategy across oncology, neurosciences and rare diseases. From February 2017 to February 2018, he served as president and head of Ipsen&#8217;s Specialty Care International Region &amp; Global Franchises.  Mr. Semerjian previously spent 16 years at Novartis Oncology, where he held various worldwide strategic and operational positions, culminating in his last role as a senior vice president and global head for Ribociclib, accountable for worldwide launch preparations. During his tenure at Novartis, Mr. Semerjian worked on numerous launches and commercial activities for various therapies, including Gleevec, Tasigna, Exjade/Jadenu, Promacta, Zometa, and Femara.  Mr. Semerjian holds an M.B.A. from Cornell University, an M.B.A. from Queen&#8217;s University, Canada, and a B.S. in Biology from the Lebanese American University in Lebanon. The Board believes that Mr. Semerjian&#8217;s long-time experience as an executive officer in the pharmaceutical industry and his significant background in commercialization activities provide a valuable contribution to our Board, in addition to his role as our Chief Executive Officer.</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:0pt;margin:0pt;"><font style="font-weight:bold;margin-bottom:12pt;visibility:hidden;">&#8203;</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">THE BOARD OF DIRECTORS RECOMMENDS</b></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><a name="_DV_M319"></a><b style="font-weight:bold;">A VOTE IN FAVOR OF EACH NAMED NOMINEE.</b></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;"><a name="_DV_M320"></a><a name="_DV_M323"></a><a name="_DV_M327"></a><a name="_DV_M328"></a><a name="_DV_M329"></a><font style="visibility:hidden;">&#8203;</font></p></div><div style="clear:both;display:table;margin-bottom:27.35pt;min-height:44.65pt;width:100%;"><div style="display:table-cell;vertical-align:bottom;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;min-height:12.0pt;text-align:center;margin:24pt 0pt 0pt 0pt;">9</p></div></div></div><hr style="background-color:#000000;clear:both;color:#000000;height:2pt;line-height:0;margin-bottom:30pt;margin-left:11.76%;margin-right:11.76%;margin-top:30pt;page-break-after:always;width:76.47%;border-width:0;"><div style="max-width:100%;padding-left:11.76%;padding-right:11.76%;position:relative;"><div style="margin-top:27.35pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"><font style="font-weight:bold;visibility:hidden;">&#8203;</font></p></div><div style="clear:both;max-width:100%;position:relative;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-variant:small-caps;font-weight:bold;line-height:1.19;margin:0pt;"><b style="font-variant:normal;font-weight:bold;">DIRECTORS CONTINUING IN OFFICE UNTIL THE 2023 ANNUAL MEETING</b></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:0pt;margin:0pt;"><font style="font-weight:bold;margin-bottom:12pt;visibility:hidden;">&#8203;</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;line-height:1.19;margin:0pt;">Patricia Andrews, age 64</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:0pt;margin:0pt;"><font style="margin-bottom:12pt;visibility:hidden;">&#8203;</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:0pt;margin:0pt;">Ms. Andrews has served as a member of our Board since June 2017. She has served since April 2017 as the chief executive officer of Sumitomo Dainippon Pharma Oncology, Inc. (and its predecessor, Boston Biomedical, Inc.), an oncology drug research and development company, and as an executive officer of its parent company, Sumitomo Dainippon Pharma Co. Ltd. Ms. Andrews joined Boston Biomedical in 2013. From 2008 to 2012, Ms. Andrews served as the chief commercial officer of Incyte Corporation, a publicly held biopharmaceutical company. From 1991 to 2008, Ms. Andrews served in various roles of increasing responsibility at Pfizer Inc., culminating in her role as a vice president and the general manager of Pfizer&#8217;s U.S. Oncology business unit. Ms. Andrews received her B.A. degree from Brown University and her M.B.A. degree from the University of Michigan. We believe Ms. Andrews&#8217; qualifications to serve on our Board include her strong leadership and demonstrated management experience within the pharmaceutical industry, including serving as a chief executive officer and a chief commercial officer, as well as her in-depth knowledge of operations and commercial strategy.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:0pt;margin:0pt;"><font style="margin-bottom:12pt;visibility:hidden;">&#8203;</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;line-height:1.19;margin:0pt;">Mark Goldberg, M.D., age 67</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:0pt;margin:0pt;"><font style="margin-bottom:12pt;visibility:hidden;">&#8203;</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:0pt;margin:0pt;">Dr. Goldberg has served as a member of our Board since 2014. Dr. Goldberg served in a number of capacities of increasing responsibility at Synageva BioPharma Corp., a biopharmaceutical company, between 2011 and 2015, including as Executive Vice President, Medical and Regulatory Strategy. Prior to joining Synageva he served in various management capacities of increasing responsibility at Genzyme Corporation, a biopharmaceutical company, from 1996 to 2011, most recently as Senior Vice President, Clinical Development and Global Therapeutic Head, Oncology and Personalized Genetic Health, and as Chairman of Genzyme&#8217;s Early Product Development Board. Prior to working at Genzyme he was a full-time staff physician at Brigham and Women&#8217;s Hospital and the Dana-Farber Cancer Institute. He still holds an appointment at Brigham and Women&#8217;s Hospital. Dr. Goldberg has also been on the faculty of Harvard Medical School since 1987 and serves as a Lecturer in Medicine (part-time). He is a board-certified medical oncologist and hematologist. Dr. Goldberg serves on the boards of directors of the public biopharmaceutical companies ImmunoGen, Inc., Idera Pharmaceuticals, Inc., Blueprint Medicines Corporation and Avacta Group plc. Within the last five years, he also served on the boards of directors of the public biopharmaceutical companies Audentes Therapeutics, Inc. and aTyr Pharma, Inc. He has also served as a member of the board of directors of the American Cancer Society since January 2019. Dr. Goldberg received his A.B. from Harvard College and his M.D. from Harvard Medical School. The Board believes that Dr.&#160;Goldberg&#8217;s prestigious medical background and significant clinical experience allow him to make particularly valuable contributions to our research and development efforts, while his public company board experience provides us with valuable strategic and operational expertise and leadership skills.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;line-height:1.19;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;line-height:1.19;margin:0pt;">Timothy Pearson, age 54</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;line-height:1.19;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:0pt;margin:0pt;"><a name="_DV_M336"></a>Mr. Pearson has served as a member of our Board since 2014 and as our Chairperson since 2019. Mr. Pearson has served as the chief executive officer of Carrick Therapeutics, a privately held oncology company, since July 2019. Mr. Pearson served as an executive vice president and the chief financial officer of TESARO, Inc., an oncology-focused biopharmaceutical company, from 2014 until its acquisition by GlaxoSmithKline in February 2019. He served as an executive vice president, chief financial officer and treasurer of Catalyst Health Solutions, a publicly held pharmacy benefit management company, from 2011 until its acquisition by SXC Health Solutions in 2012. Prior to joining Catalyst Health Solutions, Mr. Pearson served as the chief financial officer and executive vice president of MedImmune, Inc. He previously served on the board of directors of Ra Pharmaceuticals, Inc., a publicly held biopharmaceutical company until acquisition by UCB in 2020. Mr. Pearson is a Certified Public Accountant and holds dual B.S. degrees in Business Administration from the University of Delaware and in Accounting from the University of Maryland, University College, as well as an M.S. degree in Finance from Loyola College. As a result of Mr. Pearson&#8217;s educational background and professional experiences, the Board believes Mr.&#160;Pearson possesses particularly impactful knowledge and experience in accounting and finance; strategic planning and leadership of complex organizations; and human capital management, all of which strengthen the Board&#8217;s collective qualifications, skills and experience.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></div><div style="clear:both;display:table;margin-bottom:27.35pt;min-height:44.65pt;width:100%;"><div style="display:table-cell;vertical-align:bottom;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;min-height:12.0pt;text-align:center;margin:24pt 0pt 0pt 0pt;">10</p></div></div></div><hr style="background-color:#000000;clear:both;color:#000000;height:2pt;line-height:0;margin-bottom:30pt;margin-left:11.76%;margin-right:11.76%;margin-top:30pt;page-break-after:always;width:76.47%;border-width:0;"><div style="max-width:100%;padding-left:11.76%;padding-right:11.76%;position:relative;"><div style="margin-top:27.35pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"><font style="font-weight:bold;visibility:hidden;">&#8203;</font></p></div><div style="clear:both;max-width:100%;position:relative;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-variant:small-caps;font-weight:bold;line-height:1.19;margin:0pt;"><b style="font-variant:normal;font-weight:bold;">DIRECTORS CONTINUING IN OFFICE UNTIL THE 2024 ANNUAL MEETING</b></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:0pt;margin:0pt;"><b style="font-weight:bold;">Daniel Junius, age 69</b></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:0pt;margin:0pt;"><font style="font-weight:bold;margin-bottom:12pt;visibility:hidden;">&#8203;</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:0pt;margin:0pt;">Mr. Junius has served as a member of our Board since March 2016. Mr. Junius served as the president and chief executive officer of ImmunoGen, Inc., a publicly held biotechnology company, from 2009 until his retirement in May 2016. He also served as ImmunoGen&#8217;s president and chief operating officer and acting chief financial officer from July 2008 to December 2008, as an executive vice president and the chief financial officer from 2006 to July 2008, and as a senior vice president and the chief financial officer from 2005 to 2006. Mr. Junius also served as a director of ImmunoGen from 2008 until June 2018. Before joining ImmunoGen, Mr. Junius was an executive vice president and the chief financial officer of New England Business Service, Inc., or NEBS, a business-to-business direct marketing company, from 2002 until its acquisition by Deluxe Corporation in 2004 and a senior vice president and the chief financial officer of NEBS from 1998 to 2002. Prior to NEBS, he was a vice president and the chief financial officer of Nashua Corporation, a manufacturer and marketer of specialty imaging paper and label products and services. He joined Nashua Corporation in 1984 and held financial management positions of increasing responsibility before becoming chief financial officer in 1996. Mr. Junius has served on the board of directors and as chair of the audit committee of IDEXX Laboratories, Inc., a publicly held pet healthcare company, since 2014. Mr. Junius holds a Bachelor of Arts in Political Science from Boston College and a Masters in Management from Northwestern University&#8217;s Kellogg School of Management. The Board believes that Mr. Junius&#8217;s extensive experience, including service as chief executive officer and chief financial officer of public companies, in addition to his financial expertise and depth of knowledge of the biopharmaceutical industry, allows him to make valuable contributions to the Board and to bolster the Board&#8217;s overall skills and experience.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:0pt;margin:0pt;"><b style="font-weight:bold;">Rachel King, age 62</b></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:0pt;margin:0pt;"><font style="font-weight:bold;margin-bottom:12pt;visibility:hidden;">&#8203;</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:0pt;margin:0pt;">Ms. King co-founded our company and has served as a member of our Board since our inception in 2003. Ms. King served as our president and chief executive officer from our inception in 2003 until August 2021. Previously, Ms.&#160;King was an Executive in Residence at New Enterprise Associates (NEA), an investment firm, from 2001 to 2003. From 1999 to 2001, Ms.&#160;King served as a senior vice president of Novartis Corporation, a pharmaceutical company. Before joining Novartis, Ms.&#160;King spent 10 years with Genetic Therapy, Inc., a biotechnology company, where she served in a number of roles as part of the executive team, which included the company&#8217;s initial public offering and later acquisition by Novartis. After the acquisition by Novartis, she served as the chief executive officer of Genetic Therapy, which was then a wholly-owned subsidiary of Novartis. Ms.&#160;King previously worked at Alza Corporation, a pharmaceutical and medical systems company that was later acquired by Johnson&#160;&amp; Johnson, as well as at Bain and Company, a management consulting firm. Ms. King currently serves on the board of directors of Novavax, Inc., a publicly traded biotechnology company. Ms. King also serves on the board of directors of the Biotechnology Innovation Organization (BIO) and served as the chair of the board of BIO from 2013 to 2015. She was appointed by Maryland&#8217;s governor as chair of the Maryland Life Sciences Advisory Board and served in that capacity from 2013 to 2015. She also currently serves on the board of the University of Maryland BioPark. She received a B.A. from Dartmouth College and an M.B.A. from Harvard Business School. The Board believes that Ms.&#160;King&#8217;s detailed knowledge of our company as one of our co-founders and her experience with biotechnology companies prior to founding our company, in addition to her leadership skills, allow her to make valuable contributions to the Board.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><font style="font-size:12pt;font-weight:bold;visibility:hidden;">&#8203;</font></p></div><div style="clear:both;display:table;margin-bottom:27.35pt;min-height:44.65pt;width:100%;"><div style="display:table-cell;vertical-align:bottom;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;min-height:12.0pt;text-align:center;margin:24pt 0pt 0pt 0pt;">11</p></div></div></div><hr style="background-color:#000000;clear:both;color:#000000;height:2pt;line-height:0;margin-bottom:30pt;margin-left:11.76%;margin-right:11.76%;margin-top:30pt;page-break-after:always;width:76.47%;border-width:0;"><div style="max-width:100%;padding-left:11.76%;padding-right:11.76%;position:relative;"><div style="margin-top:27.35pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"><font style="font-weight:bold;visibility:hidden;">&#8203;</font></p></div><div style="clear:both;max-width:100%;position:relative;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><b style="font-size:12pt;font-weight:bold;">INFORMATION REGARDING THE BOARD OF DIRECTORS </b><b style="font-size:12pt;font-weight:bold;"><br></b><b style="font-size:12pt;font-weight:bold;">AND CORPORATE GOVERNANCE</b></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;"><font style="font-size:9pt;visibility:hidden;">&#8203;</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;line-height:1.19;margin:0pt;"><a name="_DV_M337"></a>CORPORATE GOVERNANCE POLICIES AND PRACTICES</p><p style="font-family:'Times New Roman Bold';font-size:10pt;font-weight:bold;line-height:1.19;margin:0pt;"><font style="font-family:'Times New Roman','Times','serif';font-size:9pt;margin-bottom:12pt;visibility:hidden;">&#8203;</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">We are committed to ensuring strong corporate governance practices on behalf of our stockholders, including engaging in efforts when appropriate that are designed to gain insight into our stockholders&#8217; perspectives regarding governance. Our Corporate Governance Guidelines, together with the charters of the Audit, Compensation, and Nominating and Corporate Governance Committees, establish a framework of policies and practices for our effective governance and are each described in more detail below. The Board and its committees regularly review their governance policies and practices, as well as current developments in corporate governance, and update these documents as deemed appropriate for our company.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p><p style="font-family:'Times New Roman Bold';font-size:10pt;font-weight:bold;line-height:1.19;margin:0pt;"><font style="font-family:'Times New Roman','Times','serif';font-weight:normal;">The following are highlights of our governance policies and practices:</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p><table border="0" cellpadding="0" cellspacing="0" style="border-collapse:collapse;font-family:'Times New Roman Bold';font-size:10pt;line-height:1.19;margin-bottom:10pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"></td><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><font style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">Our Board separates the Chair and Chief Executive Officer roles;</font></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="border-collapse:collapse;font-family:'Times New Roman Bold';font-size:10pt;line-height:1.19;margin-bottom:10pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"></td><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><font style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">We have historically had high attendance rates at all of our Board and committee meetings;</font></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="border-collapse:collapse;font-family:'Times New Roman Bold';font-size:10pt;line-height:1.19;margin-bottom:10pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"></td><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><font style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">All Board committees are 100% independent under applicable Nasdaq Stock Market, or Nasdaq, listing rules;</font></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="border-collapse:collapse;font-family:'Times New Roman Bold';font-size:10pt;line-height:1.19;margin-bottom:10pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"></td><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><font style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">We have a policy in place that prohibits our directors, officers and employees from engaging in short sales, transactions in put or call options, hedging transactions, margin accounts or any other inherently speculative transactions with respect to our common stock;</font></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="border-collapse:collapse;font-family:'Times New Roman Bold';font-size:10pt;line-height:1.19;margin-bottom:10pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"></td><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><font style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">We maintain Corporate Governance Guidelines</font><font style="color:#5a0402;font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">, </font><font style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">available to stockholders on our website at </font><font style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">www.glycomimetics.com</font><font style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">,</font><b style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:bold;"> </b><font style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">which are regularly reviewed and updated as needed; and</font></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="border-collapse:collapse;font-family:'Times New Roman Bold';font-size:10pt;line-height:1.19;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"></td><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><font style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">We have a robust annual performance evaluation to evaluate the performance of the Board as a whole and each committee of the Board, and the information from these evaluations is used to consider changes in Board and committee processes.</font></td></tr></table><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;line-height:1.19;margin:0pt;">BOARD LEADERSHIP STRUCTURE</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;line-height:1.19;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:0pt;margin:0pt;"><a name="_DV_M351"></a><a name="_DV_M353"></a><a name="_DV_M354"></a><a name="_DV_C165"></a><a name="_DV_M355"></a><a name="_DV_C169"></a><a name="_DV_M357"></a><a name="_DV_C171"></a><a name="_DV_M358"></a><a name="_DV_M359"></a><a name="_DV_C175"></a><a name="_DV_M360"></a><a name="_DV_C177"></a><a name="_DV_M361"></a><a name="_DV_C179"></a><a name="_DV_M362"></a><a name="_DV_M363"></a><a name="_DV_C183"></a><a name="_DV_M364"></a><a name="_DV_M365"></a><a name="_DV_C187"></a><a name="_DV_M366"></a>Our Board has an independent chairperson, Mr. Pearson, who has authority, among other things, to call and preside over Board meetings, including meetings of the independent directors, to set meeting agendas and to determine materials to be distributed to the Board. Accordingly, the Chair has substantial ability to shape the work of the Board. We believe that separation of the positions of Chair and Chief Executive Officer reinforces the independence of the Board in its oversight of our business and affairs. In addition, we believe that having an independent chairperson creates an environment that is more conducive to objective evaluation and oversight of management&#8217;s performance, increasing management accountability and improving the ability of the Board to monitor whether management&#8217;s actions are in our best interests and those of our stockholders. As a result, we believe that having an independent chairperson can enhance the effectiveness of the Board as a whole. However, the needs of our company and the individuals available to assume these roles may require different outcomes at different times, and the Board believes that retaining flexibility in these decisions is in our best interests. Therefore, the Nominating and Corporate Governance Committee may periodically review our Board leadership structure and provide recommendations to the Board.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><font style="font-weight:bold;visibility:hidden;">&#8203;</font></p></div><div style="clear:both;display:table;margin-bottom:27.35pt;min-height:44.65pt;width:100%;"><div style="display:table-cell;vertical-align:bottom;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;min-height:12.0pt;text-align:center;margin:24pt 0pt 0pt 0pt;">12</p></div></div></div><hr style="background-color:#000000;clear:both;color:#000000;height:2pt;line-height:0;margin-bottom:30pt;margin-left:11.76%;margin-right:11.76%;margin-top:30pt;page-break-after:always;width:76.47%;border-width:0;"><div style="max-width:100%;padding-left:11.76%;padding-right:11.76%;position:relative;"><div style="margin-top:27.35pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"><font style="font-weight:bold;visibility:hidden;">&#8203;</font></p></div><div style="clear:both;max-width:100%;position:relative;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;"><b style="font-weight:bold;">BOARD SKILLS MATRIX</b></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;">The Board skills matrix below depicts the key skills and capabilities that our Board has identified as particularly valuable to the oversight of our business and the execution of our strategy. We believe this skills matrix highlights the depth and breadth of the expertise of the Board.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p><div style="margin-left:0pt;" align="left"><table style="border-collapse:collapse;font-size:16pt;height:max-content;table-layout:auto;width:100%;"><tr style="height:1pt;"><td style="vertical-align:top;white-space:normal;width:24.03%;border-bottom:1px solid #000000;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="position:absolute;top:0pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;font-weight:bold;text-align:justify;margin:0pt;"><font style="font-size:1pt;visibility:hidden;">&#8203;</font></p></div></div></td><td style="vertical-align:top;width:10.57%;background:#fff4ce;border-bottom:1px solid #000000;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="position:absolute;top:0pt;width:100%;"></div></div></td><td style="vertical-align:top;width:10.57%;border-bottom:1px solid #000000;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="position:absolute;top:0pt;width:100%;"></div></div></td><td style="vertical-align:top;width:9.61%;background:#fff4ce;border-bottom:1px solid #000000;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="position:absolute;top:0pt;width:100%;"></div></div></td><td style="vertical-align:top;width:8.65%;border-bottom:1px solid #000000;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="position:absolute;top:0pt;width:100%;"></div></div></td><td style="vertical-align:top;width:6.73%;background:#fff4ce;border-bottom:1px solid #000000;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="position:absolute;top:0pt;width:100%;"></div></div></td><td style="vertical-align:top;width:8.65%;border-bottom:1px solid #000000;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="position:absolute;top:0pt;width:100%;"></div></div></td><td style="vertical-align:top;width:9.61%;background:#fff4ce;border-bottom:1px solid #000000;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="position:absolute;top:0pt;width:100%;"></div></div></td><td style="vertical-align:top;width:11.53%;border-bottom:1px solid #000000;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="position:absolute;top:0pt;width:100%;"></div></div></td></tr><tr style="height:13.05pt;"><td style="vertical-align:top;white-space:normal;width:24.03%;border-bottom:1px solid #000000;border-left:1px solid #000000;border-right:1px solid #000000;border-top:1px solid #000000;margin:0pt;padding:0pt 5.15pt 0pt 5.15pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;font-weight:bold;margin:2pt 0pt 2pt 0pt;"><font style="color:#0070c0;font-size:10pt;font-weight:normal;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:top;width:10.57%;background:#fff4ce;border-bottom:1px solid #000000;border-left:1px solid #000000;border-right:1px solid #000000;border-top:1px solid #000000;margin:0pt;padding:0pt 5.15pt 0pt 5.15pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:9pt;text-align:center;margin:2pt 0pt 2pt 0pt;"><b style="color:#0070c0;font-weight:bold;">Andrews</b></p></td><td style="vertical-align:top;width:10.57%;border-bottom:1px solid #000000;border-left:1px solid #000000;border-right:1px solid #000000;border-top:1px solid #000000;margin:0pt;padding:0pt 5.15pt 0pt 5.15pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:9pt;text-align:center;margin:2pt 0pt 2pt 0pt;"><b style="color:#0070c0;font-weight:bold;">Goldberg</b></p></td><td style="vertical-align:top;width:9.61%;background:#fff4ce;border-bottom:1px solid #000000;border-left:1px solid #000000;border-right:1px solid #000000;border-top:1px solid #000000;margin:0pt;padding:0pt 5.15pt 0pt 5.15pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:9pt;text-align:center;margin:2pt 0pt 2pt 0pt;"><b style="color:#0070c0;font-weight:bold;">Jackson</b></p></td><td style="vertical-align:top;width:8.65%;border-bottom:1px solid #000000;border-left:1px solid #000000;border-right:1px solid #000000;border-top:1px solid #000000;margin:0pt;padding:0pt 5.15pt 0pt 5.15pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:9pt;text-align:center;margin:2pt 0pt 2pt 0pt;"><b style="color:#0070c0;font-weight:bold;">Junius</b></p></td><td style="vertical-align:top;width:6.73%;background:#fff4ce;border-bottom:1px solid #000000;border-left:1px solid #000000;border-right:1px solid #000000;border-top:1px solid #000000;margin:0pt;padding:0pt 5.15pt 0pt 5.15pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:9pt;text-align:center;margin:2pt 0pt 2pt 0pt;"><b style="color:#0070c0;font-weight:bold;">King</b></p></td><td style="vertical-align:top;width:8.65%;border-bottom:1px solid #000000;border-left:1px solid #000000;border-right:1px solid #000000;border-top:1px solid #000000;margin:0pt;padding:0pt 5.15pt 0pt 5.15pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:9pt;text-align:center;margin:2pt 0pt 2pt 0pt;"><b style="color:#0070c0;font-weight:bold;">Koenig</b></p></td><td style="vertical-align:top;width:9.61%;background:#fff4ce;border-bottom:1px solid #000000;border-left:1px solid #000000;border-right:1px solid #000000;border-top:1px solid #000000;margin:0pt;padding:0pt 5.15pt 0pt 5.15pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:9pt;text-align:center;margin:2pt 0pt 2pt 0pt;"><b style="color:#0070c0;font-weight:bold;">Pearson</b></p></td><td style="vertical-align:top;width:11.53%;border-bottom:1px solid #000000;border-left:1px solid #000000;border-right:1px solid #000000;border-top:1px solid #000000;margin:0pt;padding:0pt 5.15pt 0pt 5.15pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:9pt;text-align:center;margin:2pt 0pt 2pt 0pt;"><b style="color:#0070c0;font-weight:bold;">Semerjian</b></p></td></tr><tr style="height:13.05pt;"><td colspan="9" style="vertical-align:top;white-space:normal;width:100%;background:#d9d9d9;border-bottom:1px solid #000000;border-left:1px solid #000000;border-right:1px solid #000000;border-top:1px solid #000000;margin:0pt;padding:0pt 5.15pt 0pt 5.15pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;font-weight:bold;margin:2pt 0pt 2pt 0pt;"><b style="color:#0070c0;font-size:10pt;font-weight:bold;">Leadership Experience </b><font style="font-size:10pt;font-style:italic;">&#160;</font></p></td></tr><tr style="height:13.05pt;"><td style="vertical-align:top;width:24.03%;border-bottom:1px solid #000000;border-left:1px solid #000000;border-right:1px solid #000000;border-top:1px solid #000000;margin:0pt;padding:0pt 5.15pt 0pt 5.15pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:9pt;font-weight:bold;margin:2pt 0pt 2pt 0pt;">Chief Executive Officer</p></td><td style="vertical-align:top;width:10.57%;background:#fff4ce;border-bottom:1px solid #000000;border-left:1px solid #000000;border-right:1px solid #000000;border-top:1px solid #000000;margin:0pt;padding:0pt 5.15pt 0pt 5.15pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;text-align:center;margin:2pt 0pt 2pt 0pt;"><font style="font-size:10pt;">&#9679;</font></p></td><td style="vertical-align:top;width:10.57%;border-bottom:1px solid #000000;border-left:1px solid #000000;border-right:1px solid #000000;border-top:1px solid #000000;margin:0pt;padding:0pt 5.15pt 0pt 5.15pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;text-align:center;margin:2pt 0pt 2pt 0pt;"><font style="font-size:10pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:top;width:9.61%;background:#fff4ce;border-bottom:1px solid #000000;border-left:1px solid #000000;border-right:1px solid #000000;border-top:1px solid #000000;margin:0pt;padding:0pt 5.15pt 0pt 5.15pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;text-align:center;margin:2pt 0pt 2pt 0pt;"><font style="font-size:10pt;">&#9679;</font></p></td><td style="vertical-align:top;width:8.65%;border-bottom:1px solid #000000;border-left:1px solid #000000;border-right:1px solid #000000;border-top:1px solid #000000;margin:0pt;padding:0pt 5.15pt 0pt 5.15pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;text-align:center;margin:2pt 0pt 2pt 0pt;"><font style="font-size:10pt;">&#9679;</font></p></td><td style="vertical-align:top;width:6.73%;background:#fff4ce;border-bottom:1px solid #000000;border-left:1px solid #000000;border-right:1px solid #000000;border-top:1px solid #000000;margin:0pt;padding:0pt 5.15pt 0pt 5.15pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;text-align:center;margin:2pt 0pt 2pt 0pt;"><font style="font-size:10pt;">&#9679;</font></p></td><td style="vertical-align:top;width:8.65%;border-bottom:1px solid #000000;border-left:1px solid #000000;border-right:1px solid #000000;border-top:1px solid #000000;margin:0pt;padding:0pt 5.15pt 0pt 5.15pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;text-align:center;margin:2pt 0pt 2pt 0pt;"><font style="font-size:10pt;">&#9679;</font></p></td><td style="vertical-align:top;width:9.61%;background:#fff4ce;border-bottom:1px solid #000000;border-left:1px solid #000000;border-right:1px solid #000000;border-top:1px solid #000000;margin:0pt;padding:0pt 5.15pt 0pt 5.15pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;text-align:center;margin:2pt 0pt 2pt 0pt;"><font style="font-size:10pt;">&#9679;</font></p></td><td style="vertical-align:top;width:11.53%;border-bottom:1px solid #000000;border-left:1px solid #000000;border-right:1px solid #000000;border-top:1px solid #000000;margin:0pt;padding:0pt 5.15pt 0pt 5.15pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;text-align:center;margin:2pt 0pt 2pt 0pt;"><font style="font-size:10pt;">&#9679;</font></p></td></tr><tr style="height:13.05pt;"><td style="vertical-align:top;width:24.03%;border-bottom:1px solid #000000;border-left:1px solid #000000;border-right:1px solid #000000;border-top:1px solid #000000;margin:0pt;padding:0pt 5.15pt 0pt 5.15pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:9pt;font-weight:bold;margin:2pt 0pt 2pt 0pt;">Chief Financial Officer</p></td><td style="vertical-align:top;width:10.57%;background:#fff4ce;border-bottom:1px solid #000000;border-left:1px solid #000000;border-right:1px solid #000000;border-top:1px solid #000000;margin:0pt;padding:0pt 5.15pt 0pt 5.15pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;text-align:center;margin:2pt 0pt 2pt 0pt;"><font style="font-size:10pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:top;width:10.57%;border-bottom:1px solid #000000;border-left:1px solid #000000;border-right:1px solid #000000;border-top:1px solid #000000;margin:0pt;padding:0pt 5.15pt 0pt 5.15pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;text-align:center;margin:2pt 0pt 2pt 0pt;"><font style="font-size:10pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:top;width:9.61%;background:#fff4ce;border-bottom:1px solid #000000;border-left:1px solid #000000;border-right:1px solid #000000;border-top:1px solid #000000;margin:0pt;padding:0pt 5.15pt 0pt 5.15pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;text-align:center;margin:2pt 0pt 2pt 0pt;"><font style="font-size:10pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:top;width:8.65%;border-bottom:1px solid #000000;border-left:1px solid #000000;border-right:1px solid #000000;border-top:1px solid #000000;margin:0pt;padding:0pt 5.15pt 0pt 5.15pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;text-align:center;margin:2pt 0pt 2pt 0pt;"><font style="font-size:10pt;">&#9679;</font></p></td><td style="vertical-align:top;width:6.73%;background:#fff4ce;border-bottom:1px solid #000000;border-left:1px solid #000000;border-right:1px solid #000000;border-top:1px solid #000000;margin:0pt;padding:0pt 5.15pt 0pt 5.15pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;text-align:center;margin:2pt 0pt 2pt 0pt;"><font style="font-size:10pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:top;width:8.65%;border-bottom:1px solid #000000;border-left:1px solid #000000;border-right:1px solid #000000;border-top:1px solid #000000;margin:0pt;padding:0pt 5.15pt 0pt 5.15pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;text-align:center;margin:2pt 0pt 2pt 0pt;"><font style="font-size:10pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:top;width:9.61%;background:#fff4ce;border-bottom:1px solid #000000;border-left:1px solid #000000;border-right:1px solid #000000;border-top:1px solid #000000;margin:0pt;padding:0pt 5.15pt 0pt 5.15pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;text-align:center;margin:2pt 0pt 2pt 0pt;"><font style="font-size:10pt;">&#9679;</font></p></td><td style="vertical-align:top;width:11.53%;border-bottom:1px solid #000000;border-left:1px solid #000000;border-right:1px solid #000000;border-top:1px solid #000000;margin:0pt;padding:0pt 5.15pt 0pt 5.15pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;text-align:center;margin:2pt 0pt 2pt 0pt;"><font style="font-size:10pt;visibility:hidden;">&#8203;</font></p></td></tr><tr style="height:13.05pt;"><td style="vertical-align:top;width:24.03%;border-bottom:1px solid #000000;border-left:1px solid #000000;border-right:1px solid #000000;border-top:1px solid #000000;margin:0pt;padding:0pt 5.15pt 0pt 5.15pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:9pt;font-weight:bold;margin:2pt 0pt 2pt 0pt;">Other Executive </p></td><td style="vertical-align:top;width:10.57%;background:#fff4ce;border-bottom:1px solid #000000;border-left:1px solid #000000;border-right:1px solid #000000;border-top:1px solid #000000;margin:0pt;padding:0pt 5.15pt 0pt 5.15pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;text-align:center;margin:2pt 0pt 2pt 0pt;"><font style="font-size:10pt;">&#9679;</font></p></td><td style="vertical-align:top;width:10.57%;border-bottom:1px solid #000000;border-left:1px solid #000000;border-right:1px solid #000000;border-top:1px solid #000000;margin:0pt;padding:0pt 5.15pt 0pt 5.15pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;text-align:center;margin:2pt 0pt 2pt 0pt;"><font style="font-size:10pt;">&#9679;</font></p></td><td style="vertical-align:top;width:9.61%;background:#fff4ce;border-bottom:1px solid #000000;border-left:1px solid #000000;border-right:1px solid #000000;border-top:1px solid #000000;margin:0pt;padding:0pt 5.15pt 0pt 5.15pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;text-align:center;margin:2pt 0pt 2pt 0pt;"><font style="font-size:10pt;">&#9679;</font></p></td><td style="vertical-align:top;width:8.65%;border-bottom:1px solid #000000;border-left:1px solid #000000;border-right:1px solid #000000;border-top:1px solid #000000;margin:0pt;padding:0pt 5.15pt 0pt 5.15pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;text-align:center;margin:2pt 0pt 2pt 0pt;"><font style="font-size:10pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:top;width:6.73%;background:#fff4ce;border-bottom:1px solid #000000;border-left:1px solid #000000;border-right:1px solid #000000;border-top:1px solid #000000;margin:0pt;padding:0pt 5.15pt 0pt 5.15pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;text-align:center;margin:2pt 0pt 2pt 0pt;"><font style="font-size:10pt;">&#9679;</font></p></td><td style="vertical-align:top;width:8.65%;border-bottom:1px solid #000000;border-left:1px solid #000000;border-right:1px solid #000000;border-top:1px solid #000000;margin:0pt;padding:0pt 5.15pt 0pt 5.15pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;text-align:center;margin:2pt 0pt 2pt 0pt;"><font style="font-size:10pt;">&#9679;</font></p></td><td style="vertical-align:top;width:9.61%;background:#fff4ce;border-bottom:1px solid #000000;border-left:1px solid #000000;border-right:1px solid #000000;border-top:1px solid #000000;margin:0pt;padding:0pt 5.15pt 0pt 5.15pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;text-align:center;margin:2pt 0pt 2pt 0pt;"><font style="font-size:10pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:top;width:11.53%;border-bottom:1px solid #000000;border-left:1px solid #000000;border-right:1px solid #000000;border-top:1px solid #000000;margin:0pt;padding:0pt 5.15pt 0pt 5.15pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;text-align:center;margin:2pt 0pt 2pt 0pt;"><font style="font-size:10pt;">&#9679;</font></p></td></tr><tr style="height:13.05pt;"><td style="vertical-align:top;width:24.03%;border-bottom:1px solid #000000;border-left:1px solid #000000;border-right:1px solid #000000;border-top:1px solid #000000;margin:0pt;padding:0pt 5.15pt 0pt 5.15pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:9pt;font-weight:bold;margin:2pt 0pt 2pt 0pt;">Chair/ Lead Director</p></td><td style="vertical-align:top;width:10.57%;background:#fff4ce;border-bottom:1px solid #000000;border-left:1px solid #000000;border-right:1px solid #000000;border-top:1px solid #000000;margin:0pt;padding:0pt 5.15pt 0pt 5.15pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;text-align:center;margin:2pt 0pt 2pt 0pt;"><font style="font-size:10pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:top;width:10.57%;border-bottom:1px solid #000000;border-left:1px solid #000000;border-right:1px solid #000000;border-top:1px solid #000000;margin:0pt;padding:0pt 5.15pt 0pt 5.15pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;text-align:center;margin:2pt 0pt 2pt 0pt;"><font style="font-size:10pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:top;width:9.61%;background:#fff4ce;border-bottom:1px solid #000000;border-left:1px solid #000000;border-right:1px solid #000000;border-top:1px solid #000000;margin:0pt;padding:0pt 5.15pt 0pt 5.15pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;text-align:center;margin:2pt 0pt 2pt 0pt;"><font style="font-size:10pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:top;width:8.65%;border-bottom:1px solid #000000;border-left:1px solid #000000;border-right:1px solid #000000;border-top:1px solid #000000;margin:0pt;padding:0pt 5.15pt 0pt 5.15pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;text-align:center;margin:2pt 0pt 2pt 0pt;"><font style="font-size:10pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:top;width:6.73%;background:#fff4ce;border-bottom:1px solid #000000;border-left:1px solid #000000;border-right:1px solid #000000;border-top:1px solid #000000;margin:0pt;padding:0pt 5.15pt 0pt 5.15pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;text-align:center;margin:2pt 0pt 2pt 0pt;"><font style="font-size:10pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:top;width:8.65%;border-bottom:1px solid #000000;border-left:1px solid #000000;border-right:1px solid #000000;border-top:1px solid #000000;margin:0pt;padding:0pt 5.15pt 0pt 5.15pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;text-align:center;margin:2pt 0pt 2pt 0pt;"><font style="font-size:10pt;">&#9679;</font></p></td><td style="vertical-align:top;width:9.61%;background:#fff4ce;border-bottom:1px solid #000000;border-left:1px solid #000000;border-right:1px solid #000000;border-top:1px solid #000000;margin:0pt;padding:0pt 5.15pt 0pt 5.15pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;text-align:center;margin:2pt 0pt 2pt 0pt;"><font style="font-size:10pt;">&#9679;</font></p></td><td style="vertical-align:top;width:11.53%;border-bottom:1px solid #000000;border-left:1px solid #000000;border-right:1px solid #000000;border-top:1px solid #000000;margin:0pt;padding:0pt 5.15pt 0pt 5.15pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;text-align:center;margin:2pt 0pt 2pt 0pt;"><font style="font-size:10pt;visibility:hidden;">&#8203;</font></p></td></tr><tr style="height:13.05pt;"><td colspan="9" style="vertical-align:top;white-space:normal;width:100%;background:#d9d9d9;border-bottom:1px solid #000000;border-left:1px solid #000000;border-right:1px solid #000000;border-top:1px solid #000000;margin:0pt;padding:0pt 5.15pt 0pt 5.15pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;font-weight:bold;margin:2pt 0pt 2pt 0pt;"><b style="color:#0070c0;font-size:10pt;font-weight:bold;">Other Board and Committee Service Experience</b><b style="font-size:10pt;font-weight:bold;">&#160;</b></p></td></tr><tr style="height:13.05pt;"><td style="vertical-align:top;width:24.03%;border-bottom:1px solid #000000;border-left:1px solid #000000;border-right:1px solid #000000;border-top:1px solid #000000;margin:0pt;padding:0pt 5.15pt 0pt 5.15pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:9pt;font-weight:bold;margin:2pt 0pt 2pt 0pt;">Other Public Boards</p></td><td style="vertical-align:top;width:10.57%;background:#fff4ce;border-bottom:1px solid #000000;border-left:1px solid #000000;border-right:1px solid #000000;border-top:1px solid #000000;margin:0pt;padding:0pt 5.15pt 0pt 5.15pt;"></td><td style="vertical-align:top;width:10.57%;border-bottom:1px solid #000000;border-left:1px solid #000000;border-right:1px solid #000000;border-top:1px solid #000000;margin:0pt;padding:0pt 5.15pt 0pt 5.15pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;text-align:center;margin:2pt 0pt 2pt 0pt;"><font style="font-size:10pt;">&#9679;</font></p></td><td style="vertical-align:top;width:9.61%;background:#fff4ce;border-bottom:1px solid #000000;border-left:1px solid #000000;border-right:1px solid #000000;border-top:1px solid #000000;margin:0pt;padding:0pt 5.15pt 0pt 5.15pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;text-align:center;margin:2pt 0pt 2pt 0pt;"><font style="font-size:10pt;">&#9679;</font></p></td><td style="vertical-align:top;width:8.65%;border-bottom:1px solid #000000;border-left:1px solid #000000;border-right:1px solid #000000;border-top:1px solid #000000;margin:0pt;padding:0pt 5.15pt 0pt 5.15pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;text-align:center;margin:2pt 0pt 2pt 0pt;"><font style="font-size:10pt;">&#9679;</font></p></td><td style="vertical-align:top;width:6.73%;background:#fff4ce;border-bottom:1px solid #000000;border-left:1px solid #000000;border-right:1px solid #000000;border-top:1px solid #000000;margin:0pt;padding:0pt 5.15pt 0pt 5.15pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;text-align:center;margin:2pt 0pt 2pt 0pt;"><font style="font-size:10pt;">&#9679;</font></p></td><td style="vertical-align:top;width:8.65%;border-bottom:1px solid #000000;border-left:1px solid #000000;border-right:1px solid #000000;border-top:1px solid #000000;margin:0pt;padding:0pt 5.15pt 0pt 5.15pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;text-align:center;margin:2pt 0pt 2pt 0pt;"><font style="font-size:10pt;">&#9679;</font></p></td><td style="vertical-align:top;width:9.61%;background:#fff4ce;border-bottom:1px solid #000000;border-left:1px solid #000000;border-right:1px solid #000000;border-top:1px solid #000000;margin:0pt;padding:0pt 5.15pt 0pt 5.15pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;text-align:center;margin:2pt 0pt 2pt 0pt;"><font style="font-size:10pt;">&#9679;</font></p></td><td style="vertical-align:top;width:11.53%;border-bottom:1px solid #000000;border-left:1px solid #000000;border-right:1px solid #000000;border-top:1px solid #000000;margin:0pt;padding:0pt 5.15pt 0pt 5.15pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;text-align:center;margin:2pt 0pt 2pt 0pt;"><font style="font-size:10pt;visibility:hidden;">&#8203;</font></p></td></tr><tr style="height:13.05pt;"><td style="vertical-align:top;width:24.03%;border-bottom:1px solid #000000;border-left:1px solid #000000;border-right:1px solid #000000;border-top:1px solid #000000;margin:0pt;padding:0pt 5.15pt 0pt 5.15pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:9pt;font-weight:bold;margin:2pt 0pt 2pt 0pt;">Other Private Boards</p></td><td style="vertical-align:top;width:10.57%;background:#fff4ce;border-bottom:1px solid #000000;border-left:1px solid #000000;border-right:1px solid #000000;border-top:1px solid #000000;margin:0pt;padding:0pt 5.15pt 0pt 5.15pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;text-align:center;margin:2pt 0pt 2pt 0pt;"><font style="font-size:10pt;">&#9679;</font></p></td><td style="vertical-align:top;width:10.57%;border-bottom:1px solid #000000;border-left:1px solid #000000;border-right:1px solid #000000;border-top:1px solid #000000;margin:0pt;padding:0pt 5.15pt 0pt 5.15pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;text-align:center;margin:2pt 0pt 2pt 0pt;"><font style="font-size:10pt;">&#9679;</font></p></td><td style="vertical-align:top;width:9.61%;background:#fff4ce;border-bottom:1px solid #000000;border-left:1px solid #000000;border-right:1px solid #000000;border-top:1px solid #000000;margin:0pt;padding:0pt 5.15pt 0pt 5.15pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;text-align:center;margin:2pt 0pt 2pt 0pt;"><font style="font-size:10pt;">&#9679;</font></p></td><td style="vertical-align:top;width:8.65%;border-bottom:1px solid #000000;border-left:1px solid #000000;border-right:1px solid #000000;border-top:1px solid #000000;margin:0pt;padding:0pt 5.15pt 0pt 5.15pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;text-align:center;margin:2pt 0pt 2pt 0pt;"><font style="font-size:10pt;">&#9679;</font></p></td><td style="vertical-align:top;width:6.73%;background:#fff4ce;border-bottom:1px solid #000000;border-left:1px solid #000000;border-right:1px solid #000000;border-top:1px solid #000000;margin:0pt;padding:0pt 5.15pt 0pt 5.15pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;text-align:center;margin:2pt 0pt 2pt 0pt;"><font style="font-size:10pt;">&#9679;</font></p></td><td style="vertical-align:top;width:8.65%;border-bottom:1px solid #000000;border-left:1px solid #000000;border-right:1px solid #000000;border-top:1px solid #000000;margin:0pt;padding:0pt 5.15pt 0pt 5.15pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;text-align:center;margin:2pt 0pt 2pt 0pt;"><font style="font-size:10pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:top;width:9.61%;background:#fff4ce;border-bottom:1px solid #000000;border-left:1px solid #000000;border-right:1px solid #000000;border-top:1px solid #000000;margin:0pt;padding:0pt 5.15pt 0pt 5.15pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;text-align:center;margin:2pt 0pt 2pt 0pt;"><font style="font-size:10pt;">&#9679;</font></p></td><td style="vertical-align:top;width:11.53%;border-bottom:1px solid #000000;border-left:1px solid #000000;border-right:1px solid #000000;border-top:1px solid #000000;margin:0pt;padding:0pt 5.15pt 0pt 5.15pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;text-align:center;margin:2pt 0pt 2pt 0pt;"><font style="font-size:10pt;visibility:hidden;">&#8203;</font></p></td></tr><tr style="height:13.05pt;"><td style="vertical-align:top;width:24.03%;border-bottom:1px solid #000000;border-left:1px solid #000000;border-right:1px solid #000000;border-top:1px solid #000000;margin:0pt;padding:0pt 5.15pt 0pt 5.15pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:9pt;font-weight:bold;margin:2pt 0pt 2pt 0pt;">Audit</p></td><td style="vertical-align:top;width:10.57%;background:#fff4ce;border-bottom:1px solid #000000;border-left:1px solid #000000;border-right:1px solid #000000;border-top:1px solid #000000;margin:0pt;padding:0pt 5.15pt 0pt 5.15pt;"></td><td style="vertical-align:top;width:10.57%;border-bottom:1px solid #000000;border-left:1px solid #000000;border-right:1px solid #000000;border-top:1px solid #000000;margin:0pt;padding:0pt 5.15pt 0pt 5.15pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;text-align:center;margin:2pt 0pt 2pt 0pt;"><font style="font-size:10pt;">&#9679;</font></p></td><td style="vertical-align:top;width:9.61%;background:#fff4ce;border-bottom:1px solid #000000;border-left:1px solid #000000;border-right:1px solid #000000;border-top:1px solid #000000;margin:0pt;padding:0pt 5.15pt 0pt 5.15pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;text-align:center;margin:2pt 0pt 2pt 0pt;"><font style="font-size:10pt;">&#9679;</font></p></td><td style="vertical-align:top;width:8.65%;border-bottom:1px solid #000000;border-left:1px solid #000000;border-right:1px solid #000000;border-top:1px solid #000000;margin:0pt;padding:0pt 5.15pt 0pt 5.15pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;text-align:center;margin:2pt 0pt 2pt 0pt;"><font style="font-size:10pt;">&#9679;</font></p></td><td style="vertical-align:top;width:6.73%;background:#fff4ce;border-bottom:1px solid #000000;border-left:1px solid #000000;border-right:1px solid #000000;border-top:1px solid #000000;margin:0pt;padding:0pt 5.15pt 0pt 5.15pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;text-align:center;margin:2pt 0pt 2pt 0pt;"><font style="font-size:10pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:top;width:8.65%;border-bottom:1px solid #000000;border-left:1px solid #000000;border-right:1px solid #000000;border-top:1px solid #000000;margin:0pt;padding:0pt 5.15pt 0pt 5.15pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;text-align:center;margin:2pt 0pt 2pt 0pt;"><font style="font-size:10pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:top;width:9.61%;background:#fff4ce;border-bottom:1px solid #000000;border-left:1px solid #000000;border-right:1px solid #000000;border-top:1px solid #000000;margin:0pt;padding:0pt 5.15pt 0pt 5.15pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;text-align:center;margin:2pt 0pt 2pt 0pt;"><font style="font-size:10pt;">&#9679;</font></p></td><td style="vertical-align:top;width:11.53%;border-bottom:1px solid #000000;border-left:1px solid #000000;border-right:1px solid #000000;border-top:1px solid #000000;margin:0pt;padding:0pt 5.15pt 0pt 5.15pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;text-align:center;margin:2pt 0pt 2pt 0pt;"><font style="font-size:10pt;visibility:hidden;">&#8203;</font></p></td></tr><tr style="height:13.05pt;"><td style="vertical-align:top;width:24.03%;border-bottom:1px solid #000000;border-left:1px solid #000000;border-right:1px solid #000000;border-top:1px solid #000000;margin:0pt;padding:0pt 5.15pt 0pt 5.15pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:9pt;font-weight:bold;margin:2pt 0pt 2pt 0pt;">Compensation</p></td><td style="vertical-align:top;width:10.57%;background:#fff4ce;border-bottom:1px solid #000000;border-left:1px solid #000000;border-right:1px solid #000000;border-top:1px solid #000000;margin:0pt;padding:0pt 5.15pt 0pt 5.15pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;text-align:center;margin:2pt 0pt 2pt 0pt;"><font style="font-size:10pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:top;width:10.57%;border-bottom:1px solid #000000;border-left:1px solid #000000;border-right:1px solid #000000;border-top:1px solid #000000;margin:0pt;padding:0pt 5.15pt 0pt 5.15pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;text-align:center;margin:2pt 0pt 2pt 0pt;"><font style="font-size:10pt;">&#9679;</font></p></td><td style="vertical-align:top;width:9.61%;background:#fff4ce;border-bottom:1px solid #000000;border-left:1px solid #000000;border-right:1px solid #000000;border-top:1px solid #000000;margin:0pt;padding:0pt 5.15pt 0pt 5.15pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;text-align:center;margin:2pt 0pt 2pt 0pt;"><font style="font-size:10pt;">&#9679;</font></p></td><td style="vertical-align:top;width:8.65%;border-bottom:1px solid #000000;border-left:1px solid #000000;border-right:1px solid #000000;border-top:1px solid #000000;margin:0pt;padding:0pt 5.15pt 0pt 5.15pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;text-align:center;margin:2pt 0pt 2pt 0pt;"><font style="font-size:10pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:top;width:6.73%;background:#fff4ce;border-bottom:1px solid #000000;border-left:1px solid #000000;border-right:1px solid #000000;border-top:1px solid #000000;margin:0pt;padding:0pt 5.15pt 0pt 5.15pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;text-align:center;margin:2pt 0pt 2pt 0pt;"><font style="font-size:10pt;">&#9679;</font></p></td><td style="vertical-align:top;width:8.65%;border-bottom:1px solid #000000;border-left:1px solid #000000;border-right:1px solid #000000;border-top:1px solid #000000;margin:0pt;padding:0pt 5.15pt 0pt 5.15pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;text-align:center;margin:2pt 0pt 2pt 0pt;"><font style="font-size:10pt;">&#9679;</font></p></td><td style="vertical-align:top;width:9.61%;background:#fff4ce;border-bottom:1px solid #000000;border-left:1px solid #000000;border-right:1px solid #000000;border-top:1px solid #000000;margin:0pt;padding:0pt 5.15pt 0pt 5.15pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;text-align:center;margin:2pt 0pt 2pt 0pt;"><font style="font-size:10pt;">&#9679;</font></p></td><td style="vertical-align:top;width:11.53%;border-bottom:1px solid #000000;border-left:1px solid #000000;border-right:1px solid #000000;border-top:1px solid #000000;margin:0pt;padding:0pt 5.15pt 0pt 5.15pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;text-align:center;margin:2pt 0pt 2pt 0pt;"><font style="font-size:10pt;visibility:hidden;">&#8203;</font></p></td></tr><tr style="height:13.05pt;"><td style="vertical-align:top;width:24.03%;border-bottom:1px solid #000000;border-left:1px solid #000000;border-right:1px solid #000000;border-top:1px solid #000000;margin:0pt;padding:0pt 5.15pt 0pt 5.15pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:9pt;font-weight:bold;margin:2pt 0pt 2pt 0pt;">Nominating/Governance</p></td><td style="vertical-align:top;width:10.57%;background:#fff4ce;border-bottom:1px solid #000000;border-left:1px solid #000000;border-right:1px solid #000000;border-top:1px solid #000000;margin:0pt;padding:0pt 5.15pt 0pt 5.15pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;text-align:center;margin:2pt 0pt 2pt 0pt;"><font style="font-size:10pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:top;width:10.57%;border-bottom:1px solid #000000;border-left:1px solid #000000;border-right:1px solid #000000;border-top:1px solid #000000;margin:0pt;padding:0pt 5.15pt 0pt 5.15pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;text-align:center;margin:2pt 0pt 2pt 0pt;"><font style="font-size:10pt;">&#9679;</font></p></td><td style="vertical-align:top;width:9.61%;background:#fff4ce;border-bottom:1px solid #000000;border-left:1px solid #000000;border-right:1px solid #000000;border-top:1px solid #000000;margin:0pt;padding:0pt 5.15pt 0pt 5.15pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;text-align:center;margin:2pt 0pt 2pt 0pt;"><font style="font-size:10pt;">&#9679;</font></p></td><td style="vertical-align:top;width:8.65%;border-bottom:1px solid #000000;border-left:1px solid #000000;border-right:1px solid #000000;border-top:1px solid #000000;margin:0pt;padding:0pt 5.15pt 0pt 5.15pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;text-align:center;margin:2pt 0pt 2pt 0pt;"><font style="font-size:10pt;">&#9679;</font></p></td><td style="vertical-align:top;width:6.73%;background:#fff4ce;border-bottom:1px solid #000000;border-left:1px solid #000000;border-right:1px solid #000000;border-top:1px solid #000000;margin:0pt;padding:0pt 5.15pt 0pt 5.15pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;text-align:center;margin:2pt 0pt 2pt 0pt;"><font style="font-size:10pt;">&#9679;</font></p></td><td style="vertical-align:top;width:8.65%;border-bottom:1px solid #000000;border-left:1px solid #000000;border-right:1px solid #000000;border-top:1px solid #000000;margin:0pt;padding:0pt 5.15pt 0pt 5.15pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;text-align:center;margin:2pt 0pt 2pt 0pt;"><font style="font-size:10pt;">&#9679;</font></p></td><td style="vertical-align:top;width:9.61%;background:#fff4ce;border-bottom:1px solid #000000;border-left:1px solid #000000;border-right:1px solid #000000;border-top:1px solid #000000;margin:0pt;padding:0pt 5.15pt 0pt 5.15pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;text-align:center;margin:2pt 0pt 2pt 0pt;"><font style="font-size:10pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:top;width:11.53%;border-bottom:1px solid #000000;border-left:1px solid #000000;border-right:1px solid #000000;border-top:1px solid #000000;margin:0pt;padding:0pt 5.15pt 0pt 5.15pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;text-align:center;margin:2pt 0pt 2pt 0pt;"><font style="font-size:10pt;visibility:hidden;">&#8203;</font></p></td></tr><tr style="height:13.05pt;"><td colspan="9" style="vertical-align:top;white-space:normal;width:100%;background:#d9d9d9;border-bottom:1px solid #000000;border-left:1px solid #000000;border-right:1px solid #000000;border-top:1px solid #000000;margin:0pt;padding:0pt 5.15pt 0pt 5.15pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;font-weight:bold;margin:2pt 0pt 2pt 0pt;"><b style="color:#0070c0;font-size:10pt;font-weight:bold;">Strategic Experience</b><b style="font-size:10pt;font-weight:bold;">&#160;</b></p></td></tr><tr style="height:13.05pt;"><td style="vertical-align:top;width:24.03%;border-bottom:1px solid #000000;border-left:1px solid #000000;border-right:1px solid #000000;border-top:1px solid #000000;margin:0pt;padding:0pt 5.15pt 0pt 5.15pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:9pt;font-weight:bold;margin:2pt 0pt 2pt 0pt;">Finance / Financial Literacy</p></td><td style="vertical-align:top;width:10.57%;background:#fff4ce;border-bottom:1px solid #000000;border-left:1px solid #000000;border-right:1px solid #000000;border-top:1px solid #000000;margin:0pt;padding:0pt 5.15pt 0pt 5.15pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;text-align:center;margin:2pt 0pt 2pt 0pt;"><font style="font-size:10pt;">&#9679;</font></p></td><td style="vertical-align:top;width:10.57%;border-bottom:1px solid #000000;border-left:1px solid #000000;border-right:1px solid #000000;border-top:1px solid #000000;margin:0pt;padding:0pt 5.15pt 0pt 5.15pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;text-align:center;margin:2pt 0pt 2pt 0pt;"><font style="font-size:10pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:top;width:9.61%;background:#fff4ce;border-bottom:1px solid #000000;border-left:1px solid #000000;border-right:1px solid #000000;border-top:1px solid #000000;margin:0pt;padding:0pt 5.15pt 0pt 5.15pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;text-align:center;margin:2pt 0pt 2pt 0pt;"><font style="font-size:10pt;">&#9679;</font></p></td><td style="vertical-align:top;width:8.65%;border-bottom:1px solid #000000;border-left:1px solid #000000;border-right:1px solid #000000;border-top:1px solid #000000;margin:0pt;padding:0pt 5.15pt 0pt 5.15pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;text-align:center;margin:2pt 0pt 2pt 0pt;"><font style="font-size:10pt;">&#9679;</font></p></td><td style="vertical-align:top;width:6.73%;background:#fff4ce;border-bottom:1px solid #000000;border-left:1px solid #000000;border-right:1px solid #000000;border-top:1px solid #000000;margin:0pt;padding:0pt 5.15pt 0pt 5.15pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;text-align:center;margin:2pt 0pt 2pt 0pt;"><font style="font-size:10pt;">&#9679;</font></p></td><td style="vertical-align:top;width:8.65%;border-bottom:1px solid #000000;border-left:1px solid #000000;border-right:1px solid #000000;border-top:1px solid #000000;margin:0pt;padding:0pt 5.15pt 0pt 5.15pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;text-align:center;margin:2pt 0pt 2pt 0pt;"><font style="font-size:10pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:top;width:9.61%;background:#fff4ce;border-bottom:1px solid #000000;border-left:1px solid #000000;border-right:1px solid #000000;border-top:1px solid #000000;margin:0pt;padding:0pt 5.15pt 0pt 5.15pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;text-align:center;margin:2pt 0pt 2pt 0pt;"><font style="font-size:10pt;">&#9679;</font></p></td><td style="vertical-align:top;width:11.53%;border-bottom:1px solid #000000;border-left:1px solid #000000;border-right:1px solid #000000;border-top:1px solid #000000;margin:0pt;padding:0pt 5.15pt 0pt 5.15pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;text-align:center;margin:2pt 0pt 2pt 0pt;"><font style="font-size:10pt;">&#9679;</font></p></td></tr><tr style="height:13.05pt;"><td style="vertical-align:top;width:24.03%;border-bottom:1px solid #000000;border-left:1px solid #000000;border-right:1px solid #000000;border-top:1px solid #000000;margin:0pt;padding:0pt 5.15pt 0pt 5.15pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:9pt;font-weight:bold;margin:2pt 0pt 2pt 0pt;">Business Development / Partnering</p></td><td style="vertical-align:top;width:10.57%;background:#fff4ce;border-bottom:1px solid #000000;border-left:1px solid #000000;border-right:1px solid #000000;border-top:1px solid #000000;margin:0pt;padding:0pt 5.15pt 0pt 5.15pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;text-align:center;margin:2pt 0pt 2pt 0pt;"><font style="font-size:10pt;">&#9679;</font></p></td><td style="vertical-align:top;width:10.57%;border-bottom:1px solid #000000;border-left:1px solid #000000;border-right:1px solid #000000;border-top:1px solid #000000;margin:0pt;padding:0pt 5.15pt 0pt 5.15pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;text-align:center;margin:2pt 0pt 2pt 0pt;"><font style="font-size:10pt;">&#9679;</font></p></td><td style="vertical-align:top;width:9.61%;background:#fff4ce;border-bottom:1px solid #000000;border-left:1px solid #000000;border-right:1px solid #000000;border-top:1px solid #000000;margin:0pt;padding:0pt 5.15pt 0pt 5.15pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;text-align:center;margin:2pt 0pt 2pt 0pt;"><font style="font-size:10pt;">&#9679;</font></p></td><td style="vertical-align:top;width:8.65%;border-bottom:1px solid #000000;border-left:1px solid #000000;border-right:1px solid #000000;border-top:1px solid #000000;margin:0pt;padding:0pt 5.15pt 0pt 5.15pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;text-align:center;margin:2pt 0pt 2pt 0pt;"><font style="font-size:10pt;">&#9679;</font></p></td><td style="vertical-align:top;width:6.73%;background:#fff4ce;border-bottom:1px solid #000000;border-left:1px solid #000000;border-right:1px solid #000000;border-top:1px solid #000000;margin:0pt;padding:0pt 5.15pt 0pt 5.15pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;text-align:center;margin:2pt 0pt 2pt 0pt;"><font style="font-size:10pt;">&#9679;</font></p></td><td style="vertical-align:top;width:8.65%;border-bottom:1px solid #000000;border-left:1px solid #000000;border-right:1px solid #000000;border-top:1px solid #000000;margin:0pt;padding:0pt 5.15pt 0pt 5.15pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;text-align:center;margin:2pt 0pt 2pt 0pt;"><font style="font-size:10pt;">&#9679;</font></p></td><td style="vertical-align:top;width:9.61%;background:#fff4ce;border-bottom:1px solid #000000;border-left:1px solid #000000;border-right:1px solid #000000;border-top:1px solid #000000;margin:0pt;padding:0pt 5.15pt 0pt 5.15pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;text-align:center;margin:2pt 0pt 2pt 0pt;"><font style="font-size:10pt;">&#9679;</font></p></td><td style="vertical-align:top;width:11.53%;border-bottom:1px solid #000000;border-left:1px solid #000000;border-right:1px solid #000000;border-top:1px solid #000000;margin:0pt;padding:0pt 5.15pt 0pt 5.15pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;text-align:center;margin:2pt 0pt 2pt 0pt;"><font style="font-size:10pt;">&#9679;</font></p></td></tr><tr style="height:13.05pt;"><td style="vertical-align:top;width:24.03%;border-bottom:1px solid #000000;border-left:1px solid #000000;border-right:1px solid #000000;border-top:1px solid #000000;margin:0pt;padding:0pt 5.15pt 0pt 5.15pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:9pt;font-weight:bold;margin:2pt 0pt 2pt 0pt;">M&amp;A </p></td><td style="vertical-align:top;width:10.57%;background:#fff4ce;border-bottom:1px solid #000000;border-left:1px solid #000000;border-right:1px solid #000000;border-top:1px solid #000000;margin:0pt;padding:0pt 5.15pt 0pt 5.15pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;text-align:center;margin:2pt 0pt 2pt 0pt;"><font style="font-size:10pt;">&#9679;</font></p></td><td style="vertical-align:top;width:10.57%;border-bottom:1px solid #000000;border-left:1px solid #000000;border-right:1px solid #000000;border-top:1px solid #000000;margin:0pt;padding:0pt 5.15pt 0pt 5.15pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;text-align:center;margin:2pt 0pt 2pt 0pt;"><font style="font-size:10pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:top;width:9.61%;background:#fff4ce;border-bottom:1px solid #000000;border-left:1px solid #000000;border-right:1px solid #000000;border-top:1px solid #000000;margin:0pt;padding:0pt 5.15pt 0pt 5.15pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;text-align:center;margin:2pt 0pt 2pt 0pt;"><font style="font-size:10pt;">&#9679;</font></p></td><td style="vertical-align:top;width:8.65%;border-bottom:1px solid #000000;border-left:1px solid #000000;border-right:1px solid #000000;border-top:1px solid #000000;margin:0pt;padding:0pt 5.15pt 0pt 5.15pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;text-align:center;margin:2pt 0pt 2pt 0pt;"><font style="font-size:10pt;">&#9679;</font></p></td><td style="vertical-align:top;width:6.73%;background:#fff4ce;border-bottom:1px solid #000000;border-left:1px solid #000000;border-right:1px solid #000000;border-top:1px solid #000000;margin:0pt;padding:0pt 5.15pt 0pt 5.15pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;text-align:center;margin:2pt 0pt 2pt 0pt;"><font style="font-size:10pt;">&#9679;</font></p></td><td style="vertical-align:top;width:8.65%;border-bottom:1px solid #000000;border-left:1px solid #000000;border-right:1px solid #000000;border-top:1px solid #000000;margin:0pt;padding:0pt 5.15pt 0pt 5.15pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;text-align:center;margin:2pt 0pt 2pt 0pt;"><font style="font-size:10pt;">&#9679;</font></p></td><td style="vertical-align:top;width:9.61%;background:#fff4ce;border-bottom:1px solid #000000;border-left:1px solid #000000;border-right:1px solid #000000;border-top:1px solid #000000;margin:0pt;padding:0pt 5.15pt 0pt 5.15pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;text-align:center;margin:2pt 0pt 2pt 0pt;"><font style="font-size:10pt;">&#9679;</font></p></td><td style="vertical-align:top;width:11.53%;border-bottom:1px solid #000000;border-left:1px solid #000000;border-right:1px solid #000000;border-top:1px solid #000000;margin:0pt;padding:0pt 5.15pt 0pt 5.15pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;text-align:center;margin:2pt 0pt 2pt 0pt;"><font style="font-size:10pt;">&#9679;</font></p></td></tr><tr style="height:13.05pt;"><td style="vertical-align:top;width:24.03%;border-bottom:1px solid #000000;border-left:1px solid #000000;border-right:1px solid #000000;border-top:1px solid #000000;margin:0pt;padding:0pt 5.15pt 0pt 5.15pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:9pt;font-weight:bold;margin:2pt 0pt 2pt 0pt;">Capital Raising / Financing </p></td><td style="vertical-align:top;width:10.57%;background:#fff4ce;border-bottom:1px solid #000000;border-left:1px solid #000000;border-right:1px solid #000000;border-top:1px solid #000000;margin:0pt;padding:0pt 5.15pt 0pt 5.15pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;text-align:center;margin:2pt 0pt 2pt 0pt;"><font style="font-size:10pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:top;width:10.57%;border-bottom:1px solid #000000;border-left:1px solid #000000;border-right:1px solid #000000;border-top:1px solid #000000;margin:0pt;padding:0pt 5.15pt 0pt 5.15pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;text-align:center;margin:2pt 0pt 2pt 0pt;"><font style="font-size:10pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:top;width:9.61%;background:#fff4ce;border-bottom:1px solid #000000;border-left:1px solid #000000;border-right:1px solid #000000;border-top:1px solid #000000;margin:0pt;padding:0pt 5.15pt 0pt 5.15pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;text-align:center;margin:2pt 0pt 2pt 0pt;"><font style="font-size:10pt;">&#9679;</font></p></td><td style="vertical-align:top;width:8.65%;border-bottom:1px solid #000000;border-left:1px solid #000000;border-right:1px solid #000000;border-top:1px solid #000000;margin:0pt;padding:0pt 5.15pt 0pt 5.15pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;text-align:center;margin:2pt 0pt 2pt 0pt;"><font style="font-size:10pt;">&#9679;</font></p></td><td style="vertical-align:top;width:6.73%;background:#fff4ce;border-bottom:1px solid #000000;border-left:1px solid #000000;border-right:1px solid #000000;border-top:1px solid #000000;margin:0pt;padding:0pt 5.15pt 0pt 5.15pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;text-align:center;margin:2pt 0pt 2pt 0pt;"><font style="font-size:10pt;">&#9679;</font></p></td><td style="vertical-align:top;width:8.65%;border-bottom:1px solid #000000;border-left:1px solid #000000;border-right:1px solid #000000;border-top:1px solid #000000;margin:0pt;padding:0pt 5.15pt 0pt 5.15pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;text-align:center;margin:2pt 0pt 2pt 0pt;"><font style="font-size:10pt;">&#9679;</font></p></td><td style="vertical-align:top;width:9.61%;background:#fff4ce;border-bottom:1px solid #000000;border-left:1px solid #000000;border-right:1px solid #000000;border-top:1px solid #000000;margin:0pt;padding:0pt 5.15pt 0pt 5.15pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;text-align:center;margin:2pt 0pt 2pt 0pt;"><font style="font-size:10pt;">&#9679;</font></p></td><td style="vertical-align:top;width:11.53%;border-bottom:1px solid #000000;border-left:1px solid #000000;border-right:1px solid #000000;border-top:1px solid #000000;margin:0pt;padding:0pt 5.15pt 0pt 5.15pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;text-align:center;margin:2pt 0pt 2pt 0pt;"><font style="font-size:10pt;visibility:hidden;">&#8203;</font></p></td></tr><tr style="height:13.05pt;"><td style="vertical-align:top;width:24.03%;border-bottom:1px solid #000000;border-left:1px solid #000000;border-right:1px solid #000000;border-top:1px solid #000000;margin:0pt;padding:0pt 5.15pt 0pt 5.15pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:9pt;font-weight:bold;margin:2pt 0pt 2pt 0pt;">Sales and Marketing </p></td><td style="vertical-align:top;width:10.57%;background:#fff4ce;border-bottom:1px solid #000000;border-left:1px solid #000000;border-right:1px solid #000000;border-top:1px solid #000000;margin:0pt;padding:0pt 5.15pt 0pt 5.15pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;text-align:center;margin:2pt 0pt 2pt 0pt;"><font style="font-size:10pt;">&#9679;</font></p></td><td style="vertical-align:top;width:10.57%;border-bottom:1px solid #000000;border-left:1px solid #000000;border-right:1px solid #000000;border-top:1px solid #000000;margin:0pt;padding:0pt 5.15pt 0pt 5.15pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;text-align:center;margin:2pt 0pt 2pt 0pt;"><font style="font-size:10pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:top;width:9.61%;background:#fff4ce;border-bottom:1px solid #000000;border-left:1px solid #000000;border-right:1px solid #000000;border-top:1px solid #000000;margin:0pt;padding:0pt 5.15pt 0pt 5.15pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;text-align:center;margin:2pt 0pt 2pt 0pt;"><font style="font-size:10pt;">&#9679;</font></p></td><td style="vertical-align:top;width:8.65%;border-bottom:1px solid #000000;border-left:1px solid #000000;border-right:1px solid #000000;border-top:1px solid #000000;margin:0pt;padding:0pt 5.15pt 0pt 5.15pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;text-align:center;margin:2pt 0pt 2pt 0pt;"><font style="font-size:10pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:top;width:6.73%;background:#fff4ce;border-bottom:1px solid #000000;border-left:1px solid #000000;border-right:1px solid #000000;border-top:1px solid #000000;margin:0pt;padding:0pt 5.15pt 0pt 5.15pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;text-align:center;margin:2pt 0pt 2pt 0pt;"><font style="font-size:10pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:top;width:8.65%;border-bottom:1px solid #000000;border-left:1px solid #000000;border-right:1px solid #000000;border-top:1px solid #000000;margin:0pt;padding:0pt 5.15pt 0pt 5.15pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;text-align:center;margin:2pt 0pt 2pt 0pt;"><font style="font-size:10pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:top;width:9.61%;background:#fff4ce;border-bottom:1px solid #000000;border-left:1px solid #000000;border-right:1px solid #000000;border-top:1px solid #000000;margin:0pt;padding:0pt 5.15pt 0pt 5.15pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;text-align:center;margin:2pt 0pt 2pt 0pt;"><font style="font-size:10pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:top;width:11.53%;border-bottom:1px solid #000000;border-left:1px solid #000000;border-right:1px solid #000000;border-top:1px solid #000000;margin:0pt;padding:0pt 5.15pt 0pt 5.15pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;text-align:center;margin:2pt 0pt 2pt 0pt;"><font style="font-size:10pt;">&#9679;</font></p></td></tr><tr style="height:13.8pt;"><td style="vertical-align:top;width:24.03%;border-bottom:1px solid #000000;border-left:1px solid #000000;border-right:1px solid #000000;border-top:1px solid #000000;margin:0pt;padding:0pt 5.15pt 0pt 5.15pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:9pt;font-weight:bold;margin:2pt 0pt 2pt 0pt;">Pharmaceutical Manufacturing</p></td><td style="vertical-align:top;width:10.57%;background:#fff4ce;border-bottom:1px solid #000000;border-left:1px solid #000000;border-right:1px solid #000000;border-top:1px solid #000000;margin:0pt;padding:0pt 5.15pt 0pt 5.15pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;text-align:center;margin:2pt 0pt 2pt 0pt;"><font style="font-size:10pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:top;width:10.57%;border-bottom:1px solid #000000;border-left:1px solid #000000;border-right:1px solid #000000;border-top:1px solid #000000;margin:0pt;padding:0pt 5.15pt 0pt 5.15pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;text-align:center;margin:2pt 0pt 2pt 0pt;"><font style="font-size:10pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:top;width:9.61%;background:#fff4ce;border-bottom:1px solid #000000;border-left:1px solid #000000;border-right:1px solid #000000;border-top:1px solid #000000;margin:0pt;padding:0pt 5.15pt 0pt 5.15pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;text-align:center;margin:2pt 0pt 2pt 0pt;"><font style="font-size:10pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:top;width:8.65%;border-bottom:1px solid #000000;border-left:1px solid #000000;border-right:1px solid #000000;border-top:1px solid #000000;margin:0pt;padding:0pt 5.15pt 0pt 5.15pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;text-align:center;margin:2pt 0pt 2pt 0pt;"><font style="font-size:10pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:top;width:6.73%;background:#fff4ce;border-bottom:1px solid #000000;border-left:1px solid #000000;border-right:1px solid #000000;border-top:1px solid #000000;margin:0pt;padding:0pt 5.15pt 0pt 5.15pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;text-align:center;margin:2pt 0pt 2pt 0pt;"><font style="font-size:10pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:top;width:8.65%;border-bottom:1px solid #000000;border-left:1px solid #000000;border-right:1px solid #000000;border-top:1px solid #000000;margin:0pt;padding:0pt 5.15pt 0pt 5.15pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;text-align:center;margin:2pt 0pt 2pt 0pt;"><font style="font-size:10pt;">&#9679;</font></p></td><td style="vertical-align:top;width:9.61%;background:#fff4ce;border-bottom:1px solid #000000;border-left:1px solid #000000;border-right:1px solid #000000;border-top:1px solid #000000;margin:0pt;padding:0pt 5.15pt 0pt 5.15pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;text-align:center;margin:2pt 0pt 2pt 0pt;"><font style="font-size:10pt;">&#9679;</font></p></td><td style="vertical-align:top;width:11.53%;border-bottom:1px solid #000000;border-left:1px solid #000000;border-right:1px solid #000000;border-top:1px solid #000000;margin:0pt;padding:0pt 5.15pt 0pt 5.15pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;text-align:center;margin:2pt 0pt 2pt 0pt;"><font style="font-size:10pt;">&#9679;</font></p></td></tr><tr style="height:13.8pt;"><td style="vertical-align:top;width:24.03%;border-bottom:1px solid #000000;border-left:1px solid #000000;border-right:1px solid #000000;border-top:1px solid #000000;margin:0pt;padding:0pt 5.15pt 0pt 5.15pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:9pt;font-weight:bold;margin:2pt 0pt 2pt 0pt;">Pharmaceutical Industry </p></td><td style="vertical-align:top;width:10.57%;background:#fff4ce;border-bottom:1px solid #000000;border-left:1px solid #000000;border-right:1px solid #000000;border-top:1px solid #000000;margin:0pt;padding:0pt 5.15pt 0pt 5.15pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;text-align:center;margin:2pt 0pt 2pt 0pt;"><font style="font-size:10pt;">&#9679;</font></p></td><td style="vertical-align:top;width:10.57%;border-bottom:1px solid #000000;border-left:1px solid #000000;border-right:1px solid #000000;border-top:1px solid #000000;margin:0pt;padding:0pt 5.15pt 0pt 5.15pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;text-align:center;margin:2pt 0pt 2pt 0pt;"><font style="font-size:10pt;">&#9679;</font></p></td><td style="vertical-align:top;width:9.61%;background:#fff4ce;border-bottom:1px solid #000000;border-left:1px solid #000000;border-right:1px solid #000000;border-top:1px solid #000000;margin:0pt;padding:0pt 5.15pt 0pt 5.15pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;text-align:center;margin:2pt 0pt 2pt 0pt;"><font style="font-size:10pt;">&#9679;</font></p></td><td style="vertical-align:top;width:8.65%;border-bottom:1px solid #000000;border-left:1px solid #000000;border-right:1px solid #000000;border-top:1px solid #000000;margin:0pt;padding:0pt 5.15pt 0pt 5.15pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;text-align:center;margin:2pt 0pt 2pt 0pt;"><font style="font-size:10pt;">&#9679;</font></p></td><td style="vertical-align:top;width:6.73%;background:#fff4ce;border-bottom:1px solid #000000;border-left:1px solid #000000;border-right:1px solid #000000;border-top:1px solid #000000;margin:0pt;padding:0pt 5.15pt 0pt 5.15pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;text-align:center;margin:2pt 0pt 2pt 0pt;"><font style="font-size:10pt;">&#9679;</font></p></td><td style="vertical-align:top;width:8.65%;border-bottom:1px solid #000000;border-left:1px solid #000000;border-right:1px solid #000000;border-top:1px solid #000000;margin:0pt;padding:0pt 5.15pt 0pt 5.15pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;text-align:center;margin:2pt 0pt 2pt 0pt;"><font style="font-size:10pt;">&#9679;</font></p></td><td style="vertical-align:top;width:9.61%;background:#fff4ce;border-bottom:1px solid #000000;border-left:1px solid #000000;border-right:1px solid #000000;border-top:1px solid #000000;margin:0pt;padding:0pt 5.15pt 0pt 5.15pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;text-align:center;margin:2pt 0pt 2pt 0pt;"><font style="font-size:10pt;">&#9679;</font></p></td><td style="vertical-align:top;width:11.53%;border-bottom:1px solid #000000;border-left:1px solid #000000;border-right:1px solid #000000;border-top:1px solid #000000;margin:0pt;padding:0pt 5.15pt 0pt 5.15pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;text-align:center;margin:2pt 0pt 2pt 0pt;"><font style="font-size:10pt;">&#9679;</font></p></td></tr><tr style="height:13.8pt;"><td style="vertical-align:top;width:24.03%;border-bottom:1px solid #000000;border-left:1px solid #000000;border-right:1px solid #000000;border-top:1px solid #000000;margin:0pt;padding:0pt 5.15pt 0pt 5.15pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:9pt;font-weight:bold;margin:2pt 0pt 2pt 0pt;">Commercial Pharmaceutical </p></td><td style="vertical-align:top;width:10.57%;background:#fff4ce;border-bottom:1px solid #000000;border-left:1px solid #000000;border-right:1px solid #000000;border-top:1px solid #000000;margin:0pt;padding:0pt 5.15pt 0pt 5.15pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;text-align:center;margin:2pt 0pt 2pt 0pt;"><font style="font-size:10pt;">&#9679;</font></p></td><td style="vertical-align:top;width:10.57%;border-bottom:1px solid #000000;border-left:1px solid #000000;border-right:1px solid #000000;border-top:1px solid #000000;margin:0pt;padding:0pt 5.15pt 0pt 5.15pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;text-align:center;margin:2pt 0pt 2pt 0pt;"><font style="font-size:10pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:top;width:9.61%;background:#fff4ce;border-bottom:1px solid #000000;border-left:1px solid #000000;border-right:1px solid #000000;border-top:1px solid #000000;margin:0pt;padding:0pt 5.15pt 0pt 5.15pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;text-align:center;margin:2pt 0pt 2pt 0pt;"><font style="font-size:10pt;">&#9679;</font></p></td><td style="vertical-align:top;width:8.65%;border-bottom:1px solid #000000;border-left:1px solid #000000;border-right:1px solid #000000;border-top:1px solid #000000;margin:0pt;padding:0pt 5.15pt 0pt 5.15pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;text-align:center;margin:2pt 0pt 2pt 0pt;"><font style="font-size:10pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:top;width:6.73%;background:#fff4ce;border-bottom:1px solid #000000;border-left:1px solid #000000;border-right:1px solid #000000;border-top:1px solid #000000;margin:0pt;padding:0pt 5.15pt 0pt 5.15pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;text-align:center;margin:2pt 0pt 2pt 0pt;"><font style="font-size:10pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:top;width:8.65%;border-bottom:1px solid #000000;border-left:1px solid #000000;border-right:1px solid #000000;border-top:1px solid #000000;margin:0pt;padding:0pt 5.15pt 0pt 5.15pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;text-align:center;margin:2pt 0pt 2pt 0pt;"><font style="font-size:10pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:top;width:9.61%;background:#fff4ce;border-bottom:1px solid #000000;border-left:1px solid #000000;border-right:1px solid #000000;border-top:1px solid #000000;margin:0pt;padding:0pt 5.15pt 0pt 5.15pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;text-align:center;margin:2pt 0pt 2pt 0pt;"><font style="font-size:10pt;">&#9679;</font></p></td><td style="vertical-align:top;width:11.53%;border-bottom:1px solid #000000;border-left:1px solid #000000;border-right:1px solid #000000;border-top:1px solid #000000;margin:0pt;padding:0pt 5.15pt 0pt 5.15pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;text-align:center;margin:2pt 0pt 2pt 0pt;"><font style="font-size:10pt;">&#9679;</font></p></td></tr><tr style="height:13.8pt;"><td style="vertical-align:top;width:24.03%;border-bottom:1px solid #000000;border-left:1px solid #000000;border-right:1px solid #000000;border-top:1px solid #000000;margin:0pt;padding:0pt 5.15pt 0pt 5.15pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:9pt;font-weight:bold;margin:2pt 0pt 2pt 0pt;">Clinical Development </p></td><td style="vertical-align:top;width:10.57%;background:#fff4ce;border-bottom:1px solid #000000;border-left:1px solid #000000;border-right:1px solid #000000;border-top:1px solid #000000;margin:0pt;padding:0pt 5.15pt 0pt 5.15pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;text-align:center;margin:2pt 0pt 2pt 0pt;"><font style="font-size:10pt;">&#9679;</font></p></td><td style="vertical-align:top;width:10.57%;border-bottom:1px solid #000000;border-left:1px solid #000000;border-right:1px solid #000000;border-top:1px solid #000000;margin:0pt;padding:0pt 5.15pt 0pt 5.15pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;text-align:center;margin:2pt 0pt 2pt 0pt;"><font style="font-size:10pt;">&#9679;</font></p></td><td style="vertical-align:top;width:9.61%;background:#fff4ce;border-bottom:1px solid #000000;border-left:1px solid #000000;border-right:1px solid #000000;border-top:1px solid #000000;margin:0pt;padding:0pt 5.15pt 0pt 5.15pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;text-align:center;margin:2pt 0pt 2pt 0pt;"><font style="font-size:10pt;">&#9679;</font></p></td><td style="vertical-align:top;width:8.65%;border-bottom:1px solid #000000;border-left:1px solid #000000;border-right:1px solid #000000;border-top:1px solid #000000;margin:0pt;padding:0pt 5.15pt 0pt 5.15pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;text-align:center;margin:2pt 0pt 2pt 0pt;"><font style="font-size:10pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:top;width:6.73%;background:#fff4ce;border-bottom:1px solid #000000;border-left:1px solid #000000;border-right:1px solid #000000;border-top:1px solid #000000;margin:0pt;padding:0pt 5.15pt 0pt 5.15pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;text-align:center;margin:2pt 0pt 2pt 0pt;"><font style="font-size:10pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:top;width:8.65%;border-bottom:1px solid #000000;border-left:1px solid #000000;border-right:1px solid #000000;border-top:1px solid #000000;margin:0pt;padding:0pt 5.15pt 0pt 5.15pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;text-align:center;margin:2pt 0pt 2pt 0pt;"><font style="font-size:10pt;">&#9679;</font></p></td><td style="vertical-align:top;width:9.61%;background:#fff4ce;border-bottom:1px solid #000000;border-left:1px solid #000000;border-right:1px solid #000000;border-top:1px solid #000000;margin:0pt;padding:0pt 5.15pt 0pt 5.15pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;text-align:center;margin:2pt 0pt 2pt 0pt;"><font style="font-size:10pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:top;width:11.53%;border-bottom:1px solid #000000;border-left:1px solid #000000;border-right:1px solid #000000;border-top:1px solid #000000;margin:0pt;padding:0pt 5.15pt 0pt 5.15pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;text-align:center;margin:2pt 0pt 2pt 0pt;"><font style="font-size:10pt;">&#9679;</font></p></td></tr><tr style="height:13.8pt;"><td style="vertical-align:top;width:24.03%;border-bottom:1px solid #000000;border-left:1px solid #000000;border-right:1px solid #000000;border-top:1px solid #000000;margin:0pt;padding:0pt 5.15pt 0pt 5.15pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:9pt;font-weight:bold;margin:2pt 0pt 2pt 0pt;">Research &amp; Discovery</p></td><td style="vertical-align:top;width:10.57%;background:#fff4ce;border-bottom:1px solid #000000;border-left:1px solid #000000;border-right:1px solid #000000;border-top:1px solid #000000;margin:0pt;padding:0pt 5.15pt 0pt 5.15pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;text-align:center;margin:2pt 0pt 2pt 0pt;"><font style="font-size:10pt;">&#9679;</font></p></td><td style="vertical-align:top;width:10.57%;border-bottom:1px solid #000000;border-left:1px solid #000000;border-right:1px solid #000000;border-top:1px solid #000000;margin:0pt;padding:0pt 5.15pt 0pt 5.15pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;text-align:center;margin:2pt 0pt 2pt 0pt;"><font style="font-size:10pt;">&#9679;</font></p></td><td style="vertical-align:top;width:9.61%;background:#fff4ce;border-bottom:1px solid #000000;border-left:1px solid #000000;border-right:1px solid #000000;border-top:1px solid #000000;margin:0pt;padding:0pt 5.15pt 0pt 5.15pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;text-align:center;margin:2pt 0pt 2pt 0pt;"><font style="font-size:10pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:top;width:8.65%;border-bottom:1px solid #000000;border-left:1px solid #000000;border-right:1px solid #000000;border-top:1px solid #000000;margin:0pt;padding:0pt 5.15pt 0pt 5.15pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;text-align:center;margin:2pt 0pt 2pt 0pt;"><font style="font-size:10pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:top;width:6.73%;background:#fff4ce;border-bottom:1px solid #000000;border-left:1px solid #000000;border-right:1px solid #000000;border-top:1px solid #000000;margin:0pt;padding:0pt 5.15pt 0pt 5.15pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;text-align:center;margin:2pt 0pt 2pt 0pt;"><font style="font-size:10pt;">&#9679;</font></p></td><td style="vertical-align:top;width:8.65%;border-bottom:1px solid #000000;border-left:1px solid #000000;border-right:1px solid #000000;border-top:1px solid #000000;margin:0pt;padding:0pt 5.15pt 0pt 5.15pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;text-align:center;margin:2pt 0pt 2pt 0pt;"><font style="font-size:10pt;">&#9679;</font></p></td><td style="vertical-align:top;width:9.61%;background:#fff4ce;border-bottom:1px solid #000000;border-left:1px solid #000000;border-right:1px solid #000000;border-top:1px solid #000000;margin:0pt;padding:0pt 5.15pt 0pt 5.15pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;text-align:center;margin:2pt 0pt 2pt 0pt;"><font style="font-size:10pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:top;width:11.53%;border-bottom:1px solid #000000;border-left:1px solid #000000;border-right:1px solid #000000;border-top:1px solid #000000;margin:0pt;padding:0pt 5.15pt 0pt 5.15pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;text-align:center;margin:2pt 0pt 2pt 0pt;"><font style="font-size:10pt;">&#9679;</font></p></td></tr><tr style="height:13.8pt;"><td style="vertical-align:top;width:24.03%;border-bottom:1px solid #000000;border-left:1px solid #000000;border-right:1px solid #000000;border-top:1px solid #000000;margin:0pt;padding:0pt 5.15pt 0pt 5.15pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:9pt;font-weight:bold;margin:2pt 0pt 2pt 0pt;">Regulatory </p></td><td style="vertical-align:top;width:10.57%;background:#fff4ce;border-bottom:1px solid #000000;border-left:1px solid #000000;border-right:1px solid #000000;border-top:1px solid #000000;margin:0pt;padding:0pt 5.15pt 0pt 5.15pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;text-align:center;margin:2pt 0pt 2pt 0pt;"><font style="font-size:10pt;">&#9679;</font></p></td><td style="vertical-align:top;width:10.57%;border-bottom:1px solid #000000;border-left:1px solid #000000;border-right:1px solid #000000;border-top:1px solid #000000;margin:0pt;padding:0pt 5.15pt 0pt 5.15pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;text-align:center;margin:2pt 0pt 2pt 0pt;"><font style="font-size:10pt;">&#9679;</font></p></td><td style="vertical-align:top;width:9.61%;background:#fff4ce;border-bottom:1px solid #000000;border-left:1px solid #000000;border-right:1px solid #000000;border-top:1px solid #000000;margin:0pt;padding:0pt 5.15pt 0pt 5.15pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;text-align:center;margin:2pt 0pt 2pt 0pt;"><font style="font-size:10pt;">&#9679;</font></p></td><td style="vertical-align:top;width:8.65%;border-bottom:1px solid #000000;border-left:1px solid #000000;border-right:1px solid #000000;border-top:1px solid #000000;margin:0pt;padding:0pt 5.15pt 0pt 5.15pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;text-align:center;margin:2pt 0pt 2pt 0pt;"><font style="font-size:10pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:top;width:6.73%;background:#fff4ce;border-bottom:1px solid #000000;border-left:1px solid #000000;border-right:1px solid #000000;border-top:1px solid #000000;margin:0pt;padding:0pt 5.15pt 0pt 5.15pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;text-align:center;margin:2pt 0pt 2pt 0pt;"><font style="font-size:10pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:top;width:8.65%;border-bottom:1px solid #000000;border-left:1px solid #000000;border-right:1px solid #000000;border-top:1px solid #000000;margin:0pt;padding:0pt 5.15pt 0pt 5.15pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;text-align:center;margin:2pt 0pt 2pt 0pt;"><font style="font-size:10pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:top;width:9.61%;background:#fff4ce;border-bottom:1px solid #000000;border-left:1px solid #000000;border-right:1px solid #000000;border-top:1px solid #000000;margin:0pt;padding:0pt 5.15pt 0pt 5.15pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;text-align:center;margin:2pt 0pt 2pt 0pt;"><font style="font-size:10pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:top;width:11.53%;border-bottom:1px solid #000000;border-left:1px solid #000000;border-right:1px solid #000000;border-top:1px solid #000000;margin:0pt;padding:0pt 5.15pt 0pt 5.15pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;text-align:center;margin:2pt 0pt 2pt 0pt;"><font style="font-size:10pt;">&#9679;</font></p></td></tr><tr style="height:13.8pt;"><td style="vertical-align:top;width:24.03%;border-bottom:1px solid #000000;border-left:1px solid #000000;border-right:1px solid #000000;border-top:1px solid #000000;margin:0pt;padding:0pt 5.15pt 0pt 5.15pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:9pt;font-weight:bold;margin:2pt 0pt 2pt 0pt;">Target Disease Space / Customers</p></td><td style="vertical-align:top;width:10.57%;background:#fff4ce;border-bottom:1px solid #000000;border-left:1px solid #000000;border-right:1px solid #000000;border-top:1px solid #000000;margin:0pt;padding:0pt 5.15pt 0pt 5.15pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;text-align:center;margin:2pt 0pt 2pt 0pt;"><font style="font-size:10pt;">&#9679;</font></p></td><td style="vertical-align:top;width:10.57%;border-bottom:1px solid #000000;border-left:1px solid #000000;border-right:1px solid #000000;border-top:1px solid #000000;margin:0pt;padding:0pt 5.15pt 0pt 5.15pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;text-align:center;margin:2pt 0pt 2pt 0pt;"><font style="font-size:10pt;">&#9679;</font></p></td><td style="vertical-align:top;width:9.61%;background:#fff4ce;border-bottom:1px solid #000000;border-left:1px solid #000000;border-right:1px solid #000000;border-top:1px solid #000000;margin:0pt;padding:0pt 5.15pt 0pt 5.15pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;text-align:center;margin:2pt 0pt 2pt 0pt;"><font style="font-size:10pt;">&#9679;</font></p></td><td style="vertical-align:top;width:8.65%;border-bottom:1px solid #000000;border-left:1px solid #000000;border-right:1px solid #000000;border-top:1px solid #000000;margin:0pt;padding:0pt 5.15pt 0pt 5.15pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;text-align:center;margin:2pt 0pt 2pt 0pt;"><font style="font-size:10pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:top;width:6.73%;background:#fff4ce;border-bottom:1px solid #000000;border-left:1px solid #000000;border-right:1px solid #000000;border-top:1px solid #000000;margin:0pt;padding:0pt 5.15pt 0pt 5.15pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;text-align:center;margin:2pt 0pt 2pt 0pt;"><font style="font-size:10pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:top;width:8.65%;border-bottom:1px solid #000000;border-left:1px solid #000000;border-right:1px solid #000000;border-top:1px solid #000000;margin:0pt;padding:0pt 5.15pt 0pt 5.15pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;text-align:center;margin:2pt 0pt 2pt 0pt;"><font style="font-size:10pt;">&#9679;</font></p></td><td style="vertical-align:top;width:9.61%;background:#fff4ce;border-bottom:1px solid #000000;border-left:1px solid #000000;border-right:1px solid #000000;border-top:1px solid #000000;margin:0pt;padding:0pt 5.15pt 0pt 5.15pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;text-align:center;margin:2pt 0pt 2pt 0pt;"><font style="font-size:10pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:top;width:11.53%;border-bottom:1px solid #000000;border-left:1px solid #000000;border-right:1px solid #000000;border-top:1px solid #000000;margin:0pt;padding:0pt 5.15pt 0pt 5.15pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;text-align:center;margin:2pt 0pt 2pt 0pt;"><font style="font-size:10pt;">&#9679;</font></p></td></tr><tr style="height:13.8pt;"><td style="vertical-align:top;width:24.03%;border-bottom:1px solid #000000;border-left:1px solid #000000;border-right:1px solid #000000;border-top:1px solid #000000;margin:0pt;padding:0pt 5.15pt 0pt 5.15pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:9pt;font-weight:bold;margin:2pt 0pt 2pt 0pt;">Government Affairs </p></td><td style="vertical-align:top;width:10.57%;background:#fff4ce;border-bottom:1px solid #000000;border-left:1px solid #000000;border-right:1px solid #000000;border-top:1px solid #000000;margin:0pt;padding:0pt 5.15pt 0pt 5.15pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;text-align:center;margin:2pt 0pt 2pt 0pt;"><font style="font-size:10pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:top;width:10.57%;border-bottom:1px solid #000000;border-left:1px solid #000000;border-right:1px solid #000000;border-top:1px solid #000000;margin:0pt;padding:0pt 5.15pt 0pt 5.15pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;text-align:center;margin:2pt 0pt 2pt 0pt;"><font style="font-size:10pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:top;width:9.61%;background:#fff4ce;border-bottom:1px solid #000000;border-left:1px solid #000000;border-right:1px solid #000000;border-top:1px solid #000000;margin:0pt;padding:0pt 5.15pt 0pt 5.15pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;text-align:center;margin:2pt 0pt 2pt 0pt;"><font style="font-size:10pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:top;width:8.65%;border-bottom:1px solid #000000;border-left:1px solid #000000;border-right:1px solid #000000;border-top:1px solid #000000;margin:0pt;padding:0pt 5.15pt 0pt 5.15pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;text-align:center;margin:2pt 0pt 2pt 0pt;"><font style="font-size:10pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:top;width:6.73%;background:#fff4ce;border-bottom:1px solid #000000;border-left:1px solid #000000;border-right:1px solid #000000;border-top:1px solid #000000;margin:0pt;padding:0pt 5.15pt 0pt 5.15pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;text-align:center;margin:2pt 0pt 2pt 0pt;"><font style="font-size:10pt;">&#9679;</font></p></td><td style="vertical-align:top;width:8.65%;border-bottom:1px solid #000000;border-left:1px solid #000000;border-right:1px solid #000000;border-top:1px solid #000000;margin:0pt;padding:0pt 5.15pt 0pt 5.15pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;text-align:center;margin:2pt 0pt 2pt 0pt;"><font style="font-size:10pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:top;width:9.61%;background:#fff4ce;border-bottom:1px solid #000000;border-left:1px solid #000000;border-right:1px solid #000000;border-top:1px solid #000000;margin:0pt;padding:0pt 5.15pt 0pt 5.15pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;text-align:center;margin:2pt 0pt 2pt 0pt;"><font style="font-size:10pt;">&#9679;</font></p></td><td style="vertical-align:top;width:11.53%;border-bottom:1px solid #000000;border-left:1px solid #000000;border-right:1px solid #000000;border-top:1px solid #000000;margin:0pt;padding:0pt 5.15pt 0pt 5.15pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;text-align:center;margin:2pt 0pt 2pt 0pt;"><font style="font-size:10pt;">&#9679;</font></p></td></tr><tr style="height:13.8pt;"><td style="vertical-align:top;width:24.03%;border-bottom:1px solid #000000;border-left:1px solid #000000;border-right:1px solid #000000;border-top:1px solid #000000;margin:0pt;padding:0pt 5.15pt 0pt 5.15pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:9pt;font-weight:bold;margin:2pt 0pt 2pt 0pt;">International Business </p></td><td style="vertical-align:top;width:10.57%;background:#fff4ce;border-bottom:1px solid #000000;border-left:1px solid #000000;border-right:1px solid #000000;border-top:1px solid #000000;margin:0pt;padding:0pt 5.15pt 0pt 5.15pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;text-align:center;margin:2pt 0pt 2pt 0pt;"><font style="font-size:10pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:top;width:10.57%;border-bottom:1px solid #000000;border-left:1px solid #000000;border-right:1px solid #000000;border-top:1px solid #000000;margin:0pt;padding:0pt 5.15pt 0pt 5.15pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;text-align:center;margin:2pt 0pt 2pt 0pt;"><font style="font-size:10pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:top;width:9.61%;background:#fff4ce;border-bottom:1px solid #000000;border-left:1px solid #000000;border-right:1px solid #000000;border-top:1px solid #000000;margin:0pt;padding:0pt 5.15pt 0pt 5.15pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;text-align:center;margin:2pt 0pt 2pt 0pt;"><font style="font-size:10pt;">&#9679;</font></p></td><td style="vertical-align:top;width:8.65%;border-bottom:1px solid #000000;border-left:1px solid #000000;border-right:1px solid #000000;border-top:1px solid #000000;margin:0pt;padding:0pt 5.15pt 0pt 5.15pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;text-align:center;margin:2pt 0pt 2pt 0pt;"><font style="font-size:10pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:top;width:6.73%;background:#fff4ce;border-bottom:1px solid #000000;border-left:1px solid #000000;border-right:1px solid #000000;border-top:1px solid #000000;margin:0pt;padding:0pt 5.15pt 0pt 5.15pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;text-align:center;margin:2pt 0pt 2pt 0pt;"><font style="font-size:10pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:top;width:8.65%;border-bottom:1px solid #000000;border-left:1px solid #000000;border-right:1px solid #000000;border-top:1px solid #000000;margin:0pt;padding:0pt 5.15pt 0pt 5.15pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;text-align:center;margin:2pt 0pt 2pt 0pt;"><font style="font-size:10pt;">&#9679;</font></p></td><td style="vertical-align:top;width:9.61%;background:#fff4ce;border-bottom:1px solid #000000;border-left:1px solid #000000;border-right:1px solid #000000;border-top:1px solid #000000;margin:0pt;padding:0pt 5.15pt 0pt 5.15pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;text-align:center;margin:2pt 0pt 2pt 0pt;"><font style="font-size:10pt;">&#9679;</font></p></td><td style="vertical-align:top;width:11.53%;border-bottom:1px solid #000000;border-left:1px solid #000000;border-right:1px solid #000000;border-top:1px solid #000000;margin:0pt;padding:0pt 5.15pt 0pt 5.15pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;text-align:center;margin:2pt 0pt 2pt 0pt;"><font style="font-size:10pt;">&#9679;</font></p></td></tr><tr style="height:13.8pt;"><td style="vertical-align:top;width:24.03%;border-bottom:1px solid #000000;border-left:1px solid #000000;border-right:1px solid #000000;border-top:1px solid #000000;margin:0pt;padding:0pt 5.15pt 0pt 5.15pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:9pt;font-weight:bold;margin:2pt 0pt 2pt 0pt;">Legal / Compliance </p></td><td style="vertical-align:top;width:10.57%;background:#fff4ce;border-bottom:1px solid #000000;border-left:1px solid #000000;border-right:1px solid #000000;border-top:1px solid #000000;margin:0pt;padding:0pt 5.15pt 0pt 5.15pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;text-align:center;margin:2pt 0pt 2pt 0pt;"><font style="font-size:10pt;">&#9679;</font></p></td><td style="vertical-align:top;width:10.57%;border-bottom:1px solid #000000;border-left:1px solid #000000;border-right:1px solid #000000;border-top:1px solid #000000;margin:0pt;padding:0pt 5.15pt 0pt 5.15pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;text-align:center;margin:2pt 0pt 2pt 0pt;"><font style="font-size:10pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:top;width:9.61%;background:#fff4ce;border-bottom:1px solid #000000;border-left:1px solid #000000;border-right:1px solid #000000;border-top:1px solid #000000;margin:0pt;padding:0pt 5.15pt 0pt 5.15pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;text-align:center;margin:2pt 0pt 2pt 0pt;"><font style="font-size:10pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:top;width:8.65%;border-bottom:1px solid #000000;border-left:1px solid #000000;border-right:1px solid #000000;border-top:1px solid #000000;margin:0pt;padding:0pt 5.15pt 0pt 5.15pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;text-align:center;margin:2pt 0pt 2pt 0pt;"><font style="font-size:10pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:top;width:6.73%;background:#fff4ce;border-bottom:1px solid #000000;border-left:1px solid #000000;border-right:1px solid #000000;border-top:1px solid #000000;margin:0pt;padding:0pt 5.15pt 0pt 5.15pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;text-align:center;margin:2pt 0pt 2pt 0pt;"><font style="font-size:10pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:top;width:8.65%;border-bottom:1px solid #000000;border-left:1px solid #000000;border-right:1px solid #000000;border-top:1px solid #000000;margin:0pt;padding:0pt 5.15pt 0pt 5.15pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;text-align:center;margin:2pt 0pt 2pt 0pt;"><font style="font-size:10pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:top;width:9.61%;background:#fff4ce;border-bottom:1px solid #000000;border-left:1px solid #000000;border-right:1px solid #000000;border-top:1px solid #000000;margin:0pt;padding:0pt 5.15pt 0pt 5.15pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;text-align:center;margin:2pt 0pt 2pt 0pt;"><font style="font-size:10pt;">&#9679;</font></p></td><td style="vertical-align:top;width:11.53%;border-bottom:1px solid #000000;border-left:1px solid #000000;border-right:1px solid #000000;border-top:1px solid #000000;margin:0pt;padding:0pt 5.15pt 0pt 5.15pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;text-align:center;margin:2pt 0pt 2pt 0pt;"><font style="font-size:10pt;">&#9679;</font></p></td></tr><tr style="height:13.8pt;"><td style="vertical-align:top;width:24.03%;border-bottom:1px solid #000000;border-left:1px solid #000000;border-right:1px solid #000000;border-top:1px solid #000000;margin:0pt;padding:0pt 5.15pt 0pt 5.15pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:9pt;font-weight:bold;margin:2pt 0pt 2pt 0pt;">Human Capital Management </p></td><td style="vertical-align:top;width:10.57%;background:#fff4ce;border-bottom:1px solid #000000;border-left:1px solid #000000;border-right:1px solid #000000;border-top:1px solid #000000;margin:0pt;padding:0pt 5.15pt 0pt 5.15pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;text-align:center;margin:2pt 0pt 2pt 0pt;"><font style="font-size:10pt;">&#9679;</font></p></td><td style="vertical-align:top;width:10.57%;border-bottom:1px solid #000000;border-left:1px solid #000000;border-right:1px solid #000000;border-top:1px solid #000000;margin:0pt;padding:0pt 5.15pt 0pt 5.15pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;text-align:center;margin:2pt 0pt 2pt 0pt;"><font style="font-size:10pt;">&#9679;</font></p></td><td style="vertical-align:top;width:9.61%;background:#fff4ce;border-bottom:1px solid #000000;border-left:1px solid #000000;border-right:1px solid #000000;border-top:1px solid #000000;margin:0pt;padding:0pt 5.15pt 0pt 5.15pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;text-align:center;margin:2pt 0pt 2pt 0pt;"><font style="font-size:10pt;">&#9679;</font></p></td><td style="vertical-align:top;width:8.65%;border-bottom:1px solid #000000;border-left:1px solid #000000;border-right:1px solid #000000;border-top:1px solid #000000;margin:0pt;padding:0pt 5.15pt 0pt 5.15pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;text-align:center;margin:2pt 0pt 2pt 0pt;"><font style="font-size:10pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:top;width:6.73%;background:#fff4ce;border-bottom:1px solid #000000;border-left:1px solid #000000;border-right:1px solid #000000;border-top:1px solid #000000;margin:0pt;padding:0pt 5.15pt 0pt 5.15pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;text-align:center;margin:2pt 0pt 2pt 0pt;"><font style="font-size:10pt;">&#9679;</font></p></td><td style="vertical-align:top;width:8.65%;border-bottom:1px solid #000000;border-left:1px solid #000000;border-right:1px solid #000000;border-top:1px solid #000000;margin:0pt;padding:0pt 5.15pt 0pt 5.15pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;text-align:center;margin:2pt 0pt 2pt 0pt;"><font style="font-size:10pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:top;width:9.61%;background:#fff4ce;border-bottom:1px solid #000000;border-left:1px solid #000000;border-right:1px solid #000000;border-top:1px solid #000000;margin:0pt;padding:0pt 5.15pt 0pt 5.15pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;text-align:center;margin:2pt 0pt 2pt 0pt;"><font style="font-size:10pt;">&#9679;</font></p></td><td style="vertical-align:top;width:11.53%;border-bottom:1px solid #000000;border-left:1px solid #000000;border-right:1px solid #000000;border-top:1px solid #000000;margin:0pt;padding:0pt 5.15pt 0pt 5.15pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;text-align:center;margin:2pt 0pt 2pt 0pt;"><font style="font-size:10pt;">&#9679;</font></p></td></tr><tr style="height:13.8pt;"><td style="vertical-align:top;width:24.03%;border-bottom:1px solid #000000;border-left:1px solid #000000;border-right:1px solid #000000;border-top:1px solid #000000;margin:0pt;padding:0pt 5.15pt 0pt 5.15pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:9pt;font-weight:bold;margin:2pt 0pt 2pt 0pt;">Public / Investor Relations</p></td><td style="vertical-align:top;width:10.57%;background:#fff4ce;border-bottom:1px solid #000000;border-left:1px solid #000000;border-right:1px solid #000000;border-top:1px solid #000000;margin:0pt;padding:0pt 5.15pt 0pt 5.15pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;text-align:center;margin:2pt 0pt 2pt 0pt;"><font style="font-size:10pt;">&#9679;</font></p></td><td style="vertical-align:top;width:10.57%;border-bottom:1px solid #000000;border-left:1px solid #000000;border-right:1px solid #000000;border-top:1px solid #000000;margin:0pt;padding:0pt 5.15pt 0pt 5.15pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;text-align:center;margin:2pt 0pt 2pt 0pt;"><font style="font-size:10pt;">&#9679;</font></p></td><td style="vertical-align:top;width:9.61%;background:#fff4ce;border-bottom:1px solid #000000;border-left:1px solid #000000;border-right:1px solid #000000;border-top:1px solid #000000;margin:0pt;padding:0pt 5.15pt 0pt 5.15pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;text-align:center;margin:2pt 0pt 2pt 0pt;"><font style="font-size:10pt;">&#9679;</font></p></td><td style="vertical-align:top;width:8.65%;border-bottom:1px solid #000000;border-left:1px solid #000000;border-right:1px solid #000000;border-top:1px solid #000000;margin:0pt;padding:0pt 5.15pt 0pt 5.15pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;text-align:center;margin:2pt 0pt 2pt 0pt;"><font style="font-size:10pt;">&#9679;</font></p></td><td style="vertical-align:top;width:6.73%;background:#fff4ce;border-bottom:1px solid #000000;border-left:1px solid #000000;border-right:1px solid #000000;border-top:1px solid #000000;margin:0pt;padding:0pt 5.15pt 0pt 5.15pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;text-align:center;margin:2pt 0pt 2pt 0pt;"><font style="font-size:10pt;">&#9679;</font></p></td><td style="vertical-align:top;width:8.65%;border-bottom:1px solid #000000;border-left:1px solid #000000;border-right:1px solid #000000;border-top:1px solid #000000;margin:0pt;padding:0pt 5.15pt 0pt 5.15pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;text-align:center;margin:2pt 0pt 2pt 0pt;"><font style="font-size:10pt;">&#9679;</font></p></td><td style="vertical-align:top;width:9.61%;background:#fff4ce;border-bottom:1px solid #000000;border-left:1px solid #000000;border-right:1px solid #000000;border-top:1px solid #000000;margin:0pt;padding:0pt 5.15pt 0pt 5.15pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;text-align:center;margin:2pt 0pt 2pt 0pt;"><font style="font-size:10pt;">&#9679;</font></p></td><td style="vertical-align:top;width:11.53%;border-bottom:1px solid #000000;border-left:1px solid #000000;border-right:1px solid #000000;border-top:1px solid #000000;margin:0pt;padding:0pt 5.15pt 0pt 5.15pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;text-align:center;margin:2pt 0pt 2pt 0pt;"><font style="font-size:10pt;">&#9679;</font></p></td></tr><tr style="height:13.8pt;"><td style="vertical-align:top;width:24.03%;border-bottom:1px solid #000000;border-left:1px solid #000000;border-right:1px solid #000000;border-top:1px solid #000000;margin:0pt;padding:0pt 5.15pt 0pt 5.15pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:9pt;font-weight:bold;margin:2pt 0pt 2pt 0pt;">Risk Management </p></td><td style="vertical-align:top;width:10.57%;background:#fff4ce;border-bottom:1px solid #000000;border-left:1px solid #000000;border-right:1px solid #000000;border-top:1px solid #000000;margin:0pt;padding:0pt 5.15pt 0pt 5.15pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;text-align:center;margin:2pt 0pt 2pt 0pt;"><font style="font-size:10pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:top;width:10.57%;border-bottom:1px solid #000000;border-left:1px solid #000000;border-right:1px solid #000000;border-top:1px solid #000000;margin:0pt;padding:0pt 5.15pt 0pt 5.15pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;text-align:center;margin:2pt 0pt 2pt 0pt;"><font style="font-size:10pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:top;width:9.61%;background:#fff4ce;border-bottom:1px solid #000000;border-left:1px solid #000000;border-right:1px solid #000000;border-top:1px solid #000000;margin:0pt;padding:0pt 5.15pt 0pt 5.15pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;text-align:center;margin:2pt 0pt 2pt 0pt;"><font style="font-size:10pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:top;width:8.65%;border-bottom:1px solid #000000;border-left:1px solid #000000;border-right:1px solid #000000;border-top:1px solid #000000;margin:0pt;padding:0pt 5.15pt 0pt 5.15pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;text-align:center;margin:2pt 0pt 2pt 0pt;"><font style="font-size:10pt;">&#9679;</font></p></td><td style="vertical-align:top;width:6.73%;background:#fff4ce;border-bottom:1px solid #000000;border-left:1px solid #000000;border-right:1px solid #000000;border-top:1px solid #000000;margin:0pt;padding:0pt 5.15pt 0pt 5.15pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;text-align:center;margin:2pt 0pt 2pt 0pt;"><font style="font-size:10pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:top;width:8.65%;border-bottom:1px solid #000000;border-left:1px solid #000000;border-right:1px solid #000000;border-top:1px solid #000000;margin:0pt;padding:0pt 5.15pt 0pt 5.15pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;text-align:center;margin:2pt 0pt 2pt 0pt;"><font style="font-size:10pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:top;width:9.61%;background:#fff4ce;border-bottom:1px solid #000000;border-left:1px solid #000000;border-right:1px solid #000000;border-top:1px solid #000000;margin:0pt;padding:0pt 5.15pt 0pt 5.15pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;text-align:center;margin:2pt 0pt 2pt 0pt;"><font style="font-size:10pt;">&#9679;</font></p></td><td style="vertical-align:top;width:11.53%;border-bottom:1px solid #000000;border-left:1px solid #000000;border-right:1px solid #000000;border-top:1px solid #000000;margin:0pt;padding:0pt 5.15pt 0pt 5.15pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;text-align:center;margin:2pt 0pt 2pt 0pt;"><font style="font-size:10pt;">&#9679;</font></p></td></tr></table></div><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><font style="font-size:5pt;font-weight:bold;visibility:hidden;">&#8203;</font></p></div><div style="clear:both;display:table;margin-bottom:27.35pt;min-height:44.65pt;width:100%;"><div style="display:table-cell;vertical-align:bottom;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;min-height:12.0pt;text-align:center;margin:24pt 0pt 0pt 0pt;">13</p></div></div></div><hr style="background-color:#000000;clear:both;color:#000000;height:2pt;line-height:0;margin-bottom:30pt;margin-left:11.76%;margin-right:11.76%;margin-top:30pt;page-break-after:always;width:76.47%;border-width:0;"><div style="max-width:100%;padding-left:11.76%;padding-right:11.76%;position:relative;"><div style="margin-top:27.35pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"><font style="font-weight:bold;visibility:hidden;">&#8203;</font></p></div><div style="clear:both;max-width:100%;position:relative;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;line-height:1.19;margin:0pt;">INDEPENDENCE OF THE BOARD OF DIRECTORS</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;line-height:1.19;margin:0pt;"><font style="font-weight:normal;visibility:hidden;">&#8203;</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:0pt;margin:0pt;"><a name="_DV_M338"></a><a name="_DV_M339"></a><a name="_DV_C132"></a>As required under N<a name="_DV_M340"></a>a<a name="_DV_M342"></a><a name="_DV_M343"></a>sdaq listing rules, a majority of the members of our Board must qualify as &#8220;independent,&#8221; as affirmatively determined by the Board. The Board consults with the Company&#8217;s counsel to ensure that the Board&#8217;s determinations are consistent with relevant securities and other laws and regulations regarding the definition of &#8220;independent,&#8221; including those set forth in pertinent listing standards of Nasdaq, as in effect from time to time. </p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:0pt;margin:0pt;"><font style="margin-bottom:12pt;visibility:hidden;">&#8203;</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:0pt;margin:0pt;"><a name="_DV_M344"></a>Consistent with these considerations, after review of all relevant identified transactions or relationships between each director, or any of his or her family members, and the Company, its senior management and its independent auditors, the Board has affirmatively determined that Ms. Andrews, Drs. Goldberg and Koenig, and Messrs.&#160;<a name="_DV_M346"></a>Jackson, Junius and Pearson, representing six of our eight current directors, are &#8220;independent directors&#8221; as defined under Nasdaq listing rules. In making this determination, the Board found that none of these directors had a material or other disqualifying relationship with us. Mr. Semerjian is not an independent director by virtue of his employment with us. Ms. King is not an independent director due to her employment with the Company within the prior three years. </p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:0pt;margin:0pt;"><a name="_DV_M348"></a><a name="_DV_M349"></a><a name="_DV_M350"></a><font style="margin-bottom:12pt;visibility:hidden;">&#8203;</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:0pt;margin:0pt;"><b style="font-weight:bold;">BOARD DIVERSITY MATRIX</b></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:0pt;margin:0pt;"><font style="margin-bottom:12pt;visibility:hidden;">&#8203;</font></p><div><table style="border-collapse:collapse;font-size:16pt;height:max-content;margin-left:auto;margin-right:auto;padding-left:0pt;padding-right:0pt;table-layout:auto;width:100%;" align="center"><tr style="height:1pt;"><td style="vertical-align:top;width:48.08%;border-bottom:1.0pt solid #000000;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="position:absolute;top:0pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;"><font style="font-size:1pt;visibility:hidden;">&#8203;</font></p></div></div></td><td style="vertical-align:top;width:12.85%;border-bottom:1.0pt solid #000000;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="position:absolute;top:0pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 10.15pt 0pt 11.25pt;"><font style="font-size:11pt;font-weight:bold;margin-left:0pt;margin-right:0pt;visibility:hidden;">&#8203;</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;"><font style="font-size:1pt;visibility:hidden;">&#8203;</font></p></div></div></td><td style="vertical-align:top;width:12.05%;border-bottom:1.0pt solid #000000;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="position:absolute;top:0pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 13.55pt 0pt 14.55pt;"><font style="font-size:11pt;font-weight:bold;margin-left:0pt;margin-right:0pt;visibility:hidden;">&#8203;</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;"><font style="font-size:1pt;visibility:hidden;">&#8203;</font></p></div></div></td><td style="vertical-align:top;width:13.69%;border-bottom:1.0pt solid #000000;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="position:absolute;top:0pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 1.4pt 0pt 2.45pt;"><font style="font-size:11pt;font-weight:bold;margin-left:0pt;margin-right:0pt;visibility:hidden;">&#8203;</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;"><font style="font-size:1pt;visibility:hidden;">&#8203;</font></p></div></div></td><td style="vertical-align:top;width:13.31%;border-bottom:1.0pt solid #000000;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="position:absolute;top:0pt;width:100%;"></div></div></td></tr><tr style="height:14.4pt;"><td colspan="5" style="vertical-align:top;width:100%;border-bottom:1.0pt solid #000000;border-left:1.0pt solid #000000;border-right:1.0pt solid #000000;border-top:1.0pt solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">Board</b><b style="font-weight:bold;letter-spacing:-0.1pt;"> </b><b style="font-weight:bold;">Diversity</b><b style="font-weight:bold;letter-spacing:-0.15pt;"> </b><b style="font-weight:bold;">Matrix</b><b style="font-weight:bold;letter-spacing:-0.15pt;"> </b><b style="font-weight:bold;">(as of </b><b style="font-weight:bold;letter-spacing:0.15pt;">April 11, 2022</b><b style="font-weight:bold;">)</b></p></td></tr><tr style="height:14.4pt;"><td colspan="5" style="vertical-align:top;width:100%;border-bottom:1.0pt solid #000000;border-left:1.0pt solid #000000;border-right:1.0pt solid #000000;border-top:1.0pt solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;"><b style="font-weight:bold;">Total Number of Directors: &#160; &#160; &#160; &#160; &#160; &#160; &#160; &#160; &#160; &#160; &#160; &#160; &#160; &#160; &#160; &#160; &#160; &#160; &#160; &#160; &#160; &#160; &#160; &#160; &#160; &#160; &#160; &#160; &#160; &#160; &#160; &#160; &#160; 8</b></p></td></tr><tr style="height:31.85pt;"><td style="vertical-align:bottom;width:48.08%;border-bottom:1.0pt solid #000000;border-left:1.0pt solid #000000;border-right:1.0pt solid #000000;border-top:1.0pt solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt 0pt 4pt 0pt;"><font style="visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;width:12.85%;border-bottom:1.0pt solid #000000;border-left:1.0pt solid #000000;border-right:1.0pt solid #000000;border-top:1.0pt solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 10.15pt 4pt 11.25pt;"><b style="font-weight:bold;">Female</b></p></td><td style="vertical-align:bottom;width:12.05%;border-bottom:1.0pt solid #000000;border-left:1.0pt solid #000000;border-right:1.0pt solid #000000;border-top:1.0pt solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 13.55pt 4pt 14.55pt;"><b style="font-weight:bold;">Male</b></p></td><td style="vertical-align:bottom;width:13.69%;border-bottom:1.0pt solid #000000;border-left:1.0pt solid #000000;border-right:1.0pt solid #000000;border-top:1.0pt solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 1.4pt 4pt 2.45pt;"><b style="font-weight:bold;">Non-Binary</b></p></td><td style="vertical-align:bottom;width:13.31%;border-bottom:1.0pt solid #000000;border-left:1.0pt solid #000000;border-right:1.0pt solid #000000;border-top:1.0pt solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;text-indent:0.45pt;margin:3.59pt 8.8pt 4pt 12.75pt;"><b style="font-weight:bold;">Did Not</b><b style="font-weight:bold;letter-spacing:-2.6pt;"> </b><b style="font-weight:bold;">Disclose</b></p></td></tr><tr style="height:21.5pt;"><td colspan="5" style="vertical-align:top;width:100%;background:#d9d9d9;border-bottom:1.0pt solid #000000;border-left:1.0pt solid #000000;border-right:1.0pt solid #000000;border-top:1.0pt solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:4.34pt 0pt 0pt 7.15pt;"><b style="font-weight:bold;">Part I:</b><b style="font-weight:bold;letter-spacing:0.05pt;"> </b><b style="font-weight:bold;">Gender Identity</b></p></td></tr><tr style="height:21.5pt;"><td style="vertical-align:top;width:48.08%;border-bottom:1.0pt solid #000000;border-left:1.0pt solid #000000;border-right:1.0pt solid #000000;border-top:1.0pt solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:4.09pt 0pt 0pt 7.15pt;">Directors</p></td><td style="vertical-align:top;width:12.85%;border-bottom:1.0pt solid #000000;border-left:1.0pt solid #000000;border-right:1.0pt solid #000000;border-top:1.0pt solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:9pt;text-align:center;margin:5.59pt 0pt 0pt 0.8pt;"><b style="font-weight:bold;">2</b></p></td><td style="vertical-align:top;width:12.05%;border-bottom:1.0pt solid #000000;border-left:1.0pt solid #000000;border-right:1.0pt solid #000000;border-top:1.0pt solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:9pt;text-align:center;margin:5.59pt 0pt 0pt 0.95pt;"><b style="font-weight:bold;">6</b></p></td><td style="vertical-align:top;width:13.69%;border-bottom:1.0pt solid #000000;border-left:1.0pt solid #000000;border-right:1.0pt solid #000000;border-top:1.0pt solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:9pt;text-align:center;margin:5.59pt 0pt 0pt 0.9pt;"><b style="font-weight:bold;">-</b></p></td><td style="vertical-align:top;width:13.31%;border-bottom:1.0pt solid #000000;border-left:1.0pt solid #000000;border-right:1.0pt solid #000000;border-top:1.0pt solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:9pt;text-align:center;margin:5.59pt 0pt 0pt 3.7pt;"><b style="font-weight:bold;">-</b></p></td></tr><tr style="height:21.5pt;"><td colspan="5" style="vertical-align:top;width:100%;background:#d9d9d9;border-bottom:1.0pt solid #000000;border-left:1.0pt solid #000000;border-right:1.0pt solid #000000;border-top:1.0pt solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:3.5pt 0pt 0pt 7.15pt;"><b style="font-weight:bold;">Part II:</b><b style="font-weight:bold;letter-spacing:0.05pt;"> </b><b style="font-weight:bold;">Demographic</b><b style="font-weight:bold;letter-spacing:-0.1pt;"> </b><b style="font-weight:bold;">Background</b></p></td></tr><tr style="height:21.5pt;"><td style="vertical-align:top;width:48.08%;border-bottom:1.0pt solid #000000;border-left:1.0pt solid #000000;border-right:1.0pt solid #000000;border-top:1.0pt solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:3.25pt 0pt 0pt 7.2pt;">White</p></td><td style="vertical-align:top;width:12.85%;border-bottom:1.0pt solid #000000;border-left:1.0pt solid #000000;border-right:1.0pt solid #000000;border-top:1.0pt solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:9pt;text-align:center;margin:3.54pt 0pt 0pt 0.8pt;"><b style="font-weight:bold;">2</b></p></td><td style="vertical-align:top;width:12.05%;border-bottom:1.0pt solid #000000;border-left:1.0pt solid #000000;border-right:1.0pt solid #000000;border-top:1.0pt solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:9pt;text-align:center;margin:3.54pt 0pt 0pt 0.95pt;"><b style="font-weight:bold;">6</b><sup style="font-family:'Times New Roman Bold';font-size:6.75pt;font-weight:bold;vertical-align:top;">*</sup></p></td><td style="vertical-align:top;width:13.69%;border-bottom:1.0pt solid #000000;border-left:1.0pt solid #000000;border-right:1.0pt solid #000000;border-top:1.0pt solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:9pt;text-align:center;margin:3.54pt 0pt 0pt 0.9pt;"><b style="font-weight:bold;">-</b></p></td><td style="vertical-align:top;width:13.31%;border-bottom:1.0pt solid #000000;border-left:1.0pt solid #000000;border-right:1.0pt solid #000000;border-top:1.0pt solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:9pt;text-align:center;margin:3.54pt 0pt 0pt 3.7pt;"><b style="font-weight:bold;">-</b></p></td></tr></table></div><div style="font-family:'Times New Roman','Times','serif';font-size:10.0pt;margin-bottom:0pt;margin-top:0pt;min-height:1.19em;position:relative;width:100%;"><hr noshade="true" color="#000000" size="1" width="25.0%" style="background-color:#000000;color:#000000;height:1pt;position:relative;top:0.6em;border:none;margin:0pt;" align="left"></div><p style="font-family:'Times New Roman','Times','serif';font-size:9pt;line-height:13.3pt;text-align:justify;margin:0pt;">* Includes one director who identifies as Middle Eastern.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:0pt;margin:0pt;"><font style="margin-bottom:12pt;visibility:hidden;">&#8203;</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;line-height:1.19;margin:0pt;"><a name="_DV_M367"></a><a name="_DV_M406"></a>ROLE OF THE BOARD IN RISK OVERSIGHT</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:0pt;margin:0pt;"><a name="_DV_M407"></a><a name="_DV_M409"></a>One of the Board&#8217;s key functions is informed oversight of our risk management process. The Board does not have a standing risk management committee, but rather administers this oversight function directly through the Board as a whole, as well as through various standing committees of the Board that address risks inherent in their respective areas of oversight. In particular, our Board is responsible for monitoring and assessing strategic risk exposure, including a determination of the nature and level of risk appropriate for our company. The Board also oversees and monitors environmental and social risk management. Our Audit Committee has the responsibility to consider and discuss our major financial risk exposures and the steps our management has taken to monitor and control these exposures, including guidelines and policies to govern the process by which risk assessment and management is undertaken. The Audit Committee also monitors compliance with legal and regulatory requirements related to matters involving our common stock and our operation as a public company, such as compliance with the rules and regulations of the SEC and the listing rules of Nasdaq. Audit Committee responsibilities also include oversight of cybersecurity risk management, and, to that end, the Audit Committee typically meets annually with both information technology and business personnel responsible for cybersecurity risk management. Our Nominating and Corporate Governance Committee monitors the effectiveness of our Corporate Governance Guidelines, including whether the guidelines are successful in preventing illegal or improper liability-creating conduct. Our Compensation Committee assesses and monitors whether any of our compensation policies and programs has the potential to encourage excessive risk-taking. It is the responsibility of the chairperson of each of these committees to report findings regarding material risk exposures to the Board as quickly as possible. The Board has delegated to </p></div><div style="clear:both;display:table;margin-bottom:27.35pt;min-height:44.65pt;width:100%;"><div style="display:table-cell;vertical-align:bottom;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;min-height:12.0pt;text-align:center;margin:24pt 0pt 0pt 0pt;">14</p></div></div></div><hr style="background-color:#000000;clear:both;color:#000000;height:2pt;line-height:0;margin-bottom:30pt;margin-left:11.76%;margin-right:11.76%;margin-top:30pt;page-break-after:always;width:76.47%;border-width:0;"><div style="max-width:100%;padding-left:11.76%;padding-right:11.76%;position:relative;"><div style="margin-top:27.35pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"><font style="font-weight:bold;visibility:hidden;">&#8203;</font></p></div><div style="clear:both;max-width:100%;position:relative;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Mr.&#160;<a name="_DV_M420"></a>Pearson as the Chair the responsibility of coordinating between the Board and management with regard to the determination and implementation of responses to any problematic risk management issues. </p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;line-height:1.19;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;line-height:1.19;margin:0pt;">MEETINGS OF THE BOARD OF DIRECTORS</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:0pt;margin:0pt;"><a name="_DV_M421"></a>Our Board met six times during the last fiscal year. Each Board member attended 75% or more of the aggregate number of meetings of the Board and of the committees on which he or she served, held during the portion of the last fiscal year for which he or she<b style="font-weight:bold;"> </b>was a director or committee member. </p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:0pt;margin:0pt;"><font style="margin-bottom:12pt;visibility:hidden;">&#8203;</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:0pt;margin:0pt;">In connection with each board meeting during 2021, the Company&#8217;s independent directors met in executive session at which only independent directors were present.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:0pt;margin:0pt;"><font style="margin-bottom:12pt;visibility:hidden;">&#8203;</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-variant:small-caps;font-weight:bold;line-height:1.19;margin:0pt;"><b style="font-variant:normal;font-weight:bold;">INFORMATION REGARDING COMMITTEES OF THE BOARD OF DIRECTORS</b></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:0pt;margin:0pt;"><a name="_DV_M435"></a><font style="margin-bottom:12pt;visibility:hidden;">&#8203;</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:0pt;margin:0pt;">The Board has an Audit Committee, a Compensation Committee and a Nominating and Corporate Governance Committee. The following table provides membership and meeting information for the fiscal year ended December 31, 2021 for each of these committees: </p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:0pt;margin:0pt;"><font style="margin-bottom:12pt;visibility:hidden;">&#8203;</font></p><div align="left"><table style="border-collapse:collapse;font-size:16pt;height:max-content;padding-left:0pt;padding-right:0pt;width:100.13%;"><tr style="height:1pt;"><td style="vertical-align:bottom;width:53.4%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;"><font style="font-size:1pt;visibility:hidden;">&#8203;</font></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.7%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;"><font style="font-size:1pt;visibility:hidden;">&#8203;</font></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:0.21%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;"><font style="font-size:1pt;visibility:hidden;">&#8203;</font></p></div></div></td><td style="vertical-align:middle;width:12.47%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="position:absolute;top:50%;transform:translate(0,-50%);width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;"><font style="font-size:1pt;visibility:hidden;">&#8203;</font></p></div></div></td><td style="vertical-align:middle;white-space:nowrap;width:2.13%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="position:absolute;top:50%;transform:translate(0,-50%);width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;"><font style="font-size:1pt;visibility:hidden;">&#8203;</font></p></div></div></td><td style="vertical-align:middle;width:13.16%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="position:absolute;top:50%;transform:translate(0,-50%);width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;"><font style="font-size:1pt;visibility:hidden;">&#8203;</font></p></div></div></td><td style="vertical-align:middle;white-space:nowrap;width:2.13%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="position:absolute;top:50%;transform:translate(0,-50%);width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;"><font style="font-size:1pt;visibility:hidden;">&#8203;</font></p></div></div></td><td style="vertical-align:middle;width:14.76%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="position:absolute;top:50%;transform:translate(0,-50%);width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;"><font style="font-size:1pt;visibility:hidden;">&#8203;</font></p></div></div></td></tr><tr><td style="vertical-align:bottom;width:53.4%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.7%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.21%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:middle;width:12.47%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;"><b style="font-weight:bold;"> </b><font style="font-weight:bold;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:middle;white-space:nowrap;width:2.13%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><font style="font-weight:bold;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:middle;width:13.16%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><b style="font-weight:bold;"> </b><font style="font-weight:bold;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:middle;white-space:nowrap;width:2.13%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><font style="font-weight:bold;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:middle;width:14.76%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">Nominating&#160;and</b></p></td></tr><tr><td style="vertical-align:bottom;width:53.4%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;"><font style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.7%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td style="vertical-align:middle;white-space:nowrap;width:0.21%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;"><font style="font-size:1pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:middle;width:12.47%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;"><font style="font-weight:bold;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:middle;white-space:nowrap;width:2.13%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><font style="font-weight:bold;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:middle;width:13.16%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><font style="font-weight:bold;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:middle;white-space:nowrap;width:2.13%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><font style="font-weight:bold;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:middle;width:14.76%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">Corporate</b></p></td></tr><tr><td style="vertical-align:bottom;width:53.4%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:justify;margin:0pt;"><b style="font-weight:bold;">Name</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.7%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><font style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:middle;white-space:nowrap;width:0.21%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;"><font style="font-weight:bold;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:middle;width:12.47%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">Audit</b></p></td><td style="vertical-align:middle;white-space:nowrap;width:2.13%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td style="vertical-align:middle;width:13.16%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">Compensation</b></p></td><td style="vertical-align:middle;white-space:nowrap;width:2.13%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td style="vertical-align:middle;width:14.76%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">Governance</b></p></td></tr><tr><td style="vertical-align:bottom;width:53.4%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;">Patricia Andrews</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.7%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><font style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:middle;white-space:nowrap;width:0.21%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;"><font style="font-weight:bold;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:middle;white-space:nowrap;width:12.47%;background:#cceeff;border-top:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;">&#9679;</p></td><td style="vertical-align:middle;white-space:nowrap;width:2.13%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:middle;width:13.16%;background:#cceeff;border-top:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;">  <font style="visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:middle;white-space:nowrap;width:2.13%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:top;white-space:nowrap;width:14.76%;background:#cceeff;border-top:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></td></tr><tr><td style="vertical-align:bottom;width:53.4%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;">Mark Goldberg, M.D.</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.7%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;">&#160;</p></td><td style="vertical-align:middle;white-space:nowrap;width:0.21%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:top;width:12.47%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"> <font style="visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:middle;white-space:nowrap;width:2.13%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:middle;white-space:nowrap;width:13.16%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;">&#9679;</p></td><td style="vertical-align:middle;white-space:nowrap;width:2.13%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:middle;white-space:nowrap;width:14.76%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:6pt;text-align:center;margin:0pt;">&#160;&#160;<font style="font-size:10pt;">&#9679;</font><sup style="font-size:7.5pt;vertical-align:top;">*</sup></p></td></tr><tr><td style="vertical-align:bottom;width:53.4%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;">Scott Jackson </p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.7%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:middle;white-space:nowrap;width:0.21%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:top;width:12.47%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;">&#9679;</p></td><td style="vertical-align:middle;white-space:nowrap;width:2.13%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:middle;white-space:nowrap;width:13.16%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;">&#9679;</p></td><td style="vertical-align:middle;white-space:nowrap;width:2.13%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:middle;white-space:nowrap;width:14.76%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></td></tr><tr><td style="vertical-align:bottom;width:53.4%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;">Daniel Junius</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.7%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:middle;white-space:nowrap;width:0.21%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:middle;white-space:nowrap;width:12.47%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:6pt;text-align:center;margin:0pt;">&#160;&#160;<font style="font-size:10pt;">&#9679;</font><sup style="font-size:7.5pt;vertical-align:top;">*</sup></p></td><td style="vertical-align:middle;white-space:nowrap;width:2.13%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:middle;white-space:nowrap;width:13.16%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"> <font style="visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:middle;white-space:nowrap;width:2.13%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:top;width:14.76%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;">&#9679;</p></td></tr><tr><td style="vertical-align:bottom;width:53.4%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;">Scott Koenig, M.D., Ph.D.</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.7%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:middle;white-space:nowrap;width:0.21%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:middle;width:12.47%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"> <font style="visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:middle;white-space:nowrap;width:2.13%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:middle;width:13.16%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:middle;white-space:nowrap;width:2.13%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:top;width:14.76%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;">&#9679;</p></td></tr><tr><td style="vertical-align:bottom;width:53.4%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;">Timothy Pearson</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.7%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;">&#160;</p></td><td style="vertical-align:middle;white-space:nowrap;width:0.21%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:top;width:12.47%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"> <font style="visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:middle;white-space:nowrap;width:2.13%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:middle;white-space:nowrap;width:13.16%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:6pt;text-align:center;margin:0pt;">&#160;&#160;<font style="font-size:10pt;">&#9679;</font><sup style="font-size:7.5pt;vertical-align:top;">*</sup></p></td><td style="vertical-align:middle;white-space:nowrap;width:2.13%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:top;white-space:nowrap;width:14.76%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"> <font style="visibility:hidden;">&#8203;</font></p></td></tr><tr><td style="vertical-align:top;width:53.4%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;">Total meetings in fiscal 2021</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.7%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:middle;white-space:nowrap;width:0.21%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:middle;width:12.47%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;">5</p></td><td style="vertical-align:middle;white-space:nowrap;width:2.13%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:middle;width:13.16%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;">4</p></td><td style="vertical-align:middle;white-space:nowrap;width:2.13%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:top;width:14.76%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;">3</p></td></tr></table></div><div style="font-family:'Times New Roman','Times','serif';font-size:10.0pt;margin-bottom:0pt;margin-top:0pt;min-height:1.19em;position:relative;width:100%;"><hr noshade="true" color="#000000" size="1" width="25.0%" style="background-color:#000000;color:#000000;height:1pt;position:relative;top:0.6em;border:none;margin:0pt;" align="left"></div><table border="0" cellpadding="0" cellspacing="0"><tr><td style="vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:0pt;margin-top:0pt;"><font style="font-size:9pt;">*</font></p></td><td style="padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:0pt;margin-top:0pt;"><font style="font-size:9pt;">Committee chairperson</font></p></td></tr></table><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;"><a name="_DV_M437"></a><font style="visibility:hidden;">&#8203;</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:0pt;margin:0pt;">Below is a description of each of these committees.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:0pt;margin:0pt;"><font style="margin-bottom:12pt;visibility:hidden;">&#8203;</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:0pt;margin:0pt;">Each of the committees has authority to engage legal counsel or other experts or consultants as it deems appropriate to carry out its responsibilities. <a name="_DV_M439"></a>The Board has determined that each member of each committee meets the applicable Nasdaq rules and regulations regarding &#8220;independence&#8221; and each member is free of any relationship that would impair his or her individual exercise of independent judgment with regard to the Company.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:0pt;margin:0pt;"><font style="margin-bottom:12pt;visibility:hidden;">&#8203;</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;line-height:1.19;margin:0pt;"><a name="_DV_M441"></a>Audit Committee</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;line-height:1.19;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:0pt;margin:0pt;"><a name="_DV_M442"></a>The Audit Committee of the Board was established by the Board in accordance with Section 3(a)(58)(A) of the Exchange Act to oversee the Company&#8217;s corporate accounting and financial reporting processes and audits of its financial statements. For this purpose, the Audit Committee performs several functions. The Audit Committee evaluates the performance, and assesses the qualifications, of the independent auditors; determines and approves the engagement of the independent auditors; determines whether to retain or terminate the existing independent auditors or to appoint and engage new independent auditors; reviews and approves the retention of the independent auditors to perform any proposed permissible non-audit services; monitors the rotation of partners of the independent auditors on the Company&#8217;s audit engagement team as required by law; reviews and approves or rejects transactions between the Company and any related persons; confers with management and the independent auditors regarding the effectiveness of internal controls over financial reporting; establishes procedures, as required under applicable law, for the receipt, retention and treatment of complaints received by the Company regarding accounting, internal accounting controls or auditing matters and the confidential and anonymous submission by employees of concerns regarding questionable accounting or auditing matters; and meets to review the Company&#8217;s annual audited financial statements and quarterly financial statements with management and the independent auditor, including a review of </p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></div><div style="clear:both;display:table;margin-bottom:27.35pt;min-height:44.65pt;width:100%;"><div style="display:table-cell;vertical-align:bottom;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;min-height:12.0pt;text-align:center;margin:24pt 0pt 0pt 0pt;">15</p></div></div></div><hr style="background-color:#000000;clear:both;color:#000000;height:2pt;line-height:0;margin-bottom:30pt;margin-left:11.76%;margin-right:11.76%;margin-top:30pt;page-break-after:always;width:76.47%;border-width:0;"><div style="max-width:100%;padding-left:11.76%;padding-right:11.76%;position:relative;"><div style="margin-top:27.35pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"><font style="font-weight:bold;visibility:hidden;">&#8203;</font></p></div><div style="clear:both;max-width:100%;position:relative;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:0pt;margin:0pt;"><a name="_DV_M443"></a>the Company&#8217;s disclosures under &#8220;Management&#8217;s Discussion and Analysis of Financial Condition and Results of Operations.&#8221;<b style="font-weight:bold;"> </b></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:0pt;margin:0pt;">The Audit Committee is currently composed of three directors, Messrs. Junius and Jackson and Ms. Andrews. The Audit Committee met five<b style="font-weight:bold;"> </b><a name="_DV_M445"></a>times during the fiscal year ended December 31, 2021. The Board has adopted a written Audit Committee charter that is available to stockholders<b style="font-weight:bold;"> </b>on our website at www.glycomimetics.com<a name="_DV_M446"></a>.<b style="font-weight:bold;"> </b></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:0pt;margin:0pt;"><font style="margin-bottom:12pt;visibility:hidden;">&#8203;</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:0pt;margin:0pt;"><a name="_DV_M448"></a>The Board reviews the Nasdaq<font style="color:#800080;"> </font><a name="_DV_M450"></a>listing rules definition of independence for Audit Committee members on an annual basis and has determined that all current and proposed members of our Audit Committee are independent (as independence is currently defined in Rule 5605(c)(2)(A)(i) and (ii) of the Nasdaq listing rules).</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:0pt;margin:0pt;"><font style="margin-bottom:12pt;visibility:hidden;">&#8203;</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:0pt;margin:0pt;"><a name="_DV_M451"></a>The Board has also determined that Ms. Andrews, Mr. Junius and Mr. Jackson each qualify as an &#8220;audit committee financial expert,&#8221; as defined in applicable SEC rules.<b style="font-weight:bold;"> </b>The Board made a qualitative assessment of each committee member&#8217;s level of knowledge and experience based on a number of factors, including their formal education and expertise with financial and accounting matters.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:0pt;margin:0pt;"><font style="margin-bottom:12pt;visibility:hidden;">&#8203;</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;line-height:1.19;margin:0pt;"><a name="_DV_M453"></a>Report of the Audit Committee of the Board of Directors<sup style="font-size:7.5pt;vertical-align:top;">(1)</sup></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;line-height:1.19;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><a name="_DV_M454"></a>The Audit Committee has reviewed and discussed the audited financial statements for the fiscal year ended December 31, 2021 with management of the Company. The Audit Committee has discussed with the independent registered public accounting firm the matters required to be discussed by the applicable requirements of the Public Company Accounting Oversight Board (&#8220;PCAOB&#8221;) and the SEC. The Audit Committee has also received the written disclosures and the letter from the independent registered public accounting firm required by applicable requirements of the PCAOB regarding the independent accountants&#8217; communications with the Audit Committee concerning independence, and has discussed with the independent registered public accounting firm the accounting firm&#8217;s independence. Based on the foregoing, the Audit Committee has recommended to the Board that the audited financial statements be included in the Company&#8217;s Annual Report on Form 10-K for the fiscal year ended December&#160;31, 2021.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:0pt;margin:0pt;"><font style="margin-bottom:12pt;visibility:hidden;">&#8203;</font></p><div align="left"><table style="border-collapse:collapse;font-size:16pt;height:max-content;padding-left:0pt;padding-right:0pt;table-layout:auto;width:100%;"><tr style="height:1pt;"><td style="vertical-align:top;width:67.01%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="position:absolute;top:0pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><font style="font-size:1pt;visibility:hidden;">&#8203;</font></p></div></div></td><td style="vertical-align:top;width:32.98%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="position:absolute;top:0pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><font style="font-size:1pt;visibility:hidden;">&#8203;</font></p></div></div></td></tr><tr><td style="vertical-align:top;width:67.01%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:0pt;margin:0pt;"><font style="margin-bottom:12pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:top;width:32.98%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:0pt;margin:0pt;">Mr. Daniel Junius, Chair</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:0pt;margin:0pt;">Ms. Patricia Andrews</p></td></tr><tr><td style="vertical-align:top;width:67.01%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:0pt;margin:0pt;"><font style="margin-bottom:12pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:top;width:32.98%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:0pt;margin:0pt;">Mr. Scott Jackson</p></td></tr></table></div><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:9pt;text-indent:0pt;margin:0pt;"><sup style="font-size:7.5pt;vertical-align:top;">(1)</sup><font style="font-size:10pt;"> </font>The material in this report is not &#8220;soliciting material,&#8221; is not deemed &#8220;filed&#8221; with the SEC and is not to be incorporated by reference in any filing of the Company under the Securities Act of 1933, as amended, or the Exchange Act, whether made before or after the date hereof and irrespective of any general incorporation language in any such filing.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:0pt;margin:0pt;"><font style="margin-bottom:12pt;visibility:hidden;">&#8203;</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;line-height:1.19;margin:0pt;"><a name="_DV_M456"></a><a name="_DV_M457"></a>Compensation Committee</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;line-height:1.19;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:0pt;margin:0pt;"><a name="_DV_M458"></a><a name="_DV_M463"></a><a name="_DV_C357"></a><a name="_DV_M459"></a><a name="_DV_C359"></a><a name="_DV_M460"></a><a name="_DV_M461"></a><a name="_DV_M462"></a>The Compensation Committee of the Board is currently composed of three members, Dr. Goldberg and Messrs. Pearson and Jackson. All members of our Compensation Committee are independent (as independence is currently defined in Rule 5605(d)(2) of the Nasdaq listing rules). The Compensation Committee met four times during the fiscal year ended December 31, 2021. The Board has adopted a written Compensation Committee charter that is available to stockholders on our website at www.glycomimetics.com. </p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:0pt;margin:0pt;"><font style="margin-bottom:12pt;visibility:hidden;">&#8203;</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:0pt;margin:0pt;">The Compensation Committee acts on behalf of the Board to review, adopt and oversee our compensation strategy, policies, plans and programs, including: </p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:0pt;margin:0pt;"><font style="margin-bottom:12pt;visibility:hidden;">&#8203;</font></p><table border="0" cellpadding="0" cellspacing="0" style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"></td><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><font style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;"><a name="_DV_M464"></a></font><font style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">evaluation of corporate and individual performance relevant to the compensation of our executive officers</font><font style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;"> and other senior management</font><font style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;"> in light of corporate and individual performance objectives established by the Board; </font></td></tr></table><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;padding-left:18pt;text-indent:-18pt;margin:0pt 0pt 0pt 18pt;"><font style="margin-bottom:12pt;margin-left:0pt;visibility:hidden;">&#8203;</font></p><table border="0" cellpadding="0" cellspacing="0" style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"></td><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><font style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;"><a name="_DV_M465"></a></font><font style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">review and approval</font><b style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:bold;"> </b><font style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">of the compensation and other terms of employment or service, including severance and change-in-control arrangements, of our Chief Executive Officer and </font><font style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">the other executive officers;</font></td></tr></table><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt 0pt 0pt 18pt;"><font style="margin-left:0pt;visibility:hidden;">&#8203;</font></p><table border="0" cellpadding="0" cellspacing="0" style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:10pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"></td><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><font style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">review and approval of the compensation for our independent directors; and</font></td></tr></table></div><div style="clear:both;display:table;margin-bottom:27.35pt;min-height:44.65pt;width:100%;"><div style="display:table-cell;vertical-align:bottom;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;min-height:12.0pt;text-align:center;margin:24pt 0pt 0pt 0pt;">16</p></div></div></div><hr style="background-color:#000000;clear:both;color:#000000;height:2pt;line-height:0;margin-bottom:30pt;margin-left:11.76%;margin-right:11.76%;margin-top:30pt;page-break-after:always;width:76.47%;border-width:0;"><div style="max-width:100%;padding-left:11.76%;padding-right:11.76%;position:relative;"><div style="margin-top:27.35pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"><font style="font-weight:bold;visibility:hidden;">&#8203;</font></p></div><div style="clear:both;max-width:100%;position:relative;"><table border="0" cellpadding="0" cellspacing="0" style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"></td><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><font style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;"><a name="_DV_M466"></a><a name="_DV_M467"></a></font><font style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">administration of our equity compensation plans, employee stock purchase plan and executive severance plans and other similar plans and programs. </font></td></tr></table><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><a name="_DV_M468"></a><a name="_DV_M470"></a><i style="font-style:italic;">Compensation Committee Processes and Procedures</i><a name="_DV_M471"></a><i style="font-style:italic;"> </i></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:italic;margin:0pt;"><font style="margin-bottom:12pt;visibility:hidden;">&#8203;</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:0pt;margin:0pt;"><a name="_DV_M472"></a>Typically, the Compensation Committee meets at least twice per year and with greater frequency if necessary. The agenda for each meeting is usually developed by the chairperson of the Compensation Committee, in consultation with our Chief Executive Officer. The Compensation Committee meets regularly in executive session. However, from time to time, various members of management and other employees as well as outside advisors or consultants may be invited by the Compensation Committee to make presentations, to provide financial or other background information or advice or to otherwise participate in Compensation Committee meetings. The Chief Executive Officer may not participate in, or be present during, any deliberations or determinations of the Compensation Committee regarding his compensation. The Chief Executive Officer may provide his recommendations with respect to the achievement of the corporate performance objectives established by the Board, but the Compensation Committee makes the final determination with respect to their level of achievement. </p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:0pt;margin:0pt;"><font style="margin-bottom:12pt;visibility:hidden;">&#8203;</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:0pt;margin:0pt;">The charter of the Compensation Committee grants the Compensation Committee full access to all books, records, facilities and personnel of the Company. In addition, under the charter, the Compensation Committee has the authority to obtain, at the expense of the Company, advice and assistance from compensation consultants and internal and external legal, accounting or other advisors and other external resources that the Compensation Committee considers necessary or appropriate in the performance of its duties. The Compensation Committee has direct responsibility for the oversight of the work of any consultants or advisers engaged for the purpose of advising the Compensation Committee. In particular, the Compensation Committee has the sole authority to retain, in its sole discretion, compensation consultants to assist in its evaluation of<b style="font-weight:bold;"> </b>executive<b style="font-weight:bold;"> </b><a name="_DV_M473"></a>and director compensation, including the authority to approve such consultant&#8217;s reasonable fees and other retention terms. Under the charter, the Compensation Committee may select, or receive advice from, a compensation consultant, legal counsel or other adviser to the Compensation Committee, other than in-house legal counsel and certain other types of advisers, only after taking into consideration six factors, prescribed by the SEC and Nasdaq, that bear upon the adviser&#8217;s independence; however, there is no requirement that any adviser be independent. </p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:0pt;margin:0pt;"><font style="margin-bottom:12pt;visibility:hidden;">&#8203;</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:0pt;margin:0pt;"><a name="_DV_M474"></a>During the past fiscal year,<b style="font-weight:bold;"> </b>after taking into consideration the six factors prescribed by the SEC and Nasdaq, the Compensation Committee engaged Aon&#8217;s Human Capital Solutions practice, a division of Aon plc, or Aon, a national executive compensation consulting firm,<b style="font-weight:bold;"> </b>as a compensation consultant. The Compensation Committee has assessed Aon&#8217;s independence and determined that Aon had no conflicts of interest in connection with its provision of services to the Compensation Committee. Specifically, the Compensation Committee engaged Aon to suggest a peer company group composed of public companies comparable to us and to conduct an executive compensation assessment analyzing the current cash and equity compensation of our executive officers, directors and other senior management against compensation for similarly situated executives at our peer group companies. Our management provided general information and input to assist the Compensation Committee and Aon during this assessment, but otherwise did not have the ability to direct Aon&#8217;s work.<b style="font-weight:bold;"> </b></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:0pt;margin:0pt;"><a name="_DV_M475"></a><a name="_DV_M481"></a><a name="_DV_M489"></a><a name="_DV_M497"></a>Historically, the Compensation Committee has made most of the significant adjustments to annual compensation, determined bonus and equity awards and established new performance objectives at one or more meetings held during the first quarter of the year. During 2021, the Compensation Committee recommended to the Board, and the Board approved the recommendation, that from 2022 onward new corporate performance objectives would be established by the full Board, with the Compensation Committee thereafter making a final determination with respect to their level of achievement. The Compensation Committee also considers matters related to individual compensation, such as compensation for new executive hires, as well as high-level strategic issues, such as the effectiveness of our compensation strategy, potential modifications to that strategy and new trends, plans or approaches to compensation, at various meetings throughout the year. Generally, the Compensation Committee&#8217;s process includes the determination of compensation levels against established performance objectives. For executives other than the Chief Executive Officer, the Compensation Committee solicits and considers evaluations and recommendations submitted to the Compensation Committee<b style="font-weight:bold;"> </b><a name="_DV_M498"></a>by the Chief Executive Officer.<b style="font-weight:bold;"> </b>In the case of the Chief Executive Officer, the evaluation of his performance is conducted by the Compensation Committee, which determines any adjustments to his compensation<b style="font-weight:bold;"> </b>as well as awards to be granted. For all executives and directors as part of its deliberations, the Compensation Committee may review and consider, as appropriate,<b style="font-weight:bold;"> </b>the results of the </p></div><div style="clear:both;display:table;margin-bottom:27.35pt;min-height:44.65pt;width:100%;"><div style="display:table-cell;vertical-align:bottom;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;min-height:12.0pt;text-align:center;margin:24pt 0pt 0pt 0pt;">17</p></div></div></div><hr style="background-color:#000000;clear:both;color:#000000;height:2pt;line-height:0;margin-bottom:30pt;margin-left:11.76%;margin-right:11.76%;margin-top:30pt;page-break-after:always;width:76.47%;border-width:0;"><div style="max-width:100%;padding-left:11.76%;padding-right:11.76%;position:relative;"><div style="margin-top:27.35pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"><font style="font-weight:bold;visibility:hidden;">&#8203;</font></p></div><div style="clear:both;max-width:100%;position:relative;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">self-evaluation process undertaken by our independent directors and overseen by the Nominating and Corporate Governance Committee, as well as materials such as financial reports and projections, operational data, tax and accounting information, tally sheets that set forth the total compensation that may become payable to executives in various hypothetical scenarios, executive and director stock ownership information, stock performance data, analyses of historical executive compensation levels and current Company-wide compensation levels and recommendations of the Compensation Committee&#8217;s compensation consultant, including analyses of executive and director compensation paid at other companies in our named peer group.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;line-height:1.19;margin:0pt;"><a name="_DV_M499"></a><a name="_DV_M504"></a><a name="_DV_M509"></a>Nominating and Corporate Governance Committee </p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;line-height:1.19;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:0pt;margin:0pt;"><a name="_DV_M510"></a>The Nominating and Corporate Governance Committee of the Board is responsible for identifying, reviewing and evaluating candidates to serve as directors of the Company (consistent with criteria approved by the Board), reviewing and evaluating incumbent directors, recommending to the Board candidates for election to the Board, making recommendations to the Board regarding the membership of the committees of the Board, assessing the performance of management and the Board, and developing a set of corporate governance principles for the Company<a name="_DV_M511"></a>. </p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:0pt;margin:0pt;"><font style="margin-bottom:12pt;visibility:hidden;">&#8203;</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:0pt;margin:0pt;">As part of the annual performance evaluation of the Board and each committee, the Nominating and Corporate Governance Committee oversees a series of in-person interviews and discussions with each director. The discussions cover topics such as the selection and evaluation of Board candidates, the structure and performance of the Board&#8217;s committees, Board and committee practices and communication, and CEO performance. The results are confidentially compiled by our outside counsel, which provides and discusses the evaluation results with the Nominating and Corporate Governance Committee. The Nominating and Corporate Governance Committee carefully considers the results and discusses the potential need for any corporate governance or other Board-related changes. The results are thereafter shared with the full Board, along with the Nominating and Corporate Governance Committee&#8217;s key observations or recommendations. The Board then utilizes these results in making decisions to improve the effectiveness, communication and structure of the Board and its committees.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:0pt;margin:0pt;"><font style="margin-bottom:12pt;visibility:hidden;">&#8203;</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:0pt;margin:0pt;">The Nominating and Corporate Governance Committee<b style="font-weight:bold;"> </b><a name="_DV_M512"></a><a name="_DV_M514"></a><a name="_DV_M515"></a>is composed of three directors: Drs. Goldberg and Koenig and Mr. Junius. All members of the Nominating and Corporate Governance Committee are independent (as independence is currently defined in Rule 5605(a)(2) of the Nasdaq listing rules). The Nominating and Corporate Governance Committee met three times during the fiscal year ended December 31, 2021. The Board has adopted a written Nominating and Corporate Governance Committee charter that is available to stockholders on our website at www.glycomimetics.com.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:0pt;margin:0pt;"><a name="_DV_M516"></a><a name="_DV_M517"></a>The Nominating and Corporate Governance Committee believes that candidates for director should have certain minimum qualifications, including the ability to read and understand basic financial statements and having the highest personal integrity and ethics. The Nominating and Corporate Governance Committee also intends to consider such factors as possessing relevant expertise upon which to be able to offer advice and guidance to management, having sufficient time to devote to the affairs of the Company, demonstrated excellence in his or her field, having the ability to exercise sound business judgment, having a diversity of thought, personal background, perspective and experience, and having the commitment to rigorously represent the long-term interests of our stockholders. However, the Nominating and Corporate Governance Committee retains the right to modify these qualifications from time to time. </p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:0pt;margin:0pt;"><font style="margin-bottom:12pt;visibility:hidden;">&#8203;</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:0pt;margin:0pt;">Candidates for director nominees are assessed in the context of the current composition of the Board, our operating requirements and the long-term interests of stockholders. In conducting this assessment, the Nominating and Corporate Governance Committee typically considers diversity, including gender, racial and ethnic diversity, to ensure that the Board is able to consider a wide range of perspectives, as well as experience, skills and such other factors as it deems appropriate, given the current needs of the Board and the Company, to maintain a balance of knowledge, experience and capability. The Board continues to consider the addition of one or more new directors who may be able to enhance the range of perspectives, experience and skills of the Board. To this end, the Nominating and Corporate Governance Committee has been reviewing and interviewing a number of potential candidates, specifically including diverse candidates. The Nominating and Corporate Governance Committee believes that the judgment and perspectives offered by a diverse board of directors improves the quality of decisions made by a board and enhances a company&#8217;s business performance. The Nominating and Corporate Governance </p></div><div style="clear:both;display:table;margin-bottom:27.35pt;min-height:44.65pt;width:100%;"><div style="display:table-cell;vertical-align:bottom;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;min-height:12.0pt;text-align:center;margin:24pt 0pt 0pt 0pt;">18</p></div></div></div><hr style="background-color:#000000;clear:both;color:#000000;height:2pt;line-height:0;margin-bottom:30pt;margin-left:11.76%;margin-right:11.76%;margin-top:30pt;page-break-after:always;width:76.47%;border-width:0;"><div style="max-width:100%;padding-left:11.76%;padding-right:11.76%;position:relative;"><div style="margin-top:27.35pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"><font style="font-weight:bold;visibility:hidden;">&#8203;</font></p></div><div style="clear:both;max-width:100%;position:relative;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Committee also believes that such diversity would help the Board more effectively address the needs of patients, clinicians, stockholders, employees and customers. </p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:0pt;margin:0pt;"><font style="margin-bottom:12pt;visibility:hidden;">&#8203;</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:0pt;margin:0pt;">The Nominating and Corporate Governance Committee appreciates the value of thoughtful Board refreshment, and regularly identifies and considers qualities, skills and other director attributes that would enhance the composition of the Board. In the case of incumbent directors, including incumbent directors who will be nominees because their terms of office are set to expire, the Nominating and Corporate Governance Committee reviews these directors&#8217; overall service to the Company during their tenure as a director, including the number of meetings attended, level of participation, quality of performance, and any other relationships and transactions that might impair those directors&#8217; independence. </p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:0pt;margin:0pt;"><font style="margin-bottom:12pt;visibility:hidden;">&#8203;</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:0pt;margin:0pt;">The Nominating and Corporate Governance Committee also takes into account the results of the Board&#8217;s self-assessment, conducted annually on a group basis. The self-assessment includes an evaluation of the Board&#8217;s and each committee&#8217;s contributions as a whole and effectiveness in serving the best interest of the company and our stockholders, specific areas in which the Board believes that the performance of the Board and its committees could be improved, and overall Board composition and makeup.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:0pt;margin:0pt;"><font style="margin-bottom:12pt;visibility:hidden;">&#8203;</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:0pt;margin:0pt;"><a name="_DV_M518"></a><a name="_DV_M519"></a><a name="_DV_M520"></a>In the case of new director candidates, the Nominating and Corporate Governance Committee also determines whether the nominee is independent for Nasdaq purposes, which determination is based upon applicable Nasdaq listing rules, applicable SEC rules and regulations, and the advice of counsel, if necessary. The Nominating and Corporate Governance Committee not only uses its network of contacts to identify potential candidates but has also previously engaged a professional search firm. The Nominating and Corporate Governance Committee conducts any appropriate and necessary inquiries into the backgrounds and qualifications of possible candidates after considering the function and needs of the Board. The Nominating and Corporate Governance Committee meets to discuss and consider the candidates&#8217; qualifications and then selects a nominee for recommendation to the Board by majority vote.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:0pt;margin:0pt;"><a name="_DV_M525"></a><a name="_DV_M526"></a><a name="_DV_M527"></a>The Nominating and Corporate Governance Committee will consider director candidates recommended by stockholders. The Nominating and Corporate Governance Committee does not intend to alter the manner in which it evaluates candidates, including the minimum criteria set forth above, based on whether or not the candidate was recommended by a stockholder. Stockholders who wish to recommend individuals for consideration by the Nominating and Corporate Governance Committee to become nominees for election to the Board may do so by delivering a written recommendation to the Nominating and Corporate Governance Committee at the following address: 9708 Medical Center Drive, Rockville, Maryland 20850, at least 90 days but not more than 120 days prior to the anniversary date of the mailing of the Company&#8217;s proxy statement for the last annual meeting<a name="_DV_M528"></a>. Submissions must include the full name of the proposed nominee, a description of the proposed nominee&#8217;s business experience for at least the previous five years, complete biographical information, a description of the proposed nominee&#8217;s qualifications as a director and a representation that the nominating stockholder is a beneficial or record holder of the Company&#8217;s stock and has been a holder for at least one year. Any such submission must be accompanied by the written consent of the proposed nominee to be named as a nominee and to serve as a director if elected.<b style="font-weight:bold;"> </b></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;"><a name="_DV_M529"></a><a name="_DV_M531"></a><font style="visibility:hidden;">&#8203;</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><b style="font-weight:bold;">Board Oversight of Human Capital Resources and Diversity</b></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:0pt;margin:0pt;"><font style="margin-bottom:12pt;visibility:hidden;">&#8203;</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:0pt;margin:0pt;">As part of its general oversight responsibilities, the Board oversees management&#8217;s efforts with respect to our human capital resources and diversity efforts. Our human capital resources objectives include, as applicable, identifying, recruiting, retaining, incentivizing and integrating our existing and new employees. The principal purposes of our equity incentive plans, the administration of which has been delegated to the Compensation Committee, are to attract, retain and reward high performing employees through the granting of equity-based compensation awards in order to increase shareholder value and the success of our company by motivating employees to perform to the best of their abilities and achieve our company objectives.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;line-height:1.19;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></div><div style="clear:both;display:table;margin-bottom:27.35pt;min-height:44.65pt;width:100%;"><div style="display:table-cell;vertical-align:bottom;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;min-height:12.0pt;text-align:center;margin:24pt 0pt 0pt 0pt;">19</p></div></div></div><hr style="background-color:#000000;clear:both;color:#000000;height:2pt;line-height:0;margin-bottom:30pt;margin-left:11.76%;margin-right:11.76%;margin-top:30pt;page-break-after:always;width:76.47%;border-width:0;"><div style="max-width:100%;padding-left:11.76%;padding-right:11.76%;position:relative;"><div style="margin-top:27.35pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"><font style="font-weight:bold;visibility:hidden;">&#8203;</font></p></div><div style="clear:both;max-width:100%;position:relative;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;line-height:1.19;margin:0pt;">STOCKHOLDER ENGAGEMENT AND COMMUNICATIONS WITH THE BOARD OF DIRECTORS</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><a name="_DV_M532"></a><b style="font-weight:bold;">Stockholder Engagement</b></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Our relationships with our stockholders are a high priority, and we recognize that stockholders can have divergent interests and different views on our practices, objectives and time horizons. To ensure that the Board and management have an opportunity to listen to and understand the varying perspectives of our stockholders, members of our management team have consistently engaged with certain of our stockholders. During 2021, members of our management team periodically reached out to stockholders representing nearly 40% of our outstanding shares to seek feedback regarding the Company&#8217;s corporate governance policies or business strategy. </p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><font style="white-space:pre-wrap;">Our management team has been consistently proactive in addressing various concerns of certain institutional investors and proxy advisory firms. For example, Dr. Scott Koenig, one of our directors nominated for re-election this year, was in 2019 considered to be &#8220;overboarded&#8221; due to the fact that, in addition to our Board, he served on two other public company boards of directors, including the company for which he serves as chief executive officer. This resulted in Dr. Koenig receiving more &#8220;withhold&#8221; votes than votes &#8220;for&#8221; re-election at our annual meeting that year, even though he was re-elected at that time and has been nominated for re-election this year.  Our Board recognized the potential concerns that were raised that year and directed management to conduct outreach to address the issue with our major stockholders, a practice that has continued since then. Our focus on open channels of communication has given management and the Board a better understanding of, and valuable insight into, the views of these stockholders. This year, none of the stockholders with which our management team have interacted have indicated any concerns that would cause them to cast a &#8220;withhold&#8221; vote for any director nominee in this year&#8217;s election, including Dr. Koenig.  For more detailed information about the reasons why we believe Dr. Koenig continues to be a valuable contributor to our Board, please refer to his biography above. &#160; </font></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160; </p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><b style="font-weight:bold;">Process for Stockholder Communications with the Board</b></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><a name="_DV_M534"></a>The Board has adopted a formal process by which stockholders may communicate with the Board or any of its directors. Stockholders who wish to communicate with the Board may do so by sending written communications addressed to our Corporate Secretary at 9708 Medical Center Drive, Rockville, Maryland 20850. Each communication must set forth:</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p><table border="0" cellpadding="0" cellspacing="0" style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"></td><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><font style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">the name and address of the stockholder on whose behalf the communication is sent; and</font></td></tr></table><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;padding-left:18pt;text-indent:-18pt;margin:0pt 0pt 0pt 18pt;"><font style="margin-left:0pt;visibility:hidden;">&#8203;</font></p><table border="0" cellpadding="0" cellspacing="0" style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"></td><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><font style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">the number and class of shares of the Company that are owned beneficially by such stockholder as of the date of the communication.</font></td></tr></table><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;padding-left:18pt;text-indent:-18pt;margin:0pt 0pt 0pt 36pt;"><font style="margin-left:0pt;visibility:hidden;">&#8203;</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:0pt;margin:0pt;">The Secretary will review each communication. The Secretary will forward such communication to the Board or to any individual director to whom the communication is addressed unless the communication contains advertisements or solicitations or is unduly hostile, threatening or similarly inappropriate, in which case the Secretary shall discard the communication.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:0pt;margin:0pt;"><font style="margin-bottom:12pt;visibility:hidden;">&#8203;</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;line-height:1.19;margin:0pt;"><a name="_DV_M540"></a><a name="_DV_C506"></a><a name="_DV_M541"></a>CODE OF ETHICS</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;line-height:1.19;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:0pt;margin:0pt;"><a name="_DV_M542"></a>We have adopted the GlycoMimetics, Inc.<b style="font-weight:bold;"> </b><a name="_DV_M543"></a>Code of Business Conduct and Ethics that applies to all officers, directors and employees. The Code of Business Conduct and Ethics is available on our website at www.glycomimetics.com.<b style="font-weight:bold;"> </b>If we make any substantive amendments to the Code of Business Conduct and Ethics or grant any waiver from a provision of the Code of Business Conduct and Ethics to any executive officer or director, we will promptly disclose the nature of the amendment or waiver on our website.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:0pt;margin:0pt;"><font style="margin-bottom:12pt;visibility:hidden;">&#8203;</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;line-height:1.19;margin:0pt;">CORPORATE GOVERNANCE GUIDELINES </p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;line-height:1.19;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:0pt;margin:0pt;"><a name="_DV_M549"></a>The Board has adopted Corporate Governance Guidelines to assure that the Board will have the necessary authority and practices in place to review and evaluate our business operations as needed and to make decisions that are independent of our management. The guidelines are also intended to align the interests of directors and management with those of our stockholders. The Corporate Governance Guidelines<font style="color:#5a0402;font-family:'Georgia';">, </font>available to stockholders on our website at </p></div><div style="clear:both;display:table;margin-bottom:27.35pt;min-height:44.65pt;width:100%;"><div style="display:table-cell;vertical-align:bottom;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;min-height:12.0pt;text-align:center;margin:24pt 0pt 0pt 0pt;">20</p></div></div></div><hr style="background-color:#000000;clear:both;color:#000000;height:2pt;line-height:0;margin-bottom:30pt;margin-left:11.76%;margin-right:11.76%;margin-top:30pt;page-break-after:always;width:76.47%;border-width:0;"><div style="max-width:100%;padding-left:11.76%;padding-right:11.76%;position:relative;"><div style="margin-top:27.35pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"><font style="font-weight:bold;visibility:hidden;">&#8203;</font></p></div><div style="clear:both;max-width:100%;position:relative;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">www.glycomimetics.com, set forth the practices the Board intends to follow with respect to board composition and selection (including diversity), board meetings and involvement of senior management, Chief Executive Officer performance evaluation and succession planning, and board committees and compensation. The Nominating and Corporate Governance Committee regularly reviews the Corporate Governance Guidelines, seeks advice and recommendations from outside advisors, and considers corporate governance trends and best practices in the company&#8217;s industry.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:0pt;margin:0pt;"><font style="margin-bottom:12pt;visibility:hidden;">&#8203;</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><b style="font-weight:bold;text-transform:uppercase;">Prohibition on Hedging and Pledging of Company Securities and Insider Trading Policy</b></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><font style="font-size:9pt;font-weight:bold;visibility:hidden;">&#8203;</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:0pt;margin:0pt;">The Board has approved a corporate insider trading policy to prohibit executive officers, directors and employees from purchasing our securities on margin and borrowing against our securities, holding our securities in a margin account, borrowing against any account in which our securities are held, or otherwise pledging our securities as collateral for a loan. The insider trading policy also prohibits executive officers, directors and employees from engaging in transactions in puts, calls, or other derivative securities on an exchange or in any other organized market and from engaging in any hedging transaction.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:0pt;margin:0pt;"><font style="margin-bottom:12pt;visibility:hidden;">&#8203;</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;min-height:12.0pt;text-align:justify;margin:0pt;"><b style="font-weight:bold;text-transform:uppercase;">Incentive Compensation Recoupment Policy</b></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;min-height:12.0pt;text-align:justify;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:0pt;margin:0pt;"><font style="font-family:'inherit';">In </font>June 2020, our Compensation Committee adopted a policy for recoupment of certain incentive compensation paid to our chief executive officer and chief financial officer. In the event we are required to restate our financial results due to material noncompliance with any financial reporting requirement and the misconduct of an executive officer covered by the policy contributed to such noncompliance, we may seek to recover the amount of any incentive compensation, including any cash or equity compensation granted, earned or vested based in whole or in part on the attainment of a financial reporting measure (such as under our bonus plan and any other program or plan approved after the adoption of the policy), that was paid to such covered executive officer during the three-year period preceding the date of the restatement and attributable to the erroneously reported results. In addition, if any covered executive officer sells stock acquired pursuant to an equity award granted after the policy&#39;s adoption and the sale occurs between the time our financial results are reported and the time those results are required to be restated, we may recover the excess of the actual sale proceeds over the proceeds the Board determines the executive officer would have received from the sale if the restatement had occurred prior to the sale. The misconduct covered by the policy includes any knowing violation of SEC rules and regulations or willful commission of an act of fraud, dishonesty, recklessness or gross negligence in the performance of the executive officer&#39;s duties.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:0pt;margin:0pt;"><font style="margin-bottom:12pt;visibility:hidden;">&#8203;</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:0pt;margin:0pt;"><font style="margin-bottom:12pt;visibility:hidden;">&#8203;</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></div><div style="clear:both;display:table;margin-bottom:27.35pt;min-height:44.65pt;width:100%;"><div style="display:table-cell;vertical-align:bottom;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;min-height:12.0pt;text-align:center;margin:24pt 0pt 0pt 0pt;">21</p></div></div></div><hr style="background-color:#000000;clear:both;color:#000000;height:2pt;line-height:0;margin-bottom:30pt;margin-left:11.76%;margin-right:11.76%;margin-top:30pt;page-break-after:always;width:76.47%;border-width:0;"><div style="max-width:100%;padding-left:11.76%;padding-right:11.76%;position:relative;"><div style="margin-top:27.35pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"><font style="font-weight:bold;visibility:hidden;">&#8203;</font></p></div><div style="clear:both;max-width:100%;position:relative;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-variant:small-caps;font-weight:bold;line-height:1.19;text-align:center;margin:0pt;"><a name="_DV_M551"></a><b style="font-size:12pt;font-variant:normal;font-weight:bold;">PROPOSAL 2</b></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-variant:small-caps;font-weight:bold;line-height:1.19;text-align:center;margin:0pt;"><font style="font-size:12pt;font-variant:normal;line-height:12pt;margin-bottom:12pt;margin-top:12pt;visibility:hidden;">&#8203;</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-variant:small-caps;font-weight:bold;line-height:1.19;text-align:center;margin:0pt;"><a name="_DV_M594"></a><b style="font-size:12pt;font-variant:normal;font-weight:bold;">RATIFICATION OF SELECTION OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM</b></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-variant:small-caps;font-weight:bold;line-height:1.19;text-align:center;margin:0pt;"><font style="font-size:12pt;font-variant:normal;line-height:12pt;margin-bottom:12pt;margin-top:12pt;visibility:hidden;">&#8203;</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:0pt;margin:0pt;"><a name="_DV_M595"></a>The Audit Committee of the Board has selected Ernst &amp; Young LLP as the Company&#8217;s independent registered public accounting firm for the fiscal year ending December 31<a name="_DV_M596"></a><a name="_DV_M597"></a><a name="_DV_M599"></a>, 2022, and has further directed that management submit the selection of its independent registered public accounting firm for ratification by the stockholders at the Annual Meeting. Ernst &amp; Young LLP has audited the Company&#8217;s financial statements beginning with the year ended December 31, 2011. Representatives of<b style="font-weight:bold;"> </b>Ernst &amp; Young LLP are expected to be present at the Annual Meeting. They will have an opportunity to make a statement if they so desire and will be available to respond to appropriate questions.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:0pt;margin:0pt;"><a name="_DV_M600"></a><font style="margin-bottom:12pt;visibility:hidden;">&#8203;</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:0pt;margin:0pt;">Neither the Company&#8217;s amended and restated bylaws nor other governing documents or law require stockholder ratification of the selection of Ernst &amp; Young LLP as the Company&#8217;s independent registered public accounting firm. However, the Audit Committee is submitting the selection of Ernst &amp; Young LLP to the stockholders for ratification as a matter of good corporate practice. If the stockholders fail to ratify the selection, the Audit Committee will reconsider whether or not to retain that firm. Even if the selection is ratified, the Audit Committee in its discretion may direct the appointment of different independent auditors at any time during the year if they determine that such a change would be in the best interests of the Company and its stockholders.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:0pt;margin:0pt;"><font style="margin-bottom:12pt;visibility:hidden;">&#8203;</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:0pt;margin:0pt;"><a name="_DV_M601"></a>The affirmative vote of the holders of a majority of the shares present virtually or represented by proxy and entitled to vote on the matter at the Annual Meeting will be required to ratify the selection of Ernst &amp; Young LLP. </p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:0pt;margin:0pt;"><font style="margin-bottom:12pt;visibility:hidden;">&#8203;</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;line-height:1.19;margin:0pt;"><a name="_DV_M602"></a>PRINCIPAL ACCOUNTANT FEES AND SERVICES </p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;line-height:1.19;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:0pt;margin:0pt;"><a name="_DV_M603"></a><a name="_DV_M604"></a><a name="_DV_M605"></a><a name="_DV_M607"></a>The following table represents aggregate fees billed to the Company for the fiscal years ended December 31, 2021 and 2020 by Ernst &amp; Young LLP, the Company&#8217;s principal accountant.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:0pt;margin:0pt;"><font style="margin-bottom:12pt;visibility:hidden;">&#8203;</font></p><div><table style="border-collapse:collapse;font-size:16pt;height:max-content;margin-left:auto;margin-right:auto;padding-left:0pt;padding-right:0pt;width:100%;" align="center"><tr style="height:1pt;"><td style="vertical-align:bottom;width:62.58%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;"><a name="_DV_M612"></a><a name="_DV_M614"></a><a name="_DV_M615"></a><font style="font-size:1pt;visibility:hidden;">&#8203;</font></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.7%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;"><font style="font-size:1pt;visibility:hidden;">&#8203;</font></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.12%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;"><font style="font-size:1pt;visibility:hidden;">&#8203;</font></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:15.64%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;"><font style="font-size:1pt;visibility:hidden;">&#8203;</font></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.7%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;"><font style="font-size:1pt;visibility:hidden;">&#8203;</font></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.12%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;"><font style="font-size:1pt;visibility:hidden;">&#8203;</font></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:15.68%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;"><font style="font-size:1pt;visibility:hidden;">&#8203;</font></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:0.42%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;"><font style="font-size:1pt;visibility:hidden;">&#8203;</font></p></div></div></td></tr><tr><td style="vertical-align:bottom;width:62.58%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.7%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></td><td colspan="5" style="vertical-align:bottom;white-space:nowrap;width:35.27%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">FISCAL YEAR ENDED DECEMBER 31,</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.42%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></td></tr><tr><td style="vertical-align:bottom;width:62.58%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;"><font style="font-size:8pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.7%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:16.76%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">2021</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.7%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:16.8%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">2020</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.42%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">&#160;</b></p></td></tr><tr style="height:0pt;visibility:hidden;"><td colspan="8" style="padding:0pt;"></td></tr><tr><td style="vertical-align:bottom;width:62.58%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;"><font style="font-size:8pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.7%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><font style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</font></p></td><td colspan="5" style="vertical-align:bottom;white-space:nowrap;width:35.27%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">(in thousands)</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.42%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><font style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</font></p></td></tr><tr><td style="vertical-align:bottom;width:62.58%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;">Audit fees</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.7%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.12%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:15.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.6pt 0pt 0pt;"><font style="white-space:pre-wrap;"> 597</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.7%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.12%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:15.68%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.6pt 0pt 0pt;"><font style="white-space:pre-wrap;"> 574</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.42%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></td></tr><tr><td style="vertical-align:bottom;width:62.58%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;">All other fees</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.7%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.12%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:15.64%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.6pt 0pt 0pt;"><font style="white-space:pre-wrap;"> 2</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.7%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.12%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:15.68%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.6pt 0pt 0pt;"><font style="white-space:pre-wrap;"> 3</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.42%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></td></tr><tr><td style="vertical-align:bottom;white-space:nowrap;width:62.58%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;">Total</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.7%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.12%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:15.64%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.6pt 0pt 0pt;"><font style="white-space:pre-wrap;"> 599</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.7%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.12%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:15.68%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.6pt 0pt 0pt;"><font style="white-space:pre-wrap;"> 577</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.42%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></td></tr></table></div><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Audit fees for both years include the aggregate fees billed or incurred for professional services rendered in connection with the annual audit of our consolidated financial statements<font style="background:#ffffff;">,&#160;</font>reviews of our quarterly financial statements included in our quarterly reports on Form 10-Q, accounting and financial reporting consultations and services in connection with registration statements and comfort letters. The other fees for the years ended December 31, 2021 and 2020 related to an annual subscription for an online platform for accessing and researching accounting and financial reporting content.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">All of the services of Ernst &amp; Young LLP for the years ended December 31, 2021 and 2020 described above were pre-approved by the Audit Committee.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></div><div style="clear:both;display:table;margin-bottom:27.35pt;min-height:44.65pt;width:100%;"><div style="display:table-cell;vertical-align:bottom;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;min-height:12.0pt;text-align:center;margin:24pt 0pt 0pt 0pt;">22</p></div></div></div><hr style="background-color:#000000;clear:both;color:#000000;height:2pt;line-height:0;margin-bottom:30pt;margin-left:11.76%;margin-right:11.76%;margin-top:30pt;page-break-after:always;width:76.47%;border-width:0;"><div style="max-width:100%;padding-left:11.76%;padding-right:11.76%;position:relative;"><div style="margin-top:27.35pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"><font style="font-weight:bold;visibility:hidden;">&#8203;</font></p></div><div style="clear:both;max-width:100%;position:relative;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;line-height:1.19;margin:0pt;"><a name="_DV_M616"></a>AUDIT COMMITTEE PRE-APPROVAL POLICY </p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;line-height:1.19;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:0pt;margin:0pt;"><a name="_DV_M617"></a><a name="_DV_M618"></a>The Audit Committee has adopted a policy which includes procedures for the pre-approval of audit and non-audit services rendered by the Company&#8217;s independent registered public accounting firm, Ernst &amp; Young LLP. The policy generally provides for the pre-approval of specified services in the defined categories of audit services, audit-related services and tax services up to specified amounts. Pre-approval may also be given as part of the Audit Committee&#8217;s approval of the scope of the engagement of the independent auditor or on an individual, explicit, case-by-case basis before the independent auditor is engaged to provide each service. The pre-approval of services may be given by the chairperson of the Audit Committee, but such pre-approval decision must be reported to the full Audit Committee at its next scheduled meeting for ratification by the Audit Committee. </p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><a name="_DV_M619"></a><a name="_DV_M620"></a><a name="_DV_M628"></a><font style="font-weight:bold;visibility:hidden;">&#8203;</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">THE BOARD OF DIRECTORS RECOMMENDS</b></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><a name="_DV_M629"></a><b style="font-weight:bold;">A VOTE IN FAVOR OF PROPOSAL 2</b>.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></div><div style="clear:both;display:table;margin-bottom:27.35pt;min-height:44.65pt;width:100%;"><div style="display:table-cell;vertical-align:bottom;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;min-height:12.0pt;text-align:center;margin:24pt 0pt 0pt 0pt;">23</p></div></div></div><hr style="background-color:#000000;clear:both;color:#000000;height:2pt;line-height:0;margin-bottom:30pt;margin-left:11.76%;margin-right:11.76%;margin-top:30pt;page-break-after:always;width:76.47%;border-width:0;"><div style="max-width:100%;padding-left:11.76%;padding-right:11.76%;position:relative;"><div style="margin-top:27.35pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"><font style="font-weight:bold;visibility:hidden;">&#8203;</font></p></div><div style="clear:both;max-width:100%;position:relative;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><b style="font-size:12pt;font-weight:bold;">PROPOSAL 3</b></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><b style="font-size:12pt;font-weight:bold;">APPROVAL OF AN AMENDMENT AND RESTATEMENT </b></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><b style="font-size:12pt;font-weight:bold;">OF THE 2013 EQUITY INCENTIVE PLAN</b></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><font style="white-space:pre-wrap;">The Board of Directors is requesting stockholder approval of an amendment and restatement of the GlycoMimetics, Inc. 2013 Equity Incentive Plan (the &#8220;2013 Plan&#8221;). We refer to such amendment and restatement of the 2013 Plan in this proxy statement as the &#8220;Amended 2013 Plan&#8221;. The Board approved the Amended 2013 Plan on April 7, 2022, subject to approval by our stockholders at the Annual Meeting.  The adoption of the Amended 2013 Plan is necessary to allow us to continue to make our customary annual long-term incentive awards and other equity awards to attract, retain and motivate our officers, key employees and directors, and to continue to align the interests of those individuals with the interests of our stockholders. </font>If this Proposal 3 is approved by our stockholders, the Amended 2013 Plan will become effective as of the date of its approval by the Board. In the event that our stockholders do not approve this Proposal 3, the Amended 2013 Plan will not become effective and the 2013 Plan will continue in its current form.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;">The Amended 2013 Plan contains the following material changes from the 2013 Plan:</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p><table border="0" cellpadding="0" cellspacing="0" style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;width:100%;background:#ffffff;border:0pt;"><tr><td style="width:18pt;"></td><td style="font-family:'Times New Roman','Times','serif';font-size:8pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><font style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">Subject to adjustment for certain changes in our capitalization, and subject to the annual &#8220;evergreen&#8221; increase described below, the existing share reserve under the 2013 Plan will be increased by an additional 2,619,622 shares of our common stock, which will be available for issuance under the Amended 2013 Plan.</font></td></tr></table><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;padding-left:18pt;text-align:justify;text-indent:-18pt;background:#ffffff;margin:0pt 0pt 0pt 18pt;"><font style="margin-left:0pt;visibility:hidden;">&#8203;</font></p><table border="0" cellpadding="0" cellspacing="0" style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;width:100%;background:#ffffff;border:0pt;"><tr><td style="width:18pt;"></td><td style="font-family:'Times New Roman','Times','serif';font-size:8pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><font style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">Beginning on January 1, 2023 and ending on (and including) January&#160;1, 2029, the maximum number of shares of common stock that may be issued under the Amended 2013 Plan will cumulatively be increased by 4% of the number of shares of common stock issued and outstanding on the immediately preceding December 31, or such lesser number of shares as determined by the Board or the Compensation Committee.</font></td></tr></table><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;padding-left:18pt;text-align:justify;text-indent:-18pt;background:#ffffff;margin:0pt 0pt 0pt 18pt;"><font style="margin-left:0pt;visibility:hidden;">&#8203;</font></p><table border="0" cellpadding="0" cellspacing="0" style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;width:100%;background:#ffffff;border:0pt;"><tr><td style="width:18pt;"></td><td style="font-family:'Times New Roman','Times','serif';font-size:8pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><font style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">Subject to adjustment for certain changes in our capitalization, the aggregate maximum number of shares of our common stock that may be issued pursuant to the exercise of incentive stock options under the Amended 2013 Plan will be 20,000,000 shares.</font></td></tr></table><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;padding-left:18pt;text-align:justify;text-indent:-18pt;margin:0pt 0pt 0pt 18pt;"><font style="margin-left:0pt;visibility:hidden;">&#8203;</font></p><table border="0" cellpadding="0" cellspacing="0" style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;width:100%;background:#ffffff;border:0pt;"><tr><td style="width:18pt;"></td><td style="font-family:'Times New Roman','Times','serif';font-size:8pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><font style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">The aggregate value of all compensation granted or paid, as applicable, during any calendar year to any of our non-employee directors, including awards granted and cash fees paid by us to such non-employee director during such calendar year, will not exceed (1) $750,000 in total value or (2)&#160;$1,000,000 in total value with respect to the calendar year in which the individual is first appointed or elected to the Board of Directors, in each case, calculating the value of any equity awards based on the grant date fair value of such equity awards for financial reporting purposes.</font></td></tr></table><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;padding-left:18pt;text-align:justify;text-indent:-18pt;margin:0pt 0pt 0pt 18pt;"><font style="margin-left:0pt;visibility:hidden;">&#8203;</font></p><table border="0" cellpadding="0" cellspacing="0" style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;width:100%;background:#ffffff;border:0pt;"><tr><td style="width:18pt;"></td><td style="font-family:'Times New Roman','Times','serif';font-size:8pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><font style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">The Company may satisfy any federal, state or local tax withholding obligation relating to an award granted under the Amended 2013 Plan by one or more of the following: (i) causing the </font><font style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;"><a name="_Hlk99636530"></a></font><font style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">participant to tender a cash payment; (ii) withholding shares of common stock from the shares of common stock issued or otherwise issuable to the participant in connection with the award; (iii) withholding cash from an award settled in cash; (iv) withholding payment from any amounts otherwise payable to the participant; or (v) by such other method as may be set forth in the participant&#8217;s award agreement</font><font style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">.</font></td></tr></table><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;padding-left:18pt;text-align:justify;text-indent:-18pt;margin:0pt 0pt 0pt 18pt;"><font style="margin-left:0pt;visibility:hidden;">&#8203;</font></p><table border="0" cellpadding="0" cellspacing="0" style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;width:100%;background:#ffffff;border:0pt;"><tr><td style="width:18pt;"></td><td style="font-family:'Times New Roman','Times','serif';font-size:8pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><font style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">The performance-based compensation exception to the limit on deductibility of executive compensation set forth in Section 162(m) of the Internal Revenue Code was eliminated pursuant to the 2017 Tax Cuts and Jobs Act. In light of the elimination of the performance-based compensation exception, the Amended 2013 Plan removes the annual limits in the 2013 Plan that applied to awards intended to qualify for this exception and makes certain other updates to reflect this change in law. </font></td></tr></table><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;background:#ffffff;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></div><div style="clear:both;display:table;margin-bottom:27.35pt;min-height:44.65pt;width:100%;"><div style="display:table-cell;vertical-align:bottom;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;min-height:12.0pt;text-align:center;margin:24pt 0pt 0pt 0pt;">24</p></div></div></div><hr style="background-color:#000000;clear:both;color:#000000;height:2pt;line-height:0;margin-bottom:30pt;margin-left:11.76%;margin-right:11.76%;margin-top:30pt;page-break-after:always;width:76.47%;border-width:0;"><div style="max-width:100%;padding-left:11.76%;padding-right:11.76%;position:relative;"><div style="margin-top:27.35pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"><font style="font-weight:bold;visibility:hidden;">&#8203;</font></p></div><div style="clear:both;max-width:100%;position:relative;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">Why You Should Vote to Approve the Amended 2013 Plan</b></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><font style="font-weight:bold;visibility:hidden;">&#8203;</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;"><i style="font-style:italic;">Equity Awards Are a Key Component of Our Compensation Philosophy</i></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;"><font style="font-weight:bold;visibility:hidden;">&#8203;</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">The Board believes that our future success depends, in large part, on our ability to maintain a competitive position in attracting, retaining and motivating employees, directors and consultants. The Board believes that the grant of equity awards is a key element underlying our ability to attract, retain and motivate employees, directors and consultants, and better aligns the interests of our employees, directors and consultants with those of our stockholders. The Amended 2013 Plan will allow us to continue to provide equity-based incentives to our employees, directors and consultants. Therefore, the Board believes that the Amended 2013 Plan is in the best interests of GlycoMimetics and our stockholders and recommends a vote in favor of this Proposal 3.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;"><i style="font-style:italic;">We Have Experienced, and Expect to Experience, Substantial Growth in Our Business</i></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">The Board believes that the Amended 2013 Plan is necessary to ensure that the number of shares available for issuance pursuant to equity awards will be sufficient to allow us to continue to attract, retain and motivate the services of talented individuals essential to our long-term growth and financial success. The Board strongly believes that the grant of equity awards is a key element underlying our ability to attract, retain and motivate our employees&#8212;including our executives&#8212;and our directors, and is a substantial contributing factor to our success and the growth of our business. We have relied significantly on equity awards in the form of stock options and restricted stock unit awards to attract, retain and motivate key employees, and we believe that equity awards are necessary for us to remain competitive in the marketplace for executive talent and other employees.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;"><i style="font-style:italic;">We Manage Our Equity Award Use Carefully and Dilution Is Reasonable</i></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">We believe that equity awards such as options and restricted stock unit awards are a vital part of our overall compensation program, and we grant awards to substantially all of our employees. However, we recognize that this compensation philosophy dilutes existing stockholders. Therefore, we also recognize that we must responsibly manage the growth of our equity compensation program. We are committed to monitoring our equity compensation share reserve carefully, including our &#8220;burn rate,&#8221; to ensure that we attempt to maximize stockholders&#8217; value by granting the appropriate number of equity awards necessary to attract, retain and motivate our employees, directors and consultants.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;"><i style="font-style:italic;">The Size of Our Share Reserve Increase Request Is Reasonable</i></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;"><font style="font-style:italic;visibility:hidden;">&#8203;</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">If this Proposal 3 is approved by our stockholders, in addition to the shares reserved for issuance under the 2013 Plan we will have 2,619,622 additional shares available for grant under the Amended 2013 Plan after the Annual Meeting (subject to adjustment for certain changes in our capitalization).</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">The Board of Directors believes that our request for 2,619,622 additional shares under the Amended 2013 Plan is necessary to provide an appropriate amount of equity awards for attracting, retaining, and motivating our employees, directors and consultants in accordance with our business plans, and is an amount that we believe a majority of our institutional investors would support.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;"><i style="font-style:italic;">The Amended 2013 Plan Combines Compensation and Governance Best Practices</i></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;"><font style="font-style:italic;visibility:hidden;">&#8203;</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">The Amended 2013 Plan includes provisions that are designed to protect our stockholders&#8217; interests and to reflect corporate governance best practices including:</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p><table border="0" cellpadding="0" cellspacing="0" style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"></td><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><i style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:italic;font-weight:normal;">Awards subject to forfeiture/clawback</i><font style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">. Awards granted under the Amended 2013 Plan will be subject to recoupment in accordance with any clawback policy that we are required to adopt pursuant to the listing standards of any national securities exchange or association on which our securities are listed or as is otherwise required by the Dodd-Frank Wall Street Reform and Consumer Protection Act or other applicable law, and any other clawback policy that the Company may adopt or maintain. In addition, the Board may impose other clawback, recovery or recoupment provisions in an award agreement, including a </font></td></tr></table></div><div style="clear:both;display:table;margin-bottom:27.35pt;min-height:44.65pt;width:100%;"><div style="display:table-cell;vertical-align:bottom;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;min-height:12.0pt;text-align:center;margin:24pt 0pt 0pt 0pt;">25</p></div></div></div><hr style="background-color:#000000;clear:both;color:#000000;height:2pt;line-height:0;margin-bottom:30pt;margin-left:11.76%;margin-right:11.76%;margin-top:30pt;page-break-after:always;width:76.47%;border-width:0;"><div style="max-width:100%;padding-left:11.76%;padding-right:11.76%;position:relative;"><div style="margin-top:27.35pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"><font style="font-weight:bold;visibility:hidden;">&#8203;</font></p></div><div style="clear:both;max-width:100%;position:relative;"><table border="0" cellpadding="0" cellspacing="0" style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"></td><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;"></td><td style="padding:0pt;"><font style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">reacquisition right in respect of previously acquired shares or other cash or property upon the occurrence of cause.</font></td></tr></table><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt 0pt 0pt 36pt;"><font style="margin-left:0pt;visibility:hidden;">&#8203;</font></p><table border="0" cellpadding="0" cellspacing="0" style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"></td><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><i style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:italic;font-weight:normal;">Limit on non-employee director compensation</i><font style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">. The aggregate value of all compensation granted or paid, as applicable, during any calendar year to any of our non-employee directors, including awards granted and cash fees paid by us to such non-employee director during such calendar year, will not exceed (1) $750,000 in total value or (2)&#160;$1,000,000 in total value with respect to the calendar year in which the individual is first appointed or elected to the Board of Directors, in each case, calculating the value of any equity awards based on the grant date fair value of such equity awards for financial reporting purposes.</font></td></tr></table><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">Description of the Amended 2013 Plan</b></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><font style="font-weight:bold;visibility:hidden;">&#8203;</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;">A summary of the principal features of the Amended 2013 Plan follows below. The summary is qualified by the full text of the Amended 2013 Plan that is attached as <u style="text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">Appendix A</u> to this proxy statement.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;"><i style="font-style:italic;">Purpose</i></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">The Amended 2013 Plan is designed to secure and retain the services of our employees, directors and consultants, provide incentives for our employees, directors and consultants to exert maximum efforts for the success of the Company and its affiliates, and provide a means by which our employees, directors and consultants may be given an opportunity to benefit from increases in the value of our common stock.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;"><i style="font-style:italic;">Types of Awards</i></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Our Amended 2013 Plan provides for the grant of incentive stock options, nonstatutory stock options, restricted stock awards, restricted stock unit awards, stock appreciation rights, performance awards and other awards. </p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;"><i style="font-style:italic;">Shares Available for Awards </i></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Subject to adjustment for certain changes in our capitalization, and subject to increase pursuant to the annual &#8220;evergreen&#8221; provision described below, the aggregate number of shares of our common stock that may be issued under the Amended 2013 Plan, or the Share Reserve, will not exceed 12,145,995 shares, which is the sum of (i) 2,619,622 newly requested shares that are subject to this Proposal 3, (ii) 9,506,767 shares, consisting of the shares initially reserved for issuance under the 2013 Plan as of its original effective date and shares that were added to the share reserve pursuant to the &#8220;evergreen&#8221; provision in the 2013 Plan between its original effective date and the effective date of the Amended 2013 Plan, and (iii) the Prior Plan&#8217;s Returning Shares (as defined below), as such shares become available from time to time after the effective date of the Amended 2013 Plan, in an amount not to exceed 19,606 shares as of the date that the Amended 2013 Plan becomes effective.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">The term &#8220;Prior Plan&#8217;s Returning Shares&#8221; refers to the following shares of our common stock subject to any stock awards granted under the 2003 Equity Incentive Plan that were outstanding as of the effective date of the Amended 2013 Plan, that thereafter: (i) expire or terminate for any reason prior to exercise or settlement; (ii) are forfeited, cancelled or otherwise returned to the Company because of the failure to meet a contingency or condition required to vest such shares; or (iii) are reacquired, withheld (or not issued) to satisfy a tax withholding obligation in connection with an award or to satisfy the purchase price or exercise price of a stock award.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">The following shares of our common stock, or collectively, the 2013 Plan Returning Shares, will also become available again for issuance under the Amended 2013 Plan: (i) any shares subject to a stock award granted under the Amended 2013 Plan that are not issued because such stock award expires or otherwise terminates without all of the shares covered by such stock award having been issued; (ii) any shares subject to a stock award granted under the Amended 2013 Plan that are not issued because such stock award is settled in cash; (iii) any shares issued pursuant to a stock award granted under the Amended 2013 Plan that are forfeited back to or repurchased by us because of a failure to vest; and (iv)&#160;any shares used to pay the exercise or purchase price of a stock award or to satisfy the tax withholding obligations related to a stock award. </p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></div><div style="clear:both;display:table;margin-bottom:27.35pt;min-height:44.65pt;width:100%;"><div style="display:table-cell;vertical-align:bottom;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;min-height:12.0pt;text-align:center;margin:24pt 0pt 0pt 0pt;">26</p></div></div></div><hr style="background-color:#000000;clear:both;color:#000000;height:2pt;line-height:0;margin-bottom:30pt;margin-left:11.76%;margin-right:11.76%;margin-top:30pt;page-break-after:always;width:76.47%;border-width:0;"><div style="max-width:100%;padding-left:11.76%;padding-right:11.76%;position:relative;"><div style="margin-top:27.35pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"><font style="font-weight:bold;visibility:hidden;">&#8203;</font></p></div><div style="clear:both;max-width:100%;position:relative;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">In addition, the Amended 2013 Plan contains an &#8220;evergreen&#8221; provision that provides that the Share Reserve will automatically increase on January 1st of each year following the effective date of the Amended 2013 Plan for a period of not more than seven years, commencing on January 1, 2023 and ending on (and including) January&#160;1, 2029, in an amount equal to 4% of the total number of shares of capital stock outstanding on December 31st of the preceding calendar year. Notwithstanding the foregoing, the Board may act prior to January 1st of a given year to provide that there will be no January 1st increase in the Share Reserve for such year or that the increase in the Share Reserve for such year will be a lesser number of shares of common stock than would otherwise occur pursuant to the preceding sentence. </p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;"><i style="font-style:italic;">Eligibility</i></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Our Amended 2013 Plan will provide for the grant of incentive stock options within the meaning of Section 422 of the Internal Revenue Code, or the Code, to our employees and our parent and subsidiary corporations&#8217; employees, and for the grant of nonstatutory stock options, restricted stock awards, restricted stock unit awards, stock appreciation rights, performance awards and other awards to our employees, including officers, consultants and directors. </p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:36pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">As of April 1, 2022, we (including our affiliates) had approximately 54 employees, 6 non-employee directors, and 38 consultants.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;"><i style="font-style:italic;">Non-Employee Director Compensation Limit</i></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">The aggregate value of all compensation granted or paid, as applicable, during any calendar year to any of our non-employee directors, including awards granted and cash fees paid by us to such non-employee director during such calendar year, will not exceed (1) $750,000 in total value or (2)&#160;$1,000,000 in total value with respect to the calendar year in which the individual is first appointed or elected to the Board of Directors, in each case, calculating the value of any equity awards based on the grant date fair value of such equity awards for financial reporting purposes.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;"><i style="font-style:italic;">Administration </i></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Our Board, or a duly authorized committee thereof, has the authority to administer our Amended 2013 Plan. Our Board has delegated its authority to administer our Amended 2013 Plan to our Compensation Committee under the terms of the Compensation Committee&#8217;s charter. Our Board may also delegate to one or more of our officers the authority to (i) designate employees other than officers to receive specified stock awards and (ii) determine the number of shares of our common stock to be subject to such stock awards. Subject to the terms of our Amended 2013 Plan, the administrator has the authority to determine the terms of awards, including recipients, the exercise price or strike price of stock awards, if any, the number of shares subject to each stock award, the fair market value of a share of our common stock, the vesting schedule applicable to the awards, together with any vesting acceleration, the form of consideration, if any, payable upon exercise or settlement of the stock award and the terms and conditions of the award agreements for use under our Amended 2013 Plan.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;"> <font style="visibility:hidden;">&#8203;</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><font style="white-space:pre-wrap;">The administrator has the power to modify outstanding awards under our Amended 2013 Plan. Subject to the terms of our Amended 2013 Plan, the administrator has the authority to reprice any outstanding option or stock appreciation right, cancel and re-grant any outstanding option or stock appreciation right in exchange for new stock awards, cash or other consideration or take any other action that is treated as a repricing under GAAP, with the consent of any adversely affected participant.  </font></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;"><i style="font-style:italic;">Stock Options and Stock Appreciation Rights</i></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">The Amended 2013 Plan permits the granting of (1)&#160;stock options intended to qualify as incentive stock options under Section&#160;<a name="_cp_text_1_121"></a>422 of the Code (&#8220;ISOs&#8221;), (2)&#160;<a name="_cp_text_1_122"></a><a name="_cp_text_1_123"></a>nonstatutory stock options (&#8220;NSOs&#8221;) and (3) stock appreciation rights (&#8220;SARs&#8221;). Options granted under the Amended 2013 Plan will be NSOs if they are not designated as ISOs, fail to qualify as ISOs or exceed the annual limit on ISOs. NSOs and SARs may be granted to any persons eligible to receive ISOs and to non-employee directors and consultants. </p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:36pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></div><div style="clear:both;display:table;margin-bottom:27.35pt;min-height:44.65pt;width:100%;"><div style="display:table-cell;vertical-align:bottom;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;min-height:12.0pt;text-align:center;margin:24pt 0pt 0pt 0pt;">27</p></div></div></div><hr style="background-color:#000000;clear:both;color:#000000;height:2pt;line-height:0;margin-bottom:30pt;margin-left:11.76%;margin-right:11.76%;margin-top:30pt;page-break-after:always;width:76.47%;border-width:0;"><div style="max-width:100%;padding-left:11.76%;padding-right:11.76%;position:relative;"><div style="margin-top:27.35pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"><font style="font-weight:bold;visibility:hidden;">&#8203;</font></p></div><div style="clear:both;max-width:100%;position:relative;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><font style="white-space:pre-wrap;"><a name="_cp_text_1_125"></a><a name="_cp_text_1_127"></a><a name="_cp_text_1_130"></a><a name="_cp_text_1_132"></a>The exercise price of options and SARs granted under the Amended 2013 Plan may not be less than 100% of the fair market value of the common stock subject to the option or SAR on the date of grant, and in some cases (see &#8220;Limitations on Incentive Stock Options&#8221; below), may not be less than 110% of such fair market value.  The term of options and SARs granted under the Amended 2013 Plan may not exceed ten years from the date of grant, and in some cases (see &#8220;Limitations on Incentive Stock Options&#8221; below) may not exceed five years from the date of grant. </font></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:36pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Acceptable forms of consideration for the purchase of our common stock pursuant to the exercise of an option under the Amended 2013 Plan will be determined by the Board and may include payment: (i)&#160;by cash, check, bank draft or money order payable to us; (ii)&#160;pursuant to a program developed under Regulation T as promulgated by the Federal Reserve Board; (iii)&#160;by delivery to us of shares of our common stock (either by actual delivery or attestation); (iv) by a net exercise arrangement (for NSOs only); or (v)&#160;in other legal consideration acceptable to the Board and set forth in the award agreement.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:36pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">The appreciation distribution payable upon exercise of a SAR may be paid in shares of our common stock, in cash, in a combination of cash and stock, or in any other form of consideration determined by the Board and set forth in the stock appreciation right agreement.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:36pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">The Board may impose limitations on the transferability of options and SARs granted under the Amended 2013 Plan in its discretion. Generally, a participant may not transfer an option or SAR other than by will or the laws of descent and distribution or, subject to approval by the Board, pursuant to a domestic relations order, an official marital settlement agreement, or other divorce or separation instrument. However, the Board may permit transfer of an option or SAR in a manner that is not prohibited by applicable tax and securities laws. In addition, subject to approval by the Board, a participant may designate a beneficiary who may exercise the stock option or SAR following the participant&#8217;s death. </p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:36pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;background:#ffffff;margin:0pt;">The total number of shares of common stock subject to an option or SAR may vest and become exercisable in periodic installments that may or may not be equal. Options and SARs granted under the Amended 2013 Plan may be subject to such other terms and conditions on the time or times when it may or may not be exercised (which may be based on the satisfaction of performance goals or other criteria) as the Board may determine. Shares covered by different options granted under the Amended 2013 Plan may be subject to different vesting schedules as the Board may determine.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:36pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Except as otherwise provided in a participant&#8217;s award agreement or other agreement with us or one of our affiliates, if a participant&#8217;s service relationship with us or any of our affiliates (referred to in this Proposal 3 as &#8220;continuous service&#8221;) terminates (other than for cause and other than upon the participant&#8217;s death or disability), the participant may exercise any vested options or SARs for up to three months following the participant&#8217;s termination of continuous service. Except as otherwise provided in a participant&#8217;s award agreement or other agreement with us or one of our affiliates, if a participant&#8217;s continuous service terminates due to the participant&#8217;s disability or death (or the participant dies within a specified period, if any, following termination of continuous service), the participant, or his or her beneficiary, as applicable, may exercise any vested options or SARs for up to 12 months following the participant&#8217;s termination due to the participant&#8217;s disability or for up to 18 months following the participant&#8217;s death. Except as otherwise provided in a participant&#8217;s award agreement or other agreement with us or one of our affiliates, if a participant&#8217;s continuous service is terminated for cause (as defined in the Amended 2013 Plan), all options and SARs held by the participant will terminate upon the participant&#8217;s termination of continuous service and the participant will be prohibited from exercising any option or SAR from and after such termination date. Except as otherwise provided in a participant&#8217;s award agreement or other written agreement with us or one of our affiliates, the term of an option or SAR may be extended if the exercise of the option or SAR following the participant&#8217;s termination of continuous service (other than for cause and other than upon the participant&#8217;s death or disability) would be prohibited by applicable securities laws or if the sale of any common stock received upon exercise of the option or SAR following the participant&#8217;s termination of continuous service (other than for cause) would violate our insider trading policy. In no event, however, may an option or SAR be exercised after its original expiration date.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">The closing price of a share of our common stock, as reported on the Nasdaq Global Market on April 1, 2022, was $1.15 per share.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></div><div style="clear:both;display:table;margin-bottom:27.35pt;min-height:44.65pt;width:100%;"><div style="display:table-cell;vertical-align:bottom;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;min-height:12.0pt;text-align:center;margin:24pt 0pt 0pt 0pt;">28</p></div></div></div><hr style="background-color:#000000;clear:both;color:#000000;height:2pt;line-height:0;margin-bottom:30pt;margin-left:11.76%;margin-right:11.76%;margin-top:30pt;page-break-after:always;width:76.47%;border-width:0;"><div style="max-width:100%;padding-left:11.76%;padding-right:11.76%;position:relative;"><div style="margin-top:27.35pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"><font style="font-weight:bold;visibility:hidden;">&#8203;</font></p></div><div style="clear:both;max-width:100%;position:relative;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;"><i style="font-style:italic;">Limitations on Incentive Stock Options</i></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">The aggregate fair market value, determined at the time of grant, of shares of our common stock with respect to ISOs that are exercisable for the first time by a participant during any calendar year under all of our stock plans may not exceed $100,000. The options or portions of options that exceed this limit or otherwise fail to qualify as ISOs are treated as NSOs. No ISO may be granted to any person who, at the time of grant, owns or is deemed to own stock possessing more than 10% of our total combined voting power or that of any affiliate unless the following conditions are satisfied:</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p><table border="0" cellpadding="0" cellspacing="0" style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"></td><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><font style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">the exercise price of the ISO must be at least 110% of the fair market value of the common stock subject to the ISO on the date of grant; and</font></td></tr></table><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;padding-left:18pt;text-indent:-18pt;margin:0pt 0pt 0pt 18pt;"><font style="margin-left:0pt;visibility:hidden;">&#8203;</font></p><table border="0" cellpadding="0" cellspacing="0" style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"></td><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><font style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">the term of the ISO must not exceed five years from the date of grant.</font></td></tr></table><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Subject to adjustment for certain changes in our capitalization, the aggregate maximum number of shares of our common stock that may be issued pursuant to the exercise of ISOs under the Amended 2013 Plan is 20,000,000 shares.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;"><i style="font-style:italic;">Restricted Stock Awards</i></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Restricted stock awards may be granted under the Amended 2013 Plan pursuant to restricted stock award agreements. A restricted stock award may be granted in consideration for cash, check, bank draft or money order payable to us, the participant&#8217;s services performed for us or any of our affiliates, or any other form of legal consideration acceptable to the Board. Shares of our common stock acquired under a restricted stock award may be subject to forfeiture to or repurchase by us in accordance with a vesting schedule to be determined by the Board. Rights to acquire shares of our common stock under a restricted stock award may be transferred only upon such terms and conditions as are set forth in the restricted stock award agreement. Upon a participant&#8217;s termination of continuous service for any reason, any or all shares subject to restricted stock awards held by the participant as of such termination date may be forfeited to or repurchased by us.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;"><i style="font-style:italic;">Restricted Stock Unit Awards</i></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Restricted stock unit awards may be granted under the Amended 2013 Plan pursuant to restricted stock unit award agreements. Payment of any purchase price may be made in any form of legal consideration acceptable to the Board. A restricted stock unit award may be settled by the delivery of shares of our common stock, in cash, in a combination of cash and stock, or in any other form of consideration determined by the Board and set forth in the restricted stock unit award agreement. Restricted stock unit awards may be subject to vesting in accordance with a vesting schedule to be determined by the Board, and the Board may impose restrictions or conditions that delay the delivery of the shares of common stock (or their cash equivalent) subject to a restricted stock unit award to a time after the vesting of such award. Except as otherwise provided in a participant&#8217;s award agreement or other written agreement with us or one of our affiliates, restricted stock units that have not vested will be forfeited upon the participant&#8217;s termination of continuous service for any reason.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;"><i style="font-style:italic;">Performance Awards</i></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Performance awards may be granted under the Amended 2013 Plan pursuant to award agreements. The length of any performance period, the performance goals to be achieved during the performance period, the other terms and conditions of a performance award and the measure of whether and to what degree such performance goals have been attained will be determined by the Board. To the extent permitted by applicable law, the Board may determine that cash or other property may be used in payment of performance awards.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;"><i style="font-style:italic;">Other Awards</i></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Other forms of awards valued in whole or in part by reference to, or otherwise based on, our common stock may be granted either alone or in addition to other awards under the Amended 2013 Plan. Subject to the terms of the Amended 2013 Plan, the Board will have sole and complete authority to determine the persons to whom and the </p></div><div style="clear:both;display:table;margin-bottom:27.35pt;min-height:44.65pt;width:100%;"><div style="display:table-cell;vertical-align:bottom;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;min-height:12.0pt;text-align:center;margin:24pt 0pt 0pt 0pt;">29</p></div></div></div><hr style="background-color:#000000;clear:both;color:#000000;height:2pt;line-height:0;margin-bottom:30pt;margin-left:11.76%;margin-right:11.76%;margin-top:30pt;page-break-after:always;width:76.47%;border-width:0;"><div style="max-width:100%;padding-left:11.76%;padding-right:11.76%;position:relative;"><div style="margin-top:27.35pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"><font style="font-weight:bold;visibility:hidden;">&#8203;</font></p></div><div style="clear:both;max-width:100%;position:relative;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">time or times at which such other awards will be granted, the number of shares of our common stock (or the cash equivalent thereof) to be granted and all other terms and conditions of such other awards.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;"><font style="font-style:italic;visibility:hidden;">&#8203;</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;"><i style="font-style:italic;">Tax Withholding</i></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;"><font style="font-style:italic;visibility:hidden;">&#8203;</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">The Company may satisfy any federal, state or local tax withholding obligation relating to an award granted under the Amended 2013 Plan by any one or more of the following: (i) causing the participant to tender a cash payment; (ii) withholding shares of common stock from the shares of common stock issued or otherwise issuable to the participant in connection with an award; (iii) withholding cash from an award settled in cash; (iv) withholding payment from any amounts otherwise payable to the participant; or (v) by such other method as may be set forth in the participant&#8217;s award agreement. </p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;"><font style="font-style:italic;visibility:hidden;">&#8203;</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;"><i style="font-style:italic;">Clawback Policy</i></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Awards granted under the Amended 2013 Plan will be subject to recoupment in accordance with any clawback policy that we are required to adopt pursuant to the listing standards of any national securities exchange or association on which our securities are listed or as is otherwise required by the Dodd-Frank Wall Street Reform and Consumer Protection Act or other applicable law, and any other clawback policy that the Company may adopt or maintain. In addition, the Board may impose other clawback, recovery or recoupment provisions in an award agreement, including a reacquisition right in respect of previously acquired shares or other cash or property upon the occurrence of cause.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;"><i style="font-style:italic;">Changes to Capital Structure</i></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">In the event of certain capitalization adjustments, the Board will appropriately adjust: (i)&#160;the class(es) and maximum number of securities subject to the Amended 2013 Plan; (ii)&#160;the class(es) and maximum number of securities that may be issued pursuant to the exercise of ISOs; and (iii)&#160;the class(es) and number of securities and price per share of stock subject to outstanding stock awards.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;"><i style="font-style:italic;">Corporate Transactions </i></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Our Amended 2013 Plan provides that in the event of a specified corporate transaction, including without limitation a consolidation, merger or similar transaction involving our company, the sale, lease or other disposition of all or substantially all of the assets of our company or the consolidated assets of our company and our subsidiaries, or a sale or disposition of at least 50% of the outstanding capital stock of our company, the Board will determine how to treat each outstanding equity award. The Board may:</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;"><font style="font-size:12pt;visibility:hidden;">&#8203;</font></p><table border="0" cellpadding="0" cellspacing="0" style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:10pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"></td><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><font style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">arrange for the assumption, continuation or substitution of an equity award by a successor corporation;</font></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:10pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"></td><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><font style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">arrange for the assignment of any reacquisition or repurchase rights held by us to a successor corporation;</font></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:10pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"></td><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><font style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">accelerate the vesting of the equity award and provide for its termination prior to the effective time of the corporate transaction;</font></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:10pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"></td><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><font style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">arrange for the lapse, in whole or in part, of any reacquisition or repurchase right held by us; or</font></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"></td><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><font style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">cancel the equity award prior to the transaction in exchange for a cash payment, which may be reduced by the exercise price payable in connection with the equity award.</font></td></tr></table><div style="margin-top:10pt;"></div><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">The Board is not obligated to treat all equity awards or portions of equity awards, even those that are of the same type, in the same manner. The Board may take different actions with respect to the vested and unvested portions of an equity award.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;"> <font style="visibility:hidden;">&#8203;</font></p></div><div style="clear:both;display:table;margin-bottom:27.35pt;min-height:44.65pt;width:100%;"><div style="display:table-cell;vertical-align:bottom;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;min-height:12.0pt;text-align:center;margin:24pt 0pt 0pt 0pt;">30</p></div></div></div><hr style="background-color:#000000;clear:both;color:#000000;height:2pt;line-height:0;margin-bottom:30pt;margin-left:11.76%;margin-right:11.76%;margin-top:30pt;page-break-after:always;width:76.47%;border-width:0;"><div style="max-width:100%;padding-left:11.76%;padding-right:11.76%;position:relative;"><div style="margin-top:27.35pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"><font style="font-weight:bold;visibility:hidden;">&#8203;</font></p></div><div style="clear:both;max-width:100%;position:relative;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;"><i style="font-style:italic;">Change in Control </i></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">The Board may provide, in an individual award agreement or in any other written agreement between us and the participant, that the award will be subject to additional acceleration of vesting and exercisability in the event of a change in control. In the absence of such a provision, no such acceleration of the award will occur. </p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;"><font style="font-style:italic;visibility:hidden;">&#8203;</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;"><i style="font-style:italic;">Plan Amendment or Termination </i></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Our Board has the authority to amend, suspend or terminate our Amended 2013 Plan, provided that such action does not materially impair the existing rights of any participant without such participant&#8217;s written consent. No incentive stock options may be granted after the tenth anniversary of the date our Board adopts our Amended 2013 Plan.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;"><font style="font-size:12pt;visibility:hidden;">&#8203;</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;"><b style="font-weight:bold;">U.S. Federal Income Tax Consequences</b></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">The following is a summary of the principal United States federal income tax consequences to participants and us with respect to participation in the Amended 2013 Plan. This summary is not intended to be exhaustive and does not discuss the income tax laws of any local, state or foreign jurisdiction in which a participant may reside. The information is based upon current federal income tax rules and therefore is subject to change when those rules change. Because the tax consequences to any participant may depend on his or her particular situation, each participant should consult the participant&#8217;s tax adviser regarding the federal, state, local and other tax consequences of the grant or exercise of an award or the disposition of stock acquired under the Amended 2013 Plan. The Amended 2013 Plan is not qualified under the provisions of Section&#160;401(a) of the Internal Revenue Code of 1986, as amended (the &#8220;Code&#8221;), and is not subject to any of the provisions of the Employee Retirement Income Security Act of 1974. Our ability to realize the benefit of any tax deductions described below depends on our generation of taxable income as well as the requirement of reasonableness and the satisfaction of our tax reporting obligations.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;"><font style="font-style:italic;font-weight:bold;">Nonstatutory Stock Options</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Generally, there is no taxation upon the grant of an NSO if the stock option is granted with an exercise price equal to the fair market value of the underlying stock on the grant date. Upon exercise, a participant will recognize ordinary income equal to the excess, if any, of the fair market value of the underlying stock on the date of exercise of the stock option over the exercise price. If the participant is employed by us or one of our affiliates, that income will be subject to withholding taxes. The participant&#8217;s tax basis in those shares will be equal to their fair market value on the date of exercise of the stock option, and the participant&#8217;s capital gain holding period for those shares will begin on that date.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">We will generally be entitled to a tax deduction equal to the taxable ordinary income realized by the participant.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;"><font style="font-style:italic;font-weight:bold;">Incentive Stock Options</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">The Amended 2013 Plan provides for the grant of stock options that are intended to qualify as &#8220;incentive stock options,&#8221; as defined in Section&#160;422 of the Code. Under the Code, a participant generally is not subject to ordinary income tax upon the grant or exercise of an ISO. If the participant holds a share received upon exercise of an ISO for more than two years from the date the stock option was granted and more than one year from the date the stock option was exercised, which is referred to as the required holding period, the difference, if any, between the amount realized on a sale or other taxable disposition of that share and the participant&#8217;s tax basis in that share will be long-term capital gain or loss.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 10pt 0pt;">If, however, a participant disposes of a share acquired upon exercise of an ISO before the end of the required holding period, which is referred to as a disqualifying disposition, the participant generally will recognize ordinary income in the year of the disqualifying disposition equal to the excess, if any, of the fair market value of the share on the date of exercise of the stock option over the exercise price. However, if the sales proceeds are less than the fair market value of the share on the date of exercise of the stock option, the amount of ordinary income recognized by the participant will not exceed the gain, if any, realized on the sale. If the amount realized on a disqualifying disposition exceeds the fair market value of the share on the date of exercise of the stock option, that excess will be short-term or long-term capital gain, depending on whether the holding period for the share exceeds one year.</p></div><div style="clear:both;display:table;margin-bottom:27.35pt;min-height:44.65pt;width:100%;"><div style="display:table-cell;vertical-align:bottom;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;min-height:12.0pt;text-align:center;margin:24pt 0pt 0pt 0pt;">31</p></div></div></div><hr style="background-color:#000000;clear:both;color:#000000;height:2pt;line-height:0;margin-bottom:30pt;margin-left:11.76%;margin-right:11.76%;margin-top:30pt;page-break-after:always;width:76.47%;border-width:0;"><div style="max-width:100%;padding-left:11.76%;padding-right:11.76%;position:relative;"><div style="margin-top:27.35pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"><font style="font-weight:bold;visibility:hidden;">&#8203;</font></p></div><div style="clear:both;max-width:100%;position:relative;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">For purposes of the alternative minimum tax, the amount by which the fair market value of a share of stock acquired upon exercise of an ISO exceeds the exercise price of the stock option generally will be an adjustment included in the participant&#8217;s alternative minimum taxable income for the year in which the stock option is exercised. If, however, there is a disqualifying disposition of the share in the year in which the stock option is exercised, there will be no adjustment for alternative minimum tax purposes with respect to that share. In computing alternative minimum taxable income, the tax basis of a share acquired upon exercise of an ISO is increased by the amount of the adjustment taken into account with respect to that share for alternative minimum tax purposes in the year the stock option is exercised.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">We are not allowed a tax deduction with respect to the grant or exercise of an ISO or the disposition of a share acquired upon exercise of an ISO after the required holding period. If there is a disqualifying disposition of a share, however, we will generally be entitled to a tax deduction equal to the taxable ordinary income realized by the participant, provided that either the employee includes that amount in income or we timely satisfy our reporting requirements with respect to that amount.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;"><font style="font-style:italic;font-weight:bold;">Restricted Stock Awards</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Generally, the recipient of a restricted stock award will recognize ordinary income at the time the stock is received equal to the excess, if any, of the fair market value of the stock received over any amount paid by the recipient in exchange for the stock. If, however, the stock is not vested when it is received (for example, if the employee is required to work for a period of time in order to have the right to sell the stock), the recipient generally will not recognize income until the stock becomes vested, at which time the recipient will recognize ordinary income equal to the excess, if any, of the fair market value of the stock on the date it becomes vested over any amount paid by the recipient in exchange for the stock. A recipient may, however, file an election with the Internal Revenue Service, within 30 days following his or her receipt of the stock award, to recognize ordinary income, as of the date the recipient receives the award, equal to the excess, if any, of the fair market value of the stock on the date the award is granted over any amount paid by the recipient for the stock.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">The recipient&#8217;s basis for the determination of gain or loss upon the subsequent disposition of shares acquired from a restricted stock award will be the amount paid for such shares plus any ordinary income recognized either when the stock is received or when the stock becomes vested.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">We will generally be entitled to a tax deduction equal to the taxable ordinary income realized by the recipient of the restricted stock award.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;"><font style="font-style:italic;font-weight:bold;">Restricted Stock Unit Awards</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Generally, the recipient of a restricted stock unit award structured to comply with the requirements of Section&#160;409A of the Code or an exemption to Section&#160;409A of the Code will recognize ordinary income at the time the stock is delivered equal to the excess, if any, of the fair market value of the stock received over any amount paid by the recipient in exchange for the stock. To comply with the requirements of Section&#160;409A of the Code, the stock subject to a restricted stock unit award may generally only be delivered upon one of the following events: a fixed calendar date (or dates), separation from service, death, disability or a change in control. If delivery occurs on another date, unless the restricted stock unit award otherwise complies with or qualifies for an exemption to the requirements of Section&#160;409A of the Code, in addition to the tax treatment described above, the recipient will owe an additional 20% federal tax and interest on any taxes owed.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">The recipient&#8217;s basis for the determination of gain or loss upon the subsequent disposition of shares acquired from a restricted stock unit award will be the amount paid for such shares plus any ordinary income recognized when the stock is delivered.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">We will generally be entitled to a tax deduction equal to the taxable ordinary income realized by the recipient of the restricted stock unit award.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></div><div style="clear:both;display:table;margin-bottom:27.35pt;min-height:44.65pt;width:100%;"><div style="display:table-cell;vertical-align:bottom;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;min-height:12.0pt;text-align:center;margin:24pt 0pt 0pt 0pt;">32</p></div></div></div><hr style="background-color:#000000;clear:both;color:#000000;height:2pt;line-height:0;margin-bottom:30pt;margin-left:11.76%;margin-right:11.76%;margin-top:30pt;page-break-after:always;width:76.47%;border-width:0;"><div style="max-width:100%;padding-left:11.76%;padding-right:11.76%;position:relative;"><div style="margin-top:27.35pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"><font style="font-weight:bold;visibility:hidden;">&#8203;</font></p></div><div style="clear:both;max-width:100%;position:relative;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;"><font style="font-style:italic;font-weight:bold;">Stock Appreciation Rights</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Generally, if a stock appreciation right is granted with an exercise price equal to the fair market value of the underlying stock on the grant date, the recipient will recognize ordinary income equal to the fair market value of the stock or cash received upon such exercise. We will generally be entitled to a tax deduction equal to the taxable ordinary income realized by the recipient of the stock appreciation right.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">New Plan Benefits under Amended 2013 Plan</b></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><font style="font-weight:bold;visibility:hidden;">&#8203;</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">The benefits and amounts that will be received by or allocated to participants under the Amended 2013 Plan are not yet determinable because the types and amounts of awards and selection of participants are subject to the Compensation Committee&#8217;s discretion and future determination. However, please refer to the &#8220;Executive Compensation&#8221; section of this proxy statement, which provides information on the grants made to our named executive officers in 2021, and the &#8220;Non-Employee Director Compensation&#8221; section of this proxy statement, which provides information on the grants made to our non-employee directors in 2021.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Approval of this proposal requires the vote of the holders of a majority of the shares present virtually or represented by proxy and entitled to vote on the matter at the Annual Meeting.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><b style="font-weight:bold;text-transform:uppercase;">The Board Of Directors Recommends</b></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><b style="font-weight:bold;text-transform:uppercase;">A Vote In Favor Of Proposal 3.</b></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><font style="font-weight:bold;text-transform:uppercase;visibility:hidden;">&#8203;</font></p></div><div style="clear:both;display:table;margin-bottom:27.35pt;min-height:44.65pt;width:100%;"><div style="display:table-cell;vertical-align:bottom;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;min-height:12.0pt;text-align:center;margin:24pt 0pt 0pt 0pt;">33</p></div></div></div><hr style="background-color:#000000;clear:both;color:#000000;height:2pt;line-height:0;margin-bottom:30pt;margin-left:11.76%;margin-right:11.76%;margin-top:30pt;page-break-after:always;width:76.47%;border-width:0;"><div style="max-width:100%;padding-left:11.76%;padding-right:11.76%;position:relative;"><div style="margin-top:27.35pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"><font style="font-weight:bold;visibility:hidden;">&#8203;</font></p></div><div style="clear:both;max-width:100%;position:relative;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><b style="font-size:12pt;font-weight:bold;">PROPOSAL 4</b></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><font style="font-size:12pt;font-weight:bold;visibility:hidden;">&#8203;</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><b style="font-size:12pt;font-weight:bold;">ADVISORY VOTE ON EXECUTIVE COMPENSATION</b></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 12pt 0pt;"><font style="white-space:pre-wrap;">At the 2020 annual meeting of stockholders, the stockholders indicated their preference that we solicit a non-binding advisory vote on the compensation of our named executive officers, commonly referred to as a &#8220;say-on-pay vote,&#8221; every year.  The Board has adopted a policy that is consistent with that preference. In accordance with that policy, this year, we are again asking stockholders to approve, on an advisory basis, the compensation of our named executive officers as disclosed in this proxy statement in accordance with SEC rules.</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 12pt 0pt;"><a name="_DV_C352"></a>This say-on-pay vote is not intended to address any specific item of compensation, but rather the overall compensation of the Company&#8217;s named executive officers and the policies and practices described in this proxy statement. The compensation of the Company&#8217;s named executive officers subject to the say-on-pay vote is disclosed in the compensation tables and the related narrative disclosures that accompany the compensation tables contained in the &#8220;Executive Compensation&#8221; section of this proxy statement. As described in those disclosures, the Company generally seeks to target its executive compensation to be at or near the median of the compensation paid to similarly-situated executive officers of companies in our peer group for the applicable year. Compensation of the Company&#8217;s named executive officers is designed to enable the Company to attract, retain and motivate talented and experienced executives to lead the Company successfully in a competitive environment; to provide incentives that reward the achievement of performance goals that directly correlate to the enhancement of stockholder value; and to align the named executive officers&#8217; interests with those of stockholders through long-term incentives linked to company performance.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 12pt 0pt;">Accordingly, the Board is asking stockholders to indicate their support for the compensation of the Company&#8217;s named executive officers as described in this proxy statement by casting a non-binding advisory vote &#8220;FOR&#8221; the following resolution:</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 12pt 0pt;">&#8220;RESOLVED, that the compensation paid to the Company&#8217;s named executive officers, as disclosed pursuant to Item 402 of Regulation S-K, including the compensation tables and any related material disclosed in the proxy statement for this meeting, is hereby APPROVED.&#8221;</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 12pt 0pt;">Because the say-on-pay vote is advisory, it is not binding on the Board or the Company. Nevertheless, the views expressed by stockholders, whether through this say-on-pay vote or otherwise, are important to management and the Board and, accordingly, the Board and the Compensation Committee intend to consider the results of this say-on-pay vote in making determinations in the future regarding executive compensation arrangements. </p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 12pt 0pt;">Advisory approval of this proposal requires the vote of the holders of a majority of the shares present virtually or represented by proxy and entitled to vote on the matter at the Annual Meeting. Unless the Board decides to modify its policy regarding the frequency of soliciting say-on-pay votes, the next scheduled say-on-pay vote will be at the 2023 annual meeting of stockholders.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><b style="font-weight:bold;text-transform:uppercase;">The Board Of Directors Recommends</b></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><b style="font-weight:bold;text-transform:uppercase;">A Vote In Favor Of Proposal 4.</b></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></div><div style="clear:both;display:table;margin-bottom:27.35pt;min-height:44.65pt;width:100%;"><div style="display:table-cell;vertical-align:bottom;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;min-height:12.0pt;text-align:center;margin:24pt 0pt 0pt 0pt;">34</p></div></div></div><hr style="background-color:#000000;clear:both;color:#000000;height:2pt;line-height:0;margin-bottom:30pt;margin-left:11.76%;margin-right:11.76%;margin-top:30pt;page-break-after:always;width:76.47%;border-width:0;"><div style="max-width:100%;padding-left:11.76%;padding-right:11.76%;position:relative;"><div style="margin-top:27.35pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"><font style="font-weight:bold;visibility:hidden;">&#8203;</font></p></div><div style="clear:both;max-width:100%;position:relative;"><p style="font-family:'Times New Roman Bold';font-size:10pt;font-weight:bold;line-height:1.19;text-align:center;margin:0pt;"><b style="font-family:'Times New Roman','Times','serif';font-size:12pt;font-weight:bold;">MANAGEMENT</b></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-variant:small-caps;font-weight:bold;line-height:1.19;margin:0pt;"><a name="_DV_M631"></a><a name="_DV_M632"></a><font style="font-variant:normal;font-weight:normal;">The following table sets forth information concerning our executive officers.</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p><div><table style="border-collapse:collapse;font-size:16pt;height:max-content;margin-left:auto;margin-right:auto;padding-left:0pt;padding-right:0pt;width:100%;" align="center"><tr style="height:1pt;"><td style="vertical-align:bottom;width:29.51%;margin:0pt;padding:1.5pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.13%;margin:0pt;padding:1.5pt 0pt 1.5pt 0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;"><font style="font-size:1pt;visibility:hidden;">&#8203;</font></p></div></div></td><td style="vertical-align:bottom;width:68.34%;margin:0pt;padding:1.5pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td></tr><tr><td style="vertical-align:bottom;width:29.51%;border-bottom:1px solid #000000;margin:0pt;padding:1.5pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:9pt;margin:0pt;"><b style="font-weight:bold;">Name</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.13%;border-bottom:1px solid transparent;margin:0pt;padding:1.5pt 0pt 1.5pt 0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td style="vertical-align:bottom;width:68.34%;border-bottom:1px solid #000000;margin:0pt;padding:1.5pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:9pt;margin:0pt;"><b style="font-weight:bold;">Position</b></p></td></tr><tr><td style="vertical-align:top;width:29.51%;background:#cceeff;margin:0pt;padding:1.5pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;padding-left:7.2pt;text-indent:-7.2pt;margin:0pt;">Harout Semerjian</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.13%;background:#cceeff;margin:0pt;padding:1.5pt 0pt 1.5pt 0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;width:68.34%;background:#cceeff;margin:0pt;padding:1.5pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">President and Chief Executive Officer</p></td></tr><tr><td style="vertical-align:top;width:29.51%;margin:0pt;padding:1.5pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;padding-left:7.2pt;text-indent:-7.2pt;margin:0pt;">Armand Girard</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.13%;margin:0pt;padding:1.5pt 0pt 1.5pt 0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;width:68.34%;margin:0pt;padding:1.5pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Senior Vice President of Strategy and Corporate Development and Chief Business Officer </p></td></tr><tr><td style="vertical-align:top;width:29.51%;background:#cceeff;margin:0pt;padding:1.5pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;padding-left:7.2pt;text-indent:-7.2pt;margin:0pt;">Brian Hahn</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.13%;background:#cceeff;margin:0pt;padding:1.5pt 0pt 1.5pt 0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;width:68.34%;background:#cceeff;margin:0pt;padding:1.5pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Senior Vice President of Finance and Chief Financial Officer </p></td></tr><tr><td style="vertical-align:top;width:29.51%;margin:0pt;padding:1.5pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;padding-left:7.2pt;text-indent:-7.2pt;margin:0pt;">John Magnani, Ph.D.</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.13%;margin:0pt;padding:1.5pt 0pt 1.5pt 0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;width:68.34%;margin:0pt;padding:1.5pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Senior Vice President of Research and Chief Scientific Officer</p></td></tr></table></div><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-variant:small-caps;font-weight:bold;line-height:1.19;margin:0pt;"><b style="font-variant:normal;font-weight:bold;">EXECUTIVE OFFICERS WHO ARE NOT DIRECTORS</b></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;">The following sets forth certain information with respect to our executive officers who are not directors.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;line-height:1.19;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;line-height:1.19;margin:0pt;">Armand Girard, age 53</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;line-height:1.19;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Mr. Girard has served as our Senior Vice President of Strategy and Corporate Development and Chief Business Officer since February 2020, and was previously our Senior Vice President, Strategy and Corporate Development from January 2019 until January 2020, and served as our Vice President, Corporate Development from 2014 until January 2019. Prior to joining our company, Mr. Girard held the positions of Vice President for Technical Assessment and Senior Director for Business Development at Shire Pharmaceuticals, where he was responsible for numerous licensing transactions and acquisitions. He has more than 25 years of pharmaceutical/biotech experience, spanning a variety of product planning and new product development positions with a number of companies, including Strakan Life Sciences, Pro-Virus, Inc. and Otsuka Pharmaceuticals. Mr. Girard holds an M.B.A. from St. Joseph&#8217;s University Haub School of Business and a B.A. from Lehigh University.</p><p style="font-family:'Times New Roman Bold';font-size:10pt;font-weight:bold;line-height:1.19;margin:0pt;"><font style="font-family:'Times New Roman','Times','serif';font-weight:normal;margin-bottom:12pt;visibility:hidden;">&#8203;</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;line-height:1.19;margin:0pt;">Brian Hahn, age 47</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;line-height:1.19;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Mr. Hahn has served as our Senior Vice President of Finance and Chief Financial Officer since January 2019, and was previously our Chief Financial Officer from 2012 until January 2019, and our Director of Finance and Administration from 2010 to 2012. From 2009 to 2010 he served in the position of Assistant Controller for OpGen, Inc., a biotechnology company, and from 2002 to 2009, Mr. Hahn served in the position of Executive Director of Finance at MiddleBrook Pharmaceuticals, Inc. (formerly Advancis Pharmaceutical), a specialty pharmaceutical company. From 1998 to 2001, he was a senior accountant with Bering Truck Corporation. Mr. Hahn currently serves as Co-Chair of the Biotechnology Industry Organization (BIO)&#8217;s Finance and Tax Committee. In 2015, Mr. Hahn testified on behalf of BIO before the House Subcommittee on Capital Markets and Government Sponsored Enterprises in support of the Fostering Innovation Act. Mr. Hahn received a B.B.A. from Shenandoah University and an M.B.A. from the University of Maryland.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:0pt;margin:0pt;"><font style="font-weight:bold;margin-bottom:12pt;visibility:hidden;">&#8203;</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:0pt;margin:0pt;"><b style="font-weight:bold;">John Magnani, Ph.D., age 69</b></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;line-height:1.19;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:0pt;margin:0pt;">Dr.&#160;Magnani is a co-founder of our company and has served as our Senior Vice President of Research since January 2017, as our Vice President of Research from 2003 to 2017, and as our Chief Scientific Officer since 2003. He served as a member of our Board from 2003 until May 2019. Dr.&#160;Magnani is also the founder, president and owner of GlycoTech Corporation. Prior to founding GlycoTech, Dr.&#160;Magnani was the vice president of research at BioCarb, Inc., one of the first glycobiology-based companies. Earlier in his career, Dr.&#160;Magnani was a tenured Research Chemist at the National Institute of Arthritis, Diabetes and Digestive and Kidney Diseases, part of the National Institutes of Health. Dr.&#160;Magnani received an A.B. from Washington University in St. Louis and a Ph.D. in biology from Princeton University. </p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:0pt;margin:0pt;"><font style="margin-bottom:12pt;visibility:hidden;">&#8203;</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></div><div style="clear:both;display:table;margin-bottom:27.35pt;min-height:44.65pt;width:100%;"><div style="display:table-cell;vertical-align:bottom;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;min-height:12.0pt;text-align:center;margin:24pt 0pt 0pt 0pt;">35</p></div></div></div><hr style="background-color:#000000;clear:both;color:#000000;height:2pt;line-height:0;margin-bottom:30pt;margin-left:11.76%;margin-right:11.76%;margin-top:30pt;page-break-after:always;width:76.47%;border-width:0;"><div style="max-width:100%;padding-left:11.76%;padding-right:11.76%;position:relative;"><div style="margin-top:27.35pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"><font style="font-weight:bold;visibility:hidden;">&#8203;</font></p></div><div style="clear:both;max-width:100%;position:relative;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-variant:small-caps;font-weight:bold;line-height:1.19;text-align:center;margin:0pt;"><b style="font-size:12pt;font-variant:normal;font-weight:bold;">SECURITY OWNERSHIP OF</b></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-variant:small-caps;font-weight:bold;line-height:1.19;text-align:center;margin:0pt;"><a name="_DV_M633"></a><b style="font-size:12pt;font-variant:normal;font-weight:bold;">CERTAIN BENEFICIAL OWNERS AND MANAGEMENT </b></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:0pt;margin:0pt;"><a name="_DV_M634"></a><font style="margin-bottom:12pt;visibility:hidden;">&#8203;</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">The following table sets forth certain information regarding the ownership of our common stock as of April 7, 2022 by: (i) each director; (ii) each of our named executive officers; (iii) all currently serving executive officers and directors as a group; and (iv) all those known by us to be beneficial owners of more than five percent of our common stock. Except as otherwise noted below, the address for persons listed in the table is c/o GlycoMimetics, Inc., 9708 Medical Center Drive, Rockville, Maryland 20850. </p><p style="font-family:'Times New Roman','Times','serif';font-size:12pt;margin:0pt;"><font style="font-size:10pt;margin-bottom:5pt;margin-top:5pt;visibility:hidden;">&#8203;</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">This table is based upon information supplied by our named executive officers, directors and principal stockholders. Unless otherwise indicated in the footnotes to the table and subject to common property laws where applicable, we believe that each stockholder named in the table has sole voting and investment power with regard to the shares indicated as being beneficially owned. Applicable percentages are based on 52,392,444 shares of common stock outstanding on April 7, 2022, adjusted as required by the rules promulgated by the SEC. </p><p style="font-family:'Times New Roman','Times','serif';font-size:12pt;margin:0pt;"><font style="font-size:10pt;margin-bottom:5pt;margin-top:5pt;visibility:hidden;">&#8203;</font></p><div align="left"><table style="border-collapse:collapse;font-size:16pt;height:max-content;padding-left:0pt;padding-right:0pt;width:100%;"><tr style="height:1pt;"><td style="vertical-align:bottom;white-space:nowrap;width:74.49%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;"><a name="_DV_M635"></a><a name="_DV_M636"></a><font style="font-size:1pt;visibility:hidden;">&#8203;</font></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.7%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;"><font style="font-size:1pt;visibility:hidden;">&#8203;</font></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:10.14%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;"><font style="font-size:1pt;visibility:hidden;">&#8203;</font></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.7%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;"><font style="font-size:1pt;visibility:hidden;">&#8203;</font></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:10.14%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;"><font style="font-size:1pt;visibility:hidden;">&#8203;</font></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.78%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;"><font style="font-size:1pt;visibility:hidden;">&#8203;</font></p></div></div></td></tr><tr><td style="vertical-align:bottom;white-space:nowrap;width:74.49%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.7%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.14%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">Number&#160;of</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.7%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.14%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">Percent&#160;of</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.78%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">&#160;</b></p></td></tr><tr><td style="vertical-align:bottom;width:74.49%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;"><font style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.7%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><font style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.14%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">Shares</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.7%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><font style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.14%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">Shares</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.78%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">&#160;</b></p></td></tr><tr><td style="vertical-align:bottom;width:74.49%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;"><font style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.7%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><font style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.14%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">Beneficially</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.7%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><font style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.14%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">Beneficially</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.78%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">&#160;</b></p></td></tr><tr><td style="vertical-align:bottom;width:74.49%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:justify;margin:0pt;"><b style="font-weight:bold;">Beneficial&#160;Owner</b>&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.7%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><font style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.14%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">Owned</b>&#160;&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.7%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><font style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.14%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">Owned</b>&#160;&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.78%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">&#160;</b></p></td></tr><tr><td style="vertical-align:bottom;width:74.49%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;"><i style="font-style:italic;">5% Stockholders:</i></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.7%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.14%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.7%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.14%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.78%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></td></tr><tr><td style="vertical-align:bottom;white-space:nowrap;width:74.49%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;">Entities affiliated with Biotechnology Value Fund, L.P. (1)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.7%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.14%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><font style="white-space:pre-wrap;"> 9,544,262</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.7%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.14%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><font style="white-space:pre-wrap;"> 18.2</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.78%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;">%</p></td></tr><tr><td style="vertical-align:bottom;width:74.49%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;">Entities affiliated with New Enterprise Associates, Inc. (2)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.7%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.14%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><font style="white-space:pre-wrap;"> 9,089,041</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.7%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.14%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><font style="white-space:pre-wrap;"> 17.3</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.78%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></td></tr><tr><td style="vertical-align:bottom;white-space:nowrap;width:74.49%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.7%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.14%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"> <font style="visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.7%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.14%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"> <font style="visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.78%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></td></tr><tr><td style="vertical-align:bottom;width:74.49%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;"><i style="font-style:italic;">Named Executive Officers and Directors:</i></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.7%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.14%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.7%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.14%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.78%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></td></tr><tr><td style="vertical-align:bottom;width:74.49%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;">Harout Semerjian</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.7%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.14%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><font style="font-family:'Arial','Helvetica','sans-serif';white-space:pre-wrap;"> &#8212;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.7%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.14%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><font style="white-space:pre-wrap;"> &#8212;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.78%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></td></tr><tr><td style="vertical-align:bottom;width:74.49%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;">Brian Hahn (3)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.7%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.14%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><font style="white-space:pre-wrap;"> 472,532</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.7%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.14%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;">*</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.78%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></td></tr><tr><td style="vertical-align:bottom;width:74.49%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;">John Magnani, Ph.D. (4)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.7%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.14%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><font style="white-space:pre-wrap;"> 937,375</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.7%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.14%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><font style="white-space:pre-wrap;"> 1.8</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.78%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></td></tr><tr><td style="vertical-align:bottom;width:74.49%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;">Patricia Andrews (5)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.7%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.14%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><font style="white-space:pre-wrap;"> 130,750</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.7%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.14%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;">*</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.78%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></td></tr><tr><td style="vertical-align:bottom;width:74.49%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;">Mark Goldberg, M.D. (6)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.7%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.14%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><font style="white-space:pre-wrap;"> 128,648</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.7%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.14%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;">*</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.78%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></td></tr><tr><td style="vertical-align:bottom;width:74.49%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;">Scott Jackson (7)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.7%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.14%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><font style="white-space:pre-wrap;"> 79,750</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.7%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.14%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;">*</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.78%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></td></tr><tr><td style="vertical-align:bottom;width:74.49%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;">Daniel Junius (8)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.7%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.14%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><font style="white-space:pre-wrap;"> 150,750</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.7%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.14%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;">*</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.78%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></td></tr><tr><td style="vertical-align:bottom;width:74.49%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;">Rachel King (9)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.7%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.14%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><font style="white-space:pre-wrap;"> 2,051,493</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.7%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.14%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><font style="white-space:pre-wrap;"> 3.8</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.78%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></td></tr><tr><td style="vertical-align:bottom;width:74.49%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;">Scott Koenig, M.D., Ph.D. (10)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.7%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.14%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><font style="white-space:pre-wrap;"> 101,750</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.7%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.14%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;">*</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.78%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></td></tr><tr><td style="vertical-align:bottom;width:74.49%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;">Timothy Pearson (11)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.7%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.14%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><font style="white-space:pre-wrap;"> 117,151</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.7%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.14%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;">*</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.78%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></td></tr><tr><td style="vertical-align:bottom;width:74.49%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;">All current directors and executive officers as a group (11 persons) (12)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.7%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.14%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><font style="white-space:pre-wrap;"> 4,463,710</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.7%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.14%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><font style="white-space:pre-wrap;"> 8.0</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.78%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></td></tr></table></div><div style="font-family:'Times New Roman','Times','serif';font-size:10.0pt;margin-bottom:0pt;margin-top:0pt;min-height:1.19em;position:relative;width:100%;"><hr noshade="true" color="#000000" size="1" width="25.0%" style="background-color:#000000;color:#000000;height:1pt;position:relative;top:0.6em;border:none;margin:0pt;" align="left"></div><table border="0" cellpadding="0" cellspacing="0"><tr><td style="vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:0pt;margin-top:0pt;"><font style="font-size:9pt;">*</font></p></td><td style="padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:0pt;margin-top:0pt;"><font style="font-size:9pt;">Represents beneficial ownership of less than one percent of the outstanding shares of common stock.</font><a name="_DV_M637"></a><a name="_DV_M640"></a></p></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">1)</td><td style="padding:0pt;"><font style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">As reported on a Schedule 13G/A filed by Biotechnology Value Fund, L.P., Mark Lampert and affiliated entities (collectively, &#8220;BVF&#8221;) with the SEC on February 11, 2021, which states that BVF had shared voting and dispositive power with respect to these shares as of December 31, 2021. The principal business address of BVF is 44 Montgomery Street, 40</font><sup style="font-family:'Times New Roman','Times','serif';font-size:7.5pt;font-style:normal;font-weight:normal;vertical-align:top;">th</sup><font style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;"> Floor, San Francisco, CA 94104.</font></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">2)</td><td style="padding:0pt;"><font style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">Consists of 4,995,664 shares of common stock held by New Enterprise Associates 10, L.P. (&#8220;NEA 10&#8221;) and 4,093,377 shares of common stock held by New Enterprise Associates 13, L.P. (&#8220;NEA 13&#8221;). The shares directly held by NEA 10 are indirectly held by NEA Partners 10, L.P. (&#8220;NEA Partners 10&#8221;), its sole general partner, and the individual general partner of NEA Partners 10, Scott D. Sandell (the &#8220;NEA 10 General Partner&#8221;). NEA Partners 10 and the NEA 10 General Partner may be deemed to have shared voting and dispositive power over, and be deemed indirect beneficial owners of, the shares directly held by NEA 10. The shares directly held by NEA 13 are indirectly held by NEA Partners 13, L.P. (&#8220;NEA Partners 13&#8221;), its sole general partner, NEA 13 GP, LTD (&#8220;NEA 13 LTD&#8221;), the sole general partner of NEA Partners 13, and each of the individual directors of NEA 13 LTD. The individual Directors of NEA 13 LTD are Forest Baskett, Patrick J. Kerins, and Scott D. Sandell (the &#8220;NEA 13 Directors&#8221;). NEA Partners 13, NEA 13 LTD and the NEA 13 Directors may be deemed to have shared voting and dispositive power over, and be deemed indirect beneficial owners of, the shares directly held by NEA 13. The principal business address of New Enterprise Associates, Inc. is 1954 Greenspring Drive, Suite 600, Timonium, MD 21093.</font></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">3)</td><td style="padding:0pt;"><font style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">Consists of (a) 10,968 shares of common stock and (b) 461,564 shares of common stock underlying options that are vested and exercisable within 60 days of April 7, 2022.</font></td></tr></table></div><div style="clear:both;display:table;margin-bottom:27.35pt;min-height:44.65pt;width:100%;"><div style="display:table-cell;vertical-align:bottom;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;min-height:12.0pt;text-align:center;margin:24pt 0pt 0pt 0pt;">36</p></div></div></div><hr style="background-color:#000000;clear:both;color:#000000;height:2pt;line-height:0;margin-bottom:30pt;margin-left:11.76%;margin-right:11.76%;margin-top:30pt;page-break-after:always;width:76.47%;border-width:0;"><div style="max-width:100%;padding-left:11.76%;padding-right:11.76%;position:relative;"><div style="margin-top:27.35pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"><font style="font-weight:bold;visibility:hidden;">&#8203;</font></p></div><div style="clear:both;max-width:100%;position:relative;"><table border="0" cellpadding="0" cellspacing="0" style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">4)</td><td style="padding:0pt;"><font style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;"><a name="_DV_M644"></a></font><font style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">Consists of (a) 295,158 shares of common stock held directly, (b) 637,372 shares of common stock underlying options that are vested and exercisable within 60 days of April 7, 2022 and (c) 4,845 shares of common stock held by GlycoTech Corporation, of which Dr.&#160;<a name="_DV_M645"></a>Magnani is the sole stockholder. </font></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">5)</td><td style="padding:0pt;"><font style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">Consists of (a) 40,000 shares of common stock, (b) 5,250 shares of common stock underlying restricted stock units that vest within 60 days of April 7, 2022 and (c) 85,500 shares of common stock underlying options that are vested and exercisable within 60 days of April 7, 2022.</font></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">6)</td><td style="padding:0pt;"><font style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;"><a name="_DV_M646"></a></font><font style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">Consists of (a) 11,497 shares of common stock held by family trusts for which Dr.&#160;</font><font style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;white-space:pre-wrap;">Goldberg serves as trustee,  (b) 5,250 shares of common stock underlying restricted stock units that vest within 60 days of April 7, 2022 and (c)&#160;111,901 shares of common stock underlying options that are vested and exercisable within 60 days of April 7, 2022.</font></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">7)</td><td style="padding:0pt;"><font style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">Consists of (a) 5,250 shares of common stock underlying restricted stock units that vest within 60 days of April 7, 2022 and (b)&#160;74,500 shares of common stock underlying options that are vested and exercisable within 60 days of April 7, 2022.</font></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">8)</td><td style="padding:0pt;"><font style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">Consists of (a) 38,000 shares of common stock held directly, (b) 5,250 shares of common stock underlying restricted stock units that vest within 60 days of April 7, 2022 and (c)&#160;107,500 shares of common stock underlying options that are vested and exercisable within 60 days of April 7, 2022.</font></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">9)</td><td style="padding:0pt;"><font style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">Consists of (a) 417,127 shares of common stock held directly, (b)&#160;1,496,224 shares of common stock underlying options that are vested and exercisable within 60 days of April 7, 2022, (c)&#160;45,741 shares of common stock held by Ms.&#160;King&#8217;s spouse and (d)&#160;92,401 shares of common stock held by family trusts for which Ms.&#160;King serves as trustee.</font></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">10)</td><td style="padding:0pt;"><font style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">Consists of (a) 5,250 shares of common stock underlying restricted stock units that vest within 60 days of April 7, 2022 and (b)&#160;96,500 shares of common stock underlying options that are vested and exercisable within 60 days of April 7, 2022.</font></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">11)</td><td style="padding:0pt;"><font style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;white-space:pre-wrap;">Consists of (a) 5,250 shares of common stock underlying restricted stock units that vest within 60 days of April 7, 2022 and  (b)&#160;111,901 shares of common stock underlying options that are vested and exercisable within 60 days of April 7, 2022.</font></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">12)</td><td style="padding:0pt;"><font style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;"><a name="_DV_M647"></a></font><font style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">Consists of (a) 959,648 shares of common stock, (b) 31,500 shares of common stock underlying restricted stock units that vest within 60 days of April 7, 2022, and (c) 3,472,562 shares of common stock underlying options that are vested and exercisable within 60 days of April 7, 2022.</font></td></tr></table><p style="font-family:'Times New Roman','Times','serif';font-size:12pt;min-height:12.0pt;margin:0pt;"><font style="font-size:10pt;font-weight:bold;margin-bottom:5pt;margin-top:5pt;visibility:hidden;">&#8203;</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:12pt;min-height:12.0pt;margin:0pt;"><b style="font-weight:bold;">DELINQUENT SECTION 16(A) REPORTS</b></p><p style="font-family:'Times New Roman','Times','serif';font-size:12pt;min-height:12.0pt;margin:0pt;"><font style="font-weight:bold;margin-bottom:5pt;margin-top:5pt;visibility:hidden;">&#8203;</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><font style="font-size:12pt;"><a name="_DV_M649"></a></font>Section 16(a) of the Exchange Act requires the Company&#8217;s directors and executive officers, and persons who own more than 10% of a registered class of the Company&#8217;s equity securities, to file with the SEC initial reports of ownership and reports of changes in ownership of common stock and other equity securities of the Company.&#160;&#160;Executive officers, directors and greater than 10% stockholders&#160;are required by SEC regulation to furnish the Company with copies of all Section 16(a) forms they file.</p><p style="font-family:'Times New Roman','Times','serif';font-size:12pt;margin:0pt;"><font style="font-size:10pt;margin-bottom:5pt;margin-top:5pt;visibility:hidden;">&#8203;</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><font style="font-size:12pt;"><a name="_DV_M650"></a></font>To&#160;our&#160;knowledge, based&#160;solely upon a review of&#160;the copies of such reports&#160;furnished to us and written representations provided to us&#160;that no other reports were required, we believe that during the year ended December&#160;31, 2021, all Section&#160;16(a) filing requirements applicable to&#160;our directors, executive officers and 10% stockholders&#160;were&#160;complied with, except that reports filed by five non-employee directors relating to the annual grant of equity on the date of our 2021 annual meeting of stockholders were one week late.&#160;&#160;<font style="font-size:12pt;"> </font></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></div><div style="clear:both;display:table;margin-bottom:27.35pt;min-height:44.65pt;width:100%;"><div style="display:table-cell;vertical-align:bottom;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;min-height:12.0pt;text-align:center;margin:24pt 0pt 0pt 0pt;">37</p></div></div></div><hr style="background-color:#000000;clear:both;color:#000000;height:2pt;line-height:0;margin-bottom:30pt;margin-left:11.76%;margin-right:11.76%;margin-top:30pt;page-break-after:always;width:76.47%;border-width:0;"><div style="max-width:100%;padding-left:11.76%;padding-right:11.76%;position:relative;"><div style="margin-top:27.35pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"><font style="font-weight:bold;visibility:hidden;">&#8203;</font></p></div><div style="clear:both;max-width:100%;position:relative;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-variant:small-caps;font-weight:bold;line-height:1.19;text-align:center;margin:0pt;"><a name="_DV_M665"></a><a name="_DV_M648"></a><b style="font-size:12pt;font-variant:normal;font-weight:bold;">EXECUTIVE COMPENSATION</b></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><a name="_DV_M666"></a><a name="_DV_M773"></a><a name="_DV_M1090"></a><font style="visibility:hidden;">&#8203;</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Our named executive officers for the year ended December 31, 2021 were as follows: </p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p><table border="0" cellpadding="0" cellspacing="0" style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"></td><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><font style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">Harout Semerjian, our current President and Chief Executive Officer; who served in that role beginning in August 2021;</font></td></tr></table><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0pt 18pt;"><font style="margin-left:0pt;visibility:hidden;">&#8203;</font></p><table border="0" cellpadding="0" cellspacing="0" style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"></td><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><font style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">Rachel King, our former President and Chief Executive Officer; who served in that role until August 2021;</font></td></tr></table><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p><table border="0" cellpadding="0" cellspacing="0" style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"></td><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><font style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">Brian Hahn, our Senior Vice President and Chief Financial Officer; and</font></td></tr></table><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt 0pt 0pt 36pt;"><font style="margin-left:0pt;visibility:hidden;">&#8203;</font></p><table border="0" cellpadding="0" cellspacing="0" style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"></td><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><font style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">John Magnani, Ph.D., our Senior Vice President of Research and Chief Scientific Officer.</font></td></tr></table><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:12pt 0pt 12pt 0pt;"><b style="font-weight:bold;">SUMMARY COMPENSATION TABLE</b></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">The following table presents the compensation awarded to, earned by or paid to each of our named executive officers for the years ended December 31, 2021 and 2020. </p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p><div><table style="border-collapse:collapse;font-size:16pt;height:max-content;margin-left:-0.06944656%;padding-left:0pt;padding-right:0pt;width:100.13%;" align="center"><tr style="height:1pt;"><td style="vertical-align:bottom;width:31.78%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;"><font style="font-size:1pt;visibility:hidden;">&#8203;</font></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:0.74%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;"><font style="font-size:1pt;visibility:hidden;">&#8203;</font></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:4.6%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;"><font style="font-size:1pt;visibility:hidden;">&#8203;</font></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:0.74%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;"><font style="font-size:1pt;visibility:hidden;">&#8203;</font></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:6.14%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;"><font style="font-size:1pt;visibility:hidden;">&#8203;</font></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.12%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;"><font style="font-size:1pt;visibility:hidden;">&#8203;</font></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:5.7%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;"><font style="font-size:1pt;visibility:hidden;">&#8203;</font></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:0.74%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;"><font style="font-size:1pt;visibility:hidden;">&#8203;</font></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:6.64%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;"><font style="font-size:1pt;visibility:hidden;">&#8203;</font></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:0.74%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;"><font style="font-size:1pt;visibility:hidden;">&#8203;</font></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:6.82%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;"><font style="font-size:1pt;visibility:hidden;">&#8203;</font></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:0.74%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;"><font style="font-size:1pt;visibility:hidden;">&#8203;</font></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:12.36%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;"><font style="font-size:1pt;visibility:hidden;">&#8203;</font></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:0.74%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;"><font style="font-size:1pt;visibility:hidden;">&#8203;</font></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:12.36%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;"><font style="font-size:1pt;visibility:hidden;">&#8203;</font></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:0.74%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;"><font style="font-size:1pt;visibility:hidden;">&#8203;</font></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:6.82%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;"><font style="font-size:1pt;visibility:hidden;">&#8203;</font></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:0.37%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;"><font style="font-size:1pt;visibility:hidden;">&#8203;</font></p></div></div></td></tr><tr><td style="vertical-align:bottom;width:31.78%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><font style="font-size:7pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.74%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">&#160;&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:4.6%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><font style="font-size:7pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.74%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">&#160;&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.14%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><font style="font-size:7pt;font-weight:bold;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.12%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">&#160;&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:5.7%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><font style="font-size:7pt;font-weight:bold;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.74%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">&#160;&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><font style="font-size:7pt;font-weight:bold;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.74%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">&#160;&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.82%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><font style="font-size:7pt;font-weight:bold;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.74%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">&#160;&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.36%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">NON-EQUITY</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.74%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">&#160;&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.36%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;text-align:center;margin:0pt;"><b style="font-weight:bold;"> </b><font style="font-weight:bold;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.74%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">&#160;&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.82%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><font style="font-size:7pt;font-weight:bold;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.37%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">&#160;</b></p></td></tr><tr><td style="vertical-align:bottom;width:31.78%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;"><font style="font-size:7pt;font-weight:bold;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.74%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><font style="font-size:7pt;font-weight:bold;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:4.6%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><font style="font-size:7pt;font-weight:bold;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.74%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><font style="font-size:7pt;font-weight:bold;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.14%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><font style="font-size:7pt;font-weight:bold;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.12%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><font style="font-size:7pt;font-weight:bold;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:5.7%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><font style="font-size:7pt;font-weight:bold;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.74%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><font style="font-size:7pt;font-weight:bold;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><font style="font-size:7pt;font-weight:bold;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.74%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><font style="font-size:7pt;font-weight:bold;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.82%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><font style="font-size:7pt;font-weight:bold;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.74%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><font style="font-size:7pt;font-weight:bold;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.36%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">INCENTIVE</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.74%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><font style="font-size:7pt;font-weight:bold;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.36%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;text-align:center;margin:0pt;"><b style="font-weight:bold;"> </b><font style="font-weight:bold;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.74%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><font style="font-size:7pt;font-weight:bold;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.82%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><font style="font-size:7pt;font-weight:bold;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.37%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">&#160;</b></p></td></tr><tr><td style="vertical-align:bottom;width:31.78%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;"><font style="font-size:7pt;font-weight:bold;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.74%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><font style="font-size:7pt;font-weight:bold;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:4.6%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><font style="font-size:7pt;font-weight:bold;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.74%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><font style="font-size:7pt;font-weight:bold;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.14%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><font style="font-size:7pt;font-weight:bold;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.12%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><font style="font-size:7pt;font-weight:bold;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:5.7%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><font style="font-size:7pt;font-weight:bold;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.74%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><font style="font-size:7pt;font-weight:bold;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">STOCK</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.74%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><font style="font-size:7pt;font-weight:bold;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.82%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">OPTION</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.74%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;"><font style="font-size:7pt;font-weight:bold;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.36%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">PLAN</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.74%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><font style="font-size:7pt;font-weight:bold;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.36%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">ALL OTHER</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.74%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><font style="font-size:7pt;font-weight:bold;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.82%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><font style="font-size:7pt;font-weight:bold;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.37%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">&#160;</b></p></td></tr><tr><td style="vertical-align:bottom;width:31.78%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;"><font style="font-size:7pt;font-weight:bold;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.74%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><font style="font-size:7pt;font-weight:bold;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:4.6%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><font style="font-size:7pt;font-weight:bold;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.74%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><font style="font-size:7pt;font-weight:bold;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.14%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">SALARY</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.12%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;"><font style="font-size:7pt;font-weight:bold;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:5.7%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">BONUS</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.74%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;"><font style="font-size:7pt;font-weight:bold;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">AWARDS</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.74%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;"><font style="font-size:7pt;font-weight:bold;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.82%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">AWARDS</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.74%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;"><font style="font-size:7pt;font-weight:bold;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.36%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">COMPENSATION</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.74%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><font style="font-size:7pt;font-weight:bold;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.36%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">COMPENSATION</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.74%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><font style="font-size:7pt;font-weight:bold;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.82%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">TOTAL</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.37%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">&#160;</b></p></td></tr><tr><td style="vertical-align:bottom;width:31.78%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;text-align:justify;margin:0pt;"><b style="font-weight:bold;">NAME&#160;AND&#160;PRINCIPAL&#160;POSITION</b>&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.74%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><font style="font-size:7pt;font-weight:bold;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:4.6%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">YEAR</b>&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.74%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><font style="font-size:7pt;font-weight:bold;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.14%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">($)</b>&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.12%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;"><font style="font-size:7pt;font-weight:bold;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:5.7%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">($)</b><sup style="font-size:5.25pt;font-weight:bold;vertical-align:top;">(1)</sup><sup style="font-size:5.25pt;vertical-align:top;">&#160;</sup></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.74%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;"><font style="font-size:7pt;font-weight:bold;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.64%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">($)</b><sup style="font-size:5.25pt;font-weight:bold;vertical-align:top;">(2)</sup><sup style="font-size:5.25pt;vertical-align:top;">&#160;</sup></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.74%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;"><font style="font-size:7pt;font-weight:bold;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.82%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">($)</b><sup style="font-size:5.25pt;font-weight:bold;vertical-align:top;">(2)</sup><sup style="font-size:5.25pt;vertical-align:top;">&#160;</sup></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.74%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;"><font style="font-size:7pt;font-weight:bold;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.36%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">($)</b><sup style="font-size:5.25pt;font-weight:bold;vertical-align:top;">(3)</sup><sup style="font-size:5.25pt;vertical-align:top;">&#160;</sup></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.74%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><font style="font-size:7pt;font-weight:bold;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.36%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">($)</b><sup style="font-size:5.25pt;font-weight:bold;vertical-align:top;">(4)</sup><sup style="font-size:5.25pt;vertical-align:top;">&#160;</sup></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.74%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><font style="font-size:7pt;font-weight:bold;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.82%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">($)</b>&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.37%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">&#160;</b></p></td></tr><tr><td style="vertical-align:bottom;width:31.78%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;text-align:justify;margin:0pt;">Harout Semerjian<b style="font-weight:bold;"> </b><sup style="font-size:5.25pt;vertical-align:top;">(5)</sup></p></td><td style="vertical-align:bottom;width:0.74%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:justify;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;width:4.6%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;text-align:center;margin:0pt;">2021</p></td><td style="vertical-align:bottom;width:0.74%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;text-align:justify;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.14%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;text-align:right;margin:0pt 2.25pt 0pt 0pt;"><font style="white-space:pre-wrap;"> 243,721</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.12%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;text-align:right;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:5.7%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;text-align:right;margin:0pt 2.25pt 0pt 0pt;"><font style="white-space:pre-wrap;"> 100,000</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.74%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"><font style="font-size:7pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;text-align:right;margin:0pt 2.25pt 0pt 0pt;"><font style="white-space:pre-wrap;"> &#8212;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.74%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"><font style="font-size:7pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.82%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;text-align:right;margin:0pt 2.25pt 0pt 0pt;"><font style="white-space:pre-wrap;"> 2,394,160</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.74%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;text-align:right;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.36%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;text-align:right;margin:0pt 2.25pt 0pt 0pt;"><font style="white-space:pre-wrap;"> 129,537</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.74%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;text-align:right;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.36%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;text-align:right;margin:0pt 2.25pt 0pt 0pt;"><font style="white-space:pre-wrap;"> 8,700</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.74%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"><font style="font-size:7pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.82%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;text-align:right;margin:0pt 2.25pt 0pt 0pt;"><font style="white-space:pre-wrap;"> 2,876,118</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.37%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;"><font style="font-size:7pt;visibility:hidden;">&#8203;</font></p></td></tr><tr><td style="vertical-align:bottom;width:31.78%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;text-align:justify;margin:0pt;">-President and Chief Executive Officer</p></td><td style="vertical-align:bottom;width:0.74%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:justify;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;width:4.6%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;text-align:justify;margin:0pt;"> <font style="visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;width:0.74%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;text-align:justify;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;width:6.14%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;text-align:justify;margin:0pt;"> <font style="visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;width:1.12%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;text-align:justify;margin:0pt;"> <font style="visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;width:5.7%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;text-align:justify;margin:0pt;"> <font style="visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;width:0.74%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;text-align:justify;margin:0pt;"> <font style="visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;width:6.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;text-align:justify;margin:0pt;"> <font style="visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;width:0.74%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;text-align:justify;margin:0pt;"> <font style="visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;width:6.82%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;text-align:justify;margin:0pt;"> <font style="visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;width:0.74%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;text-align:justify;margin:0pt;"> <font style="visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;width:12.36%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;text-align:justify;margin:0pt;"> <font style="visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;width:0.74%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;text-align:justify;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;width:12.36%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;text-align:justify;margin:0pt;"> <font style="visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;width:0.74%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;text-align:justify;margin:0pt;"> <font style="visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;width:6.82%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;text-align:justify;margin:0pt;"> <font style="visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.37%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;"><font style="font-size:7pt;visibility:hidden;">&#8203;</font></p></td></tr><tr><td style="vertical-align:bottom;width:31.78%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;text-align:justify;margin:0pt;">Rachel King<sup style="font-size:5.25pt;vertical-align:top;"> (6)</sup></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.74%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;text-align:justify;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:4.6%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;text-align:center;margin:0pt;">2021</p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.74%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;text-align:justify;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.14%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;text-align:right;margin:0pt 2.25pt 0pt 0pt;"><font style="white-space:pre-wrap;"> 511,146</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.12%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;text-align:center;margin:0pt;"><sup style="font-size:5.25pt;vertical-align:top;">(7)</sup><font style="vertical-align:top;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:5.7%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;text-align:right;margin:0pt 2.25pt 0pt 0pt;"><font style="white-space:pre-wrap;"> &#8212;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.74%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"><font style="font-size:7pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;text-align:right;margin:0pt 2.25pt 0pt 0pt;">366,713</p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.74%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"><font style="font-size:7pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.82%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;text-align:right;margin:0pt 2.25pt 0pt 0pt;"><font style="white-space:pre-wrap;"> 520,955</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.74%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;text-align:right;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.36%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;text-align:right;margin:0pt 2.25pt 0pt 0pt;"><font style="white-space:pre-wrap;"> &#8212;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.74%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;text-align:right;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.36%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;text-align:right;margin:0pt 2.25pt 0pt 0pt;"><font style="white-space:pre-wrap;"> 22,034</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.74%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"><font style="font-size:7pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.82%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;text-align:right;margin:0pt 2.25pt 0pt 0pt;"><font style="white-space:pre-wrap;"> 1,420,848</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.37%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;"><font style="font-size:7pt;visibility:hidden;">&#8203;</font></p></td></tr><tr><td style="vertical-align:bottom;width:31.78%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;text-align:justify;margin:0pt;">-Former President and Chief Executive Officer</p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.74%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;text-align:justify;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:4.6%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;text-align:center;margin:0pt;">2020</p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.74%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;text-align:justify;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.14%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;text-align:right;margin:0pt 2.25pt 0pt 0pt;"><font style="white-space:pre-wrap;"> 576,079</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.12%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;text-align:right;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:5.7%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;text-align:right;margin:0pt 2.25pt 0pt 0pt;">279,650</p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.74%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"><font style="font-size:7pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;text-align:right;margin:0pt 2.25pt 0pt 0pt;"><font style="white-space:pre-wrap;"> &#8212;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.74%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"><font style="font-size:7pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.82%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;text-align:right;margin:0pt 2.25pt 0pt 0pt;"><font style="white-space:pre-wrap;"> 1,190,090</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.74%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;text-align:right;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.36%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;text-align:right;margin:0pt 2.25pt 0pt 0pt;"><font style="white-space:pre-wrap;"> 332,686</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.74%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;text-align:right;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.36%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;text-align:right;margin:0pt 2.25pt 0pt 0pt;"><font style="white-space:pre-wrap;"> 8,645</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.74%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"><font style="font-size:7pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.82%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;text-align:right;margin:0pt 2.25pt 0pt 0pt;"><font style="white-space:pre-wrap;"> 2,387,150</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.37%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;"><font style="font-size:7pt;visibility:hidden;">&#8203;</font></p></td></tr><tr><td style="vertical-align:bottom;width:31.78%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;text-align:justify;margin:0pt;">Brian Hahn</p></td><td style="vertical-align:bottom;width:0.74%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:justify;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;width:4.6%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;text-align:center;margin:0pt;">2021</p></td><td style="vertical-align:bottom;width:0.74%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;text-align:justify;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.14%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;text-align:right;margin:0pt 2.25pt 0pt 0pt;"><font style="white-space:pre-wrap;"> 428,622</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.12%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;text-align:right;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:5.7%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;text-align:right;margin:0pt 2.25pt 0pt 0pt;"><font style="white-space:pre-wrap;"> 202,500</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.74%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"><font style="font-size:7pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;text-align:right;margin:0pt 2.25pt 0pt 0pt;"><font style="white-space:pre-wrap;"> 131,445</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.74%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"><font style="font-size:7pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.82%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;text-align:right;margin:0pt 2.25pt 0pt 0pt;"><font style="white-space:pre-wrap;"> 186,732</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.74%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;text-align:right;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.36%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;text-align:right;margin:0pt 2.25pt 0pt 0pt;"><font style="white-space:pre-wrap;"> 164,562</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.74%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;text-align:right;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.36%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;text-align:right;margin:0pt 2.25pt 0pt 0pt;"><font style="white-space:pre-wrap;"> 8,700</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.74%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"><font style="font-size:7pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.82%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;text-align:right;margin:0pt 2.25pt 0pt 0pt;"><font style="white-space:pre-wrap;"> 1,122,561</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.37%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;"><font style="font-size:7pt;visibility:hidden;">&#8203;</font></p></td></tr><tr><td style="vertical-align:bottom;width:31.78%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;text-align:justify;margin:0pt;">-Senior Vice President and Chief Financial Officer</p></td><td style="vertical-align:bottom;width:0.74%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:justify;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;width:4.6%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;text-align:center;margin:0pt;">2020</p></td><td style="vertical-align:bottom;width:0.74%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;text-align:justify;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.14%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;text-align:right;margin:0pt 2.25pt 0pt 0pt;"><font style="white-space:pre-wrap;"> 417,150</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.12%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;text-align:right;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:5.7%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;text-align:right;margin:0pt 2.25pt 0pt 0pt;"><font style="white-space:pre-wrap;"> 202,500</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.74%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"><font style="font-size:7pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;text-align:right;margin:0pt 2.25pt 0pt 0pt;"><font style="white-space:pre-wrap;"> &#8212;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.74%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"><font style="font-size:7pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.82%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;text-align:right;margin:0pt 2.25pt 0pt 0pt;"><font style="white-space:pre-wrap;"> 409,200</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.74%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;text-align:right;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.36%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;text-align:right;margin:0pt 2.25pt 0pt 0pt;"><font style="white-space:pre-wrap;"> 175,203</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.74%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;text-align:right;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.36%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;text-align:right;margin:0pt 2.25pt 0pt 0pt;"><font style="white-space:pre-wrap;"> 8,667</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.74%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"><font style="font-size:7pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.82%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;text-align:right;margin:0pt 2.25pt 0pt 0pt;"><font style="white-space:pre-wrap;"> 1,212,720</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.37%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;"><font style="font-size:7pt;visibility:hidden;">&#8203;</font></p></td></tr><tr><td style="vertical-align:bottom;width:31.78%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;text-align:justify;margin:0pt;">John Magnani, Ph.D.<sup style="font-size:5.25pt;vertical-align:top;"> (8)</sup></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.74%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;text-align:justify;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:4.6%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;text-align:center;margin:0pt;">2021</p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.74%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;text-align:justify;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.14%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;text-align:right;margin:0pt 2.25pt 0pt 0pt;"><font style="white-space:pre-wrap;"> 428,410</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.12%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;text-align:right;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:5.7%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;text-align:right;margin:0pt 2.25pt 0pt 0pt;">202,400</p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.74%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"><font style="font-size:7pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;text-align:right;margin:0pt 2.25pt 0pt 0pt;"><font style="white-space:pre-wrap;"> 131,445</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.74%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"><font style="font-size:7pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.82%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;text-align:right;margin:0pt 2.25pt 0pt 0pt;"><font style="white-space:pre-wrap;"> 186,732</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.74%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;text-align:right;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.36%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;text-align:right;margin:0pt 2.25pt 0pt 0pt;"><font style="white-space:pre-wrap;"> 164,481</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.74%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;text-align:right;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.36%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;text-align:right;margin:0pt 2.25pt 0pt 0pt;"><font style="white-space:pre-wrap;"> 7,869</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.74%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"><font style="font-size:7pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.82%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;text-align:right;margin:0pt 2.25pt 0pt 0pt;"><font style="white-space:pre-wrap;"> 1,121,337</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.37%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;"><font style="font-size:7pt;visibility:hidden;">&#8203;</font></p></td></tr><tr><td style="vertical-align:bottom;width:31.78%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;text-align:justify;margin:0pt;">-Senior Vice President of Research and Chief Scientific Officer</p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.74%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;text-align:justify;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:4.6%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;text-align:center;margin:0pt;"> <font style="visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.74%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;text-align:justify;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.14%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;text-align:right;margin:0pt;"> <font style="visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.12%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;text-align:right;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:5.7%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;text-align:justify;margin:0pt;"> <font style="visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.74%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"><font style="font-size:7pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;text-align:right;margin:0pt;"> <font style="visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.74%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"><font style="font-size:7pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.82%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;text-align:right;margin:0pt;"> <font style="visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.74%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;text-align:right;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.36%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;text-align:right;margin:0pt;"> <font style="visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.74%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;text-align:right;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.36%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;text-align:right;margin:0pt;"> <font style="visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.74%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"><font style="font-size:7pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.82%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;text-align:right;margin:0pt;"> <font style="visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.37%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;"><font style="font-size:7pt;visibility:hidden;">&#8203;</font></p></td></tr></table></div><div style="font-family:'Times New Roman','Times','serif';font-size:10.0pt;margin-bottom:0pt;margin-top:0pt;min-height:1.19em;position:relative;width:100%;"><hr noshade="true" color="#000000" size="1" width="25.0%" style="background-color:#000000;color:#000000;height:1pt;position:relative;top:0.6em;border:none;margin:0pt;" align="left"></div><table border="0" cellpadding="0" cellspacing="0" style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="font-family:'Times New Roman','Times','serif';font-size:9pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">(1)</td><td style="padding:0pt;"><font style="font-family:'Times New Roman','Times','serif';font-size:9pt;font-style:normal;font-weight:normal;">For officers other than Mr. Semerjian, amounts in this column represent a retention bonus initially awarded in September 2019 and paid one-half in September 2020 and one-half in September 2021. Ms. King retired prior to earning the second tranche of her retention bonus in 2021. For Mr. Semerjian only, the amount in this column represents the first installment of a signing bonus. The second installment is payable in August 2022. </font></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="font-family:'Times New Roman','Times','serif';font-size:9pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">(2)</td><td style="padding:0pt;"><font style="font-family:'Times New Roman','Times','serif';font-size:9pt;font-style:normal;font-weight:normal;">The amounts reflect the full grant date fair value for restricted stock unit (RSU) awards and stock option awards granted during the indicated year. The grant date fair value was computed in accordance with ASC Topic 718, </font><i style="font-family:'Times New Roman','Times','serif';font-size:9pt;font-style:italic;font-weight:normal;">Compensation&#8212;Stock Compensation</i><font style="font-family:'Times New Roman','Times','serif';font-size:9pt;font-style:normal;font-weight:normal;">. This calculation does not give effect to any estimate of forfeitures related to service-based vesting, but assumes that the executive will perform the requisite service for the award to vest in full. The assumptions we used in valuing RSUs and stock options are described in Note 9 to our audited financial statements included in our Annual Report on Form 10-K for the fiscal year ended December 31, 2021. </font></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="font-family:'Times New Roman','Times','serif';font-size:9pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">(3)</td><td style="padding:0pt;"><font style="font-family:'Times New Roman','Times','serif';font-size:9pt;font-style:normal;font-weight:normal;">The amounts reflect the portion of each officer&#8217;s target bonus paid based on the achievement of pre-specified corporate and/or individual performance goals, which for 2021 are discussed further below under &#8220;&#8212;Executive Compensation Process and Narrative to Summary Compensation Table&#8212;Annual Bonus.&#8221; </font></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="font-family:'Times New Roman','Times','serif';font-size:9pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">(4)</td><td style="padding:0pt;"><font style="font-family:'Times New Roman','Times','serif';font-size:9pt;font-style:normal;font-weight:normal;">Amounts in this column reflect matching contributions under the Company&#8217;s 401(k) plan. For Ms. King only, the amount reported for 2021 also includes $13,334 of board fees earned for service as a director after her retirement as our President and Chief Executive Officer.</font></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="font-family:'Times New Roman','Times','serif';font-size:9pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">(5)</td><td style="padding:0pt;"><font style="font-family:'Times New Roman','Times','serif';font-size:9pt;font-style:normal;font-weight:normal;">Mr. Semerjian was appointed President and Chief Executive Officer effective August 6, 2021.</font></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="font-family:'Times New Roman','Times','serif';font-size:9pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">(6)</td><td style="padding:0pt;"><font style="font-family:'Times New Roman','Times','serif';font-size:9pt;font-style:normal;font-weight:normal;">Ms. King retired as President and Chief Executive Officer effective August 6, 2021.</font></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="font-family:'Times New Roman','Times','serif';font-size:9pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">(7)</td><td style="padding:0pt;"><font style="font-family:'Times New Roman','Times','serif';font-size:9pt;font-style:normal;font-weight:normal;">Amount consists of $394,134 in base salary through termination of employment, $47,172 of accrued paid time off that was paid following termination of employment, and $69,840 in fees earned for service as a consultant in 2021 following termination of employment.</font></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="font-family:'Times New Roman','Times','serif';font-size:9pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">(8)</td><td style="padding:0pt;"><font style="font-family:'Times New Roman','Times','serif';font-size:9pt;font-style:normal;font-weight:normal;">Dr. Magnani was not a named executive officer for 2020, and as a result his compensation for that year has been omitted pursuant to applicable SEC rules and regulations.</font></td></tr></table><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></div><div style="clear:both;display:table;margin-bottom:27.35pt;min-height:44.65pt;width:100%;"><div style="display:table-cell;vertical-align:bottom;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;min-height:12.0pt;text-align:center;margin:24pt 0pt 0pt 0pt;">38</p></div></div></div><hr style="background-color:#000000;clear:both;color:#000000;height:2pt;line-height:0;margin-bottom:30pt;margin-left:11.76%;margin-right:11.76%;margin-top:30pt;page-break-after:always;width:76.47%;border-width:0;"><div style="max-width:100%;padding-left:11.76%;padding-right:11.76%;position:relative;"><div style="margin-top:27.35pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"><font style="font-weight:bold;visibility:hidden;">&#8203;</font></p></div><div style="clear:both;max-width:100%;position:relative;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><b style="font-weight:bold;">Executive Compensation Process and Narrative to Summary Compensation Table</b></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><font style="font-weight:bold;visibility:hidden;">&#8203;</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">The overall objectives of our executive compensation program are based on the following key principles:</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><font style="font-size:8pt;visibility:hidden;">&#8203;</font></p><table border="0" cellpadding="0" cellspacing="0" style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"></td><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><font style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">attracting, retaining and motivating superior executive talent;</font></td></tr></table><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;padding-left:18pt;text-indent:-18pt;margin:0pt 0pt 0pt 18pt;"><font style="font-size:8pt;margin-left:0pt;visibility:hidden;">&#8203;</font></p><table border="0" cellpadding="0" cellspacing="0" style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"></td><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><font style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">providing incentives that reward the achievement of performance goals that directly correlate to the enhancement of stockholder value, as well as to facilitate executive retention; and</font></td></tr></table><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;padding-left:18pt;text-indent:-18pt;margin:0pt 0pt 0pt 18pt;"><font style="font-size:8pt;margin-left:0pt;visibility:hidden;">&#8203;</font></p><table border="0" cellpadding="0" cellspacing="0" style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"></td><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><font style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">aligning the executives&#8217; interests with those of stockholders through long-term incentives linked to company performance.</font></td></tr></table><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;padding-left:18pt;text-indent:-18pt;margin:0pt 0pt 0pt 18pt;"><font style="margin-left:0pt;visibility:hidden;">&#8203;</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">We review compensation annually for all employees, including our executives. In setting executive base salaries and bonuses and granting equity incentive awards, we consider compensation for comparable positions in the market, the historical compensation levels of our executives, individual performance as compared to our expectations and objectives, our desire to motivate our employees to achieve short- and long-term results that are in the best interests of our stockholders and a long-term commitment to our company. We do not target a specific mix of compensation among base salary, bonus or long-term incentives. </p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">The Compensation Committee of our Board determines our officers&#8217; compensation. Our Compensation Committee typically reviews and discusses management&#8217;s proposed compensation with the Chief Executive Officer for all officers other than the Chief Executive Officer. Based on those discussions and its discretion, the Compensation Committee then recommends the compensation for each executive officer. Our Compensation Committee, without members of management present, discusses and ultimately approves the compensation of our executive officers. </p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">The Compensation Committee retained Aon&#8217;s Human Capital Solutions practice, a division of Aon plc, or Aon, to evaluate our executive compensation program for 2021. Aon&#8217;s engagement included assisting the Compensation Committee with the selection of a peer group of companies for benchmarking purposes, an analysis of our existing executive compensation, including our equity incentive plan and option granting practices, and an analysis of our director compensation policy. Aon presented the Compensation Committee with data about the compensation paid by our peer group of companies, described below, and other employers, who we believe compete with us for executives, updated the Compensation Committee on new developments in areas that fall within the Compensation Committee&#8217;s jurisdiction and advised the Compensation Committee regarding its responsibilities. The compensation consultant serves at the pleasure of the Compensation Committee rather than us, and the compensation consultant&#8217;s fees are approved by the Compensation Committee. </p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><font style="font-style:italic;font-weight:bold;">Peer Group and Comparative Benchmarking </font></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">In consultation with Aon, we evaluate our executive compensation program, including base salary, total cash compensation and equity awards, against compensation paid or awarded by a peer group of biopharmaceutical companies recommended by Aon and approved by our Compensation Committee.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">In identifying a peer group for us for purposes of evaluating and benchmarking our executive compensation program, Aon considered such factors as stage of product development and commercialization, product pipeline, location, market capitalization, revenue, employee headcount and therapeutic focus. </p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></div><div style="clear:both;display:table;margin-bottom:27.35pt;min-height:44.65pt;width:100%;"><div style="display:table-cell;vertical-align:bottom;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;min-height:12.0pt;text-align:center;margin:24pt 0pt 0pt 0pt;">39</p></div></div></div><hr style="background-color:#000000;clear:both;color:#000000;height:2pt;line-height:0;margin-bottom:30pt;margin-left:11.76%;margin-right:11.76%;margin-top:30pt;page-break-after:always;width:76.47%;border-width:0;"><div style="max-width:100%;padding-left:11.76%;padding-right:11.76%;position:relative;"><div style="margin-top:27.35pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"><font style="font-weight:bold;visibility:hidden;">&#8203;</font></p></div><div style="clear:both;max-width:100%;position:relative;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">The peer group analysis for purposes of establishing 2021 and 2022 compensation resulted in the selection of the following companies: </p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p><div><table style="border-collapse:collapse;font-size:16pt;height:max-content;margin-left:auto;margin-right:auto;padding-left:0pt;padding-right:0pt;width:100%;" align="center"><tr style="height:1pt;"><td style="vertical-align:bottom;white-space:nowrap;width:48.14%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.77%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:49.08%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td></tr><tr style="height:15pt;"><td style="vertical-align:bottom;white-space:nowrap;width:48.14%;border-bottom:1.0pt solid #000000;border-top:1.0pt solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><b style="font-weight:bold;">2021 Compensation Peer Group</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.77%;border-bottom:1.0pt solid #000000;border-top:1.0pt solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:49.08%;border-bottom:1.0pt solid #000000;border-top:1.0pt solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><b style="font-weight:bold;">2022 Compensation Peer Group</b></p></td></tr><tr style="height:12.75pt;"><td style="vertical-align:middle;white-space:nowrap;width:48.14%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Abeona Therapeutics, Inc.</p></td><td style="vertical-align:middle;width:2.77%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:top;white-space:nowrap;width:49.08%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Abeona Therapeutics, Inc.</p></td></tr><tr style="height:12.75pt;"><td style="vertical-align:middle;white-space:nowrap;width:48.14%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Aeglea BioTherapeutics, Inc.</p></td><td style="vertical-align:middle;width:2.77%;margin:0pt;padding:0pt;"></td><td style="vertical-align:top;white-space:nowrap;width:49.08%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Actinium Pharmaceuticals, Inc.</p></td></tr><tr style="height:12.75pt;"><td style="vertical-align:middle;white-space:nowrap;width:48.14%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Allena Pharmaceuticals, Inc.</p></td><td style="vertical-align:middle;width:2.77%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:top;white-space:nowrap;width:49.08%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Aeglea BioTherapeutics, Inc.</p></td></tr><tr style="height:12.75pt;"><td style="vertical-align:middle;white-space:nowrap;width:48.14%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Ardelyx, Inc.</p></td><td style="vertical-align:middle;width:2.77%;margin:0pt;padding:0pt;"></td><td style="vertical-align:top;width:49.08%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Alaunos Therapeutics (formerly ZIOPHARM Oncology)</p></td></tr><tr style="height:12.75pt;"><td style="vertical-align:middle;white-space:nowrap;width:48.14%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">CASI Pharmaceuticals, Inc.</p></td><td style="vertical-align:middle;width:2.77%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:top;white-space:nowrap;width:49.08%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Allena Pharmaceuticals, Inc.</p></td></tr><tr style="height:12.75pt;"><td style="vertical-align:middle;white-space:nowrap;width:48.14%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Catalyst Biosciences, Inc.</p></td><td style="vertical-align:middle;width:2.77%;margin:0pt;padding:0pt;"></td><td style="vertical-align:top;white-space:nowrap;width:49.08%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Ardelyx, Inc.</p></td></tr><tr style="height:12.75pt;"><td style="vertical-align:middle;white-space:nowrap;width:48.14%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Chimerix, Inc.</p></td><td style="vertical-align:middle;width:2.77%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:top;white-space:nowrap;width:49.08%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">CASI Pharmaceuticals, Inc.</p></td></tr><tr style="height:12.75pt;"><td style="vertical-align:middle;white-space:nowrap;width:48.14%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Cidara Therapeutics, Inc.</p></td><td style="vertical-align:middle;width:2.77%;margin:0pt;padding:0pt;"></td><td style="vertical-align:top;width:49.08%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Catalyst Biosciences, Inc.</p></td></tr><tr style="height:12.75pt;"><td style="vertical-align:middle;white-space:nowrap;width:48.14%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Concert Pharmaceuticals, Inc.</p></td><td style="vertical-align:middle;width:2.77%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:top;white-space:nowrap;width:49.08%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Cidara Therapeutics, Inc.</p></td></tr><tr style="height:12.75pt;"><td style="vertical-align:middle;white-space:nowrap;width:48.14%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">CymaBay Therapeutics, Inc.</p></td><td style="vertical-align:middle;width:2.77%;margin:0pt;padding:0pt;"></td><td style="vertical-align:top;white-space:nowrap;width:49.08%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Concert Pharmaceuticals, Inc.</p></td></tr><tr style="height:12.75pt;"><td style="vertical-align:middle;white-space:nowrap;width:48.14%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Fulcrum Therapeutics, Inc.</p></td><td style="vertical-align:middle;width:2.77%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:top;white-space:nowrap;width:49.08%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Corvus Pharmaceuticals, Inc.</p></td></tr><tr style="height:12.75pt;"><td style="vertical-align:bottom;white-space:nowrap;width:48.14%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Geron Corporation</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.77%;margin:0pt;padding:0pt;"></td><td style="vertical-align:top;white-space:nowrap;width:49.08%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">CymaBay Therapeutics, Inc.</p></td></tr><tr style="height:12.75pt;"><td style="vertical-align:bottom;white-space:nowrap;width:48.14%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Idera Pharmaceuticals, Inc.</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.77%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:top;white-space:nowrap;width:49.08%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Geron Corporation</p></td></tr><tr style="height:12.75pt;"><td style="vertical-align:middle;white-space:nowrap;width:48.14%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">ImmunoGen, Inc.</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.77%;margin:0pt;padding:0pt;"></td><td style="vertical-align:top;white-space:nowrap;width:49.08%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Idera Pharmaceuticals, Inc.</p></td></tr><tr style="height:12.75pt;"><td style="vertical-align:middle;white-space:nowrap;width:48.14%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">MEI Pharma, Inc.</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.77%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:top;white-space:nowrap;width:49.08%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">MEI Pharma, Inc.</p></td></tr><tr style="height:12.75pt;"><td style="vertical-align:middle;white-space:nowrap;width:48.14%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Sesen Bio, Inc.</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.77%;margin:0pt;padding:0pt;"></td><td style="vertical-align:top;white-space:nowrap;width:49.08%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Sesen Bio, Inc.</p></td></tr><tr style="height:12.75pt;"><td style="vertical-align:middle;white-space:nowrap;width:48.14%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Syndax Pharmaceuticals, Inc.</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.77%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:top;white-space:nowrap;width:49.08%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Sierra Oncology, Inc.</p></td></tr><tr style="height:14.4pt;"><td style="vertical-align:middle;white-space:nowrap;width:48.14%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Syros Pharmaceuticals, Inc.</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.77%;margin:0pt;padding:0pt;"></td><td style="vertical-align:top;white-space:nowrap;width:49.08%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Syros Pharmaceuticals, Inc.</p></td></tr><tr style="height:14.4pt;"><td style="vertical-align:middle;white-space:nowrap;width:48.14%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">ZIOPHARM Oncology, Inc.</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.77%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:top;white-space:nowrap;width:49.08%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">X4 Pharmaceuticals, Inc.</p></td></tr></table></div><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">In addition to reviewing the SEC filings for these peer companies, our Compensation Committee also considers broader surveys of compensation practices for companies in our industry, such as Aon&#8217;s 2021 Trends Report. In general, our Compensation Committee seeks to target our named executive officers&#8217; base salaries, total cash compensation and equity compensation to be at or near the median of similarly situated executive officers of companies in our peer group.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><font style="font-style:italic;font-weight:bold;">Annual Base Salary </font></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><font style="font-style:italic;font-weight:bold;visibility:hidden;">&#8203;</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">The following table presents the base salaries for each of our named executive officers. </p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p><div><table style="border-collapse:collapse;font-size:16pt;height:max-content;margin-left:auto;margin-right:auto;padding-left:0pt;padding-right:0pt;width:80%;" align="center"><tr style="height:1pt;"><td style="vertical-align:bottom;white-space:nowrap;width:62.33%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;"><font style="font-size:1pt;visibility:hidden;">&#8203;</font></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.15%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;"><font style="font-size:1pt;visibility:hidden;">&#8203;</font></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:10.4%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;"><font style="font-size:1pt;visibility:hidden;">&#8203;</font></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.15%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;"><font style="font-size:1pt;visibility:hidden;">&#8203;</font></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:10.4%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;"><font style="font-size:1pt;visibility:hidden;">&#8203;</font></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.15%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;"><font style="font-size:1pt;visibility:hidden;">&#8203;</font></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:10.4%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;"><font style="font-size:1pt;visibility:hidden;">&#8203;</font></p></div></div></td></tr><tr><td style="vertical-align:bottom;white-space:nowrap;width:62.33%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.15%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.4%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">2022&#160;BASE</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.15%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.4%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">2021&#160;BASE</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.15%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.4%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">2020&#160;BASE</b></p></td></tr><tr><td style="vertical-align:bottom;width:62.33%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;"><font style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.15%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><font style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.4%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">SALARY</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.15%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><font style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.4%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">SALARY</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.15%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.4%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">SALARY</b></p></td></tr><tr><td style="vertical-align:bottom;width:62.33%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:justify;margin:0pt;"><b style="font-weight:bold;">NAME</b>&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.15%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><font style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.4%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">($)</b>&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.15%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><font style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.4%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">($)</b>&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.15%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.4%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">($)</b>&#160;</p></td></tr><tr><td style="vertical-align:bottom;width:62.33%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;">Harout Semerjian <sup style="font-size:7.5pt;vertical-align:top;">(1)</sup></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.15%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><font style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.4%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><font style="white-space:pre-wrap;"> 615,825</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.15%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"><font style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.4%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><font style="white-space:pre-wrap;"> 595,000</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.15%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"><font style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.4%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><font style="white-space:pre-wrap;"> &#8212;</font></p></td></tr><tr><td style="vertical-align:bottom;width:62.33%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;">Rachel King <sup style="font-size:7.5pt;vertical-align:top;">(2)</sup></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.15%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.4%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><font style="white-space:pre-wrap;"> &#8212;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.15%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.4%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><font style="white-space:pre-wrap;"> 593,361</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.15%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.4%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><font style="white-space:pre-wrap;"> 576,079</font></p></td></tr><tr><td style="vertical-align:bottom;width:62.33%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;">Brian Hahn</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.15%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.4%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><font style="white-space:pre-wrap;"> 444,703</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.15%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.4%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><font style="white-space:pre-wrap;"> 429,665</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.15%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.4%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><font style="white-space:pre-wrap;"> 417,150</font></p></td></tr><tr><td style="vertical-align:bottom;width:62.33%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;">John Magnani, Ph.D <sup style="font-size:7.5pt;vertical-align:top;">(3)</sup></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.15%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.4%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><font style="white-space:pre-wrap;"> 444,483</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.15%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.4%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><font style="white-space:pre-wrap;"> 429,452</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.15%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.4%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;">N/A</p></td></tr><tr><td style="vertical-align:bottom;white-space:nowrap;width:62.33%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.15%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.4%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.15%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.4%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.15%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.4%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></td></tr><tr><td colspan="7" style="vertical-align:bottom;width:100%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:9pt;text-align:justify;margin:0pt;"><sup style="font-size:6.75pt;vertical-align:top;">1 </sup>Mr. Semerjian was appointed President and Chief Executive Officer effective August 6, 2021.</p></td></tr><tr><td colspan="7" style="vertical-align:bottom;white-space:nowrap;width:100%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:9pt;text-align:justify;margin:0pt;"><sup style="font-size:6.75pt;vertical-align:top;">2 </sup>Ms. King retired as President and Chief Executive Officer effective August 6, 2021.</p></td></tr><tr><td colspan="7" style="vertical-align:bottom;white-space:nowrap;width:100%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:9pt;text-align:justify;margin:0pt;"><sup style="font-size:6.75pt;vertical-align:top;">3 </sup>Dr. Magnani was not a named executive for 2020.</p></td></tr></table></div><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><font style="font-style:italic;font-weight:bold;visibility:hidden;">&#8203;</font></p></div><div style="clear:both;display:table;margin-bottom:27.35pt;min-height:44.65pt;width:100%;"><div style="display:table-cell;vertical-align:bottom;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;min-height:12.0pt;text-align:center;margin:24pt 0pt 0pt 0pt;">40</p></div></div></div><hr style="background-color:#000000;clear:both;color:#000000;height:2pt;line-height:0;margin-bottom:30pt;margin-left:11.76%;margin-right:11.76%;margin-top:30pt;page-break-after:always;width:76.47%;border-width:0;"><div style="max-width:100%;padding-left:11.76%;padding-right:11.76%;position:relative;"><div style="margin-top:27.35pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"><font style="font-weight:bold;visibility:hidden;">&#8203;</font></p></div><div style="clear:both;max-width:100%;position:relative;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><font style="font-style:italic;font-weight:bold;">Annual Bonus </font></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><font style="font-size:11pt;visibility:hidden;">&#8203;</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">We seek to motivate and reward our executives for achievements relative to our corporate goals and expectations for each fiscal year. Each named executive officer has a target bonus opportunity, defined as a percentage of his annual salary. The following table presents the target bonus of each of our named executive officers for 2021: </p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><font style="font-size:11pt;visibility:hidden;">&#8203;</font></p><div><table style="border-collapse:collapse;font-size:16pt;height:max-content;margin-left:auto;margin-right:auto;padding-left:0pt;padding-right:0pt;width:80%;" align="center"><tr style="height:1pt;"><td style="vertical-align:bottom;white-space:nowrap;width:78.27%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;"><font style="font-size:1pt;visibility:hidden;">&#8203;</font></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.13%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;"><font style="font-size:1pt;visibility:hidden;">&#8203;</font></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:19.59%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;"><font style="font-size:1pt;visibility:hidden;">&#8203;</font></p></div></div></td></tr><tr><td style="vertical-align:bottom;white-space:nowrap;width:78.27%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.13%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:19.59%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;"> </b><font style="font-weight:bold;visibility:hidden;">&#8203;</font></p></td></tr><tr><td style="vertical-align:bottom;width:78.27%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;"><font style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.13%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><font style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:19.59%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">TARGET&#160;BONUS</b></p></td></tr><tr><td style="vertical-align:bottom;width:78.27%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:justify;margin:0pt;"><b style="font-weight:bold;">NAME</b>&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.13%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><font style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:19.59%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">(%&#160;OF&#160;SALARY)</b>&#160;</p></td></tr><tr><td style="vertical-align:bottom;width:78.27%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;">Harout Semerjian <sup style="font-size:7.5pt;vertical-align:top;">(1)</sup></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.13%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:19.59%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;">55</p></td></tr><tr><td style="vertical-align:bottom;width:78.27%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;">Brian Hahn</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.13%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:19.59%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;">40</p></td></tr><tr><td style="vertical-align:bottom;width:78.27%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;">John Magnani, Ph.D.</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.13%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:19.59%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;">40</p></td></tr><tr><td style="vertical-align:bottom;white-space:nowrap;width:78.27%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.13%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:19.59%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></td></tr><tr><td colspan="3" style="vertical-align:bottom;width:100%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:9pt;text-align:justify;margin:0pt;"><sup style="font-size:6.75pt;vertical-align:top;">1 </sup>Ms. King retired, and Mr. Semerjian was appointed, as President and Chief Executive Officer effective August 6, 2021. Mr. Semerjian&#39; s bonus opportunity was prorated on the portion of 2021 in which he served in that role. Ms. King was not eligible to receive a bonus payout for 2021 due to her retirement.</p></td></tr></table></div><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><font style="font-size:11pt;visibility:hidden;">&#8203;</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">To reinforce the importance of integrated and collaborative leadership, bonuses for executives other than the Chief Executive Officer have been based primarily on company performance, but also contain an individual performance component. Our Chief Executive Officer&#8217;s bonus has historically been based exclusively on company performance. In no event may a bonus awarded to an executive exceed 150% of such executive&#8217;s target bonus.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><font style="font-size:11pt;visibility:hidden;">&#8203;</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">For 2021, the corporate objectives approved by our Compensation Committee and subsequently confirmed by the Board were: </p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><font style="font-size:11pt;visibility:hidden;">&#8203;</font></p><div style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:0pt;margin-left:18pt;margin-top:0pt;padding-left:18pt;text-indent:-18pt;"><font style="display:inline-block;min-width:16.05pt;text-indent:0pt;white-space:nowrap;">&#9679;</font>advance our comprehensive acute myeloid leukemia (AML) program and build visibility, awareness and excitement towards a data readout from our ongoing Phase 3 clinical trial of uproleselan, including specified sub-goals related to Phase 3 trial enrollment, collaborator activities, pediatric plan development, investigator-sponsored trials, and CMC activities (45% collective weighting);</div><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;padding-left:18pt;text-indent:-18pt;margin:0pt 0pt 0pt 18pt;"><font style="font-size:11pt;margin-left:0pt;visibility:hidden;">&#8203;</font></p><div style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:0pt;margin-left:18pt;margin-top:0pt;padding-left:18pt;text-indent:-18pt;"><font style="display:inline-block;min-width:16.05pt;text-indent:0pt;white-space:nowrap;">&#9679;</font>continue advancing quality dataset and NDA planning towards uproleselan registration (20% weighting);</div><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;padding-left:18pt;text-indent:-18pt;margin:0pt 0pt 0pt 18pt;"><font style="margin-left:0pt;visibility:hidden;">&#8203;</font></p><div style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:0pt;margin-left:18pt;margin-top:0pt;padding-left:18pt;text-indent:-18pt;"><font style="display:inline-block;min-width:16.05pt;text-indent:0pt;white-space:nowrap;">&#9679;</font>define the path to submission of an IND for GMI-1687 by the first half of 2022, including implementation of specified critical path activities (10% collective weighting);</div><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;padding-left:18pt;text-indent:-18pt;margin:0pt 0pt 0pt 18pt;"><font style="font-size:11pt;margin-left:0pt;visibility:hidden;">&#8203;</font></p><div style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:0pt;margin-left:18pt;margin-top:0pt;padding-left:18pt;text-indent:-18pt;"><font style="display:inline-block;min-width:16.05pt;text-indent:0pt;white-space:nowrap;">&#9679;</font>generate sufficient proceeds to extend available cash through a specified date (10% weighting);</div><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;padding-left:18pt;text-indent:-18pt;margin:0pt 0pt 0pt 18pt;"><font style="margin-left:0pt;visibility:hidden;">&#8203;</font></p><div style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:0pt;margin-left:18pt;margin-top:0pt;padding-left:18pt;text-indent:-18pt;"><font style="display:inline-block;min-width:16.05pt;text-indent:0pt;white-space:nowrap;">&#9679;</font>continue to build our product candidate pipeline (10% weighting); and</div><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;padding-left:18pt;text-indent:-18pt;margin:0pt 0pt 0pt 18pt;"><font style="margin-left:0pt;visibility:hidden;">&#8203;</font></p><div style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:0pt;margin-left:18pt;margin-top:0pt;padding-left:18pt;text-indent:-18pt;"><font style="display:inline-block;min-width:16.05pt;text-indent:0pt;white-space:nowrap;">&#9679;</font>continue to develop a human resources infrastructure that supports retention and growth of our employees, including ongoing professional development and paths to advancement, and attract, retain and develop a diverse and talented workforce (5% weighting).</div><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;"><font style="font-size:11pt;visibility:hidden;">&#8203;</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><font style="white-space:pre-wrap;">The Committee considered the achievement of specific performance levels against these 2021 objectives in the context of the ongoing impact of the COVID-19 pandemic and the overall performance of the biotech sector, as well as expected third party perspectives of our performance against the stated metrics.  Based on these considerations, among others, the Committee determined that we had fully achieved each of our objectives related to GMI-1687 development, cash runway and human resources objectives described above, which collectively represented 25% of the corporate goal weighting. With respect to our AML program objectives, the Committee noted that we had exceeded the CMC sub-goal to determine that we had exceeded the overall corporate objective, thereby earning 47.5% credit, which slightly exceeded the 45% weighting for these objectives. In regards to the objective for dataset advancement and NDA planning, the Committee determined that we had not fully achieved the objective due to not reaching pre-specified dataset lock thresholds by year-end 2021, but took note of our efforts to implement additional measures to manage and accelerate our process, awarding a total of 15% credit out of the available 20%. With respect to the product pipeline objective, the Committee determined that we had fallen slightly short of the objective </font></p></div><div style="clear:both;display:table;margin-bottom:27.35pt;min-height:44.65pt;width:100%;"><div style="display:table-cell;vertical-align:bottom;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;min-height:12.0pt;text-align:center;margin:24pt 0pt 0pt 0pt;">41</p></div></div></div><hr style="background-color:#000000;clear:both;color:#000000;height:2pt;line-height:0;margin-bottom:30pt;margin-left:11.76%;margin-right:11.76%;margin-top:30pt;page-break-after:always;width:76.47%;border-width:0;"><div style="max-width:100%;padding-left:11.76%;padding-right:11.76%;position:relative;"><div style="margin-top:27.35pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"><font style="font-weight:bold;visibility:hidden;">&#8203;</font></p></div><div style="clear:both;max-width:100%;position:relative;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><font style="white-space:pre-wrap;">due to certain preclinical modeling activities that were not fully completed by the end of 2021, and awarded a total of 7.5% credit out of the available 10%.   </font></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><font style="font-size:11pt;visibility:hidden;">&#8203;</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><font style="white-space:pre-wrap;">Therefore, based on our corporate accomplishments during 2021, our Compensation Committee concluded that we had achieved an aggregate of 95% of the weighting of the corporate objectives and approved the payment of that same percentage of the portion of each named executive officer&#8217;s target bonus attributable to corporate objectives.  Mr. Semerjian&#8217;s target bonus was based solely upon the achievement of corporate objectives for 2021, and accordingly, his bonus for 2021, which was prorated for the term of his employment in 2021, was equal to 95% of his target bonus. For Mr. Hahn and Dr. Magnani, the 2021 corporate objectives represented 85% of their respective target bonus amount, and accordingly, they were awarded approximately 81% credit toward their target bonus based on the Company&#8217;s accomplishments described above. Based on the achievement of their individual performance objectives during the year, Mr. Hahn and Dr. Magnani were each awarded the remaining 15% credit toward their target bonus in full, resulting in a total bonus payment of approximately 96% of their target bonus for 2021.  Bonus payouts for each of the named executive officers at the aforementioned levels are reflected in the &#8220;Non-Equity Incentive Plan Compensation&#8221; column of the Summary Compensation Table above for 2021. Ms. King did not receive a bonus payout for 2021 due to her retirement during the year.  </font></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;"><font style="font-style:italic;font-weight:bold;">Retention Bonuses</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;"><font style="font-style:italic;font-weight:bold;visibility:hidden;">&#8203;</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">In August 2019, we announced that a Phase 3 clinical trial of our product candidate rivipansel, conducted by our collaborator Pfizer, did not meet its primary or key secondary efficacy endpoints. Following this announcement, the price of our common stock declined over 60% in the succeeding month. In September 2019, the Board and the Compensation Committee, in consultation with its consultant Radford (now known as Aon), approved a company-wide retention program. For all employees other than executive officers, the Board approved the one-time award of RSUs that would vest over time. However, for our executive officers, including the named executive officers, the Compensation Committee determined that it would be in the best interest of the Company and its stockholders to avoid dilution from the issuance of additional equity awards and, as an alternative, the Committee approved one-time retention bonuses that would be payable over a two-year period.</p><p style="font-family:'Times New Roman','Times','serif';font-size:12pt;margin:0pt;"><font style="font-size:10pt;margin-bottom:5pt;margin-top:5pt;visibility:hidden;">&#8203;</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">The amount of the retention bonus for each executive officer was equal to one times his or her annual base salary in effect in September 2019. One-half of the bonus was paid to each executive officer in a lump sum in September 2020 and the remainder of the retention bonus was paid in a lump sum in September 2021, subject in each case to each executive&#8217;s continuing employment with the Company on a full-time basis in good performance standing through and including such applicable payment date. The retention payouts made in 2021 are reflected in the &#8220;Bonus&#8221; column of the Summary Compensation Table above for 2021. Ms. King forfeited the second tranche of her retention bonus upon her retirement in August 2021.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><font style="white-space:pre-wrap;">In January 2022, the Compensation Committee, in consultation with its compensation consultant Aon, approved an additional cash retention program for selected employees, including the Company&#8217;s executive officers other than the Chief Executive Officer. Under the program, each participant who is not a named executive officer will have the opportunity to receive an individual cash award up to 1.5 times the amount of such participant&#8217;s 2021 annual bonus target, with forty percent (40%) of such award payable in a lump sum in August 2022 and the remaining sixty percent (60%) of such award payable in a lump sum in August 2023, subject to continued employment at that time. With respect to the named executive officers, Mr. Hahn will have the opportunity to earn an award of up to 60% of his 2021 base salary as part of this program, and Dr. Magnani will have the opportunity to earn an award of up to 20% of his 2021 base salary, in each case payable on the same dates and in the same proportions as described above.  The potential cash retention awards described above are, for each named executive officer, in addition to his annual bonus opportunity, described under &#8220;Annual Bonus&#8221; above.</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><font style="font-style:italic;font-weight:bold;visibility:hidden;">&#8203;</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><font style="font-style:italic;font-weight:bold;">Long-Term Incentives </font></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><font style="font-style:italic;font-weight:bold;visibility:hidden;">&#8203;</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 10pt 0pt;">We have historically issued a mix of stock options and restricted stock units to our named executive officers. We award stock options on the date the Compensation Committee approves the grant. We set the option exercise price and grant date fair value based on the closing price of our common stock on the Nasdaq Global Market on the date of grant. We typically grant stock options at the start of employment and annually as part of the Compensation Committee review process.</p></div><div style="clear:both;display:table;margin-bottom:27.35pt;min-height:44.65pt;width:100%;"><div style="display:table-cell;vertical-align:bottom;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;min-height:12.0pt;text-align:center;margin:24pt 0pt 0pt 0pt;">42</p></div></div></div><hr style="background-color:#000000;clear:both;color:#000000;height:2pt;line-height:0;margin-bottom:30pt;margin-left:11.76%;margin-right:11.76%;margin-top:30pt;page-break-after:always;width:76.47%;border-width:0;"><div style="max-width:100%;padding-left:11.76%;padding-right:11.76%;position:relative;"><div style="margin-top:27.35pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"><font style="font-weight:bold;visibility:hidden;">&#8203;</font></p></div><div style="clear:both;max-width:100%;position:relative;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">In January 2021, in connection with its annual compensation review for 2020, our Compensation Committee reviewed the peer group and market data presented by Aon and granted options to purchase shares of our common stock and restricted stock units to our named executive officers. The shares of common stock subject to the option grants vest as to one-fourth of the shares one year after the date of grant, with the balance of the shares vesting in 36 successive equal monthly installments thereafter, subject to the officer&#8217;s service with us as of each such date. Each option had an exercise price of $3.81 per share, the closing price of our common stock on the grant date. The restricted stock units vest 25% on each of the first four anniversaries of the grant date, subject to the reporting person&#8217;s continuous service as of each such vesting date. The following equity grants were made on January 20, 2021: </p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p><div><table style="border-collapse:collapse;font-size:16pt;height:max-content;margin-left:auto;margin-right:auto;padding-left:0pt;padding-right:0pt;width:100%;" align="center"><tr style="height:1pt;"><td style="vertical-align:bottom;width:64.29%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;"><font style="font-size:1pt;visibility:hidden;">&#8203;</font></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.73%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;"><font style="font-size:1pt;visibility:hidden;">&#8203;</font></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:15.92%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;"><font style="font-size:1pt;visibility:hidden;">&#8203;</font></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.7%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;"><font style="font-size:1pt;visibility:hidden;">&#8203;</font></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:16.33%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;"><font style="font-size:1pt;visibility:hidden;">&#8203;</font></p></div></div></td></tr><tr><td style="vertical-align:bottom;width:64.29%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;"><font style="font-size:8pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.73%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:15.92%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">Number&#160;of&#160;Shares</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.7%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:16.33%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;"> </b><font style="font-weight:bold;visibility:hidden;">&#8203;</font></p></td></tr><tr><td style="vertical-align:bottom;width:64.29%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;"><font style="font-size:8pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.73%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><font style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:15.92%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">Underlying</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.7%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:16.33%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;"> </b><font style="font-weight:bold;visibility:hidden;">&#8203;</font></p></td></tr><tr><td style="vertical-align:bottom;width:64.29%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;"><font style="font-size:8pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.73%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><font style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:15.92%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">Option&#160;Grant</b>&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.7%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:16.33%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">Restricted Stock Units</b></p></td></tr><tr><td style="vertical-align:bottom;width:64.29%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;">Rachel King <sup style="font-size:7.5pt;vertical-align:top;">(1)</sup></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.73%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:15.92%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;">192,500</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.7%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:16.33%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;">96,250</p></td></tr><tr><td style="vertical-align:bottom;width:64.29%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;">Brian Hahn</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.73%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:15.92%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;">69,000</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.7%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:16.33%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;">34,500</p></td></tr><tr><td style="vertical-align:bottom;width:64.29%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;">John Magnani, Ph.D.</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.73%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:15.92%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;">69,000</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.7%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:16.33%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;">34,500</p></td></tr><tr><td style="vertical-align:bottom;white-space:nowrap;width:64.29%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.73%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:15.92%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.7%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:16.33%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></td></tr><tr><td colspan="5" style="vertical-align:bottom;width:100%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:9pt;text-align:justify;margin:0pt;"><sup style="font-size:6.75pt;vertical-align:top;">1 </sup>Ms. King&#39;s stock option and restricted stock unit awards continue to vest during her service as a director of our company.</p></td></tr></table></div><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">In connection with the appointment of Mr. Semerjian as our President and Chief Executive Officer in August 2021, the Board approved the grant to Mr. Semerjian of an option to purchase 1,098,400 shares, subject to vesting as to 25% of the underlying shares on August 3, 2022, and as to the remaining underlying shares in equal monthly installments over 36 months thereafter, subject to Mr. Semerjian&#8217;s continued service through each such vesting date, as well as an option to purchase 549,200 shares, one-half of which will vest upon FDA approval of uproleselan as a treatment for relapsed/refractory acute myeloid leukemia and the remainder of which will vest upon the first commercial sale of uproleselan in the United States or abroad, subject in each case to Mr. Semerjian&#8217;s continued service through the applicable vesting date. The option grants have an exercise price of $2.03 per share, the closing price of our common stock on the grant date.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">In January 2022, in connection with its annual compensation review for 2021, our Compensation Committee reviewed the peer group and market data presented by Aon and granted options to purchase shares of our common stock to our named executive officers. A portion of the stock options contained a service-based vesting schedule, and the remainder contained performance-based vesting. Mr. Semerjian was awarded a service-based option only, in recognition of the fact that he had received a performance-based option upon the commencement of his employment in August 2021. </p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">The shares of common stock subject to the option grants under the service-based awards vest as to one-fourth of the shares one year after the date of grant, with the balance of the shares vesting in 36 successive equal monthly installments thereafter, subject to the named executive officer&#8217;s service with us as of each such date. The performance-based options have the same performance-based vesting as Mr. Semerjian&#8217;s option granted in August 2021. Each option had an exercise price of $1.11 per share, the closing price of our common stock on the grant date. The following equity grants were made on January 21, 2022: </p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p><div><table style="border-collapse:collapse;font-size:16pt;height:max-content;margin-left:auto;margin-right:auto;padding-left:0pt;padding-right:0pt;width:100%;" align="center"><tr style="height:1pt;"><td style="vertical-align:bottom;width:48.7%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;"><font style="font-size:1pt;visibility:hidden;">&#8203;</font></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.7%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;"><font style="font-size:1pt;visibility:hidden;">&#8203;</font></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:21.84%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;"><font style="font-size:1pt;visibility:hidden;">&#8203;</font></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.7%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;"><font style="font-size:1pt;visibility:hidden;">&#8203;</font></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:26.02%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;"><font style="font-size:1pt;visibility:hidden;">&#8203;</font></p></div></div></td></tr><tr><td style="vertical-align:bottom;width:48.7%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;"><font style="font-size:8pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.7%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:21.84%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">Number&#160;of&#160;Shares</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.7%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:26.02%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">Number&#160;of&#160;Shares</b></p></td></tr><tr><td style="vertical-align:bottom;width:48.7%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;"><font style="font-size:8pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.7%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><font style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:21.84%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">Underlying</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.7%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:26.02%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">Underlying</b></p></td></tr><tr><td style="vertical-align:bottom;width:48.7%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;"><font style="font-size:8pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.7%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><font style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:21.84%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">Option&#160;Grant&#160;(Service-Based)</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.7%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:26.02%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">Option&#160;Grant (Performance-Based)</b></p></td></tr><tr><td style="vertical-align:bottom;width:48.7%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;">Harout Semerjian</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.7%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:21.84%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;">423,500</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.7%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:26.02%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><font style="font-family:'Arial','Helvetica','sans-serif';white-space:pre-wrap;"> &#8212;</font></p></td></tr><tr><td style="vertical-align:bottom;width:48.7%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;">Brian Hahn</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.7%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:21.84%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;">164,700</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.7%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:26.02%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;">47,700</p></td></tr><tr><td style="vertical-align:bottom;width:48.7%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;">John Magnani, Ph.D.</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.7%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:21.84%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;">100,000</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.7%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:26.02%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;">25,000</p></td></tr></table></div><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><font style="font-weight:bold;visibility:hidden;">&#8203;</font></p></div><div style="clear:both;display:table;margin-bottom:27.35pt;min-height:44.65pt;width:100%;"><div style="display:table-cell;vertical-align:bottom;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;min-height:12.0pt;text-align:center;margin:24pt 0pt 0pt 0pt;">43</p></div></div></div><hr style="background-color:#000000;clear:both;color:#000000;height:2pt;line-height:0;margin-bottom:30pt;margin-left:11.76%;margin-right:11.76%;margin-top:30pt;page-break-after:always;width:76.47%;border-width:0;"><div style="max-width:100%;padding-left:11.76%;padding-right:11.76%;position:relative;"><div style="margin-top:27.35pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"><font style="font-weight:bold;visibility:hidden;">&#8203;</font></p></div><div style="clear:both;max-width:100%;position:relative;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><b style="font-weight:bold;">Outstanding Equity Awards at End of 2021 </b></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><font style="font-weight:bold;visibility:hidden;">&#8203;</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">The following table provides information about outstanding stock options held by each of our named executive officers at December 31, 2021. </p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><font style="font-size:8pt;visibility:hidden;">&#8203;</font></p><div align="left"><table style="border-collapse:collapse;font-size:16pt;height:max-content;padding-left:0pt;padding-right:0pt;width:100%;"><tr style="height:1pt;"><td style="vertical-align:bottom;width:7.71%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;"><font style="font-size:1pt;visibility:hidden;">&#8203;</font></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.54%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;"><font style="font-size:1pt;visibility:hidden;">&#8203;</font></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:11.1%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;"><font style="font-size:1pt;visibility:hidden;">&#8203;</font></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.49%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;"><font style="font-size:1pt;visibility:hidden;">&#8203;</font></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:13.25%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;"><font style="font-size:1pt;visibility:hidden;">&#8203;</font></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.99%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;"><font style="font-size:1pt;visibility:hidden;">&#8203;</font></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:14.75%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;"><font style="font-size:1pt;visibility:hidden;">&#8203;</font></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.99%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;"><font style="font-size:1pt;visibility:hidden;">&#8203;</font></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:7.64%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;"><font style="font-size:1pt;visibility:hidden;">&#8203;</font></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.49%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;"><font style="font-size:1pt;visibility:hidden;">&#8203;</font></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:9.61%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;"><font style="font-size:1pt;visibility:hidden;">&#8203;</font></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.92%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;"><font style="font-size:1pt;visibility:hidden;">&#8203;</font></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:9.6%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;"><font style="font-size:1pt;visibility:hidden;">&#8203;</font></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.49%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;"><font style="font-size:1pt;visibility:hidden;">&#8203;</font></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:12.35%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;"><font style="font-size:1pt;visibility:hidden;">&#8203;</font></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.99%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;"><font style="font-size:1pt;visibility:hidden;">&#8203;</font></p></div></div></td></tr><tr><td style="vertical-align:bottom;width:7.71%;border-left:1px solid #000000;border-right:1px solid #000000;border-top:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;"><font style="font-size:7pt;visibility:hidden;">&#8203;</font></p></td><td colspan="10" style="vertical-align:middle;white-space:nowrap;width:64.91%;border-bottom:1px solid #000000;border-left:1px solid #000000;border-right:1px solid #000000;border-top:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">OPTION AWARDS</b></p></td><td colspan="5" style="vertical-align:middle;white-space:nowrap;width:27.37%;border-bottom:1px solid #000000;border-left:1px solid #000000;border-right:1px solid #000000;border-top:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">STOCK AWARDS</b></p></td></tr><tr><td style="vertical-align:bottom;width:7.71%;border-left:1px solid #000000;border-right:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;"><font style="font-size:7pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.54%;border-left:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;"><font style="font-size:7pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.1%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;"><font style="font-size:7pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.49%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;"><font style="font-size:7pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:13.25%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;"><font style="font-size:7pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.99%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><font style="font-size:7pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:14.75%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">EQUITY INCENTIVE</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.99%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><font style="font-size:7pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;"><font style="font-size:7pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.49%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;"><font style="font-size:7pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.61%;border-right:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;"><font style="font-size:7pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.92%;border-left:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;"><font style="font-size:7pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.6%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;"><font style="font-size:7pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.49%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;"><font style="font-size:7pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.35%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;"><font style="font-size:7pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.99%;border-right:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><font style="font-size:7pt;visibility:hidden;">&#8203;</font></p></td></tr><tr><td style="vertical-align:bottom;width:7.71%;border-left:1px solid #000000;border-right:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;"><font style="font-size:7pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.54%;border-left:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;"><font style="font-size:7pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.1%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;"><font style="font-size:7pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.49%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;"><font style="font-size:7pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:13.25%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;"><font style="font-size:7pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.99%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><font style="font-size:7pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:14.75%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">PLAN AWARS:</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.99%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><font style="font-size:7pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;"><font style="font-size:7pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.49%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;"><font style="font-size:7pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.61%;border-right:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;"><font style="font-size:7pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.92%;border-left:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;"><font style="font-size:7pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.6%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;"><font style="font-size:7pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.49%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;"><font style="font-size:7pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.35%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;"><font style="font-size:7pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.99%;border-right:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><font style="font-size:7pt;visibility:hidden;">&#8203;</font></p></td></tr><tr><td style="vertical-align:bottom;width:7.71%;border-left:1px solid #000000;border-right:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><font style="font-size:7pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.54%;border-left:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.1%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><font style="font-size:7pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.49%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:13.25%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><font style="font-size:7pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.99%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:14.75%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">NUMBER&#160;OF</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.99%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><font style="font-size:7pt;font-weight:bold;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><font style="font-size:7pt;font-weight:bold;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.49%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.61%;border-right:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><font style="font-size:7pt;font-weight:bold;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.92%;border-left:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.6%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">NUMBER&#160;OF</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.49%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;"><font style="font-size:7pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.35%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">MARKET VALUE</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.99%;border-right:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td></tr><tr><td style="vertical-align:bottom;width:7.71%;border-left:1px solid #000000;border-right:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;"><font style="font-size:7pt;font-weight:bold;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.54%;border-left:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><font style="font-size:7pt;font-weight:bold;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.1%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">NUMBER&#160;OF</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.49%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><font style="font-size:7pt;font-weight:bold;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:13.25%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">NUMBER&#160;OF</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.99%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><font style="font-size:7pt;font-weight:bold;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:14.75%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">SECURITIES</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.99%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><font style="font-size:7pt;font-weight:bold;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><font style="font-size:7pt;font-weight:bold;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.49%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><font style="font-size:7pt;font-weight:bold;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.61%;border-right:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><font style="font-size:7pt;font-weight:bold;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.92%;border-left:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.6%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">SHARES</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.49%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.35%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">OF SHARES</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.99%;border-right:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><font style="font-size:7pt;font-weight:bold;visibility:hidden;">&#8203;</font></p></td></tr><tr><td style="vertical-align:bottom;width:7.71%;border-left:1px solid #000000;border-right:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;"><font style="font-size:7pt;font-weight:bold;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.54%;border-left:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><font style="font-size:7pt;font-weight:bold;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.1%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">SECURITIES</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.49%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><font style="font-size:7pt;font-weight:bold;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:13.25%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">SECURITIES</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.99%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><font style="font-size:7pt;font-weight:bold;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:14.75%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">UNDERLYING</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.99%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><font style="font-size:7pt;font-weight:bold;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><font style="font-size:7pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.49%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><font style="font-size:7pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.61%;border-right:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><font style="font-size:7pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.92%;border-left:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.6%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">OR UNITS</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.49%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><font style="font-size:7pt;font-weight:bold;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.35%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">OR UNITS OF </b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.99%;border-right:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><font style="font-size:7pt;font-weight:bold;visibility:hidden;">&#8203;</font></p></td></tr><tr><td style="vertical-align:bottom;width:7.71%;border-left:1px solid #000000;border-right:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;"><font style="font-size:7pt;font-weight:bold;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.54%;border-left:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><font style="font-size:7pt;font-weight:bold;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.1%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">UNDERLYING</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.49%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><font style="font-size:7pt;font-weight:bold;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:13.25%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">UNDERLYING</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.99%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><font style="font-size:7pt;font-weight:bold;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:14.75%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">UNEXERCISED</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.99%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><font style="font-size:7pt;font-weight:bold;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">OPTION</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.49%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><font style="font-size:7pt;font-weight:bold;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.61%;border-right:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><font style="font-size:7pt;font-weight:bold;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.92%;border-left:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.6%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">OF STOCK </b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.49%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><font style="font-size:7pt;font-weight:bold;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.35%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">STOCK THAT</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.99%;border-right:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><font style="font-size:7pt;font-weight:bold;visibility:hidden;">&#8203;</font></p></td></tr><tr><td style="vertical-align:bottom;width:7.71%;border-left:1px solid #000000;border-right:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;"><font style="font-size:7pt;font-weight:bold;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.54%;border-left:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><font style="font-size:7pt;font-weight:bold;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.1%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">UNEXERCISED</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.49%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><font style="font-size:7pt;font-weight:bold;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:13.25%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">UNEXERCISED</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.99%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><font style="font-size:7pt;font-weight:bold;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:14.75%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">UNEARNED</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.99%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><font style="font-size:7pt;font-weight:bold;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">EXERCISE</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.49%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><font style="font-size:7pt;font-weight:bold;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.61%;border-right:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">OPTION</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.92%;border-left:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><font style="font-size:7pt;font-weight:bold;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.6%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">THAT HAVE</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.49%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><font style="font-size:7pt;font-weight:bold;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.35%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">HAVE NOT</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.99%;border-right:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><font style="font-size:7pt;font-weight:bold;visibility:hidden;">&#8203;</font></p></td></tr><tr><td style="vertical-align:bottom;width:7.71%;border-left:1px solid #000000;border-right:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;"><font style="font-size:7pt;font-weight:bold;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.54%;border-left:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><font style="font-size:7pt;font-weight:bold;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.1%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">OPTIONS&#160;(#)</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.49%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><font style="font-size:7pt;font-weight:bold;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:13.25%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">OPTIONS&#160;(#)</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.99%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><font style="font-size:7pt;font-weight:bold;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:14.75%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">OPTIONS&#160;(#)</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.99%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><font style="font-size:7pt;font-weight:bold;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">PRICE</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.49%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><font style="font-size:7pt;font-weight:bold;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.61%;border-right:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">EXPIRATION</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.92%;border-left:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.6%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">NOT VESTED</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.49%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><font style="font-size:7pt;font-weight:bold;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.35%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">VESTED (2)</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.99%;border-right:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><font style="font-size:7pt;font-weight:bold;visibility:hidden;">&#8203;</font></p></td></tr><tr><td style="vertical-align:bottom;width:7.71%;border-bottom:1px solid #000000;border-left:1px solid #000000;border-right:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;text-align:justify;margin:0pt;"><b style="font-weight:bold;">NAME</b>&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.54%;border-bottom:1px solid #000000;border-left:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><font style="font-size:7pt;font-weight:bold;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.1%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">EXERCISABLE</b>&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.49%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><font style="font-size:7pt;font-weight:bold;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:13.25%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">UNEXERCISABLE</b>&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.99%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><font style="font-size:7pt;font-weight:bold;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:14.75%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">UNEXERCISABLE</b>&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.99%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><font style="font-size:7pt;font-weight:bold;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.64%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">($)</b>&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.49%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><font style="font-size:7pt;font-weight:bold;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.61%;border-bottom:1px solid #000000;border-right:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">DATE</b>&#160;<b style="font-weight:bold;">(1)</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.92%;border-bottom:1px solid #000000;border-left:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.6%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">(#)</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.49%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><font style="font-size:7pt;font-weight:bold;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.35%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">($)</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.99%;border-bottom:1px solid #000000;border-right:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><font style="font-size:7pt;font-weight:bold;visibility:hidden;">&#8203;</font></p></td></tr><tr><td style="vertical-align:bottom;width:7.71%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:justify;margin:0pt;">Harout Semerjian</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.54%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><font style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.1%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:right;margin:0pt 2.4pt 0pt 0pt;"><font style="white-space:pre-wrap;"> &#8212;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.49%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><font style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:13.25%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:right;margin:0pt 2.4pt 0pt 0pt;"><font style="white-space:pre-wrap;"> 1,098,400</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.99%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;">(3)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:14.75%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:right;margin:0pt;"> <font style="visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.99%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><font style="font-size:8pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:right;margin:0pt 2.4pt 0pt 0pt;"><font style="white-space:pre-wrap;"> 2.03</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.49%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><font style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.61%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:right;margin:0pt 2.4pt 0pt 0pt;">08/02/2031</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.92%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><font style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.6%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"><font style="font-size:8pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.49%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"><font style="font-size:8pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.35%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"><font style="font-size:8pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.99%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><font style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</font></p></td></tr><tr><td style="vertical-align:bottom;width:7.71%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;"><font style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.54%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><font style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.1%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:right;margin:0pt 2.4pt 0pt 0pt;"><font style="white-space:pre-wrap;"> &#8212;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.49%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><font style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:13.25%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:right;margin:0pt;"> <font style="visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.99%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"> <font style="visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:14.75%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:right;margin:0pt 2.4pt 0pt 0pt;"><font style="white-space:pre-wrap;"> 549,200</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.99%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;">(4)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:right;margin:0pt 2.4pt 0pt 0pt;"><font style="white-space:pre-wrap;"> 2.03</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.49%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><font style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.61%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:right;margin:0pt 2.4pt 0pt 0pt;">08/02/2031</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.92%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><font style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.6%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"><font style="font-size:8pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.49%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"><font style="font-size:8pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.35%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"><font style="font-size:8pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.99%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><font style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</font></p></td></tr><tr><td style="vertical-align:bottom;width:7.71%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:justify;margin:0pt;">Rachel King</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.54%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:justify;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.1%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:right;margin:0pt 2.4pt 0pt 0pt;"><font style="white-space:pre-wrap;"> 375,639</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.49%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:justify;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:13.25%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:right;margin:0pt 2.4pt 0pt 0pt;"><font style="white-space:pre-wrap;"> &#8212;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.99%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><font style="font-size:8pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:14.75%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"><font style="font-size:8pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.99%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><font style="font-size:8pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:right;margin:0pt 2.4pt 0pt 0pt;"><font style="white-space:pre-wrap;"> 8.00</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.49%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:justify;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.61%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:right;margin:0pt 2.4pt 0pt 0pt;">01/09/2024</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.92%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;"><font style="font-size:8pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.6%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"><font style="font-size:8pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.49%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"><font style="font-size:8pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.35%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"><font style="font-size:8pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.99%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;">&#160;</p></td></tr><tr><td style="vertical-align:bottom;width:7.71%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;"><font style="font-size:8pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.54%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:justify;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.1%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:right;margin:0pt 2.4pt 0pt 0pt;"><font style="white-space:pre-wrap;"> 141,000</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.49%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:justify;margin:0pt;"> <font style="visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:13.25%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:right;margin:0pt 2.4pt 0pt 0pt;"><font style="white-space:pre-wrap;"> &#8212;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.99%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><font style="font-size:8pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:14.75%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"><font style="font-size:8pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.99%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><font style="font-size:8pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:right;margin:0pt 2.4pt 0pt 0pt;"><font style="white-space:pre-wrap;"> 7.15</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.49%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:justify;margin:0pt;"> <font style="visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.61%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:right;margin:0pt 2.4pt 0pt 0pt;">01/07/2025</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.92%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;"><font style="font-size:8pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.6%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"><font style="font-size:8pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.49%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"><font style="font-size:8pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.35%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"><font style="font-size:8pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.99%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"> <font style="visibility:hidden;">&#8203;</font></p></td></tr><tr><td style="vertical-align:bottom;width:7.71%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;"><font style="font-size:8pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.54%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;"><font style="font-size:8pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.1%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:right;margin:0pt 2.4pt 0pt 0pt;"><font style="white-space:pre-wrap;"> 141,000</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.49%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;"><font style="font-size:8pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:13.25%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:right;margin:0pt 2.4pt 0pt 0pt;"><font style="white-space:pre-wrap;"> &#8212;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.99%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"> <font style="visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:14.75%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"><font style="font-size:8pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.99%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><font style="font-size:8pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:right;margin:0pt 2.4pt 0pt 0pt;"><font style="white-space:pre-wrap;"> 5.22</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.49%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;"><font style="font-size:8pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.61%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:right;margin:0pt 2.4pt 0pt 0pt;">01/06/2026</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.92%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;"><font style="font-size:8pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.6%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"><font style="font-size:8pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.49%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"><font style="font-size:8pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.35%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"><font style="font-size:8pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.99%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><font style="font-size:8pt;visibility:hidden;">&#8203;</font></p></td></tr><tr><td style="vertical-align:bottom;width:7.71%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;"><font style="font-size:8pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.54%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;"><font style="font-size:8pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.1%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:right;margin:0pt 2.4pt 0pt 0pt;"><font style="white-space:pre-wrap;"> 175,000</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.49%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;"><font style="font-size:8pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:13.25%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:right;margin:0pt 2.4pt 0pt 0pt;"><font style="white-space:pre-wrap;"> &#8212;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.99%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"> <font style="visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:14.75%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"><font style="font-size:8pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.99%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><font style="font-size:8pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:right;margin:0pt 2.4pt 0pt 0pt;"><font style="white-space:pre-wrap;"> 6.33</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.49%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;"><font style="font-size:8pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.61%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:right;margin:0pt 2.4pt 0pt 0pt;">01/03/2027</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.92%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;"><font style="font-size:8pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.6%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"><font style="font-size:8pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.49%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"><font style="font-size:8pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.35%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"><font style="font-size:8pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.99%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><font style="font-size:8pt;visibility:hidden;">&#8203;</font></p></td></tr><tr><td style="vertical-align:bottom;width:7.71%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;"><font style="font-size:8pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.54%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;"><font style="font-size:8pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.1%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:right;margin:0pt 2.4pt 0pt 0pt;"><font style="white-space:pre-wrap;"> 171,355</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.49%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;"><font style="font-size:8pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:13.25%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:right;margin:0pt 2.4pt 0pt 0pt;"><font style="white-space:pre-wrap;"> 3,645</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.99%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;">(5)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:14.75%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"><font style="font-size:8pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.99%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><font style="font-size:8pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:right;margin:0pt 2.4pt 0pt 0pt;"><font style="white-space:pre-wrap;"> 20.03</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.49%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;"><font style="font-size:8pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.61%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:right;margin:0pt 2.4pt 0pt 0pt;">01/09/2028</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.92%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;"><font style="font-size:8pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.6%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"><font style="font-size:8pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.49%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"><font style="font-size:8pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.35%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"><font style="font-size:8pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.99%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><font style="font-size:8pt;visibility:hidden;">&#8203;</font></p></td></tr><tr><td style="vertical-align:bottom;width:7.71%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;"><font style="font-size:8pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.54%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;"><font style="font-size:8pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.1%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:right;margin:0pt 2.4pt 0pt 0pt;"><font style="white-space:pre-wrap;"> 193,230</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.49%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;"><font style="font-size:8pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:13.25%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:right;margin:0pt 2.4pt 0pt 0pt;"><font style="white-space:pre-wrap;"> 71,770</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.99%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;">(6)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:14.75%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"><font style="font-size:8pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.99%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><font style="font-size:8pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:right;margin:0pt 2.4pt 0pt 0pt;"><font style="white-space:pre-wrap;"> 10.59</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.49%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;"><font style="font-size:8pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.61%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:right;margin:0pt 2.4pt 0pt 0pt;">01/16/2029</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.92%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;"><font style="font-size:8pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.6%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"><font style="font-size:8pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.49%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"><font style="font-size:8pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.35%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"><font style="font-size:8pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.99%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><font style="font-size:8pt;visibility:hidden;">&#8203;</font></p></td></tr><tr><td style="vertical-align:bottom;width:7.71%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;"><font style="font-size:8pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.54%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;"><font style="font-size:8pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.1%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:right;margin:0pt 2.4pt 0pt 0pt;"><font style="white-space:pre-wrap;"> 167,230</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.49%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;"><font style="font-size:8pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:13.25%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:right;margin:0pt 2.4pt 0pt 0pt;"><font style="white-space:pre-wrap;"> 181,770</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.99%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;">(7)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:14.75%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"><font style="font-size:8pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.99%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><font style="font-size:8pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:right;margin:0pt 2.4pt 0pt 0pt;"><font style="white-space:pre-wrap;"> 4.72</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.49%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;"><font style="font-size:8pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.61%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:right;margin:0pt 2.4pt 0pt 0pt;">01/21/2030</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.92%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;"><font style="font-size:8pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.6%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"><font style="font-size:8pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.49%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"><font style="font-size:8pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.35%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"><font style="font-size:8pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.99%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><font style="font-size:8pt;visibility:hidden;">&#8203;</font></p></td></tr><tr><td style="vertical-align:bottom;width:7.71%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;"><font style="font-size:8pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.54%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;"><font style="font-size:8pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.1%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:right;margin:0pt 2.4pt 0pt 0pt;"><font style="white-space:pre-wrap;"> &#8212;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.49%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;"><font style="font-size:8pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:13.25%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:right;margin:0pt 2.4pt 0pt 0pt;"><font style="white-space:pre-wrap;"> 192,500</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.99%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;">(8)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:14.75%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"><font style="font-size:8pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.99%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><font style="font-size:8pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:right;margin:0pt 2.4pt 0pt 0pt;"><font style="white-space:pre-wrap;"> 3.81</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.49%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;"><font style="font-size:8pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.61%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:right;margin:0pt 2.4pt 0pt 0pt;">01/19/2031</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.92%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;"><font style="font-size:8pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.6%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"><font style="font-size:8pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.49%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"><font style="font-size:8pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.35%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"><font style="font-size:8pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.99%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><font style="font-size:8pt;visibility:hidden;">&#8203;</font></p></td></tr><tr><td style="vertical-align:bottom;width:7.71%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;"><font style="font-size:8pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.54%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;"><font style="font-size:8pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.1%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:right;margin:0pt;"> <font style="visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.49%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;"><font style="font-size:8pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:13.25%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:right;margin:0pt;"> <font style="visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.99%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"> <font style="visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:14.75%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"><font style="font-size:8pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.99%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><font style="font-size:8pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:right;margin:0pt;"> <font style="visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.49%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;"><font style="font-size:8pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.61%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:right;margin:0pt;"> <font style="visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.92%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;"><font style="font-size:8pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.6%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:right;margin:0pt 2.4pt 0pt 0pt;"><font style="white-space:pre-wrap;"> 96,250</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.49%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;"><font style="font-size:8pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.35%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:right;margin:0pt 2.4pt 0pt 0pt;"><font style="white-space:pre-wrap;"> 138,600</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.99%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;">(9)</p></td></tr><tr><td style="vertical-align:bottom;width:7.71%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:justify;margin:0pt;">Brian Hahn</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.54%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:justify;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.1%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:right;margin:0pt 2.4pt 0pt 0pt;"><font style="white-space:pre-wrap;"> 73,859</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.49%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:justify;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:13.25%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:right;margin:0pt 2.4pt 0pt 0pt;"><font style="white-space:pre-wrap;"> &#8212;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.99%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"> <font style="visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:14.75%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"><font style="font-size:8pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.99%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><font style="font-size:8pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:right;margin:0pt 2.4pt 0pt 0pt;"><font style="white-space:pre-wrap;"> 1.98</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.49%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:justify;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.61%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:right;margin:0pt 2.4pt 0pt 0pt;">03/20/2022</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.92%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;"><font style="font-size:8pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.6%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"><font style="font-size:8pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.49%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"><font style="font-size:8pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.35%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"><font style="font-size:8pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.99%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;">&#160;</p></td></tr><tr><td style="vertical-align:bottom;width:7.71%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;"><font style="font-size:8pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.54%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:justify;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.1%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:right;margin:0pt 2.4pt 0pt 0pt;"><font style="white-space:pre-wrap;"> 37,564</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.49%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:justify;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:13.25%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:right;margin:0pt 2.4pt 0pt 0pt;"><font style="white-space:pre-wrap;"> &#8212;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.99%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><font style="font-size:8pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:14.75%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"><font style="font-size:8pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.99%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><font style="font-size:8pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:right;margin:0pt 2.4pt 0pt 0pt;"><font style="white-space:pre-wrap;"> 8.00</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.49%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:justify;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.61%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:right;margin:0pt 2.4pt 0pt 0pt;">01/09/2024</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.92%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;"><font style="font-size:8pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.6%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"><font style="font-size:8pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.49%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"><font style="font-size:8pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.35%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"><font style="font-size:8pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.99%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;">&#160;</p></td></tr><tr><td style="vertical-align:bottom;width:7.71%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;"><font style="font-size:8pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.54%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:justify;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.1%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:right;margin:0pt 2.4pt 0pt 0pt;"><font style="white-space:pre-wrap;"> 61,000</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.49%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:justify;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:13.25%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:right;margin:0pt 2.4pt 0pt 0pt;"><font style="white-space:pre-wrap;"> &#8212;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.99%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><font style="font-size:8pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:14.75%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"><font style="font-size:8pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.99%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><font style="font-size:8pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:right;margin:0pt 2.4pt 0pt 0pt;"><font style="white-space:pre-wrap;"> 7.15</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.49%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:justify;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.61%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:right;margin:0pt 2.4pt 0pt 0pt;">01/07/2025</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.92%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;"><font style="font-size:8pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.6%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"><font style="font-size:8pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.49%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"><font style="font-size:8pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.35%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"><font style="font-size:8pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.99%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;">&#160;</p></td></tr><tr><td style="vertical-align:bottom;width:7.71%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;"><font style="font-size:8pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.54%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;"><font style="font-size:8pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.1%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:right;margin:0pt 2.4pt 0pt 0pt;"><font style="white-space:pre-wrap;"> 65,000</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.49%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;"><font style="font-size:8pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:13.25%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:right;margin:0pt 2.4pt 0pt 0pt;"><font style="white-space:pre-wrap;"> &#8212;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.99%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><font style="font-size:8pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:14.75%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"><font style="font-size:8pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.99%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><font style="font-size:8pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:right;margin:0pt 2.4pt 0pt 0pt;"><font style="white-space:pre-wrap;"> 5.22</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.49%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;"><font style="font-size:8pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.61%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:right;margin:0pt 2.4pt 0pt 0pt;">01/06/2026</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.92%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;"><font style="font-size:8pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.6%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"><font style="font-size:8pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.49%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"><font style="font-size:8pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.35%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"><font style="font-size:8pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.99%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><font style="font-size:8pt;visibility:hidden;">&#8203;</font></p></td></tr><tr><td style="vertical-align:bottom;width:7.71%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;"><font style="font-size:8pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.54%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;"><font style="font-size:8pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.1%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:right;margin:0pt 2.4pt 0pt 0pt;"><font style="white-space:pre-wrap;"> 65,000</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.49%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;"><font style="font-size:8pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:13.25%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:right;margin:0pt 2.4pt 0pt 0pt;"><font style="white-space:pre-wrap;"> &#8212;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.99%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"> <font style="visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:14.75%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"><font style="font-size:8pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.99%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><font style="font-size:8pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:right;margin:0pt 2.4pt 0pt 0pt;"><font style="white-space:pre-wrap;"> 6.33</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.49%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;"><font style="font-size:8pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.61%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:right;margin:0pt 2.4pt 0pt 0pt;">01/03/2027</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.92%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;"><font style="font-size:8pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.6%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"><font style="font-size:8pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.49%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"><font style="font-size:8pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.35%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"><font style="font-size:8pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.99%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><font style="font-size:8pt;visibility:hidden;">&#8203;</font></p></td></tr><tr><td style="vertical-align:bottom;width:7.71%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;"><font style="font-size:8pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.54%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;"><font style="font-size:8pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.1%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:right;margin:0pt 2.4pt 0pt 0pt;"><font style="white-space:pre-wrap;"> 63,646</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.49%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;"><font style="font-size:8pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:13.25%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:right;margin:0pt 2.4pt 0pt 0pt;"><font style="white-space:pre-wrap;"> 1,354</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.99%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;">(5)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:14.75%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"><font style="font-size:8pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.99%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><font style="font-size:8pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:right;margin:0pt 2.4pt 0pt 0pt;"><font style="white-space:pre-wrap;"> 20.03</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.49%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;"><font style="font-size:8pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.61%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:right;margin:0pt 2.4pt 0pt 0pt;">01/09/2028</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.92%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;"><font style="font-size:8pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.6%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"><font style="font-size:8pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.49%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"><font style="font-size:8pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.35%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"><font style="font-size:8pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.99%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><font style="font-size:8pt;visibility:hidden;">&#8203;</font></p></td></tr><tr><td style="vertical-align:bottom;width:7.71%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;"><font style="font-size:8pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.54%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;"><font style="font-size:8pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.1%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:right;margin:0pt 2.4pt 0pt 0pt;"><font style="white-space:pre-wrap;"> 65,625</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.49%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;"><font style="font-size:8pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:13.25%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:right;margin:0pt 2.4pt 0pt 0pt;"><font style="white-space:pre-wrap;"> 24,375</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.99%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;">(6)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:14.75%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"><font style="font-size:8pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.99%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><font style="font-size:8pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:right;margin:0pt 2.4pt 0pt 0pt;"><font style="white-space:pre-wrap;"> 10.59</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.49%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;"><font style="font-size:8pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.61%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:right;margin:0pt 2.4pt 0pt 0pt;">01/16/2029</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.92%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;"><font style="font-size:8pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.6%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"><font style="font-size:8pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.49%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"><font style="font-size:8pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.35%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"><font style="font-size:8pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.99%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><font style="font-size:8pt;visibility:hidden;">&#8203;</font></p></td></tr><tr><td style="vertical-align:bottom;width:7.71%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:justify;margin:0pt;"> <font style="visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.54%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;"><font style="font-size:8pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.1%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:right;margin:0pt 2.4pt 0pt 0pt;"><font style="white-space:pre-wrap;"> 57,500</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.49%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;"><font style="font-size:8pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:13.25%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:right;margin:0pt 2.4pt 0pt 0pt;"><font style="white-space:pre-wrap;"> 62,500</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.99%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;">(7)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:14.75%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"><font style="font-size:8pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.99%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><font style="font-size:8pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:right;margin:0pt 2.4pt 0pt 0pt;"><font style="white-space:pre-wrap;"> 4.72</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.49%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;"><font style="font-size:8pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.61%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:right;margin:0pt 2.4pt 0pt 0pt;">01/21/2030</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.92%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;"><font style="font-size:8pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.6%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"><font style="font-size:8pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.49%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"><font style="font-size:8pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.35%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"><font style="font-size:8pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.99%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><font style="font-size:8pt;visibility:hidden;">&#8203;</font></p></td></tr><tr><td style="vertical-align:bottom;width:7.71%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;"><font style="font-size:8pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.54%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;"><font style="font-size:8pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.1%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:right;margin:0pt 2.4pt 0pt 0pt;"><font style="white-space:pre-wrap;"> &#8212;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.49%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;"><font style="font-size:8pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:13.25%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:right;margin:0pt 2.4pt 0pt 0pt;"><font style="white-space:pre-wrap;"> 69,000</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.99%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;">(8)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:14.75%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"><font style="font-size:8pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.99%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><font style="font-size:8pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:right;margin:0pt 2.4pt 0pt 0pt;"><font style="white-space:pre-wrap;"> 3.81</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.49%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;"><font style="font-size:8pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.61%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:right;margin:0pt 2.4pt 0pt 0pt;">01/19/2031</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.92%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;"><font style="font-size:8pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.6%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"><font style="font-size:8pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.49%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"><font style="font-size:8pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.35%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"><font style="font-size:8pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.99%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><font style="font-size:8pt;visibility:hidden;">&#8203;</font></p></td></tr><tr><td style="vertical-align:bottom;width:7.71%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;"><font style="font-size:8pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.54%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;"><font style="font-size:8pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.1%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:right;margin:0pt;"> <font style="visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.49%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;"><font style="font-size:8pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:13.25%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:right;margin:0pt;"> <font style="visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.99%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"> <font style="visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:14.75%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"><font style="font-size:8pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.99%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><font style="font-size:8pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:right;margin:0pt;"> <font style="visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.49%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;"><font style="font-size:8pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.61%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:right;margin:0pt;"> <font style="visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.92%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;"><font style="font-size:8pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.6%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:right;margin:0pt 2.4pt 0pt 0pt;"><font style="white-space:pre-wrap;"> 34,500</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.49%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:justify;margin:0pt;"> <font style="visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.35%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:right;margin:0pt 2.4pt 0pt 0pt;"><font style="white-space:pre-wrap;"> 49,680</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.99%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;">(9)</p></td></tr><tr><td style="vertical-align:bottom;width:7.71%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:justify;margin:0pt;">John Magnani, Ph.D.</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.54%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:justify;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.1%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:right;margin:0pt 2.4pt 0pt 0pt;"><font style="white-space:pre-wrap;"> 169,038</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.49%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:justify;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:13.25%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:right;margin:0pt 2.4pt 0pt 0pt;"><font style="white-space:pre-wrap;"> &#8212;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.99%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"> <font style="visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:14.75%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"><font style="font-size:8pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.99%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><font style="font-size:8pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:right;margin:0pt 2.4pt 0pt 0pt;"><font style="white-space:pre-wrap;"> 8.00</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.49%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:justify;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.61%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:right;margin:0pt 2.4pt 0pt 0pt;">01/09/2024</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.92%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;"><font style="font-size:8pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.6%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"><font style="font-size:8pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.49%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"><font style="font-size:8pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.35%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"><font style="font-size:8pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.99%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;">&#160;</p></td></tr><tr><td style="vertical-align:bottom;width:7.71%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;"><font style="font-size:8pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.54%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:justify;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.1%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:right;margin:0pt 2.4pt 0pt 0pt;"><font style="white-space:pre-wrap;"> 71,000</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.49%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:justify;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:13.25%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:right;margin:0pt 2.4pt 0pt 0pt;"><font style="white-space:pre-wrap;"> &#8212;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.99%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><font style="font-size:8pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:14.75%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"><font style="font-size:8pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.99%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><font style="font-size:8pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:right;margin:0pt 2.4pt 0pt 0pt;"><font style="white-space:pre-wrap;"> 7.15</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.49%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:justify;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.61%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:right;margin:0pt 2.4pt 0pt 0pt;">01/07/2025</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.92%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;"><font style="font-size:8pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.6%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"><font style="font-size:8pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.49%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"><font style="font-size:8pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.35%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"><font style="font-size:8pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.99%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;">&#160;</p></td></tr><tr><td style="vertical-align:bottom;width:7.71%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;"><font style="font-size:8pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.54%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;"><font style="font-size:8pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.1%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:right;margin:0pt 2.4pt 0pt 0pt;"><font style="white-space:pre-wrap;"> 71,000</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.49%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;"><font style="font-size:8pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:13.25%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:right;margin:0pt 2.4pt 0pt 0pt;"><font style="white-space:pre-wrap;"> &#8212;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.99%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><font style="font-size:8pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:14.75%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"><font style="font-size:8pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.99%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><font style="font-size:8pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:right;margin:0pt 2.4pt 0pt 0pt;"><font style="white-space:pre-wrap;"> 5.22</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.49%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;"><font style="font-size:8pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.61%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:right;margin:0pt 2.4pt 0pt 0pt;">01/06/2026</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.92%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;"><font style="font-size:8pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.6%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"><font style="font-size:8pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.49%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"><font style="font-size:8pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.35%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"><font style="font-size:8pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.99%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><font style="font-size:8pt;visibility:hidden;">&#8203;</font></p></td></tr><tr><td style="vertical-align:bottom;width:7.71%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;"><font style="font-size:8pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.54%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;"><font style="font-size:8pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.1%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:right;margin:0pt 2.4pt 0pt 0pt;"><font style="white-space:pre-wrap;"> 75,000</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.49%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;"><font style="font-size:8pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:13.25%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:right;margin:0pt 2.4pt 0pt 0pt;"><font style="white-space:pre-wrap;"> &#8212;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.99%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><font style="font-size:8pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:14.75%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"><font style="font-size:8pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.99%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><font style="font-size:8pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:right;margin:0pt 2.4pt 0pt 0pt;"><font style="white-space:pre-wrap;"> 6.33</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.49%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;"><font style="font-size:8pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.61%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:right;margin:0pt 2.4pt 0pt 0pt;">01/03/2027</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.92%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;"><font style="font-size:8pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.6%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"><font style="font-size:8pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.49%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"><font style="font-size:8pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.35%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"><font style="font-size:8pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.99%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><font style="font-size:8pt;visibility:hidden;">&#8203;</font></p></td></tr><tr><td style="vertical-align:bottom;width:7.71%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;"><font style="font-size:8pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.54%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;"><font style="font-size:8pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.1%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:right;margin:0pt 2.4pt 0pt 0pt;"><font style="white-space:pre-wrap;"> 73,438</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.49%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;"><font style="font-size:8pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:13.25%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:right;margin:0pt 2.4pt 0pt 0pt;"><font style="white-space:pre-wrap;"> 1,562</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.99%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;">(5)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:14.75%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"><font style="font-size:8pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.99%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><font style="font-size:8pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:right;margin:0pt 2.4pt 0pt 0pt;"><font style="white-space:pre-wrap;"> 20.03</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.49%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;"><font style="font-size:8pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.61%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:right;margin:0pt 2.4pt 0pt 0pt;">01/09/2028</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.92%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;"><font style="font-size:8pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.6%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"><font style="font-size:8pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.49%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"><font style="font-size:8pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.35%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"><font style="font-size:8pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.99%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><font style="font-size:8pt;visibility:hidden;">&#8203;</font></p></td></tr><tr><td style="vertical-align:bottom;width:7.71%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;"><font style="font-size:8pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.54%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;"><font style="font-size:8pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.1%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:right;margin:0pt 2.4pt 0pt 0pt;"><font style="white-space:pre-wrap;"> 72,917</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.49%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;"><font style="font-size:8pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:13.25%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:right;margin:0pt 2.4pt 0pt 0pt;"><font style="white-space:pre-wrap;"> 27,083</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.99%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;">(6)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:14.75%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"><font style="font-size:8pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.99%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><font style="font-size:8pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:right;margin:0pt 2.4pt 0pt 0pt;"><font style="white-space:pre-wrap;"> 10.59</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.49%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;"><font style="font-size:8pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.61%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:right;margin:0pt 2.4pt 0pt 0pt;">01/16/2029</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.92%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;"><font style="font-size:8pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.6%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"><font style="font-size:8pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.49%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"><font style="font-size:8pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.35%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"><font style="font-size:8pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.99%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><font style="font-size:8pt;visibility:hidden;">&#8203;</font></p></td></tr><tr><td style="vertical-align:bottom;width:7.71%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;"><font style="font-size:8pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.54%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;"><font style="font-size:8pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.1%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:right;margin:0pt 2.4pt 0pt 0pt;"><font style="white-space:pre-wrap;"> 57,500</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.49%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;"><font style="font-size:8pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:13.25%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:right;margin:0pt 2.4pt 0pt 0pt;"><font style="white-space:pre-wrap;"> 62,500</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.99%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;">(7)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:14.75%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"><font style="font-size:8pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.99%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><font style="font-size:8pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:right;margin:0pt 2.4pt 0pt 0pt;"><font style="white-space:pre-wrap;"> 4.72</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.49%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;"><font style="font-size:8pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.61%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:right;margin:0pt 2.4pt 0pt 0pt;">01/21/2030</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.92%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;"><font style="font-size:8pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.6%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"><font style="font-size:8pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.49%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"><font style="font-size:8pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.35%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"><font style="font-size:8pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.99%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><font style="font-size:8pt;visibility:hidden;">&#8203;</font></p></td></tr><tr><td style="vertical-align:bottom;width:7.71%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;"><font style="font-size:8pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.54%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;"><font style="font-size:8pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.1%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:right;margin:0pt 2.4pt 0pt 0pt;"><font style="white-space:pre-wrap;"> &#8212;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.49%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;"><font style="font-size:8pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:13.25%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:right;margin:0pt 2.4pt 0pt 0pt;"><font style="white-space:pre-wrap;"> 69,000</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.99%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;">(8)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:14.75%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"><font style="font-size:8pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.99%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><font style="font-size:8pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:right;margin:0pt 2.4pt 0pt 0pt;"><font style="white-space:pre-wrap;"> 3.81</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.49%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;"><font style="font-size:8pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.61%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:right;margin:0pt 2.4pt 0pt 0pt;">01/19/2031</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.92%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;"><font style="font-size:8pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.6%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"><font style="font-size:8pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.49%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"><font style="font-size:8pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.35%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"><font style="font-size:8pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.99%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><font style="font-size:8pt;visibility:hidden;">&#8203;</font></p></td></tr><tr><td style="vertical-align:bottom;width:7.71%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;"><font style="font-size:8pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.54%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;"><font style="font-size:8pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.1%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:right;margin:0pt;"> <font style="visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.49%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;"><font style="font-size:8pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:13.25%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:right;margin:0pt;"> <font style="visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.99%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"> <font style="visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:14.75%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"><font style="font-size:8pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.99%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><font style="font-size:8pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:right;margin:0pt;"> <font style="visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.49%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;"><font style="font-size:8pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.61%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:right;margin:0pt;"> <font style="visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.92%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;"><font style="font-size:8pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.6%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:right;margin:0pt 2.4pt 0pt 0pt;"><font style="white-space:pre-wrap;"> 34,500</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.49%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:justify;margin:0pt;"> <font style="visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.35%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:right;margin:0pt 2.4pt 0pt 0pt;"><font style="white-space:pre-wrap;"> 49,680</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.99%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;">(9)</p></td></tr></table></div><div style="font-family:'Times New Roman','Times','serif';font-size:1.0pt;margin-bottom:0pt;margin-top:0pt;min-height:1.19em;position:relative;width:100%;"><hr noshade="true" color="#000000" size="1" width="25.0%" style="background-color:#000000;color:#000000;height:1pt;position:relative;top:0.6em;border:none;margin:0pt;" align="left"></div><table border="0" cellpadding="0" cellspacing="0" style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="font-family:'Times New Roman','Times','serif';font-size:9pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">(1)</td><td style="padding:0pt;"><font style="font-family:'Times New Roman','Times','serif';font-size:9pt;font-style:normal;font-weight:normal;">In each case the option expiration date is ten years after the date of grant.</font></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="font-family:'Times New Roman','Times','serif';font-size:9pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">(2)</td><td style="padding:0pt;"><font style="font-family:'Times New Roman','Times','serif';font-size:9pt;font-style:normal;font-weight:normal;">Market value of restricted stock units that have not vested was determined by multiplying the number of shares by $1.44, the closing price of our common stock on December 31, 2021.</font></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="font-family:'Times New Roman','Times','serif';font-size:9pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">(3)</td><td style="padding:0pt;"><font style="font-family:'Times New Roman','Times','serif';font-size:9pt;font-style:normal;font-weight:normal;">25% of the total shares underlying this option will vest on August 1, 2022, and the remaining shares will vest 1/36th monthly through August 1, 2025, in each case subject to the officer&#8217;s continued service through the applicable vesting date.</font></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="font-family:'Times New Roman','Times','serif';font-size:9pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">(4)</td><td style="padding:0pt;"><font style="font-family:'Times New Roman','Times','serif';font-size:9pt;font-style:normal;font-weight:normal;">This option will vest upon achievement of specified development and commercialization milestones, as described above under &#8220;Executive Compensation Process and Narrative to Summary Compensation Table&#8212;Long-Term Incentives.&#8221;</font></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="font-family:'Times New Roman','Times','serif';font-size:9pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">(5)</td><td style="padding:0pt;"><font style="font-family:'Times New Roman','Times','serif';font-size:9pt;font-style:normal;font-weight:normal;">25% of the total shares underlying this option vested on January 10, 2019. The remaining shares vested 1/36th monthly through January&#160;10, 2022. </font></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="font-family:'Times New Roman','Times','serif';font-size:9pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">(6)</td><td style="padding:0pt;"><font style="font-family:'Times New Roman','Times','serif';font-size:9pt;font-style:normal;font-weight:normal;">25% of the total shares underlying this option vested on January 17, 2020. The remaining shares vest 1/36th monthly through January&#160;17, 2023, subject to the officer&#8217;s continued service through each applicable vesting date.</font></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="font-family:'Times New Roman','Times','serif';font-size:9pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">(7)</td><td style="padding:0pt;"><font style="font-family:'Times New Roman','Times','serif';font-size:9pt;font-style:normal;font-weight:normal;">25% of the total shares underlying this option vested on January 22, 2021. The remaining shares vest 1/36th monthly through January&#160;22, 2024, subject to the officer&#8217;s continued service through each applicable vesting date.</font></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="font-family:'Times New Roman','Times','serif';font-size:9pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">(8)</td><td style="padding:0pt;"><font style="font-family:'Times New Roman','Times','serif';font-size:9pt;font-style:normal;font-weight:normal;">25% of the total shares underlying this option vested on January 20, 2022. The remaining shares vest 1/36th monthly through January&#160;20, 2025, subject to the officer&#8217;s continued service through each applicable vesting date.</font></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="font-family:'Times New Roman','Times','serif';font-size:9pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">(9)</td><td style="padding:0pt;"><font style="font-family:'Times New Roman','Times','serif';font-size:9pt;font-style:normal;font-weight:normal;">25% of these restricted stock units vested on January 20, 2022. The remaining shares vest in three annual installments on each of January 20, 2023, 2024 and 2025, subject to the officer&#8217;s continuous service as of each such vesting date.</font></td></tr></table></div><div style="clear:both;display:table;margin-bottom:27.35pt;min-height:44.65pt;width:100%;"><div style="display:table-cell;vertical-align:bottom;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;min-height:12.0pt;text-align:center;margin:24pt 0pt 0pt 0pt;">44</p></div></div></div><hr style="background-color:#000000;clear:both;color:#000000;height:2pt;line-height:0;margin-bottom:30pt;margin-left:11.76%;margin-right:11.76%;margin-top:30pt;page-break-after:always;width:76.47%;border-width:0;"><div style="max-width:100%;padding-left:11.76%;padding-right:11.76%;position:relative;"><div style="margin-top:27.35pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"><font style="font-weight:bold;visibility:hidden;">&#8203;</font></p></div><div style="clear:both;max-width:100%;position:relative;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><b style="font-weight:bold;">Pension Benefits and Nonqualified Deferred Compensation </b></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Our named executive officers did not participate in, or otherwise receive any benefits under, any pension plan or nonqualified deferred compensation plan sponsored by us during 2021. </p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><font style="font-weight:bold;visibility:hidden;">&#8203;</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><b style="font-weight:bold;">Employment Agreements and Potential Payments upon Termination of Employment or upon Change in Control </b></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><font style="font-weight:bold;visibility:hidden;">&#8203;</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Pursuant to their employment agreements with us, each named executive officer other than Ms. King is eligible for severance benefits in specified circumstances. Under the terms of the agreements, upon execution and effectiveness of a severance agreement and release of claims, each such named executive officer will be entitled to severance payments if we terminate his employment without cause, or he terminates employment with us for good reason. </p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><font style="white-space:pre-wrap;">Ms. King retired in August 2021 and was not eligible for post-termination payments under her employment agreement with us. We and Ms. King entered into a consulting agreement under which she will continue to provide services to us, up to 20 hours per week, through August 31, 2022.  In consideration for such services, Ms. King will receive a monthly consulting fee. Following her retirement, Ms. King will continue to serve on the Board, which constitutes &#8220;continuous service&#8221; under our equity incentive plan for purposes of continued vesting of her stock options.     </font></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">The following definitions have been adopted in the current employment agreements with our named executive officers: </p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p><table border="0" cellpadding="0" cellspacing="0" style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"></td><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><font style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">&#8220;cause&#8221; means that we have determined in our sole discretion that any of the following occurred: (a) the executive officer&#8217;s breach of fiduciary duty or substantial misconduct with respect to our business and affairs, (b) the executive officer&#8217;s neglect of duties or failure to act which can reasonably be expected to materially adversely affect our business or affairs, (c) the executive officer&#8217;s material breach of the employment agreement, or of any provision of the proprietary information, assignment of inventions, noncompetition and nonsolicitation agreement to which the executive is a party which, to the extent curable, is not cured within 15 days after written notice thereof is given to the executive officer, (d) the commission by the executive officer of an act involving moral turpitude or fraud, (e) the executive officer&#8217;s conviction of any felony, or of any misdemeanor involving fraud, theft, embezzlement, forgery or moral turpitude, (f) other conduct by the executive officer that is materially harmful to our business or reputation, including but not limited to conduct found to be in violation of our policies prohibiting harassment or discrimination, or (g) the expiration of the employment agreement; </font></td></tr></table><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;padding-left:18pt;text-indent:-18pt;margin:0pt 0pt 0pt 18pt;"><font style="margin-left:0pt;visibility:hidden;">&#8203;</font></p><table border="0" cellpadding="0" cellspacing="0" style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"></td><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><font style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">&#8220;good reason&#8221; means any of the following without the executive officer&#8217;s prior written consent: (a) any material diminution of the executive officer&#8217;s duties or responsibilities under the employment agreement (except in each case in connection with a termination for cause or as a result of the executive officer&#8217;s death or disability), or the assignment to the executive officer of duties or responsibilities that are materially inconsistent with the executive officer&#8217;s then-current position, with the exception of certain situations involving the acquisition of the Company; (b) a reduction of at least 10% of the executive&#8217;s base salary unless pursuant to a salary reduction program applicable generally to similarly-situated employees; (c) any material breach of the employment agreement by us which we have not cured within 15 business days after written notice thereof is given to us; or (d) a relocation of the executive officer from our principal office to a location more than 35 miles from the location of our principal office, other than on required travel by the executive officer on business or on a temporary basis not to exceed a period equal to two calendar months; and </font></td></tr></table><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;padding-left:18pt;text-indent:-18pt;margin:0pt 0pt 0pt 18pt;"><font style="margin-left:0pt;visibility:hidden;">&#8203;</font></p><table border="0" cellpadding="0" cellspacing="0" style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"></td><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><font style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">&#8220;change in control&#8221; means any of the following: (a) a sale, lease, exchange or other transfer in one transaction or a series of related transactions of all or substantially all of our assets, other than the transfer of our assets to a majority-owned subsidiary corporation; (b) a merger or consolidation in which we are not the surviving corporation, unless the holders of our outstanding voting stock immediately prior to such transaction own, immediately after such transaction, securities representing at least 50% of the voting power of the corporation or other entity surviving such transaction; (c) a reverse merger in which we are the surviving corporation but the shares of our common stock outstanding immediately preceding the </font></td></tr></table></div><div style="clear:both;display:table;margin-bottom:27.35pt;min-height:44.65pt;width:100%;"><div style="display:table-cell;vertical-align:bottom;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;min-height:12.0pt;text-align:center;margin:24pt 0pt 0pt 0pt;">45</p></div></div></div><hr style="background-color:#000000;clear:both;color:#000000;height:2pt;line-height:0;margin-bottom:30pt;margin-left:11.76%;margin-right:11.76%;margin-top:30pt;page-break-after:always;width:76.47%;border-width:0;"><div style="max-width:100%;padding-left:11.76%;padding-right:11.76%;position:relative;"><div style="margin-top:27.35pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"><font style="font-weight:bold;visibility:hidden;">&#8203;</font></p></div><div style="clear:both;max-width:100%;position:relative;"><table border="0" cellpadding="0" cellspacing="0" style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"></td><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;"></td><td style="padding:0pt;"><font style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">merger are converted by virtue of the merger into other property, whether in the form of securities, cash or otherwise, unless the holders of our outstanding voting stock immediately prior to such transaction own, immediately after such transaction, securities representing at least 50% of our voting power; or (d) any transaction or series of related transactions in which in excess of 50% of our voting power is transferred; provided that, where required to avoid additional taxation under Section 409A of the Internal Revenue Code, the event that occurs must also be a &#8220;change in the ownership or effective control of a corporation, or a change in the ownership of a substantial portion of the assets of a corporation&#8221; as defined under applicable regulations. </font></td></tr></table><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">The following table summarizes the schedule of severance payments each of our named executive officers would receive in the event of a qualifying termination. </p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p><div align="left"><table style="border-collapse:collapse;font-size:16pt;height:max-content;padding-left:0pt;padding-right:0pt;width:100%;"><tr style="height:1pt;"><td style="vertical-align:bottom;width:26%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;"><font style="font-size:1pt;visibility:hidden;">&#8203;</font></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.7%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;"><font style="font-size:1pt;visibility:hidden;">&#8203;</font></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:16.1%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;"><font style="font-size:1pt;visibility:hidden;">&#8203;</font></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.7%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;"><font style="font-size:1pt;visibility:hidden;">&#8203;</font></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:12.22%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;"><font style="font-size:1pt;visibility:hidden;">&#8203;</font></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.98%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;"><font style="font-size:1pt;visibility:hidden;">&#8203;</font></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:18.29%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;"><font style="font-size:1pt;visibility:hidden;">&#8203;</font></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.7%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;"><font style="font-size:1pt;visibility:hidden;">&#8203;</font></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:16.77%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;"><font style="font-size:1pt;visibility:hidden;">&#8203;</font></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.5%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;"><font style="font-size:1pt;visibility:hidden;">&#8203;</font></p></div></div></td></tr><tr><td style="vertical-align:bottom;width:26%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;"><font style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.7%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:16.1%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><font style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.7%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.22%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><font style="font-size:8pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.98%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:18.29%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">CONTINUATION&#160;OF</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.7%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:16.77%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><font style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.5%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">&#160;</b></p></td></tr><tr><td style="vertical-align:bottom;width:26%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;"><font style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.7%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><font style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:16.1%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><font style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.7%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><font style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.22%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><font style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.98%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><font style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:18.29%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">EMPLOYER&#160;PORTION</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.7%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><font style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:16.77%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><font style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.5%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">&#160;</b></p></td></tr><tr><td style="vertical-align:bottom;width:26%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;"><font style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.7%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><font style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:16.1%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><font style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.7%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><font style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.22%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><font style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.98%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><font style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:18.29%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">OF&#160;MEDICAL,</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.7%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><font style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:16.77%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">ACCELERATION&#160;OF</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.5%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">&#160;</b></p></td></tr><tr><td style="vertical-align:bottom;width:26%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;"><font style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.7%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><font style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:16.1%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">SALARY</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.7%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><font style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.22%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><font style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.98%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><font style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:18.29%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">DENTAL&#160;AND&#160;VISION</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.7%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><font style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:16.77%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">UNVESTED</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.5%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">&#160;</b></p></td></tr><tr><td style="vertical-align:bottom;width:26%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:justify;margin:0pt;"><b style="font-weight:bold;">TERMINATION&#160;SCENARIO</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.7%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><font style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:16.1%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">CONTINUATION(1)</b>&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.7%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><font style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.22%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">BONUS</b>&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.98%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><font style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:18.29%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">BENEFIT&#160;PREMIUMS</b>&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.7%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><font style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:16.77%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">EQUITY&#160;AWARDS</b>&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.5%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">&#160;</b></p></td></tr><tr><td style="vertical-align:bottom;width:26%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;">Prior to or More than 12 Months Following a Change in Control</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.7%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:16.1%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.7%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.22%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.98%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:18.29%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.7%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:16.77%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.5%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></td></tr><tr><td style="vertical-align:bottom;width:26%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt 0pt 0pt 24pt;">Harout Semerjian</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.7%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:16.1%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;">18&#160;months</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.7%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.22%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;">None</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.98%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:18.29%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;">18&#160;months</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.7%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:16.77%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;">None</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.5%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></td></tr><tr><td style="vertical-align:bottom;width:26%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt 0pt 0pt 24pt;">Brian Hahn</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.7%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:16.1%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;">12 months</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.7%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.22%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;">None</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.98%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:18.29%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;">12 months</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.7%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:16.77%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;">None</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.5%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></td></tr><tr><td style="vertical-align:bottom;width:26%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt 0pt 0pt 24pt;">John Magnani, Ph.D.</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.7%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:16.1%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;">15 months</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.7%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.22%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;">None</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.98%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:18.29%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;">15 months</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.7%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:16.77%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;">None</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.5%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></td></tr><tr><td style="vertical-align:bottom;width:26%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;">Within 12 Months Following a Change in Control</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.7%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:16.1%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.7%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.22%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.98%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:18.29%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.7%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:16.77%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.5%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></td></tr><tr><td style="vertical-align:bottom;width:26%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt 0pt 0pt 24pt;">Harout Semerjian</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.7%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:16.1%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;">18&#160;months</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.7%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.22%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;">Target&#160;Bonus</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.98%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;">(2)<font style="font-family:'Calibri','Helvetica','sans-serif';">&#160;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:18.29%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;">18&#160;months</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.7%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:16.77%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;">Full&#160;Acceleration</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.5%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;">(3)</p></td></tr><tr><td style="vertical-align:bottom;width:26%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt 0pt 0pt 24pt;">Brian Hahn</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.7%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:16.1%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;">12 months</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.7%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.22%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;">Target&#160;Bonus</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.98%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;">(2)<font style="font-family:'Calibri','Helvetica','sans-serif';">&#160;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:18.29%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;">12 months</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.7%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:16.77%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;">Full&#160;Acceleration</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.5%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;">(3)</p></td></tr><tr><td style="vertical-align:bottom;width:26%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt 0pt 0pt 24pt;">John Magnani, Ph.D.</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.7%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:16.1%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;">15 months</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.7%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.22%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;">Target&#160;Bonus</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.98%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;">(2)<font style="font-family:'Calibri','Helvetica','sans-serif';">&#160;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:18.29%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;">15 months</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.7%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:16.77%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;">Full&#160;Acceleration</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.5%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;">(3)</p></td></tr></table></div><div style="font-family:'Times New Roman','Times','serif';font-size:10.0pt;margin-bottom:0pt;margin-top:0pt;min-height:1.19em;position:relative;width:100%;"><hr noshade="true" color="#000000" size="1" width="25.0%" style="background-color:#000000;color:#000000;height:1pt;position:relative;top:0.6em;border:none;margin:0pt;" align="left"></div><table border="0" cellpadding="0" cellspacing="0" style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">(1)</td><td style="padding:0pt;"><font style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">If the termination is prior to, or more than 12 months following a change, in control, the executive officer&#8217;s salary continuation will be paid on our regular payroll dates, less applicable withholdings and deductions. If the termination is within 12 months following a change in control, the executive officer&#8217;s salary continuation will be paid in a lump-sum cash payment, less applicable withholdings and deductions, within 60 days following the change in control termination. </font></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">(2)</td><td style="padding:0pt;"><font style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;white-space:pre-wrap;">The executive officer will receive payment of the executive officer&#8217;s target bonus award for the 18 months, in the case of  Mr. Semerjian, or 12 months, in the case of Mr. Hahn, or 15 months, in the case of Dr. Magnani, immediately prior to the executive officer&#8217;s change in control termination, payable in a lump-sum cash payment, less applicable withholdings and deductions, within 60 days following the change in control termination. </font></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">(3)</td><td style="padding:0pt;"><font style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">The executive officer will receive accelerated vesting of all then unvested equity awards that he may have, if any. </font></td></tr></table><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><b style="font-weight:bold;">Health and Welfare Benefits </b></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><font style="font-weight:bold;visibility:hidden;">&#8203;</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Our named executive officers are eligible to participate in all of our employee benefit plans, such as medical, dental, vision, group life and disability insurance, in each case on the same basis as our other employees. </p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">We also maintain a defined contribution employee retirement plan for our employees, including our named executive officers. Our 401(k) plan is intended to qualify as a tax-qualified plan under Section&#160;401 of the Internal Revenue Code so that contributions to our 401(k) plan, and income earned on such contributions, are not taxable to participants until withdrawn or distributed from the 401(k) plan. Our 401(k) plan provides that each participant may contribute a portion of his or her pre-tax compensation, up to a statutory limit, which was $19,500 for 2021 and is $20,500 for 2022. Participants who are at least 50 years old can also make &#8220;catch-up&#8221; contributions, which was and is up to an additional $6,500 for 2021 and 2022. Under our 401(k) plan, each employee is fully vested in his or her deferred salary contributions. Employee contributions are held and invested by the plan&#8217;s trustee, subject to participants&#8217; ability to give investment directions by following specified procedures. In 2021, we provided matching contributions of up to 50% of the first 6% of each employee&#8217;s eligible contributions to the 401(k) plan.</p></div><div style="clear:both;display:table;margin-bottom:27.35pt;min-height:44.65pt;width:100%;"><div style="display:table-cell;vertical-align:bottom;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;min-height:12.0pt;text-align:center;margin:24pt 0pt 0pt 0pt;">46</p></div></div></div><hr style="background-color:#000000;clear:both;color:#000000;height:2pt;line-height:0;margin-bottom:30pt;margin-left:11.76%;margin-right:11.76%;margin-top:30pt;page-break-after:always;width:76.47%;border-width:0;"><div style="max-width:100%;padding-left:11.76%;padding-right:11.76%;position:relative;"><div style="margin-top:27.35pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"><font style="font-weight:bold;visibility:hidden;">&#8203;</font></p></div><div style="clear:both;max-width:100%;position:relative;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;">We do not provide perquisites or personal benefits to our named executive officers. We do, however, pay the premiums for term life insurance and long-term care for all of our employees, including our named executive officers.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><b style="font-size:12pt;font-weight:bold;">NON-EMPLOYEE DIRECTOR COMPENSATION</b></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><font style="font-family:'Times New Roman Bold';font-size:12pt;font-weight:bold;visibility:hidden;">&#8203;</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">As compensation for serving on our Board of Directors, each director who is not an employee of our company receives a cash retainer for service on the Board and for service on each committee on which the director is a member. The compensation of our directors is based on market practice information provided by our independent compensation consultant, Aon. This compensation is periodically reviewed with respect to cash retainers and equity incentives.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">The retainers paid to non-employee directors for 2021 and 2022 for service on the Board and for service on each committee of the Board on which the director is a member are as follows: </p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p><div><table style="border-collapse:collapse;font-size:16pt;height:max-content;margin-left:auto;margin-right:auto;padding-left:0pt;padding-right:0pt;width:93.46%;" align="center"><tr style="height:1pt;"><td style="vertical-align:bottom;width:61.01%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;"><font style="font-size:1pt;visibility:hidden;">&#8203;</font></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.82%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;"><font style="font-size:1pt;visibility:hidden;">&#8203;</font></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.29%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;"><font style="font-size:1pt;visibility:hidden;">&#8203;</font></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:15.12%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;"><font style="font-size:1pt;visibility:hidden;">&#8203;</font></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.82%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;"><font style="font-size:1pt;visibility:hidden;">&#8203;</font></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.45%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;"><font style="font-size:1pt;visibility:hidden;">&#8203;</font></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:16.99%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;"><font style="font-size:1pt;visibility:hidden;">&#8203;</font></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:0.45%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;"><font style="font-size:1pt;visibility:hidden;">&#8203;</font></p></div></div></td></tr><tr><td style="vertical-align:bottom;width:61.01%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;"><font style="font-size:8pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.82%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.29%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><font style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:15.12%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">MEMBER</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.82%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:18.44%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">CHAIR&#160;ADDITIONAL</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.45%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">&#160;</b></p></td></tr><tr><td style="vertical-align:bottom;width:61.01%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;"><font style="font-size:8pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.82%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><font style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</font></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:16.41%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">ANNUAL&#160;SERVICE</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.82%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><font style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</font></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:18.44%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">ANNUAL&#160;SERVICE</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.45%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">&#160;</b></p></td></tr><tr><td style="vertical-align:bottom;width:61.01%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;"><font style="font-size:8pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.82%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><font style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</font></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:16.41%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">RETAINER</b>&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.82%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><font style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</font></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:18.44%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">RETAINER</b>&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.45%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">&#160;</b></p></td></tr><tr><td style="vertical-align:bottom;width:61.01%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;">Board of Directors</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.82%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.29%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:15.12%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><font style="white-space:pre-wrap;"> 40,000</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.82%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.45%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:16.99%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><font style="white-space:pre-wrap;"> 30,000</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.45%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></td></tr><tr><td style="vertical-align:bottom;width:61.01%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;">Audit Committee</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.82%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.29%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:15.12%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><font style="white-space:pre-wrap;"> 9,000</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.82%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.45%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:16.99%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><font style="white-space:pre-wrap;"> 9,000</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.45%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></td></tr><tr><td style="vertical-align:bottom;width:61.01%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;">Compensation Committee</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.82%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.29%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:15.12%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><font style="white-space:pre-wrap;"> 6,000</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.82%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.45%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:16.99%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><font style="white-space:pre-wrap;"> 6,000</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.45%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></td></tr><tr><td style="vertical-align:bottom;width:61.01%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;">Nominating and Corporate Governance Committee</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.82%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.29%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:15.12%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><font style="white-space:pre-wrap;"> 4,500</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.82%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.45%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:16.99%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><font style="white-space:pre-wrap;"> 4,500</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.45%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></td></tr></table></div><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">These retainers are payable in arrears in four equal quarterly installments on the last day of each quarter, provided that the amount of such payment is prorated for any portion of such quarter that the director is not serving on our Board. We also reimburse our non-employee directors for reasonable travel and out-of-pocket expenses incurred in connection with attending our Board and committee meetings. </p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><font style="white-space:pre-wrap;">In addition, any new non-employee director receives an option grant to purchase 42,000 shares of common stock upon becoming a director. This grant will vest in three equal installments on the first, second and third anniversaries of the grant date. Further, on the date of each annual meeting of stockholders, each non-employee director that continues to serve as a non-employee member on our Board receives an option to purchase 21,000 shares of common stock. The annual grant to the non-employee director vests on the first full anniversary of the date of grant.  The exercise price of options granted to directors is equal to the closing price of our common stock on the Nasdaq Global Market the date of grant. </font></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">In 2021, under the compensation policy in effect at the time, the Board could grant a combination of stock options and restricted stock units for the annual director grant. Under that policy, the Board approved the grant of, and the Company issued to each non-employee director in May 2021, an option to purchase 10,500 shares of common stock and 5,250 restricted stock units, both of which awards vest on the first anniversary of the date of grant.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></div><div style="clear:both;display:table;margin-bottom:27.35pt;min-height:44.65pt;width:100%;"><div style="display:table-cell;vertical-align:bottom;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;min-height:12.0pt;text-align:center;margin:24pt 0pt 0pt 0pt;">47</p></div></div></div><hr style="background-color:#000000;clear:both;color:#000000;height:2pt;line-height:0;margin-bottom:30pt;margin-left:11.76%;margin-right:11.76%;margin-top:30pt;page-break-after:always;width:76.47%;border-width:0;"><div style="max-width:100%;padding-left:11.76%;padding-right:11.76%;position:relative;"><div style="margin-top:27.35pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"><font style="font-weight:bold;visibility:hidden;">&#8203;</font></p></div><div style="clear:both;max-width:100%;position:relative;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><b style="font-weight:bold;">2021 Director Compensation </b></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">The following table shows the compensation earned by each of our non-employee directors for the year ended December&#160;31, 2021: </p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p><div><table style="border-collapse:collapse;font-size:16pt;height:max-content;margin-left:auto;margin-right:auto;padding-left:0pt;padding-right:0pt;width:80.27%;" align="center"><tr style="height:1pt;"><td style="vertical-align:bottom;width:27.54%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;"><font style="font-size:1pt;visibility:hidden;">&#8203;</font></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.07%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;"><font style="font-size:1pt;visibility:hidden;">&#8203;</font></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:18.07%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;"><font style="font-size:1pt;visibility:hidden;">&#8203;</font></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.07%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;"><font style="font-size:1pt;visibility:hidden;">&#8203;</font></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:16.98%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;"><font style="font-size:1pt;visibility:hidden;">&#8203;</font></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.07%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;"><font style="font-size:1pt;visibility:hidden;">&#8203;</font></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:17.89%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;"><font style="font-size:1pt;visibility:hidden;">&#8203;</font></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.07%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;"><font style="font-size:1pt;visibility:hidden;">&#8203;</font></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:10.7%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;"><font style="font-size:1pt;visibility:hidden;">&#8203;</font></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:0.49%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;"><font style="font-size:1pt;visibility:hidden;">&#8203;</font></p></div></div></td></tr><tr><td style="vertical-align:bottom;width:27.54%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;"><font style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.07%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:18.07%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">FEES EARNED OR </b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.07%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:16.98%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">STOCK AWARDS</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.07%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:17.89%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">OPTION AWARDS</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.07%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.7%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;"> </b><font style="font-weight:bold;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.49%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">&#160;</b></p></td></tr><tr><td style="vertical-align:bottom;width:27.54%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:justify;margin:0pt;"><b style="font-weight:bold;">Name</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.07%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><font style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:18.07%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">PAID IN CASH&#160;($)</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.07%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><font style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:16.98%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">($)</b><sup style="font-size:6pt;font-weight:bold;vertical-align:top;">(1)</sup><sup style="font-size:6pt;vertical-align:top;">&#160;</sup></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.07%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><font style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:17.89%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">($)</b><sup style="font-size:6pt;font-weight:bold;vertical-align:top;">(1)</sup><sup style="font-size:6pt;vertical-align:top;">&#160;</sup></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.07%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><font style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.7%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">TOTAL&#160;($)</b>&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.49%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">&#160;</b></p></td></tr><tr><td style="vertical-align:top;white-space:nowrap;width:27.54%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;">Patricia Andrews</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.07%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:18.07%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><font style="white-space:pre-wrap;"> 49,000</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.07%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:16.98%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><font style="white-space:pre-wrap;"> 13,388</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.07%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:17.89%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><font style="white-space:pre-wrap;"> 19,187</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.07%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.7%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><font style="white-space:pre-wrap;"> 81,575</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.49%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><font style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</font></p></td></tr><tr><td style="vertical-align:top;white-space:nowrap;width:27.54%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;">Mark Goldberg, M.D.</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.07%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:18.07%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><font style="white-space:pre-wrap;"> 55,000</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.07%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:16.98%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><font style="white-space:pre-wrap;"> 13,388</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.07%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:17.89%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><font style="white-space:pre-wrap;"> 19,187</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.07%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.7%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><font style="white-space:pre-wrap;"> 87,575</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.49%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></td></tr><tr><td style="vertical-align:top;white-space:nowrap;width:27.54%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;">Scott Jackson</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.07%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:18.07%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><font style="white-space:pre-wrap;"> 55,000</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.07%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:16.98%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><font style="white-space:pre-wrap;"> 13,388</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.07%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:17.89%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><font style="white-space:pre-wrap;"> 19,187</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.07%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.7%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><font style="white-space:pre-wrap;"> 87,575</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.49%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></td></tr><tr><td style="vertical-align:top;white-space:nowrap;width:27.54%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;">Daniel Junius</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.07%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:18.07%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><font style="white-space:pre-wrap;"> 62,500</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.07%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:16.98%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><font style="white-space:pre-wrap;"> 13,388</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.07%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:17.89%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><font style="white-space:pre-wrap;"> 19,187</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.07%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.7%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><font style="white-space:pre-wrap;"> 95,075</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.49%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></td></tr><tr><td style="vertical-align:top;white-space:nowrap;width:27.54%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;">Rachel King <sup style="font-size:7.5pt;vertical-align:top;">(2)</sup></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.07%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:18.07%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><font style="white-space:pre-wrap;"> &#8212;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.07%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:16.98%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><font style="white-space:pre-wrap;"> &#8212;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.07%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:17.89%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><font style="white-space:pre-wrap;"> &#8212;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.07%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.7%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><font style="white-space:pre-wrap;"> &#8212;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.49%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></td></tr><tr><td style="vertical-align:top;white-space:nowrap;width:27.54%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;">Scott Koenig, M.D., Ph.D.</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.07%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:18.07%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><font style="white-space:pre-wrap;"> 44,500</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.07%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:16.98%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><font style="white-space:pre-wrap;"> 13,388</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.07%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:17.89%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><font style="white-space:pre-wrap;"> 19,187</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.07%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.7%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><font style="white-space:pre-wrap;"> 77,075</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.49%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></td></tr><tr><td style="vertical-align:top;white-space:nowrap;width:27.54%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;">Timothy Pearson</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.07%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:18.07%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><font style="white-space:pre-wrap;"> 82,000</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.07%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:16.98%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><font style="white-space:pre-wrap;"> 13,388</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.07%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:17.89%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><font style="white-space:pre-wrap;"> 19,187</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.07%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.7%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><font style="white-space:pre-wrap;"> 114,575</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.49%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></td></tr></table></div><div style="font-family:'Times New Roman','Times','serif';font-size:10.0pt;margin-bottom:0pt;margin-top:0pt;min-height:1.19em;position:relative;width:100%;"><hr noshade="true" color="#000000" size="1" width="25.0%" style="background-color:#000000;color:#000000;height:1pt;position:relative;top:0.6em;border:none;margin:0pt;" align="left"></div><table border="0" cellpadding="0" cellspacing="0" style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">(1)</td><td style="padding:0pt;"><font style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">Reflects the aggregate grant date fair value of options and restricted stock units granted during the fiscal year ended December 31, 2021 calculated in accordance with FASB ASC Topic 718. For a discussion of valuation assumptions, see Note 9 to our audited consolidated financial statements included in our Annual Report on Form&#160;10-K for the fiscal year ended December&#160;31, 2021. Our directors will not realize the estimated value of these awards until the awards are vested, exercised (in the case of stock options), and the underlying shares are sold. </font></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">(2)</td><td style="padding:0pt;"><font style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">Ms. King was a director for the full year but became eligible for compensation under our director compensation policy as a non-employee director following her retirement as our President and Chief Executive Officer in August 2021. Ms. King&#8217;s fees earned of $13,334 as a non-employee director are included in the Summary Compensation Table under the &#8220;All Other Compensation&#8221; column. </font></td></tr></table><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">As of December 31, 2021, our non-employee directors held the following restricted stock units and stock options: </p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> <font style="visibility:hidden;">&#8203;</font></p><div><table style="border-collapse:collapse;font-size:16pt;height:max-content;margin-left:auto;margin-right:auto;padding-left:0pt;padding-right:0pt;width:79.99%;" align="center"><tr style="height:1pt;"><td style="vertical-align:bottom;width:65.1%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;"><font style="font-size:1pt;visibility:hidden;">&#8203;</font></p></div></div></td><td style="vertical-align:bottom;width:2.21%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;"><font style="font-size:1pt;visibility:hidden;">&#8203;</font></p></div></div></td><td style="vertical-align:bottom;width:12.42%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;"><font style="font-size:1pt;visibility:hidden;">&#8203;</font></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.21%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;"><font style="font-size:1pt;visibility:hidden;">&#8203;</font></p></div></div></td><td style="vertical-align:bottom;width:18.04%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;"><font style="font-size:1pt;visibility:hidden;">&#8203;</font></p></div></div></td></tr><tr><td style="vertical-align:bottom;width:65.1%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:justify;margin:0pt;"><b style="font-weight:bold;">Name</b></p></td><td style="vertical-align:bottom;width:2.21%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:justify;margin:0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td style="vertical-align:bottom;width:12.42%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">Stock Awards (#)</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.21%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td style="vertical-align:bottom;width:18.04%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">Shares Subject to Outstanding Options (#)</b></p></td></tr><tr><td style="vertical-align:bottom;width:65.1%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;">Patricia Andrews</p></td><td style="vertical-align:bottom;width:2.21%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.42%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><font style="white-space:pre-wrap;"> 5,250</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.21%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:18.04%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><font style="white-space:pre-wrap;"> 85,500</font></p></td></tr><tr><td style="vertical-align:bottom;width:65.1%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;">Mark Goldberg, M.D.</p></td><td style="vertical-align:bottom;width:2.21%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.42%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><font style="white-space:pre-wrap;"> 5,250</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.21%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:18.04%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><font style="white-space:pre-wrap;"> 111,901</font></p></td></tr><tr><td style="vertical-align:bottom;width:65.1%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;">Scott Jackson</p></td><td style="vertical-align:bottom;width:2.21%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.42%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><font style="white-space:pre-wrap;"> 5,250</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.21%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:18.04%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><font style="white-space:pre-wrap;"> 74,500</font></p></td></tr><tr><td style="vertical-align:bottom;width:65.1%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;">Daniel Junius</p></td><td style="vertical-align:bottom;width:2.21%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.42%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><font style="white-space:pre-wrap;"> 5,250</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.21%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:18.04%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><font style="white-space:pre-wrap;"> 107,500</font></p></td></tr><tr><td style="vertical-align:bottom;width:65.1%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;">Rachel King <sup style="font-size:7.5pt;vertical-align:top;">(1)</sup></p></td><td style="vertical-align:bottom;width:2.21%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.42%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><font style="white-space:pre-wrap;"> &#8212;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.21%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:18.04%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><font style="white-space:pre-wrap;"> &#8212;</font></p></td></tr><tr><td style="vertical-align:bottom;width:65.1%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;">Scott Koenig, M.D., Ph.D.</p></td><td style="vertical-align:bottom;width:2.21%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.42%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><font style="white-space:pre-wrap;"> 5,250</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.21%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:18.04%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><font style="white-space:pre-wrap;"> 96,500</font></p></td></tr><tr><td style="vertical-align:bottom;width:65.1%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;">Timothy Pearson</p></td><td style="vertical-align:bottom;width:2.21%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.42%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><font style="white-space:pre-wrap;"> 5,250</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.21%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:18.04%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><font style="white-space:pre-wrap;"> 111,901</font></p></td></tr></table></div><div style="font-family:'Times New Roman','Times','serif';font-size:10.0pt;margin-bottom:0pt;margin-top:0pt;min-height:1.19em;position:relative;width:100%;"><hr noshade="true" color="#000000" size="1" width="25.0%" style="background-color:#000000;color:#000000;height:1pt;position:relative;top:0.6em;border:none;margin:0pt;" align="left"></div><table border="0" cellpadding="0" cellspacing="0" style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">(1)</td><td style="padding:0pt;"><font style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">Ms. King&#8217;s awards outstanding are included in the table entitled &#8220;Outstanding Equity Awards at End of 2021&#8221;.</font></td></tr></table><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></div><div style="clear:both;display:table;margin-bottom:27.35pt;min-height:44.65pt;width:100%;"><div style="display:table-cell;vertical-align:bottom;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;min-height:12.0pt;text-align:center;margin:24pt 0pt 0pt 0pt;">48</p></div></div></div><hr style="background-color:#000000;clear:both;color:#000000;height:2pt;line-height:0;margin-bottom:30pt;margin-left:11.76%;margin-right:11.76%;margin-top:30pt;page-break-after:always;width:76.47%;border-width:0;"><div style="max-width:100%;padding-left:11.76%;padding-right:11.76%;position:relative;"><div style="margin-top:27.35pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"><font style="font-weight:bold;visibility:hidden;">&#8203;</font></p></div><div style="clear:both;max-width:100%;position:relative;"><p style="font-family:'Times New Roman','Times','serif';font-size:12pt;font-weight:bold;text-align:center;margin:0pt;">SECURITIES AUTHORIZED FOR ISSUANCE UNDER EQUITY COMPENSATION PLANS</p><p style="font-family:'Times New Roman','Times','serif';font-size:16pt;font-weight:bold;text-align:center;margin:0pt;"><font style="font-family:'Times New Roman Bold';font-size:12pt;margin-bottom:3pt;margin-top:12pt;visibility:hidden;">&#8203;</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">The following table provides certain information regarding our equity compensation plans in effect as of </p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">December 31, 2021: </p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p><div align="left"><table style="border-collapse:collapse;font-size:16pt;height:max-content;padding-left:0pt;padding-right:0pt;width:100%;"><tr style="height:1pt;"><td style="vertical-align:bottom;white-space:nowrap;width:39.88%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;"><font style="font-size:1pt;visibility:hidden;">&#8203;</font></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.7%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;"><font style="font-size:1pt;visibility:hidden;">&#8203;</font></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:17.05%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;"><font style="font-size:1pt;visibility:hidden;">&#8203;</font></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:3.56%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;"><font style="font-size:1pt;visibility:hidden;">&#8203;</font></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.32%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;"><font style="font-size:1pt;visibility:hidden;">&#8203;</font></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:13.3%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;"><font style="font-size:1pt;visibility:hidden;">&#8203;</font></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:3.56%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;"><font style="font-size:1pt;visibility:hidden;">&#8203;</font></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:17.09%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;"><font style="font-size:1pt;visibility:hidden;">&#8203;</font></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.5%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;"><font style="font-size:1pt;visibility:hidden;">&#8203;</font></p></div></div></td></tr><tr><td style="vertical-align:bottom;white-space:nowrap;width:39.88%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.7%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:17.05%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><font style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.56%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:justify;margin:0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.32%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><font style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:13.3%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><font style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.56%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:justify;margin:0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:17.09%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">Number&#160;of&#160;securities</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.5%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:justify;margin:0pt;"><b style="font-weight:bold;">&#160;</b></p></td></tr><tr><td style="vertical-align:bottom;width:39.88%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;"><font style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.7%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><font style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:17.05%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><font style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.56%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;"><font style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.32%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><font style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:13.3%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><font style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.56%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;"><font style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:17.09%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">remaining&#160;available&#160;for</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.5%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:justify;margin:0pt;"><b style="font-weight:bold;">&#160;</b></p></td></tr><tr><td style="vertical-align:bottom;width:39.88%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;"><font style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.7%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><font style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:17.05%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><font style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.56%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;"><font style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</font></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:14.62%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">Weighted-average</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.56%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;"><font style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:17.09%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">future&#160;issuance&#160;under</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.5%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:justify;margin:0pt;"><b style="font-weight:bold;">&#160;</b></p></td></tr><tr><td style="vertical-align:bottom;width:39.88%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;"><font style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.7%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><font style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:17.05%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">Number&#160;of&#160;securities&#160;to</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.56%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;"><font style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</font></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:14.62%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">exercise</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.56%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;"><font style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:17.09%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">equity&#160;compensation</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.5%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:justify;margin:0pt;"><b style="font-weight:bold;">&#160;</b></p></td></tr><tr><td style="vertical-align:bottom;width:39.88%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;"><font style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.7%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><font style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:17.05%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">be&#160;issued&#160;upon&#160;exercise</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.56%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;"><font style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</font></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:14.62%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">price&#160;of&#160;outstanding</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.56%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;"><font style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:17.09%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">plans</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.5%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:justify;margin:0pt;"><b style="font-weight:bold;">&#160;</b></p></td></tr><tr><td style="vertical-align:bottom;width:39.88%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;"><font style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.7%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><font style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:17.05%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">of&#160;outstanding&#160;options,</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.56%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;"><font style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</font></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:14.62%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">options,</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.56%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;"><font style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:17.09%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">(excluding&#160;securities</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.5%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:justify;margin:0pt;"><b style="font-weight:bold;">&#160;</b></p></td></tr><tr><td style="vertical-align:bottom;width:39.88%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;"><font style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.7%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><font style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:17.05%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">warrants&#160;and&#160;rights</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.56%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;"><font style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</font></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:14.62%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">warrants&#160;and&#160;rights</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.56%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;"><font style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:17.09%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">reflected&#160;in&#160;column&#160;(a))</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.5%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:justify;margin:0pt;"><b style="font-weight:bold;">&#160;</b></p></td></tr><tr><td style="vertical-align:bottom;width:39.88%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:justify;margin:0pt;"><b style="font-weight:bold;">Plan&#160;Category</b>&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.7%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><font style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:17.05%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">(a)</b>&#160;&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.56%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;"><font style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</font></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:14.62%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">(b)</b>&#160;&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.56%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;"><font style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:17.09%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">(c)</b>&#160;&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.5%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:justify;margin:0pt;"><b style="font-weight:bold;">&#160;</b></p></td></tr><tr><td style="vertical-align:bottom;width:39.88%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;">Equity compensation plans approved by security holders </p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.7%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:17.05%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><font style="white-space:pre-wrap;"> 6,094,522</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.56%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;">(1)&#160;&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.32%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:13.3%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;">7.73</p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.56%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;">(2)&#160;&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:17.09%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><font style="white-space:pre-wrap;"> 3,889,292</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.5%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;">(3)</p></td></tr><tr><td style="vertical-align:bottom;width:39.88%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;">Equity compensation plans not approved by security holders (4)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.7%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:17.05%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><font style="white-space:pre-wrap;"> 1,813,600</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.56%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.32%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:13.3%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;">2.08</p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.56%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:17.09%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><font style="white-space:pre-wrap;"> 176,308</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.5%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></td></tr><tr><td style="vertical-align:bottom;width:39.88%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;">Total</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.7%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:17.05%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><font style="white-space:pre-wrap;"> 7,908,122</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.56%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.32%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:13.3%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.56%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:17.09%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><font style="white-space:pre-wrap;"> 4,065,600</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.5%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></td></tr></table></div><div style="font-family:'Times New Roman','Times','serif';font-size:10.0pt;margin-bottom:0pt;margin-top:0pt;min-height:1.19em;position:relative;width:100%;"><hr noshade="true" color="#000000" size="1" width="25.0%" style="background-color:#000000;color:#000000;height:1pt;position:relative;top:0.6em;border:none;margin:0pt;" align="left"></div><table border="0" cellpadding="0" cellspacing="0" style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">(1)</td><td style="padding:0pt;"><font style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">Includes shares issuable upon exercise of outstanding options under our 2003 Stock Incentive Plan, shares issuable upon exercise of outstanding options and shares issuable upon settlement of outstanding restricted stock units (&#8220;RSUs&#8221;) under our 2013 Plan. </font></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">(2)</td><td style="padding:0pt;"><font style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">Gives effect to outstanding RSUs, which have no exercise price. Excluding the RSUs, the weighted average exercise price would be $8.20 per share.</font></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">(3)</td><td style="padding:0pt;"><font style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">Consists of 1,401,843 shares available under the 2013 Plan and 2,487,449 shares available under the 2013 Employee Stock Purchase Plan (&#8220;2013 ESPP&#8221;). On January 1 of each year, the number of shares reserved under the 2013 Plan and 2013 ESPP is automatically increased by 3% and 1%, respectively, of the total number of shares of common stock that are outstanding at that time, or a lesser number of shares as may be determined by our Board. An additional 1,569,416 and 523,138 shares were added to the number of available shares under the 2013 Plan and the 2013 ESPP, respectively, in each case effective January 1, 2022.</font></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">(4)</td><td style="padding:0pt;"><font style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">Represents shares issued and issuable under our Inducement Plan. A description of the Inducement Plan is contained in Note 9 to our consolidated financial statements included in our Annual Report on Form 10-K for the year ended December 31, 2021. In January 2022, the Company&#8217;s board of directors adopted an amendment to increase the number of shares reserved for the Inducement Plan by an additional 1,000,000 shares.</font></td></tr></table><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></div><div style="clear:both;display:table;margin-bottom:27.35pt;min-height:44.65pt;width:100%;"><div style="display:table-cell;vertical-align:bottom;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;min-height:12.0pt;text-align:center;margin:24pt 0pt 0pt 0pt;">49</p></div></div></div><hr style="background-color:#000000;clear:both;color:#000000;height:2pt;line-height:0;margin-bottom:30pt;margin-left:11.76%;margin-right:11.76%;margin-top:30pt;page-break-after:always;width:76.47%;border-width:0;"><div style="max-width:100%;padding-left:11.76%;padding-right:11.76%;position:relative;"><div style="margin-top:27.35pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"><font style="font-weight:bold;visibility:hidden;">&#8203;</font></p></div><div style="clear:both;max-width:100%;position:relative;"><p style="font-family:'Times New Roman','Times','serif';font-size:12pt;font-weight:bold;text-align:center;margin:0pt;">TRANSACTIONS WITH RELATED PERSONS</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:0pt;margin:0pt;"><a name="_DV_M1138"></a><b style="font-weight:bold;">RELATED PERSON TRANSACTIONS POLICY AND PROCEDURES</b><a name="_DV_M1139"></a></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><a name="_DV_M1140"></a>We have adopted a related person transaction policy that sets forth our procedures for the identification, review, consideration and approval or ratification of related person transactions. </p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">For purposes of our policy only, a related person transaction is a transaction, arrangement or relationship, or any series of similar transactions, arrangements or relationships, in which we and any related person are, were or will be participants in which the amount involved exceeds $120,000. Transactions involving compensation for services provided to us as an employee or director are not covered by this policy. A related person is any executive officer, director or beneficial owner of more than 5% of any class of our voting securities, including any of their immediate family members and any entity owned or controlled by such persons. </p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Under the policy, if a transaction has been identified as a related person transaction, including any transaction that was not a related person transaction when originally consummated or any transaction that was not initially identified as a related person transaction prior to consummation, our management must present information regarding the related person transaction to our Audit Committee, or, if Audit Committee approval would be inappropriate, to another independent body of our Board, for review, consideration and approval or ratification. The presentation must include a description of, among other things, the material facts, the interests, direct and indirect, of the related persons, the benefits to us of the transaction and whether the transaction is on terms that are comparable to the terms available to or from, as the case may be, an unrelated third party or to or from employees generally. Under the policy, we will collect information that we deem reasonably necessary from each director, executive officer and, to the extent feasible, significant stockholder to enable us to identify any existing or potential related-person transactions and to effectuate the terms of the policy. In addition, under our Code of Business Conduct and Ethics, our employees and directors have an affirmative responsibility to disclose any transaction or relationship that reasonably could be expected to give rise to a conflict of interest. </p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">In considering related person transactions, our Audit Committee, or other independent body of our Board, will take into account the relevant available facts and circumstances including, but not limited to: </p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><font style="font-size:7pt;visibility:hidden;">&#8203;</font></p><table border="0" cellpadding="0" cellspacing="0" style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"></td><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><font style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">the risks, costs and benefits to us; </font></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"></td><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><font style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">the impact on a director&#8217;s independence in the event that the related person is a director, immediate family member of a director or an entity with which a director is affiliated; </font></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"></td><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><font style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">the availability of other sources for comparable services or products; and </font></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"></td><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><font style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">the terms available to or from, as the case may be, unrelated third parties or to or from employees generally. </font></td></tr></table><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:0pt;margin:0pt;">The policy requires that, in determining whether to approve, ratify or reject a related person transaction, our Audit Committee, or other independent body of our Board, must consider, in light of known circumstances, whether the transaction is in, or is not inconsistent with, our best interests and those of our stockholders, as our Audit Committee, or other independent body of our Board, determines in the good faith exercise of its discretion.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;"><a name="_DV_M1143"></a><font style="visibility:hidden;">&#8203;</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:0pt;margin:0pt;"><b style="font-weight:bold;">CERTAIN RELATED PERSON TRANSACTIONS</b></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">There have been no transactions since January&#160;1, 2021 to which we have been a participant in which the amount involved exceeded or will exceed $120,000, and in which any of our directors, executive officers or holders of more than 5% of our capital stock, or any members of their immediate family, had or will have a direct or indirect material interest, other than compensation arrangements that are described under &#8220;Executive Compensation&#8221; and &#8220;Non-Employee Director Compensation.&#8221; </p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><b style="font-weight:bold;">Indemnification Agreements </b></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Our amended and restated certificate of incorporation contains provisions limiting the liability of directors, and our amended and restated bylaws provide that we will indemnify each of our directors to the fullest extent permitted under Delaware law. Our amended and restated certificate of incorporation and amended and restated bylaws also </p></div><div style="clear:both;display:table;margin-bottom:27.35pt;min-height:44.65pt;width:100%;"><div style="display:table-cell;vertical-align:bottom;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;min-height:12.0pt;text-align:center;margin:24pt 0pt 0pt 0pt;">50</p></div></div></div><hr style="background-color:#000000;clear:both;color:#000000;height:2pt;line-height:0;margin-bottom:30pt;margin-left:11.76%;margin-right:11.76%;margin-top:30pt;page-break-after:always;width:76.47%;border-width:0;"><div style="max-width:100%;padding-left:11.76%;padding-right:11.76%;position:relative;"><div style="margin-top:27.35pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"><font style="font-weight:bold;visibility:hidden;">&#8203;</font></p></div><div style="clear:both;max-width:100%;position:relative;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">provide our Board with discretion to indemnify our officers and employees when determined appropriate by the Board. </p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">In addition, we have entered into an indemnification agreement with each of our directors and executive officers. </p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;"><a name="_DV_M1147"></a><a name="_DV_M1144"></a><a name="_DV_M1155"></a><font style="visibility:hidden;">&#8203;</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;text-indent:0pt;margin:0pt;"><font style="font-size:12pt;font-weight:bold;margin-bottom:12pt;visibility:hidden;">&#8203;</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;text-indent:0pt;margin:0pt;"><b style="font-size:12pt;font-weight:bold;">HOUSEHOLDING OF PROXY MATERIALS</b></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:0pt;margin:0pt;"><a name="_DV_M1157"></a><a name="OLE_LINK16"></a><a name="OLE_LINK17"></a>The SEC has adopted rules that permit companies and intermediaries (e.g., brokers) to satisfy the delivery requirements for annual meeting materials<a name="_DV_M1158"></a> <a name="_DV_M1159"></a><a name="_DV_M1160"></a><a name="_DV_M1161"></a>with respect to two or more stockholders sharing the same address by delivering a single set of annual meeting materials addressed to those stockholders. This process, which is commonly referred to as &#8220;householding,&#8221; potentially means extra convenience for<b style="font-weight:bold;"> </b>stockholders and cost savings for companies.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:0pt;margin:0pt;"><a name="_DV_M1162"></a><a name="_DV_C868"></a><a name="_DV_M1163"></a><a name="_DV_M1164"></a><a name="OLE_LINK21"></a><a name="OLE_LINK22"></a>This year, a number of brokers with account holders who are GlycoMimetics stockholders will be &#8220;householding&#8221; the Company&#8217;s proxy materials. A single set of annual meeting materials will be delivered to multiple stockholders sharing an address unless contrary instructions have been received from the affected stockholders. Once you have received notice from your broker that they will be &#8220;householding&#8221; communications to your address, &#8220;householding&#8221; will continue until you are notified otherwise or until you revoke your consent. If, at any time, you no longer wish to participate in &#8220;householding&#8221; and would prefer to receive a separate set of annual meeting materials, please notify your broker or GlycoMimetics. Direct your written request to GlycoMimetics, Inc., Attn: Corporate Secretary, 9708 Medical Center Drive, Rockville, Maryland 20850.<a name="_DV_M1165"></a> Stockholders who currently receive multiple copies of the annual meeting materials at their addresses and would like to request &#8220;householding&#8221; of their communications should contact their brokers.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:0pt;margin:0pt;"><font style="margin-bottom:12pt;visibility:hidden;">&#8203;</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-variant:small-caps;font-weight:bold;line-height:1.19;text-align:center;margin:0pt;"><a name="_DV_M1166"></a><b style="font-size:12pt;font-variant:normal;font-weight:bold;">OTHER MATTERS</b></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:18pt;margin:0pt;"><font style="margin-bottom:12pt;visibility:hidden;">&#8203;</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:0pt;margin:0pt;"><a name="_DV_M1167"></a>The Board of Directors knows of no other matters that will be presented for consideration at the 2022 Annual Meeting of Stockholders. If any other matters are properly brought before the meeting, it is the intention of the persons named in the accompanying proxy to vote on such matters in accordance with their best judgment.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:0pt;margin:0pt;"><font style="margin-bottom:12pt;visibility:hidden;">&#8203;</font></p><div align="left"><table style="border-collapse:collapse;font-size:16pt;height:max-content;padding-left:0pt;padding-right:0pt;table-layout:auto;width:100%;"><tr style="height:1pt;"><td style="vertical-align:top;width:58.34%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="position:absolute;top:0pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;"><a name="_DV_M1168"></a><a name="_DV_M1172"></a><font style="font-size:1pt;visibility:hidden;">&#8203;</font></p></div></div></td><td style="vertical-align:top;width:41.65%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="position:absolute;top:0pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;"><font style="font-size:1pt;visibility:hidden;">&#8203;</font></p></div></div></td></tr><tr><td style="vertical-align:top;width:58.34%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:top;width:41.65%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;">By Order of the Board of Directors</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></td></tr><tr><td style="vertical-align:top;width:58.34%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:top;width:41.65%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;"><a name="_DV_M1169"></a><img src="tmb-20220518xdef14a001.jpg" alt="Graphic" style="display:inline-block;height:21.6pt;left:0%;padding-bottom:0pt;position:relative;top:0pt;width:107.55pt;"></p></td></tr><tr><td style="vertical-align:top;width:58.34%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:top;width:41.65%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;"><a name="_DV_M1170"></a><font style="visibility:hidden;">&#8203;</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;">Christian B. Dinneen-Long</p></td></tr><tr><td style="vertical-align:top;width:58.34%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:top;width:41.65%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;"><a name="_DV_M1171"></a>Secretary</p></td></tr></table></div><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;"><font style="visibility:hidden;background:#ffff00;">&#8203;</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;">April 11, 2022</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:0pt;margin:0pt;"><a name="_DV_M1173"></a><font style="font-weight:bold;margin-bottom:12pt;visibility:hidden;">&#8203;</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:0pt;margin:0pt;"><b style="font-weight:bold;">A copy of the Company&#8217;s Annual Report to the SEC on Form 10-K for the fiscal year ended December 31, 2021 is available without charge upon written request to: Corporate Secretary, </b><b style="font-weight:bold;">GlycoMimetics, Inc.</b><b style="font-weight:bold;">, 9708 Medical Center Drive, Rockville, Maryland 20850.</b></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:0pt;margin:0pt;"><font style="margin-bottom:12pt;visibility:hidden;">&#8203;</font></p><p style="display:none;line-height:0pt;text-indent:0pt;margin:0pt;"><font style="font-family:'Times New Roman','Times','serif';font-size:0pt;margin-bottom:12pt;visibility:hidden;">&#8203;</font></p></div><div style="clear:both;display:table;margin-bottom:27.35pt;min-height:44.65pt;width:100%;"><div style="display:table-cell;vertical-align:bottom;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;min-height:12.0pt;text-align:center;margin:24pt 0pt 0pt 0pt;">51</p></div></div></div><hr style="background-color:#000000;clear:both;color:#000000;height:2pt;line-height:0;margin-bottom:30pt;margin-left:11.76%;margin-right:11.76%;margin-top:30pt;page-break-after:always;width:76.47%;border-width:0;"><div style="max-width:100%;padding-left:11.76%;padding-right:11.76%;position:relative;"><div style="margin-top:27.35pt;min-height:44.65pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 30pt 0pt;"><b style="font-weight:bold;text-transform:uppercase;">appendix A </b></p></div><div style="clear:both;max-width:100%;position:relative;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;text-align:center;margin:0pt 0pt 12pt 0pt;">GLYCOMIMETICS, INC.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;text-align:center;margin:0pt 0pt 12pt 0pt;">AMENDED AND RESTATED 2013 EQUITY INCENTIVE PLAN</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;text-align:center;margin:0pt;">AMENDED AND RESTATED BY THE BOARD OF DIRECTORS: APRIL 7, 2022<br>APPROVED BY THE STOCKHOLDERS: [&#9679;], 2022<br>EFFECTIVE DATE OF AMENDMENT AND RESTATEMENT: [&#9679;], 2022</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;text-align:center;margin:0pt 0pt 12pt 0pt;"><font style="visibility:hidden;">&#8203;</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:9.5pt;padding-left:36pt;text-align:justify;text-indent:-36pt;margin:0pt 0pt 12pt 0pt;"><b style="font-size:10pt;font-variant:small-caps;font-weight:bold;">1.&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;General.</b></p><p style="font-family:'Times New Roman','Times','serif';font-size:9.5pt;text-align:justify;text-indent:36pt;margin:0pt 0pt 12pt 0pt;"><b style="font-size:10pt;font-weight:bold;">(a)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Successor to Prior Plan</b><font style="font-size:10pt;">. The Plan is intended as the successor to the GlycoMimetics, Inc. 2003 Stock Incentive Plan, as amended (the &#8220;</font><font style="font-size:10pt;font-style:italic;font-weight:bold;">Prior Plan</font><font style="font-size:10pt;">&#8221;). From and after 12:01 a.m. Eastern time on the Original Effective Date, all outstanding stock awards granted under the Prior Plan will remain subject to the terms of the Prior Plan; </font><i style="font-size:10pt;font-style:italic;">provided, however,</i><font style="font-size:10pt;"> that any shares subject to outstanding stock awards granted under the Prior Plan that, from and after 12:01 a.m. Eastern time on the Original Effective Date (i) expire or terminate for any reason prior to exercise or settlement; (ii) are forfeited, cancelled or otherwise returned to the Company because of the failure to meet a contingency or condition required to vest such shares; or (iii) are reacquired, withheld (or not issued) to satisfy a tax withholding obligation in connection with an award or to satisfy the purchase price or exercise price of a stock award (the &#8220;</font><font style="font-size:10pt;font-style:italic;font-weight:bold;">Returning Shares</font><font style="font-size:10pt;">&#8221;) will immediately be added to the Share Reserve (as further described in Section 3(a) below) as and when such shares become Returning Shares up to the maximum number set forth in Section 3(a) below, and become available for issuance pursuant to Awards granted hereunder. For the avoidance of doubt, any shares subject to outstanding stock awards granted under the Prior Plan that expire or terminate, are forfeited, cancelled or otherwise returned to the Company or are reacquired, withheld (or not issued) before the Original Effective Date shall not become Returning Shares. All Awards granted on or after 12:01 a.m. Eastern time on the Original Effective Date are subject to the terms of this Plan.</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:9.5pt;text-align:justify;text-indent:36pt;margin:0pt 0pt 12pt 0pt;"><b style="font-size:10pt;font-weight:bold;">(b)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Eligible Award Recipients</b><font style="font-size:10pt;">. Employees, Directors and Consultants are eligible to receive Awards.</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:9.5pt;text-align:justify;text-indent:36pt;margin:0pt 0pt 12pt 0pt;"><b style="font-size:10pt;font-weight:bold;">(c)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Available Awards</b><font style="font-size:10pt;">. The Plan provides for the grant of the following Awards: (i) Incentive Stock Options, (ii) Nonstatutory Stock Options, (iii) Stock Appreciation Rights (iv) Restricted Stock Awards, (v) Restricted Stock Unit Awards, (vi) Performance Awards, and (vii) Other Awards.</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:9.5pt;text-align:justify;text-indent:36pt;margin:0pt 0pt 12pt 0pt;"><b style="font-size:10pt;font-weight:bold;">(d)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Purpose</b><font style="font-size:10pt;">. This Plan, through the granting of Awards, is intended to help the Company secure and retain the services of eligible award recipients, provide incentives for such persons to exert maximum efforts for the success of the Company and any Affiliate, and provide a means by which the eligible recipients may benefit from increases in value of the Common Stock.</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:9.5pt;padding-left:36pt;text-align:justify;text-indent:-36pt;margin:0pt 0pt 12pt 0pt;"><b style="font-size:10pt;font-variant:small-caps;font-weight:bold;">2.&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Administration.</b></p><p style="font-family:'Times New Roman','Times','serif';font-size:9.5pt;text-align:justify;text-indent:36pt;margin:0pt 0pt 12pt 0pt;"><b style="font-size:10pt;font-weight:bold;">(a)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Administration by Board</b><font style="font-size:10pt;">. The Board will administer the Plan. The Board may delegate administration of the Plan to a Committee or Committees, as provided in Section 2(c).</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:9.5pt;text-align:justify;text-indent:36pt;margin:0pt 0pt 12pt 0pt;"><b style="font-size:10pt;font-weight:bold;">(b)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Powers of Board</b><font style="font-size:10pt;">. The Board will have the power, subject to, and within the limitations of, the express provisions of the Plan:</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:9.5pt;text-align:justify;text-indent:72pt;margin:0pt 0pt 12pt 0pt;"><b style="font-size:10pt;font-weight:bold;">(i)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</b><font style="font-size:10pt;">To determine: (A) who will be granted Awards; (B) when and how each Award will be granted; (C) what type of Award will be granted; (D) the provisions of each Award (which need not be identical), including when a person will be permitted to exercise or otherwise receive cash or Common Stock under the Award; (E) the number of shares of Common Stock subject to, or the cash value of, an Award; and (F) the Fair Market Value applicable to an Award.</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:9.5pt;text-align:justify;text-indent:72pt;margin:0pt;"><b style="font-size:10pt;font-weight:bold;">(ii)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</b><font style="font-size:10pt;">To construe and interpret the Plan and Awards granted under it, and to establish, amend and revoke rules and regulations for administration of the Plan and Awards. The Board, in the exercise of these powers, </font></p></div><div style="clear:both;display:table;margin-bottom:27.35pt;min-height:44.65pt;width:100%;"><div style="display:table-cell;vertical-align:bottom;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;min-height:12.0pt;text-align:center;margin:0pt;">1</p></div></div></div><hr style="background-color:#000000;clear:both;color:#000000;height:2pt;line-height:0;margin-bottom:30pt;margin-left:11.76%;margin-right:11.76%;margin-top:30pt;page-break-after:always;width:76.47%;border-width:0;"><div style="max-width:100%;padding-left:11.76%;padding-right:11.76%;position:relative;"><div style="margin-top:27.35pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"><font style="font-weight:bold;visibility:hidden;">&#8203;</font></p></div><div style="clear:both;max-width:100%;position:relative;"><p style="font-family:'Times New Roman','Times','serif';font-size:9.5pt;text-align:justify;margin:0pt 0pt 12pt 0pt;"><font style="font-size:10pt;">may correct any defect, omission or inconsistency in the Plan or in any Award Agreement or in the written terms of an Award, in a manner and to the extent it will deem necessary or expedient to make the Plan or Award fully effective.</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:9.5pt;text-align:justify;text-indent:72pt;margin:0pt 0pt 12pt 0pt;"><b style="font-size:10pt;font-weight:bold;">(iii)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</b><font style="font-size:10pt;">To settle all controversies regarding the Plan and Awards granted under it.</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:9.5pt;text-align:justify;text-indent:72pt;margin:0pt 0pt 12pt 0pt;"><b style="font-size:10pt;font-weight:bold;">(iv)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</b><font style="font-size:10pt;">To accelerate, in whole or in part, the time at which an Award may be exercised or vest (or at which cash or shares of Common Stock may be issued).</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:9.5pt;text-align:justify;text-indent:72pt;margin:0pt 0pt 12pt 0pt;"><b style="font-size:10pt;font-weight:bold;">(v)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</b><font style="font-size:10pt;">To suspend or terminate the Plan at any time. Except as otherwise provided in the Plan or an Award Agreement, suspension or termination of the Plan will not materially impair a Participant&#8217;s rights under his or her then-outstanding Award without his or her written consent except as provided in Section 2(b)(viii) below.</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:9.5pt;text-align:justify;text-indent:72pt;margin:0pt 0pt 12pt 0pt;"><b style="font-size:10pt;font-weight:bold;">(vi)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</b><font style="font-size:10pt;">To amend the Plan in any respect the Board deems necessary or advisable, including, without limitation, by adopting amendments relating to Incentive Stock Options and certain nonqualified deferred compensation under Section 409A of the Code and/or to bring the Plan or Awards granted under the Plan compliant with the requirements for Incentive Stock Options or exempt from or compliant with the requirements for nonqualified deferred compensation under Section 409A of the Code, subject to the limitations, if any, of applicable law. If required by applicable law or listing requirements, and except as provided in Section 9(a) relating to Capitalization Adjustments, the Company will seek stockholder approval of any amendment of the Plan that (A) materially increases the number of shares of Common Stock available for issuance under the Plan, (B) materially expands the class of individuals eligible to receive Awards under the Plan, (C) materially increases the benefits accruing to Participants under the Plan, (D) materially reduces the price at which shares of Common Stock may be issued or purchased under the Plan, (E) materially extends the term of the Plan, or (F) materially expands the types of Awards available for issuance under the Plan. Except as otherwise provided in the Plan or an Award Agreement, no amendment of the Plan will materially impair a Participant&#8217;s rights under an outstanding Award without the Participant&#8217;s written consent.</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:9.5pt;text-align:justify;text-indent:72pt;margin:0pt 0pt 12pt 0pt;"><b style="font-size:10pt;font-weight:bold;">(vii)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</b><font style="font-size:10pt;">To the extent required by applicable law or listing requirements, to submit any amendment to the Plan for stockholder approval.</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:9.5pt;text-align:justify;text-indent:72pt;margin:0pt 0pt 12pt 0pt;"><b style="font-size:10pt;font-weight:bold;">(viii)&#160;&#160;&#160;&#160;&#160;&#160;&#160;</b><font style="font-size:10pt;">To approve forms of Award Agreements for use under the Plan and to amend the terms of any one or more Awards, including, but not limited to, amendments to provide terms more favorable to the Participant than previously provided in the Award Agreement, subject to any specified limits in the Plan that are not subject to Board discretion; provided however, that a Participant&#8217;s rights under any Award will not be impaired by any such amendment unless (A) the Company requests the consent of the affected Participant, and (B) such Participant consents in writing. Notwithstanding the foregoing, (1) a Participant&#8217;s rights will not be deemed to have been impaired by any such amendment if the Board, in its sole discretion, determines that the amendment, taken as a whole, does not materially impair the Participant&#8217;s rights, and (2) subject to the limitations of applicable law, if any, the Board may amend the terms of any one or more Awards without the affected Participant&#8217;s consent (A) to maintain the qualified status of the Award as an Incentive Stock Option under Section 422 of the Code; (B) to change the terms of an Incentive Stock Option, if such change results in impairment of the Award solely because it impairs the qualified status of the Award as an Incentive Stock Option under Section 422 of the Code; (C) to clarify the manner of exemption from, or to bring the Award into compliance with, Section 409A of the Code; or (D) to comply with other applicable laws or listing requirements.</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:9.5pt;text-align:justify;text-indent:72pt;margin:0pt 0pt 12pt 0pt;"><b style="font-size:10pt;font-weight:bold;">(ix)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</b><font style="font-size:10pt;">Generally, to exercise such powers and to perform such acts as the Board deems necessary or expedient to promote the best interests of the Company and that are not in conflict with the provisions of the Plan or Awards.</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:9.5pt;text-align:justify;text-indent:72pt;margin:0pt 0pt 12pt 0pt;"><b style="font-size:10pt;font-weight:bold;">(x)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</b><font style="font-size:10pt;">To adopt such procedures and sub-plans as are necessary or appropriate to permit participation in the Plan by Employees, Directors or Consultants who are foreign nationals or employed outside the United States (provided that Board approval will not be necessary for immaterial modifications to the Plan or any Award Agreement that are required for compliance with the laws of the relevant foreign jurisdiction).</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:9.5pt;text-align:justify;text-indent:72pt;margin:0pt;"><b style="font-size:10pt;font-weight:bold;">(xi)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</b><font style="font-size:10pt;">To effect, with the consent of any adversely affected Participant, (A) the reduction of the exercise, purchase or strike price of any outstanding Award; (B) the cancellation of any outstanding Award and the </font></p></div><div style="clear:both;display:table;margin-bottom:27.35pt;min-height:44.65pt;width:100%;"><div style="display:table-cell;vertical-align:bottom;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;min-height:12.0pt;text-align:center;margin:24pt 0pt 0pt 0pt;">2</p></div></div></div><hr style="background-color:#000000;clear:both;color:#000000;height:2pt;line-height:0;margin-bottom:30pt;margin-left:11.76%;margin-right:11.76%;margin-top:30pt;page-break-after:always;width:76.47%;border-width:0;"><div style="max-width:100%;padding-left:11.76%;padding-right:11.76%;position:relative;"><div style="margin-top:27.35pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"><font style="font-weight:bold;visibility:hidden;">&#8203;</font></p></div><div style="clear:both;max-width:100%;position:relative;"><p style="font-family:'Times New Roman','Times','serif';font-size:9.5pt;text-align:justify;margin:0pt 0pt 12pt 0pt;"><font style="font-size:10pt;">grant in substitution therefor of a new (1) Option or SAR, (2) Restricted Stock Award, (3) Restricted Stock Unit Award, (4) Other Award, (5) cash award and/or (6) award of other valuable consideration determined by the Board, in its sole discretion, with any such substituted award (x) covering the same or a different number of shares of Common Stock as the cancelled Award and (y) granted under the Plan or another equity or compensatory plan of the Company; or (C) any other action that is treated as a repricing under generally accepted accounting principles.</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:9.5pt;text-align:justify;text-indent:36pt;margin:0pt 0pt 12pt 0pt;"><b style="font-size:10pt;font-weight:bold;">(c)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Delegation to Committee</b><font style="font-size:10pt;">.</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:9.5pt;text-align:justify;text-indent:72pt;margin:0pt 0pt 12pt 0pt;"><b style="font-size:10pt;font-weight:bold;">(i)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;General</b><font style="font-size:10pt;">. The Board may delegate some or all of the administration of the Plan to a Committee or Committees. If administration of the Plan is delegated to a Committee, the Committee will have, in connection with the administration of the Plan, the powers theretofore possessed by the Board that have been delegated to the Committee, including the power to delegate to a subcommittee of the Committee any of the administrative powers the Committee is authorized to exercise (and references in this Plan to the Board will thereafter be to the Committee or subcommittee, as applicable). Any delegation of administrative powers will be reflected in resolutions, not inconsistent with the provisions of the Plan, adopted from time to time by the Board or Committee (as applicable). The Board may retain the authority to concurrently administer the Plan with the Committee and may, at any time, revest in the Board some or all of the powers previously delegated.</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:9.5pt;text-align:justify;text-indent:72pt;margin:0pt 0pt 12pt 0pt;"><b style="font-size:10pt;font-weight:bold;">(ii)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Rule 16b-3 Compliance</b><font style="font-size:10pt;">. To the extent an Award is intended to qualify for the exemption from Section 16(b) of the Exchange Act that is available under Rule 16b-3 of the Exchange Act, the Award will be granted by the Board or a Committee that consists solely of two or more Non-Employee Directors, as determined under Rule 16b-3(b)(3) of the Exchange Act and thereafter any action establishing or modifying the terms of the Award will be approved by the Board or a Committee meeting such requirements to the extent necessary for such exemption to remain available.</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:9.5pt;text-align:justify;text-indent:36pt;margin:0pt 0pt 12pt 0pt;"><b style="font-size:10pt;font-weight:bold;">(d)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Delegation to an Officer</b><font style="font-size:10pt;">. The Board may delegate to one (1) or more Officers the authority to do one or both of the following (i) designate Employees who are not Officers to be recipients of Options and SARs (and, to the extent permitted by applicable law, other Awards) and, to the extent permitted by applicable law, the terms of such Awards, and (ii) determine the number of shares of Common Stock to be subject to such Awards granted to such Employees; </font><i style="font-size:10pt;font-style:italic;">provided, however,</i><font style="font-size:10pt;"> that the Board resolutions regarding such delegation will specify the total number of shares of Common Stock that may be subject to the Awards granted by such Officer and that such Officer may not grant an Award to himself or herself. Any such Awards will be granted on the form of Award Agreement most recently approved for use by the Committee or the Board, unless otherwise provided in the resolutions approving the delegation authority. The Board may not delegate authority to an Officer who is acting solely in the capacity of an Officer (and not also as a Director) to determine the Fair Market Value.</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:9.5pt;text-align:justify;text-indent:36pt;margin:0pt 0pt 12pt 0pt;"><b style="font-size:10pt;font-weight:bold;">(e)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Effect of Board&#8217;s Decision</b><font style="font-size:10pt;">. All determinations, interpretations and constructions made by the Board in good faith will not be subject to review by any person and will be final, binding and conclusive on all persons.</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:9.5pt;padding-left:36pt;text-align:justify;text-indent:-36pt;margin:0pt 0pt 12pt 0pt;"><b style="font-size:10pt;font-variant:small-caps;font-weight:bold;">3.&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Shares Subject to the Plan.</b></p><p style="font-family:'Times New Roman','Times','serif';font-size:9.5pt;text-align:justify;text-indent:36pt;margin:0pt;"><b style="font-size:10pt;font-weight:bold;">(a)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Share Reserve</b><font style="font-size:10pt;">. Subject to Section 9(a) relating to Capitalization Adjustments, and the following sentence regarding the annual increase, the aggregate number of shares of Common Stock that may be issued pursuant to Awards will not exceed 12,145,995 shares (the &#8220;</font><font style="font-size:10pt;font-style:italic;font-weight:bold;">Share Reserve</font><font style="font-size:10pt;">&#8221;), which number is the sum of (i) 2,619,622 shares of Common Stock added to the Share Reserve as of the A&amp;R Effective Date, plus (ii) 9,506,767 shares of Common Stock, consisting of the shares reserved under the Plan as of the Original Effective Date, plus shares previously added to the Share Reserve pursuant to the &#8220;evergreen&#8221; provision in Section 3(a) of the Plan between the Original Effective Date and the A&amp;R Effective Date, plus (iii) the Returning Shares, if any, in an amount not to exceed 19,606 shares of Common Stock, which become available for grant under this Plan from time to time on or after the A&amp;R Effective Date. In addition, the Share Reserve will automatically increase on January 1</font><sup style="font-size:7.5pt;vertical-align:top;">st</sup><font style="font-size:10pt;"> of each year, for a period of not more than seven years following the A&amp;R Effective Date, commencing on January 1</font><sup style="font-size:7.5pt;vertical-align:top;">st</sup><font style="font-size:10pt;"> of the year following the year in which the A&amp;R Effective Date occurs and ending on (and including) January 1, 2029, in an amount equal to 4% of the total number of shares of Capital Stock outstanding on December 31</font><sup style="font-size:7.5pt;vertical-align:top;">st</sup><font style="font-size:10pt;"> of the preceding calendar year. Notwithstanding the foregoing, the Board may act prior to January 1</font><sup style="font-size:7.5pt;vertical-align:top;">st</sup><font style="font-size:10pt;"> of a given year to provide that there will be no January 1</font><sup style="font-size:7.5pt;vertical-align:top;">st</sup><font style="font-size:10pt;"> increase in the Share Reserve for such year or that the increase in the Share Reserve for such year will be a lesser number of shares of Common Stock than would otherwise occur pursuant to the preceding sentence. For </font></p></div><div style="clear:both;display:table;margin-bottom:27.35pt;min-height:44.65pt;width:100%;"><div style="display:table-cell;vertical-align:bottom;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;min-height:12.0pt;text-align:center;margin:24pt 0pt 0pt 0pt;">3</p></div></div></div><hr style="background-color:#000000;clear:both;color:#000000;height:2pt;line-height:0;margin-bottom:30pt;margin-left:11.76%;margin-right:11.76%;margin-top:30pt;page-break-after:always;width:76.47%;border-width:0;"><div style="max-width:100%;padding-left:11.76%;padding-right:11.76%;position:relative;"><div style="margin-top:27.35pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"><font style="font-weight:bold;visibility:hidden;">&#8203;</font></p></div><div style="clear:both;max-width:100%;position:relative;"><p style="font-family:'Times New Roman','Times','serif';font-size:9.5pt;text-align:justify;margin:0pt 0pt 12pt 0pt;"><font style="font-size:10pt;">clarity, the Share Reserve is a limitation on the number of shares of Common Stock that may be issued under the Plan. Accordingly, this Section 3(a) does not limit the granting of Awards except as provided in Section 7(a). Shares may be issued in connection with a merger or acquisition as permitted by NASDAQ Listing Rule 5635(c) or, if applicable, NYSE Listed Company Manual Section 303A.08, AMEX Company Guide Section 711 or other applicable rule, and such issuance will not reduce the number of shares available for issuance under the Plan.</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:9.5pt;text-align:justify;text-indent:36pt;margin:0pt 0pt 12pt 0pt;"><b style="font-size:10pt;font-weight:bold;">(b)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Reversion of Shares to the Share Reserve</b><font style="font-size:10pt;">. If an Award or any portion thereof (i) expires or otherwise terminates without all of the shares covered by such Award having been issued or (ii) is settled in cash (i.e., the Participant receives cash rather than stock), such expiration, termination or settlement will not reduce (or otherwise offset) the number of shares of Common Stock that may be available for issuance under the Plan. If any shares of Common Stock issued pursuant to an Award are forfeited back to or repurchased by the Company because of the failure to meet a contingency or condition required to vest such shares in the Participant, then the shares that are forfeited or repurchased will revert to and again become available for issuance under the Plan. Any shares reacquired by the Company in satisfaction of tax withholding obligations on an Award or as consideration for the exercise or purchase price of an Award will again become available for issuance under the Plan.</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:9.5pt;text-align:justify;text-indent:36pt;margin:0pt 0pt 12pt 0pt;"><b style="font-size:10pt;font-weight:bold;">(c)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Incentive Stock Option Limit</b><font style="font-size:10pt;">. Subject to the provisions of Section 9(a) relating to Capitalization Adjustments, the aggregate maximum number of shares of Common Stock that may be issued pursuant to the exercise of Incentive Stock Options will be 20,000,000 shares of Common Stock.</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:9.5pt;text-align:justify;text-indent:36pt;margin:0pt 0pt 12pt 0pt;"><b style="font-size:10pt;font-weight:bold;">(d)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Source of Shares</b><font style="font-size:10pt;">. The stock issuable under the Plan will be shares of authorized but unissued or reacquired Common Stock, including shares repurchased by the Company on the open market or otherwise.</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:9.5pt;text-align:justify;text-indent:36pt;margin:0pt 0pt 12pt 0pt;"><b style="font-size:10pt;font-weight:bold;">(e)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Non-Employee Director Compensation Limit</b><font style="font-size:10pt;">. &#160;The aggregate value of all compensation granted or paid, as applicable, to any individual for service as a Non-Employee Director with respect to any calendar year, including Awards granted and cash fees paid by the Company to such Non-Employee Director, will not exceed (1) $750,000 in total value or (2)&#160;in the event such Non-Employee Director is first appointed or elected to the Board during such calendar year, $1,000,000 in total value, in each case, calculating the value of any equity awards based on the grant date fair value of such equity awards for financial reporting purposes.&#160;</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:9.5pt;padding-left:36pt;text-align:justify;text-indent:-36pt;margin:0pt 0pt 12pt 0pt;"><b style="font-size:10pt;font-variant:small-caps;font-weight:bold;">4.&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Eligibility.</b></p><p style="font-family:'Times New Roman','Times','serif';font-size:9.5pt;text-align:justify;text-indent:36pt;margin:0pt 0pt 12pt 0pt;"><b style="font-size:10pt;font-weight:bold;">(a)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Eligibility for Specific Awards</b><font style="font-size:10pt;">. Incentive Stock Options may be granted only to employees of the Company or a &#8220;parent corporation&#8221; or &#8220;subsidiary corporation&#8221; thereof (as such terms are defined in Sections 424(e) and 424(f) of the Code). Awards other than Incentive Stock Options may be granted to Employees, Directors and Consultants; </font><i style="font-size:10pt;font-style:italic;">provided, however,</i><font style="font-size:10pt;"> that Awards may not be granted to Employees, Directors and Consultants who are providing Continuous Service only to any &#8220;parent&#8221; of the Company, as such term is defined in Rule 405 of the Securities Act, unless (i) the stock underlying such Awards is treated as &#8220;service recipient stock&#8221; under Section 409A of the Code (for example, because the Awards are granted pursuant to a corporate transaction such as a spin off transaction), (ii) the Company, in consultation with its legal counsel, has determined that such Awards are otherwise exempt from Section 409A of the Code, or (iii) the Company, in consultation with its legal counsel, has determined that such Awards comply with the distribution requirements of Section 409A of the Code.</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:9.5pt;text-align:justify;text-indent:36pt;margin:0pt 0pt 12pt 0pt;"><b style="font-size:10pt;font-weight:bold;">(b)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Ten Percent Stockholders</b><font style="font-size:10pt;">. A Ten Percent Stockholder will not be granted an Incentive Stock Option unless the exercise price of such Option is at least 110% of the Fair Market Value on the date of grant and the Option is not exercisable after the expiration of five years from the date of grant.</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:9.5pt;padding-left:36pt;text-align:justify;text-indent:-36pt;margin:0pt 0pt 12pt 0pt;"><b style="font-size:10pt;font-variant:small-caps;font-weight:bold;">5.&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Provisions Relating to Options and Stock Appreciation Rights.</b></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:18pt;margin:0pt;">Each Option or SAR will be in such form and will contain such terms and conditions as the Board deems appropriate. All Options will be separately designated Incentive Stock Options or Nonstatutory Stock Options at the time of grant, and, if certificates are issued, a separate certificate or certificates will be issued for shares of Common Stock purchased on exercise of each type of Option. If an Option is not specifically designated as an Incentive Stock Option, or if an Option is designated as an Incentive Stock Option but some portion or all of the Option fails to qualify as an Incentive Stock Option under the applicable rules, then the Option (or portion thereof) will be a Nonstatutory </p></div><div style="clear:both;display:table;margin-bottom:27.35pt;min-height:44.65pt;width:100%;"><div style="display:table-cell;vertical-align:bottom;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;min-height:12.0pt;text-align:center;margin:24pt 0pt 0pt 0pt;">4</p></div></div></div><hr style="background-color:#000000;clear:both;color:#000000;height:2pt;line-height:0;margin-bottom:30pt;margin-left:11.76%;margin-right:11.76%;margin-top:30pt;page-break-after:always;width:76.47%;border-width:0;"><div style="max-width:100%;padding-left:11.76%;padding-right:11.76%;position:relative;"><div style="margin-top:27.35pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"><font style="font-weight:bold;visibility:hidden;">&#8203;</font></p></div><div style="clear:both;max-width:100%;position:relative;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt 0pt 12pt 0pt;">Stock Option. The provisions of separate Options or SARs need not be identical; <i style="font-style:italic;">provided, however,</i> that each Award Agreement will conform to (through incorporation of provisions hereof by reference in the applicable Award Agreement or otherwise) the substance of each of the following provisions:</p><p style="font-family:'Times New Roman','Times','serif';font-size:9.5pt;text-align:justify;text-indent:36pt;margin:0pt 0pt 12pt 0pt;"><b style="font-size:10pt;font-weight:bold;">(a)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Term</b><font style="font-size:10pt;">. Subject to the provisions of Section 4(b) regarding Ten Percent Stockholders, no Option or SAR will be exercisable after the expiration of ten years from the date of its grant or such shorter period specified in the Award Agreement.</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:9.5pt;text-align:justify;text-indent:36pt;margin:0pt 0pt 12pt 0pt;"><b style="font-size:10pt;font-weight:bold;">(b)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Exercise Price</b><font style="font-size:10pt;">. Subject to the provisions of Section 4(b) regarding Ten Percent Stockholders, the exercise or strike price of each Option or SAR will be not less than 100% of the Fair Market Value of the Common Stock subject to the Option or SAR on the date the Award is granted. Notwithstanding the foregoing, an Option or SAR may be granted with an exercise or strike price lower than 100% of the Fair Market Value of the Common Stock subject to the Award if such Award is granted pursuant to an assumption of or substitution for another option or stock appreciation right pursuant to a Corporate Transaction and in a manner consistent with the provisions of Section 409A and, if applicable, Section 424(a) of the Code. Each SAR will be denominated in shares of Common Stock equivalents.</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:9.5pt;text-align:justify;text-indent:36pt;margin:0pt 0pt 12pt 0pt;"><b style="font-size:10pt;font-weight:bold;">(c)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Purchase Price for Options</b><font style="font-size:10pt;">. The purchase price of Common Stock acquired pursuant to the exercise of an Option may be paid, to the extent permitted by applicable law and as determined by the Board in its sole discretion, by any combination of the methods of payment set forth below. The Board will have the authority to grant Options that do not permit all of the following methods of payment (or otherwise restrict the ability to use certain methods) and to grant Options that require the consent of the Company to use a particular method of payment. The permitted methods of payment are as follows:</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:9.5pt;text-align:justify;text-indent:72pt;margin:0pt 0pt 12pt 0pt;"><b style="font-size:10pt;font-weight:bold;">(i)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</b><font style="font-size:10pt;">by cash, check, bank draft or money order payable to the Company;</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:9.5pt;text-align:justify;text-indent:72pt;margin:0pt 0pt 12pt 0pt;"><b style="font-size:10pt;font-weight:bold;">(ii)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</b><font style="font-size:10pt;">pursuant to a program developed under Regulation T as promulgated by the Federal Reserve Board that, prior to the issuance of the stock subject to the Option, results in either the receipt of cash (or check) by the Company or the receipt of irrevocable instructions to pay the aggregate exercise price to the Company from the sales proceeds;</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:9.5pt;text-align:justify;text-indent:72pt;margin:0pt 0pt 12pt 0pt;"><b style="font-size:10pt;font-weight:bold;">(iii)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</b><font style="font-size:10pt;">by delivery to the Company (either by actual delivery or attestation) of shares of Common Stock;</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:9.5pt;text-align:justify;text-indent:72pt;margin:0pt 0pt 12pt 0pt;"><b style="font-size:10pt;font-weight:bold;">(iv)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</b><font style="font-size:10pt;">if an Option is a Nonstatutory Stock Option, by a &#8220;net exercise&#8221; arrangement pursuant to which the Company will reduce the number of shares of Common Stock issuable upon exercise by the largest whole number of shares with a Fair Market Value that does not exceed the aggregate exercise price; </font><i style="font-size:10pt;font-style:italic;">provided, however,</i><font style="font-size:10pt;"> that the Company will accept a cash or other payment from the Participant to the extent of any remaining balance of the aggregate exercise price not satisfied by such reduction in the number of whole shares to be issued. Shares of Common Stock will no longer be subject to an Option and will not be exercisable thereafter to the extent that (A) shares issuable upon exercise are reduced to pay the exercise price pursuant to the &#8220;net exercise,&#8221; (B) shares are delivered to the Participant as a result of such exercise, and (C) shares are withheld to satisfy tax withholding obligations; or</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:9.5pt;text-align:justify;text-indent:72pt;margin:0pt 0pt 12pt 0pt;"><b style="font-size:10pt;font-weight:bold;">(v)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</b><font style="font-size:10pt;">in any other form of legal consideration that may be acceptable to the Board and specified in the applicable Award Agreement.</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:9.5pt;text-align:justify;text-indent:36pt;margin:0pt 0pt 12pt 0pt;"><b style="font-size:10pt;font-weight:bold;">(d)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Exercise and Payment of a SAR</b><font style="font-size:10pt;">. To exercise any outstanding SAR, the Participant must provide written notice of exercise to the Company in compliance with the provisions of the Stock Appreciation Right Agreement evidencing such SAR. The appreciation distribution payable on the exercise of a SAR will be not greater than an amount equal to the excess of (A) the aggregate Fair Market Value (on the date of the exercise of the SAR) of a number of shares of Common Stock equal to the number of Common Stock equivalents in which the Participant is vested under such SAR, and with respect to which the Participant is exercising the SAR on such date, over (B) the aggregate strike price of the number of Common Stock equivalents with respect to which the Participant is exercising the SAR on such date. The appreciation distribution may be paid in Common Stock, in cash, in any combination of the two or in any other form of consideration, as determined by the Board and contained in the Award Agreement evidencing such SAR.</font></p></div><div style="clear:both;display:table;margin-bottom:27.35pt;min-height:44.65pt;width:100%;"><div style="display:table-cell;vertical-align:bottom;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;min-height:12.0pt;text-align:center;margin:24pt 0pt 0pt 0pt;">5</p></div></div></div><hr style="background-color:#000000;clear:both;color:#000000;height:2pt;line-height:0;margin-bottom:30pt;margin-left:11.76%;margin-right:11.76%;margin-top:30pt;page-break-after:always;width:76.47%;border-width:0;"><div style="max-width:100%;padding-left:11.76%;padding-right:11.76%;position:relative;"><div style="margin-top:27.35pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"><font style="font-weight:bold;visibility:hidden;">&#8203;</font></p></div><div style="clear:both;max-width:100%;position:relative;"><p style="font-family:'Times New Roman','Times','serif';font-size:9.5pt;text-align:justify;text-indent:36pt;margin:0pt 0pt 12pt 0pt;"><b style="font-size:10pt;font-weight:bold;">(e)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Transferability of Options and SARs</b><font style="font-size:10pt;">. The Board may, in its sole discretion, impose such limitations on the transferability of Options and SARs as the Board will determine. In the absence of such a determination by the Board to the contrary, the following restrictions on the transferability of Options and SARs will apply:</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:9.5pt;text-align:justify;text-indent:72pt;margin:0pt 0pt 12pt 0pt;"><b style="font-size:10pt;font-weight:bold;">(i)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Restrictions on Transfer</b><font style="font-size:10pt;">. An Option or SAR will not be transferable except by will or by the laws of descent and distribution (or pursuant to subsections (ii) and (iii) below), and will be exercisable during the lifetime of the Participant only by the Participant. The Board may permit transfer of the Option or SAR in a manner that is not prohibited by applicable tax and securities laws. Except as explicitly provided herein, neither an Option nor a SAR may be transferred for consideration.</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:9.5pt;text-align:justify;text-indent:72pt;margin:0pt 0pt 12pt 0pt;"><b style="font-size:10pt;font-weight:bold;">(ii)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Domestic Relations Orders</b><font style="font-size:10pt;">. Subject to the approval of the Board or a duly authorized Officer, an Option or SAR may be transferred pursuant to the terms of a domestic relations order, official marital settlement agreement or other divorce or separation instrument as permitted by Treasury Regulations Section 1.421-1(b)(2). If an Option is an Incentive Stock Option, such Option may be deemed to be a Nonstatutory Stock Option as a result of such transfer.</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:9.5pt;text-align:justify;text-indent:72pt;margin:0pt 0pt 12pt 0pt;"><b style="font-size:10pt;font-weight:bold;">(iii)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Beneficiary Designation</b><font style="font-size:10pt;">. Subject to the approval of the Board or a duly authorized Officer, a Participant may, by delivering written notice to the Company, in a form approved by the Company (or the designated broker), designate a third party who, on the death of the Participant, will thereafter be entitled to exercise the Option or SAR and receive the Common Stock or other consideration resulting from such exercise. In the absence of such a designation, the executor or administrator of the Participant&#8217;s estate will be entitled to exercise the Option or SAR and receive the Common Stock or other consideration resulting from such exercise. However, the Company may prohibit designation of a beneficiary at any time, including due to any conclusion by the Company that such designation would be inconsistent with the provisions of applicable laws.</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:9.5pt;text-align:justify;text-indent:36pt;margin:0pt 0pt 12pt 0pt;"><b style="font-size:10pt;font-weight:bold;">(f)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Vesting Generally</b><font style="font-size:10pt;">. The total number of shares of Common Stock subject to an Option or SAR may vest and become exercisable in periodic installments that may or may not be equal. The Option or SAR may be subject to such other terms and conditions on the time or times when it may or may not be exercised (which may be based on the satisfaction of Performance Goals or other criteria) as the Board may deem appropriate. The vesting provisions of individual Options or SARs may vary. The provisions of this Section 5(f) are subject to any Option or SAR provisions governing the minimum number of shares of Common Stock as to which an Option or SAR may be exercised.</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:9.5pt;text-align:justify;text-indent:36pt;margin:0pt 0pt 12pt 0pt;"><b style="font-size:10pt;font-weight:bold;">(g)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Termination of Continuous Service</b><font style="font-size:10pt;">. Except as otherwise provided in the applicable Award Agreement or other agreement between the Participant and the Company, if a Participant&#8217;s Continuous Service terminates (other than for Cause and other than upon the Participant&#8217;s death or Disability), the Participant may exercise his or her Option or SAR (to the extent that the Participant was entitled to exercise such Award as of the date of termination of Continuous Service) within the period of time ending on the earlier of (i) the date three months following the termination of the Participant&#8217;s Continuous Service (or such longer or shorter period specified in the applicable Award Agreement), and (ii) the expiration of the term of the Option or SAR as set forth in the Award Agreement. If, after termination of Continuous Service, the Participant does not exercise his or her Option or SAR (as applicable) within the applicable time frame, the Option or SAR will terminate.</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:9.5pt;text-align:justify;text-indent:36pt;margin:0pt;"><b style="font-size:10pt;font-weight:bold;">(h)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Extension of Termination Date</b><font style="font-size:10pt;">. If the exercise of an Option or SAR following the termination of the Participant&#8217;s Continuous Service (other than for Cause and other than upon the Participant&#8217;s death or Disability) would be prohibited at any time solely because the issuance of shares of Common Stock would violate the registration requirements under the Securities Act, then the Option or SAR will terminate on the earlier of (i) the expiration of a total period of time (that need not be consecutive) equal to the applicable post termination exercise period after the termination of the Participant&#8217;s Continuous Service during which the exercise of the Option or SAR would not be in violation of such registration requirements, and (ii) the expiration of the term of the Option or SAR as set forth in the applicable Award Agreement. In addition, unless otherwise provided in a Participant&#8217;s Award Agreement, if the sale of any Common Stock received on exercise of an Option or SAR following the termination of the Participant&#8217;s Continuous Service (other than for Cause) would violate the Company&#8217;s insider trading policy, then the Option or SAR will terminate on the earlier of (i) the expiration of a period of months (that need not be consecutive) equal to the applicable post-termination exercise period after the termination of the Participant&#8217;s Continuous Service during which the sale of the Common Stock received upon exercise of the Option or SAR would not be in violation of the </font></p></div><div style="clear:both;display:table;margin-bottom:27.35pt;min-height:44.65pt;width:100%;"><div style="display:table-cell;vertical-align:bottom;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;min-height:12.0pt;text-align:center;margin:24pt 0pt 0pt 0pt;">6</p></div></div></div><hr style="background-color:#000000;clear:both;color:#000000;height:2pt;line-height:0;margin-bottom:30pt;margin-left:11.76%;margin-right:11.76%;margin-top:30pt;page-break-after:always;width:76.47%;border-width:0;"><div style="max-width:100%;padding-left:11.76%;padding-right:11.76%;position:relative;"><div style="margin-top:27.35pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"><font style="font-weight:bold;visibility:hidden;">&#8203;</font></p></div><div style="clear:both;max-width:100%;position:relative;"><p style="font-family:'Times New Roman','Times','serif';font-size:9.5pt;text-align:justify;margin:0pt 0pt 12pt 0pt;"><font style="font-size:10pt;">Company&#8217;s insider trading policy, or (ii) the expiration of the term of the Option or SAR as set forth in the applicable Award Agreement.</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:9.5pt;text-align:justify;text-indent:36pt;margin:0pt 0pt 12pt 0pt;"><b style="font-size:10pt;font-weight:bold;">(i)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Disability of Participant</b><font style="font-size:10pt;">. Except as otherwise provided in the applicable Award Agreement or other agreement between the Participant and the Company, if a Participant&#8217;s Continuous Service terminates as a result of the Participant&#8217;s Disability, the Participant may exercise his or her Option or SAR (to the extent that the Participant was entitled to exercise such Option or SAR as of the date of termination of Continuous Service), but only within such period of time ending on the earlier of (i) the date 12 months following such termination of Continuous Service (or such longer or shorter period specified in the Award Agreement), and (ii) the expiration of the term of the Option or SAR as set forth in the Award Agreement. If, after termination of Continuous Service, the Participant does not exercise his or her Option or SAR within the applicable time frame, the Option or SAR (as applicable) will terminate.</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:9.5pt;text-align:justify;text-indent:36pt;margin:0pt 0pt 12pt 0pt;"><b style="font-size:10pt;font-weight:bold;">(j)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Death of Participant</b><font style="font-size:10pt;">. Except as otherwise provided in the applicable Award Agreement or other agreement between the Participant and the Company, if (i) a Participant&#8217;s Continuous Service terminates as a result of the Participant&#8217;s death, or (ii) the Participant dies within the period (if any) specified in the Award Agreement for exercisability after the termination of the Participant&#8217;s Continuous Service for a reason other than death, then the Option or SAR may be exercised (to the extent the Participant was entitled to exercise such Option or SAR as of the date of death) by the Participant&#8217;s estate, by a person who acquired the right to exercise the Option or SAR by bequest or inheritance or by a person designated to exercise the Option or SAR upon the Participant&#8217;s death, but only within the period ending on the earlier of (i) the date 18 months following the date of death (or such longer or shorter period specified in the Award Agreement), and (ii) the expiration of the term of such Option or SAR as set forth in the Award Agreement. If, after the Participant&#8217;s death, the Option or SAR is not exercised within the applicable time frame, the Option or SAR will terminate.</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:9.5pt;text-align:justify;text-indent:36pt;margin:0pt 0pt 12pt 0pt;"><b style="font-size:10pt;font-weight:bold;">(k)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Termination for Cause</b><font style="font-size:10pt;">. Except as explicitly provided otherwise in a Participant&#8217;s Award Agreement or other individual written agreement between the Company or any Affiliate and the Participant, if a Participant&#8217;s Continuous Service is terminated for Cause, the Option or SAR will terminate immediately upon such Participant&#8217;s termination of Continuous Service, and the Participant will be prohibited from exercising his or her Option or SAR from and after the date of such termination of Continuous Service.</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:9.5pt;text-align:justify;text-indent:36pt;margin:0pt 0pt 12pt 0pt;"><b style="font-size:10pt;font-weight:bold;">(l)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Non-Exempt Employees</b><font style="font-size:10pt;">. If an Option or SAR is granted to an Employee who is a non-exempt employee for purposes of the Fair Labor Standards Act of 1938, as amended, the Option or SAR will not be first exercisable for any shares of Common Stock until at least six (6) months following the date of grant of the Option or SAR (although the Award may vest prior to such date). Consistent with the provisions of the Worker Economic Opportunity Act, (i) if such non-exempt Employee dies or suffers a Disability, (ii) upon a Corporate Transaction in which such Option or SAR is not assumed, continued, or substituted, (iii) upon a Change in Control, or (iv) upon the Participant&#8217;s retirement (as such term may be defined in the Participant&#8217;s Award Agreement in another agreement between the Participant and the Company, or, if no such definition, in accordance with the Company&#8217;s then current employment policies and guidelines), the vested portion of any Options and SARs may be exercised earlier than six months following the date of grant. The foregoing provision is intended to operate so that any income derived by a non-exempt employee in connection with the exercise or vesting of an Option or SAR will be exempt from his or her regular rate of pay. To the extent permitted and/or required for compliance with the Worker Economic Opportunity Act to ensure that any income derived by a non-exempt employee in connection with the exercise, vesting or issuance of any shares under any other Award will be exempt from the employee&#8217;s regular rate of pay, the provisions of this Section 5(l) will apply to all Awards and are hereby incorporated by reference into such Award Agreements.</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:9.5pt;padding-left:36pt;text-align:justify;text-indent:-36pt;margin:0pt 0pt 12pt 0pt;"><b style="font-size:10pt;font-variant:small-caps;font-weight:bold;">6.&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Provisions of Awards Other Than Options and SARS.</b></p><p style="font-family:'Times New Roman','Times','serif';font-size:9.5pt;text-align:justify;text-indent:36pt;margin:0pt;"><b style="font-size:10pt;font-weight:bold;">(a)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Restricted Stock Awards</b><font style="font-size:10pt;">. Each Restricted Stock Award Agreement will be in such form and will contain such terms and conditions as the Board will deem appropriate. To the extent consistent with the Company&#8217;s bylaws, at the Board&#8217;s election, shares of Common Stock may be (x) held in book entry form subject to the Company&#8217;s instructions until any restrictions relating to the Restricted Stock Award lapse&#894; or (y) evidenced by a certificate, which certificate will be held in such form and manner as determined by the Board. The terms and conditions of Restricted Stock Award Agreements may change from time to time, and the terms and conditions of separate Restricted Stock Award Agreements need not be identical. Each Restricted Stock Award Agreement will conform to (through </font></p></div><div style="clear:both;display:table;margin-bottom:27.35pt;min-height:44.65pt;width:100%;"><div style="display:table-cell;vertical-align:bottom;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;min-height:12.0pt;text-align:center;margin:24pt 0pt 0pt 0pt;">7</p></div></div></div><hr style="background-color:#000000;clear:both;color:#000000;height:2pt;line-height:0;margin-bottom:30pt;margin-left:11.76%;margin-right:11.76%;margin-top:30pt;page-break-after:always;width:76.47%;border-width:0;"><div style="max-width:100%;padding-left:11.76%;padding-right:11.76%;position:relative;"><div style="margin-top:27.35pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"><font style="font-weight:bold;visibility:hidden;">&#8203;</font></p></div><div style="clear:both;max-width:100%;position:relative;"><p style="font-family:'Times New Roman','Times','serif';font-size:9.5pt;text-align:justify;margin:0pt 0pt 12pt 0pt;"><font style="font-size:10pt;">incorporation of the provisions hereof by reference in the agreement or otherwise) the substance of each of the following provisions:</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:9.5pt;text-align:justify;text-indent:72pt;margin:0pt 0pt 12pt 0pt;"><b style="font-size:10pt;font-weight:bold;">(i)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Consideration</b><font style="font-size:10pt;">. A Restricted Stock Award may be awarded in consideration for (A) cash, check, bank draft or money order payable to the Company, (B) past services to the Company or an Affiliate, or (C) any other form of legal consideration (including future services) that may be acceptable to the Board, in its sole discretion, and permissible under applicable law.</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:9.5pt;text-align:justify;text-indent:72pt;margin:0pt 0pt 12pt 0pt;"><b style="font-size:10pt;font-weight:bold;">(ii)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Vesting</b><font style="font-size:10pt;">. Shares of Common Stock awarded under the Restricted Stock Award Agreement may be subject to forfeiture to the Company in accordance with a vesting schedule to be determined by the Board.</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:9.5pt;text-align:justify;text-indent:72pt;margin:0pt 0pt 12pt 0pt;"><b style="font-size:10pt;font-weight:bold;">(iii)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Termination of Participant&#8217;s Continuous Service</b><font style="font-size:10pt;">. If a Participant&#8217;s Continuous Service terminates, the Company may receive through a forfeiture condition or a repurchase right any or all of the shares of Common Stock held by the Participant as of the date of termination of Continuous Service under the terms of the Restricted Stock Award Agreement.</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:9.5pt;text-align:justify;text-indent:72pt;margin:0pt 0pt 12pt 0pt;"><b style="font-size:10pt;font-weight:bold;">(iv)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Transferability</b><font style="font-size:10pt;">. Rights to acquire shares of Common Stock under the Restricted Stock Award Agreement will be transferable by the Participant only upon such terms and conditions as are set forth in the Restricted Stock Award Agreement, as the Board will determine in its sole discretion, so long as Common Stock awarded under the Restricted Stock Award Agreement remains subject to the terms of the Restricted Stock Award Agreement.</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:9.5pt;text-align:justify;text-indent:72pt;margin:0pt 0pt 12pt 0pt;"><b style="font-size:10pt;font-weight:bold;">(v)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Dividends</b><font style="font-size:10pt;">. A Restricted Stock Award Agreement may provide that any dividends paid on Restricted Stock will be subject to the same vesting and forfeiture restrictions as apply to the shares subject to the Restricted Stock Award to which they relate.</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:9.5pt;text-align:justify;text-indent:36pt;margin:0pt 0pt 12pt 0pt;"><b style="font-size:10pt;font-weight:bold;">(b)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Restricted Stock Unit Awards</b><font style="font-size:10pt;">. Each Restricted Stock Unit Award Agreement will be in such form and will contain such terms and conditions as the Board will deem appropriate. The terms and conditions of Restricted Stock Unit Award Agreements may change from time to time, and the terms and conditions of separate Restricted Stock Unit Award Agreements need not be identical. Each Restricted Stock Unit Award Agreement will conform to (through incorporation of the provisions hereof by reference in the Agreement or otherwise) the substance of each of the following provisions:</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:9.5pt;text-align:justify;text-indent:72pt;margin:0pt 0pt 12pt 0pt;"><b style="font-size:10pt;font-weight:bold;">(i)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Consideration</b><font style="font-size:10pt;">. At the time of grant of a Restricted Stock Unit Award, the Board will determine the consideration, if any, to be paid by the Participant upon delivery of each share of Common Stock subject to the Restricted Stock Unit Award. The consideration to be paid (if any) by the Participant for each share of Common Stock subject to a Restricted Stock Unit Award may be paid in any form of legal consideration that may be acceptable to the Board, in its sole discretion, and permissible under applicable law.</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:9.5pt;text-align:justify;text-indent:72pt;margin:0pt 0pt 12pt 0pt;"><b style="font-size:10pt;font-weight:bold;">(ii)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Vesting</b><font style="font-size:10pt;">. At the time of the grant of a Restricted Stock Unit Award, the Board may impose such restrictions on or conditions to the vesting of the Restricted Stock Unit Award as it, in its sole discretion, deems appropriate.</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:9.5pt;text-align:justify;text-indent:72pt;margin:0pt 0pt 12pt 0pt;"><b style="font-size:10pt;font-weight:bold;">(iii)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Payment</b><font style="font-size:10pt;">. A Restricted Stock Unit Award may be settled by the delivery of shares of Common Stock, their cash equivalent, any combination thereof or in any other form of consideration, as determined by the Board and contained in the Restricted Stock Unit Award Agreement.</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:9.5pt;text-align:justify;text-indent:72pt;margin:0pt 0pt 12pt 0pt;"><b style="font-size:10pt;font-weight:bold;">(iv)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Additional Restrictions</b><font style="font-size:10pt;">. At the time of the grant of a Restricted Stock Unit Award, the Board, as it deems appropriate, may impose such restrictions or conditions that delay the delivery of the shares of Common Stock (or their cash equivalent) subject to a Restricted Stock Unit Award to a time after the vesting of such Restricted Stock Unit Award.</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:9.5pt;text-align:justify;text-indent:72pt;margin:0pt;"><b style="font-size:10pt;font-weight:bold;">(v)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Dividend Equivalents</b><font style="font-size:10pt;">. Dividend equivalents may be credited in respect of shares of Common Stock covered by a Restricted Stock Unit Award, as determined by the Board and contained in the Restricted Stock Unit Award Agreement. At the sole discretion of the Board, such dividend equivalents may be converted into </font></p></div><div style="clear:both;display:table;margin-bottom:27.35pt;min-height:44.65pt;width:100%;"><div style="display:table-cell;vertical-align:bottom;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;min-height:12.0pt;text-align:center;margin:24pt 0pt 0pt 0pt;">8</p></div></div></div><hr style="background-color:#000000;clear:both;color:#000000;height:2pt;line-height:0;margin-bottom:30pt;margin-left:11.76%;margin-right:11.76%;margin-top:30pt;page-break-after:always;width:76.47%;border-width:0;"><div style="max-width:100%;padding-left:11.76%;padding-right:11.76%;position:relative;"><div style="margin-top:27.35pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"><font style="font-weight:bold;visibility:hidden;">&#8203;</font></p></div><div style="clear:both;max-width:100%;position:relative;"><p style="font-family:'Times New Roman','Times','serif';font-size:9.5pt;text-align:justify;margin:0pt 0pt 12pt 0pt;"><font style="font-size:10pt;">additional shares of Common Stock covered by the Restricted Stock Unit Award in such manner as determined by the Board. Any additional shares covered by the Restricted Stock Unit Award credited by reason of such dividend equivalents will be subject to all of the same terms and conditions of the underlying Restricted Stock Unit Award Agreement to which they relate.</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:9.5pt;text-align:justify;text-indent:72pt;margin:0pt 0pt 12pt 0pt;"><b style="font-size:10pt;font-weight:bold;">(vi)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Termination of Participant&#8217;s Continuous Service</b><font style="font-size:10pt;">. Except as otherwise provided in the applicable Restricted Stock Unit Award Agreement, such portion of the Restricted Stock Unit Award that has not vested will be forfeited upon the Participant&#8217;s termination of Continuous Service.</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:9.5pt;text-align:justify;text-indent:36pt;margin:0pt 0pt 12pt 0pt;"><b style="font-size:10pt;font-weight:bold;">(c)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Performance Awards</b><font style="font-size:10pt;">. </font><a name="_Ref98847765"></a><a name="_Ref218923319"></a><font style="font-size:10pt;">With respect to any Performance Award, the length of any Performance Period, the Performance Goals to be achieved during the Performance Period, the other terms and conditions of such Award and the measure of whether and to what degree such Performance Goals have been attained will be determined by the Board.</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:9.5pt;text-align:justify;text-indent:36pt;margin:0pt 0pt 12pt 0pt;"><b style="font-size:10pt;font-weight:bold;">(d)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Other Awards</b><font style="font-size:10pt;">. Other forms of Awards valued in whole or in part by reference to, or otherwise based on, Common Stock, including the appreciation in value thereof (e.g., options or stock rights with an exercise price or strike price less than 100% of the Fair Market Value of the Common Stock at the time of grant) may be granted either alone or in addition to Awards provided for under Section 5 and the preceding provisions of this Section 6. Subject to the provisions of the Plan, the Board will have sole and complete authority to determine the persons to whom and the time or times at which such Other Awards will be granted, the number of shares of Common Stock (or the cash equivalent thereof) to be granted pursuant to such Other Awards and all other terms and conditions of such Other Awards.</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:9.5pt;padding-left:36pt;text-align:justify;text-indent:-36pt;margin:0pt 0pt 12pt 0pt;"><b style="font-size:10pt;font-variant:small-caps;font-weight:bold;">7.&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Covenants of the Company.</b></p><p style="font-family:'Times New Roman','Times','serif';font-size:9.5pt;text-align:justify;text-indent:36pt;margin:0pt 0pt 12pt 0pt;"><b style="font-size:10pt;font-weight:bold;">(a)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Availability of Shares</b><font style="font-size:10pt;">. The Company will keep available at all times the number of shares of Common Stock reasonably required to satisfy then-outstanding Awards.</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:9.5pt;text-align:justify;text-indent:36pt;margin:0pt 0pt 12pt 0pt;"><b style="font-size:10pt;font-weight:bold;">(b)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Securities Law Compliance</b><font style="font-size:10pt;">. The Company will seek to obtain from each regulatory commission or agency having jurisdiction over the Plan such authority as may be required to grant Awards and to issue and sell shares of Common Stock upon exercise of the Awards; </font><i style="font-size:10pt;font-style:italic;">provided, however,</i><font style="font-size:10pt;"> that this undertaking will not require the Company to register under the Securities Act the Plan, any Award or any Common Stock issued or issuable pursuant to any such Award. If, after reasonable efforts and at a reasonable cost, the Company is unable to obtain from any such regulatory commission or agency the authority that counsel for the Company deems necessary for the lawful issuance and sale of Common Stock under the Plan, the Company will be relieved from any liability for failure to issue and sell Common Stock upon exercise of such Awards unless and until such authority is obtained. A Participant will not be eligible for the grant of an Award or the subsequent issuance of cash or Common Stock pursuant to the Award if such grant or issuance would be in violation of any applicable securities law.</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:9.5pt;text-align:justify;text-indent:36pt;margin:0pt 0pt 12pt 0pt;"><b style="font-size:10pt;font-weight:bold;">(c)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;No Obligation to Notify or Minimize Taxes</b><font style="font-size:10pt;">. The Company will have no duty or obligation to any Participant to advise such holder as to the time or manner of exercising such Award. Furthermore, the Company will have no duty or obligation to warn or otherwise advise such holder of a pending termination or expiration of an Award or a possible period in which the Award may not be exercised. The Company has no duty or obligation to minimize the tax consequences of an Award to the holder of such Award.</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:9.5pt;padding-left:36pt;text-align:justify;text-indent:-36pt;margin:0pt 0pt 12pt 0pt;"><b style="font-size:10pt;font-variant:small-caps;font-weight:bold;">8.&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Miscellaneous.</b></p><p style="font-family:'Times New Roman','Times','serif';font-size:9.5pt;text-align:justify;text-indent:36pt;margin:0pt 0pt 12pt 0pt;"><b style="font-size:10pt;font-weight:bold;">(a)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Use of Proceeds from Sales of Common Stock</b><font style="font-size:10pt;">. Proceeds from the sale of shares of Common Stock pursuant to Awards will constitute general funds of the Company.</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:9.5pt;text-align:justify;text-indent:36pt;margin:0pt;"><b style="font-size:10pt;font-weight:bold;">(b)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Corporate Action Constituting Grant of Awards</b><font style="font-size:10pt;">. Corporate action constituting a grant by the Company of an Award to any Participant will be deemed completed as of the date of such corporate action, unless otherwise determined by the Board, regardless of when the instrument, certificate, or letter evidencing the Award is communicated to, or actually received or accepted by, the Participant. In the event that the corporate records (e.g., Board consents, resolutions or minutes) documenting the corporate action constituting the grant contain terms (e.g., </font></p></div><div style="clear:both;display:table;margin-bottom:27.35pt;min-height:44.65pt;width:100%;"><div style="display:table-cell;vertical-align:bottom;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;min-height:12.0pt;text-align:center;margin:24pt 0pt 0pt 0pt;">9</p></div></div></div><hr style="background-color:#000000;clear:both;color:#000000;height:2pt;line-height:0;margin-bottom:30pt;margin-left:11.76%;margin-right:11.76%;margin-top:30pt;page-break-after:always;width:76.47%;border-width:0;"><div style="max-width:100%;padding-left:11.76%;padding-right:11.76%;position:relative;"><div style="margin-top:27.35pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"><font style="font-weight:bold;visibility:hidden;">&#8203;</font></p></div><div style="clear:both;max-width:100%;position:relative;"><p style="font-family:'Times New Roman','Times','serif';font-size:9.5pt;text-align:justify;margin:0pt 0pt 12pt 0pt;"><font style="font-size:10pt;">exercise price, vesting schedule or number of shares) that are inconsistent with those in the Award Agreement or related grant documents as a result of a clerical error in the papering of the Award Agreement or related grant documents, the corporate records will control and the Participant will have no legally binding right to the incorrect term in the Award Agreement or related grant documents.</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:9.5pt;text-align:justify;text-indent:36pt;margin:0pt 0pt 12pt 0pt;"><b style="font-size:10pt;font-weight:bold;">(c)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Stockholder Rights</b><font style="font-size:10pt;">. No Participant will be deemed to be the holder of, or to have any of the rights of a holder with respect to, any shares of Common Stock subject to an Award unless and until (i) such Participant has satisfied all requirements for exercise of, or the issuance of shares under, the Award pursuant to its terms, and (ii) the issuance of the Common Stock subject to such Award has been entered into the books and records of the Company.</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:9.5pt;text-align:justify;text-indent:36pt;margin:0pt 0pt 12pt 0pt;"><b style="font-size:10pt;font-weight:bold;">(d)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;No Employment or Other Service Rights</b><font style="font-size:10pt;">. Nothing in the Plan, any Award Agreement or any other instrument executed thereunder or in connection with any Award granted pursuant thereto will confer upon any Participant any right to continue to serve the Company or an Affiliate in the capacity in effect at the time the Award was granted or will affect the right of the Company or an Affiliate to terminate (i) the employment of an Employee with or without notice and with or without cause, (ii) the service of a Consultant pursuant to the terms of such Consultant&#8217;s agreement with the Company or an Affiliate, or (iii) the service of a Director pursuant to the bylaws of the Company or an Affiliate, and any applicable provisions of the corporate law of the state in which the Company or the Affiliate is incorporated, as the case may be.</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:9.5pt;text-align:justify;text-indent:36pt;margin:0pt 0pt 12pt 0pt;"><b style="font-size:10pt;font-weight:bold;">(e)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Change in Time Commitment</b><font style="font-size:10pt;">. In the event a Participant&#8217;s regular level of time commitment in the performance of his or her services for the Company and any Affiliates is reduced (for example, and without limitation, if the Participant is an Employee of the Company and the Employee has a change in status from a full-time Employee to a part-time Employee or takes an extended leave of absence) after the date of grant of any Award to the Participant, the Board has the right in its sole discretion to (x) make a corresponding reduction in the number of shares or cash amount subject to any portion of such Award that is scheduled to vest or become payable after the date of such change in time commitment, and (y) in lieu of or in combination with such a reduction, extend the vesting or payment schedule applicable to such Award. In the event of any such reduction, the Participant will have no right with respect to any portion of the Award that is so reduced.</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:9.5pt;text-align:justify;text-indent:36pt;margin:0pt 0pt 12pt 0pt;"><b style="font-size:10pt;font-weight:bold;">(f)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Incentive Stock Option Limitations</b><font style="font-size:10pt;">. To the extent that the aggregate Fair Market Value (determined at the time of grant) of Common Stock with respect to which Incentive Stock Options are exercisable for the first time by any Optionholder during any calendar year (under all plans of the Company and any Affiliates) exceeds $100,000 (or such other limit established in the Code) or otherwise does not comply with the rules governing Incentive Stock Options, the Options or portions thereof that exceed such limit (according to the order in which they were granted) or otherwise do not comply with the rules will be treated as Nonstatutory Stock Options, notwithstanding any contrary provision of the applicable Option Agreement(s).</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:9.5pt;text-align:justify;text-indent:36pt;margin:0pt 0pt 12pt 0pt;"><b style="font-size:10pt;font-weight:bold;">(g)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Investment Assurances</b><font style="font-size:10pt;">. The Company may require a Participant, as a condition of exercising or acquiring Common Stock under any Award, (i) to give written assurances satisfactory to the Company as to the Participant&#8217;s knowledge and experience in financial and business matters and/or to employ a purchaser representative reasonably satisfactory to the Company who is knowledgeable and experienced in financial and business matters and that he or she is capable of evaluating, alone or together with the purchaser representative, the merits and risks of exercising the Award; and (ii) to give written assurances satisfactory to the Company stating that the Participant is acquiring Common Stock subject to the Award for the Participant&#8217;s own account and not with any present intention of selling or otherwise distributing the Common Stock. The foregoing requirements, and any assurances given pursuant to such requirements, will be inoperative if (A) the issuance of the shares upon the exercise or acquisition of Common Stock under the Award has been registered under a then currently effective registration statement under the Securities Act, or (B) as to any particular requirement, a determination is made by counsel for the Company that such requirement need not be met in the circumstances under the then applicable securities laws. The Company may, upon advice of counsel to the Company, place legends on stock certificates issued under the Plan as such counsel deems necessary or appropriate in order to comply with applicable securities laws, including, but not limited to, legends restricting the transfer of the Common Stock.</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:9.5pt;text-align:justify;text-indent:36pt;margin:0pt;"><b style="font-size:10pt;font-weight:bold;">(h)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Withholding Obligations</b><font style="font-size:10pt;">. Unless prohibited by the terms of an Award Agreement, the Company may, in its sole discretion, satisfy any federal, state or local tax withholding obligation relating to an Award by any of the following means or by a combination of such means: (i) causing the Participant to tender a cash payment; (ii) </font></p></div><div style="clear:both;display:table;margin-bottom:27.35pt;min-height:44.65pt;width:100%;"><div style="display:table-cell;vertical-align:bottom;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;min-height:12.0pt;text-align:center;margin:24pt 0pt 0pt 0pt;">10</p></div></div></div><hr style="background-color:#000000;clear:both;color:#000000;height:2pt;line-height:0;margin-bottom:30pt;margin-left:11.76%;margin-right:11.76%;margin-top:30pt;page-break-after:always;width:76.47%;border-width:0;"><div style="max-width:100%;padding-left:11.76%;padding-right:11.76%;position:relative;"><div style="margin-top:27.35pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"><font style="font-weight:bold;visibility:hidden;">&#8203;</font></p></div><div style="clear:both;max-width:100%;position:relative;"><p style="font-family:'Times New Roman','Times','serif';font-size:9.5pt;text-align:justify;margin:0pt 0pt 12pt 0pt;"><font style="font-size:10pt;">withholding shares of Common Stock from the shares of Common Stock issued or otherwise issuable to the Participant in connection with the Award; (iii) withholding cash from an Award settled in cash; (iv) withholding payment from any amounts otherwise payable to the Participant; or (v) by such other method as may be set forth in the Award Agreement.</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:9.5pt;text-align:justify;text-indent:36pt;margin:0pt 0pt 12pt 0pt;"><b style="font-size:10pt;font-weight:bold;">(i)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Electronic Delivery and Participation</b><font style="font-size:10pt;">. Any reference herein or in an Award Agreement to a &#8220;written&#8221; agreement or document will include any agreement or document delivered electronically, filed publicly at www.sec.gov (or any successor website thereto) or posted on the Company&#8217;s intranet (or other shared electronic medium controlled by the Company to which the Participant has access). By accepting any Award, a Participant consents to receive documents by electronic delivery and to participate in the Plan through any online electronic system established and maintained by the Company or a third party selected by the Company. The form of delivery of any Common Stock (e.g., a stock certificate or electronic entry evidencing such shares) shall be determined by the Company.</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:9.5pt;text-align:justify;text-indent:36pt;margin:0pt 0pt 12pt 0pt;"><b style="font-size:10pt;font-weight:bold;">(j)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Deferrals</b><font style="font-size:10pt;">. To the extent permitted by applicable law, the Board, in its sole discretion, may determine that the delivery of Common Stock or the payment of cash, upon the exercise, vesting or settlement of all or a portion of any Award may be deferred and may establish programs and procedures for deferral elections to be made by Participants. Deferrals by Participants will be made in accordance with Section 409A of the Code. Consistent with Section 409A of the Code, the Board may provide for distributions while a Participant is still an employee or otherwise providing services to the Company. The Board is authorized to make deferrals of Awards and determine when, and in what annual percentages, Participants may receive payments, including lump sum payments, following the Participant&#8217;s termination of Continuous Service, and implement such other terms and conditions consistent with the provisions of the Plan and in accordance with applicable law.</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:9.5pt;text-align:justify;text-indent:36pt;margin:0pt 0pt 12pt 0pt;"><b style="font-size:10pt;font-weight:bold;">(k)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Compliance with Section 409A</b><font style="font-size:10pt;">. Unless otherwise expressly provided for in an Award Agreement, the Plan and Award Agreements will be interpreted to the greatest extent possible in a manner that makes the Plan and the Awards granted hereunder exempt from Section 409A of the Code, and, to the extent not so exempt, in compliance with Section 409A of the Code. If the Board determines that any Award granted hereunder is not exempt from and is therefore subject to Section 409A of the Code, the Award Agreement evidencing such Award will incorporate the terms and conditions necessary to avoid the consequences specified in Section 409A(a)(1) of the Code, and to the extent an Award Agreement is silent on terms necessary for compliance, such terms are hereby incorporated by reference into the Award Agreement. Notwithstanding anything to the contrary in this Plan (and unless the Award Agreement specifically provides otherwise), if the shares of Common Stock are publicly traded, and if a Participant holding an Award that constitutes &#8220;deferred compensation&#8221; under Section 409A of the Code is a &#8220;specified employee&#8221; for purposes of Section 409A of the Code, no distribution or payment of any amount that is due because of a &#8220;separation from service&#8221; (as defined in Section 409A of the Code without regard to alternative definitions thereunder) will be issued or paid before the date that is six months following the date of such Participant&#8217;s &#8220;separation from service&#8221; or, if earlier, the date of the Participant&#8217;s death, unless such distribution or payment can be made in a manner that complies with Section 409A of the Code, and any amounts so deferred will be paid in a lump sum on the day after such six month period elapses, with the balance paid thereafter on the original schedule.</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:9.5pt;text-align:justify;text-indent:36pt;margin:0pt 0pt 12pt 0pt;"><b style="font-size:10pt;font-weight:bold;">(l)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Clawback/Recovery</b><font style="font-size:10pt;">. All Awards granted under the Plan will be subject to recoupment in accordance with any clawback policy that the Company is required to adopt pursuant to the listing standards of any national securities exchange or association on which the Company&#8217;s securities are listed or as is otherwise required by the Dodd-Frank Wall Street Reform and Consumer Protection Act or other applicable law, and any other clawback policy that the Company may adopt or maintain from time to time. In addition, the Board may impose such other clawback, recovery or recoupment provisions in an Award Agreement as the Board determines necessary or appropriate, including but not limited to a reacquisition right in respect of previously acquired shares of Common Stock or other cash or property upon the occurrence of Cause. No recovery of compensation under such a clawback policy will be an event giving rise to a right to resign for &#8220;good reason&#8221; or &#8220;constructive termination&#8221; (or similar term) under any agreement with the Company.</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:9.5pt;padding-left:36pt;text-align:justify;text-indent:-36pt;margin:0pt 0pt 12pt 0pt;"><b style="font-size:10pt;font-variant:small-caps;font-weight:bold;">9.&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Adjustments Upon Changes in Common Stock; Other Corporate Events.</b></p><p style="font-family:'Times New Roman','Times','serif';font-size:9.5pt;text-align:justify;text-indent:36pt;margin:0pt;"><b style="font-size:10pt;font-weight:bold;">(a)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Capitalization Adjustments</b><font style="font-size:10pt;">. In the event of a Capitalization Adjustment, the Board will appropriately and proportionately adjust: (i) the class(es) and maximum number of securities subject to the Plan </font></p></div><div style="clear:both;display:table;margin-bottom:27.35pt;min-height:44.65pt;width:100%;"><div style="display:table-cell;vertical-align:bottom;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;min-height:12.0pt;text-align:center;margin:24pt 0pt 0pt 0pt;">11</p></div></div></div><hr style="background-color:#000000;clear:both;color:#000000;height:2pt;line-height:0;margin-bottom:30pt;margin-left:11.76%;margin-right:11.76%;margin-top:30pt;page-break-after:always;width:76.47%;border-width:0;"><div style="max-width:100%;padding-left:11.76%;padding-right:11.76%;position:relative;"><div style="margin-top:27.35pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"><font style="font-weight:bold;visibility:hidden;">&#8203;</font></p></div><div style="clear:both;max-width:100%;position:relative;"><p style="font-family:'Times New Roman','Times','serif';font-size:9.5pt;text-align:justify;margin:0pt 0pt 12pt 0pt;"><font style="font-size:10pt;">pursuant to Section 3(a), (ii) the class(es) and maximum number of securities that may be issued pursuant to the exercise of Incentive Stock Options pursuant to Section 3(c), and (iii) the class(es) and number of securities and price per share of stock subject to outstanding Awards. The Board will make such adjustments, and its determination will be final, binding and conclusive.</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:9.5pt;text-align:justify;text-indent:36pt;margin:0pt 0pt 12pt 0pt;"><b style="font-size:10pt;font-weight:bold;">(b)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Dissolution or Liquidation</b><font style="font-size:10pt;">. Except as otherwise provided in the Award Agreement, in the event of a dissolution or liquidation of the Company, all outstanding Awards (other than Awards consisting of vested and outstanding shares of Common Stock not subject to a forfeiture condition or the Company&#8217;s right of repurchase) will terminate immediately prior to the completion of such dissolution or liquidation, and the shares of Common Stock subject to the Company&#8217;s repurchase rights or subject to a forfeiture condition may be repurchased or reacquired by the Company notwithstanding the fact that the holder of such Award is providing Continuous Service; </font><i style="font-size:10pt;font-style:italic;">provided, however,</i><font style="font-size:10pt;"> that the Board may, in its sole discretion, cause some or all Awards to become fully vested, exercisable and/or no longer subject to repurchase or forfeiture (to the extent such Awards have not previously expired or terminated) before the dissolution or liquidation is completed but contingent on its completion.</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:9.5pt;text-align:justify;text-indent:36pt;margin:0pt 0pt 12pt 0pt;"><b style="font-size:10pt;font-weight:bold;">(c)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Corporate Transaction</b><font style="font-size:10pt;">. The following provisions will apply to Awards in the event of a Corporate Transaction unless otherwise provided in the instrument evidencing the Award or any other written agreement between the Company or any Affiliate and the Participant or unless otherwise expressly provided by the Board at the time of grant of an Award. In the event of a Corporate Transaction, then, notwithstanding any other provision of the Plan, the Board will take one or more of the following actions with respect to Awards, contingent upon the closing or completion of the Corporate Transaction:</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:9.5pt;text-align:justify;text-indent:72pt;margin:0pt 0pt 12pt 0pt;"><b style="font-size:10pt;font-weight:bold;">(i)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</b><font style="font-size:10pt;">arrange for the surviving corporation or acquiring corporation (or the surviving or acquiring corporation&#8217;s parent company) to assume or continue the Award or to substitute a similar award for the Award (including, but not limited to, an award to acquire the same consideration paid to the stockholders of the Company pursuant to the Corporate Transaction);</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:9.5pt;text-align:justify;text-indent:72pt;margin:0pt 0pt 12pt 0pt;"><b style="font-size:10pt;font-weight:bold;">(ii)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</b><font style="font-size:10pt;">arrange for the assignment of any reacquisition or repurchase rights held by the Company in respect of Common Stock issued pursuant to the Award to the surviving corporation or acquiring corporation (or the surviving or acquiring corporation&#8217;s parent company)&#894;</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:9.5pt;text-align:justify;text-indent:72pt;margin:0pt 0pt 12pt 0pt;"><b style="font-size:10pt;font-weight:bold;">(iii)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</b><font style="font-size:10pt;">accelerate the vesting, in whole or in part, of the Award (and, if applicable, the time at which the Award may be exercised) to a date prior to the effective time of such Corporate Transaction as the Board will determine (or, if the Board will not determine such a date, to the date that is five days prior to the effective date of the Corporate Transaction), with such Award terminating if not exercised (if applicable) at or prior to the effective time of the Corporate Transaction;</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:9.5pt;text-align:justify;text-indent:72pt;margin:0pt 0pt 12pt 0pt;"><b style="font-size:10pt;font-weight:bold;">(iv)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</b><font style="font-size:10pt;">arrange for the lapse, in whole or in part, of any reacquisition or repurchase rights held by the Company with respect to the Award;</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:9.5pt;text-align:justify;text-indent:72pt;margin:0pt 0pt 12pt 0pt;"><b style="font-size:10pt;font-weight:bold;">(v)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</b><font style="font-size:10pt;">cancel or arrange for the cancellation of the Award, to the extent not vested or not exercised prior to the effective time of the Corporate Transaction, in exchange for such cash consideration, if any, as the Board, in its sole discretion, may consider appropriate; and</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:9.5pt;text-align:justify;text-indent:72pt;margin:0pt 0pt 12pt 0pt;"><b style="font-size:10pt;font-weight:bold;">(vi)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</b><font style="font-size:10pt;">make a payment, in such form as may be determined by the Board equal to the excess, if any, of (A) the value of the property the Participant would have received upon the exercise of the Award immediately prior to the effective time of the Corporate Transaction, over (B) any exercise price payable by such holder in connection with such exercise.</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">The Board need not take the same action or actions with respect to all Awards or portions thereof or with respect to all Participants. The Board may take different actions with respect to the vested and unvested portions of an Award.</p><p style="font-family:'Times New Roman','Times','serif';font-size:9.5pt;text-align:justify;text-indent:36pt;margin:0pt;"><b style="font-size:10pt;font-weight:bold;">(d)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Change in Control</b><font style="font-size:10pt;">. An Award may be subject to additional acceleration of vesting and exercisability upon or after a Change in Control as may be provided in the Award Agreement for such Award or as </font></p></div><div style="clear:both;display:table;margin-bottom:27.35pt;min-height:44.65pt;width:100%;"><div style="display:table-cell;vertical-align:bottom;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;min-height:12.0pt;text-align:center;margin:24pt 0pt 0pt 0pt;">12</p></div></div></div><hr style="background-color:#000000;clear:both;color:#000000;height:2pt;line-height:0;margin-bottom:30pt;margin-left:11.76%;margin-right:11.76%;margin-top:30pt;page-break-after:always;width:76.47%;border-width:0;"><div style="max-width:100%;padding-left:11.76%;padding-right:11.76%;position:relative;"><div style="margin-top:27.35pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"><font style="font-weight:bold;visibility:hidden;">&#8203;</font></p></div><div style="clear:both;max-width:100%;position:relative;"><p style="font-family:'Times New Roman','Times','serif';font-size:9.5pt;text-align:justify;margin:0pt 0pt 12pt 0pt;"><font style="font-size:10pt;">may be provided in any other written agreement between the Company or any Affiliate and the Participant, but in the absence of such provision, no such acceleration will occur.</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:9.5pt;padding-left:36pt;text-align:justify;text-indent:-36pt;margin:0pt 0pt 12pt 0pt;"><b style="font-size:10pt;font-variant:small-caps;font-weight:bold;">10.&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Plan Term; Earlier Termination or Suspension of the Plan.</b></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">The Board may suspend or terminate the Plan at any time. No Incentive Stock Options may be granted after the tenth anniversary of the A&amp;R Effective Date. No Awards may be granted under the Plan while the Plan is suspended or after it is terminated.</p><p style="font-family:'Times New Roman','Times','serif';font-size:9.5pt;padding-left:36pt;text-align:justify;text-indent:-36pt;margin:0pt 0pt 12pt 0pt;"><b style="font-size:10pt;font-variant:small-caps;font-weight:bold;">11.&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Effective Date of the Plan.</b></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">The Plan, as amended and restated hereby, will become effective on the A&amp;R Effective Date. In addition, no Award will be exercised (or, in the case of a Restricted Stock Award, Restricted Stock Unit Award, Performance Award, or Other Award, no Award will be granted) and no cash award will be settled unless and until the Plan has been approved by the stockholders of the Company, which approval will be within 12 months before or after the date the Plan is adopted by the Board.</p><p style="font-family:'Times New Roman','Times','serif';font-size:9.5pt;padding-left:36pt;text-align:justify;text-indent:-36pt;margin:0pt 0pt 12pt 0pt;"><b style="font-size:10pt;font-variant:small-caps;font-weight:bold;">12.&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Choice of Law.</b></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">The law of the State of Delaware will govern all questions concerning the construction, validity and interpretation of the Plan, without regard to that state&#8217;s conflict of laws rules.</p><p style="font-family:'Times New Roman','Times','serif';font-size:9.5pt;padding-left:36pt;text-align:justify;text-indent:-36pt;margin:0pt 0pt 12pt 0pt;"><b style="font-size:10pt;font-variant:small-caps;font-weight:bold;">13.&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Definitions.</b></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">As used in the Plan, the following definitions will apply to the capitalized terms indicated below:</p><p style="font-family:'Times New Roman','Times','serif';font-size:9.5pt;text-align:justify;text-indent:36pt;margin:0pt 0pt 12pt 0pt;"><b style="font-size:10pt;font-weight:bold;">(a)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</b><font style="font-size:10pt;">&#8220;</font><font style="font-size:10pt;font-style:italic;font-weight:bold;">A&amp;R Effective Date</font><font style="font-size:10pt;">&#8221; means the date that the amended and restated Plan is adopted by the Board.</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:9.5pt;text-align:justify;text-indent:36pt;margin:0pt 0pt 12pt 0pt;"><b style="font-size:10pt;font-weight:bold;">(b)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</b><font style="font-size:10pt;">&#8220;</font><font style="font-size:10pt;font-style:italic;font-weight:bold;">Affiliate</font><font style="font-size:10pt;">&#8221; means, at the time of determination, any &#8220;parent&#8221; or &#8220;subsidiary&#8221; of the Company as such terms are defined in Rule 405 of the Securities Act. The Board will have the authority to determine the time or times at which &#8220;parent&#8221; or &#8220;subsidiary&#8221; status is determined within the foregoing definition.</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:9.5pt;text-align:justify;text-indent:36pt;margin:0pt 0pt 12pt 0pt;"><b style="font-size:10pt;font-weight:bold;">(c)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</b><font style="font-size:10pt;">&#8220;</font><font style="font-size:10pt;font-style:italic;font-weight:bold;">Award</font><font style="font-size:10pt;">&#8221; means any right to receive Common Stock, cash or other property granted under the Plan (including an Incentive Stock Option, a Nonstatutory Stock Option, a Restricted Stock Award, a Restricted Stock Unit Award, a SAR, a Performance Award or any Other Award).</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:9.5pt;text-align:justify;text-indent:36pt;margin:0pt 0pt 12pt 0pt;"><b style="font-size:10pt;font-weight:bold;">(d)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</b><font style="font-size:10pt;">&#8220;</font><font style="font-size:10pt;font-style:italic;font-weight:bold;">Award Agreement</font><font style="font-size:10pt;">&#8221; means a written or electronic agreement between the Company and a Participant evidencing the terms and conditions of an Award.</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:9.5pt;text-align:justify;text-indent:36pt;margin:0pt 0pt 12pt 0pt;"><b style="font-size:10pt;font-weight:bold;">(e)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</b><font style="font-size:10pt;">&#8220;</font><font style="font-size:10pt;font-style:italic;font-weight:bold;">Board</font><font style="font-size:10pt;">&#8221; means the Board of Directors of the Company.</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:9.5pt;text-align:justify;text-indent:36pt;margin:0pt 0pt 12pt 0pt;"><b style="font-size:10pt;font-weight:bold;">(f)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</b><font style="font-size:10pt;">&#8220;</font><font style="font-size:10pt;font-style:italic;font-weight:bold;">Capital Stock</font><font style="font-size:10pt;">&#8221; means each and every class of common stock of the Company, regardless of the number of votes per share.</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:9.5pt;text-align:justify;text-indent:36pt;margin:0pt 0pt 12pt 0pt;"><b style="font-size:10pt;font-weight:bold;">(g)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</b><font style="font-size:10pt;">&#8220;</font><font style="font-size:10pt;font-style:italic;font-weight:bold;">Capitalization Adjustment</font><font style="font-size:10pt;">&#8221; means any change that is made in, or other events that occur with respect to, the Common Stock subject to the Plan or subject to any Award after the Adoption Date without the receipt of consideration by the Company through merger, consolidation, reorganization, recapitalization, reincorporation, stock dividend, dividend in property other than cash, large nonrecurring cash dividend, stock split, reverse stock split, liquidating dividend, combination of shares, exchange of shares, change in corporate structure or any similar equity restructuring transaction, as that term is used in Statement of Financial Accounting Standards Board Accounting Standards Codification Topic 718 (or any successor thereto). Notwithstanding the foregoing, the conversion of any convertible securities of the Company will not be treated as a Capitalization Adjustment.</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:9.5pt;text-align:justify;text-indent:36pt;margin:0pt;"><b style="font-size:10pt;font-weight:bold;">(h)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</b><font style="font-size:10pt;">&#8220;</font><font style="font-size:10pt;font-style:italic;font-weight:bold;">Cause</font><font style="font-size:10pt;">&#8221; will have the meaning ascribed to such term in any written agreement between the Participant and the Company defining such term and, in the absence of such agreement, such term means, with respect </font></p></div><div style="clear:both;display:table;margin-bottom:27.35pt;min-height:44.65pt;width:100%;"><div style="display:table-cell;vertical-align:bottom;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;min-height:12.0pt;text-align:center;margin:24pt 0pt 0pt 0pt;">13</p></div></div></div><hr style="background-color:#000000;clear:both;color:#000000;height:2pt;line-height:0;margin-bottom:30pt;margin-left:11.76%;margin-right:11.76%;margin-top:30pt;page-break-after:always;width:76.47%;border-width:0;"><div style="max-width:100%;padding-left:11.76%;padding-right:11.76%;position:relative;"><div style="margin-top:27.35pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"><font style="font-weight:bold;visibility:hidden;">&#8203;</font></p></div><div style="clear:both;max-width:100%;position:relative;"><p style="font-family:'Times New Roman','Times','serif';font-size:9.5pt;text-align:justify;margin:0pt 0pt 12pt 0pt;"><font style="font-size:10pt;">to a Participant, the occurrence of any of the following events: (i) such Participant&#8217;s conviction of any felony or any crime involving fraud; (ii) such Participant&#8217;s participation (whether by affirmative act or omission) in a fraud or felonious act against the Company and/or its Affiliates; (iii) conduct by such Participant which, based upon a good faith and reasonable factual investigation by the Company (or, if such Participant is an Officer, by the Board), demonstrates such Participant&#8217;s unfitness to serve; (iv) such Participant&#8217;s violation of any statutory or fiduciary duty, or duty of loyalty owed to the Company and/or its Affiliates and which has a material adverse effect on the Company and/or its Affiliates; (v) such Participant&#8217;s violation of state or federal law in connection with such Participant&#8217;s performance of such Participant&#8217;s job which has a material adverse effect on the Company and/or its Affiliates; (vi) breach of any material term of any contract between such Participant and the Company and/or its Affiliates; and (vii) such Participant&#8217;s violation of any material Company policy. Notwithstanding the foregoing, such Participant&#8217;s death or Disability shall not constitute Cause as set forth herein. The determination that a termination of the Participant&#8217;s Continuous Service is either for Cause or without Cause will be made by the Board or Committee, as applicable, in its sole and exclusive judgment and discretion. Any determination by the Company that the Continuous Service of a Participant was terminated with or without Cause for the purposes of outstanding Awards held by such Participant will have no effect upon any determination of the rights or obligations of the Company or such Participant for any other purpose.</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:9.5pt;text-align:justify;text-indent:36pt;margin:0pt 0pt 12pt 0pt;"><b style="font-size:10pt;font-weight:bold;">(i)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</b><font style="font-size:10pt;">&#8220;</font><font style="font-size:10pt;font-style:italic;font-weight:bold;">Change in Control</font><font style="font-size:10pt;">&#8221; means the occurrence, in a single transaction or in a series of related transactions, of any one or more of the following events:</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:9.5pt;text-align:justify;text-indent:72pt;margin:0pt 0pt 12pt 0pt;"><b style="font-size:10pt;font-weight:bold;">(i)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</b><font style="font-size:10pt;">any Exchange Act Person becomes the Owner, directly or indirectly, of securities of the Company representing more than 50% of the combined voting power of the Company&#8217;s then outstanding securities other than by virtue of a merger, consolidation or similar transaction. Notwithstanding the foregoing, a Change in Control will not be deemed to occur (A) on account of the acquisition of securities of the Company directly from the Company, (B) on account of the acquisition of securities of the Company by an investor, any affiliate thereof or any other Exchange Act Person that acquires the Company&#8217;s securities in a transaction or series of related transactions the primary purpose of which is to obtain financing for the Company through the issuance of equity securities, (C) on account of the acquisition of securities of the Company by any individual who is, on the IPO Date, either an executive officer or a Director (either, an &#8220;</font><font style="font-size:10pt;font-style:italic;font-weight:bold;">IPO Investor</font><font style="font-size:10pt;">&#8221;) and/or any entity in which an IPO Investor has a direct or indirect interest (whether in the form of voting rights or participation in profits or capital contributions) of more than 50% (collectively, the &#8220;</font><font style="font-size:10pt;font-style:italic;font-weight:bold;">IPO Entities</font><font style="font-size:10pt;">&#8221; ) or on account of the IPO Entities continuing to hold shares that come to represent more than 50% of the combined voting power of the Company&#8217;s then outstanding securities as a result of the conversion of any class of the Company&#8217;s securities into another class of the Company&#8217;s securities having a different number of votes per share pursuant to the conversion provisions set forth in the Company&#8217;s Amended and Restated Certificate of Incorporation&#894; or (D) solely because the level of Ownership held by any Exchange Act Person (the &#8220;</font><font style="font-size:10pt;font-style:italic;font-weight:bold;">Subject Person</font><font style="font-size:10pt;">&#8221;) exceeds the designated percentage threshold of the outstanding voting securities as a result of a repurchase or other acquisition of voting securities by the Company reducing the number of shares outstanding, provided that if a Change in Control would occur (but for the operation of this sentence) as a result of the acquisition of voting securities by the Company, and after such share acquisition, the Subject Person becomes the Owner of any additional voting securities that, assuming the repurchase or other acquisition had not occurred, increases the percentage of the then outstanding voting securities Owned by the Subject Person over the designated percentage threshold, then a Change in Control will be deemed to occur;</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:9.5pt;text-align:justify;text-indent:72pt;margin:0pt 0pt 12pt 0pt;"><b style="font-size:10pt;font-weight:bold;">(ii)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</b><font style="font-size:10pt;">there is consummated a merger, consolidation or similar transaction involving (directly or indirectly) the Company and, immediately after the consummation of such merger, consolidation or similar transaction, the stockholders of the Company immediately prior thereto do not Own, directly or indirectly, either (A) outstanding voting securities representing more than 50% of the combined outstanding voting power of the surviving Entity in such merger, consolidation or similar transaction or (B) more than 50% of the combined outstanding voting power of the parent of the surviving Entity in such merger, consolidation or similar transaction, in each case in substantially the same proportions as their Ownership of the outstanding voting securities of the Company immediately prior to such transaction; </font><i style="font-size:10pt;font-style:italic;">provided, however,</i><font style="font-size:10pt;"> that a merger, consolidation or similar transaction will not constitute a Change in Control under this prong of the definition if the outstanding voting securities representing more than 50% of the combined voting power of the surviving Entity or its parent are owned by the IPO Entities;</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:9.5pt;text-align:justify;text-indent:72pt;margin:0pt;"><b style="font-size:10pt;font-weight:bold;">(iii)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</b><font style="font-size:10pt;">there is consummated a sale, lease, exclusive license or other disposition of all or substantially all of the consolidated assets of the Company and its Subsidiaries, other than a sale, lease, license or </font></p></div><div style="clear:both;display:table;margin-bottom:27.35pt;min-height:44.65pt;width:100%;"><div style="display:table-cell;vertical-align:bottom;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;min-height:12.0pt;text-align:center;margin:24pt 0pt 0pt 0pt;">14</p></div></div></div><hr style="background-color:#000000;clear:both;color:#000000;height:2pt;line-height:0;margin-bottom:30pt;margin-left:11.76%;margin-right:11.76%;margin-top:30pt;page-break-after:always;width:76.47%;border-width:0;"><div style="max-width:100%;padding-left:11.76%;padding-right:11.76%;position:relative;"><div style="margin-top:27.35pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"><font style="font-weight:bold;visibility:hidden;">&#8203;</font></p></div><div style="clear:both;max-width:100%;position:relative;"><p style="font-family:'Times New Roman','Times','serif';font-size:9.5pt;text-align:justify;margin:0pt 0pt 12pt 0pt;"><font style="font-size:10pt;">other disposition of all or substantially all of the consolidated assets of the Company and its Subsidiaries to an Entity, more than fifty percent (50%) of the combined voting power of the voting securities of which are Owned by stockholders of the Company in substantially the same proportions as their Ownership of the outstanding voting securities of the Company immediately prior to such sale, lease, license or other disposition; </font><i style="font-size:10pt;font-style:italic;">provided, however,</i><font style="font-size:10pt;"> that a sale, lease, exclusive license or other disposition of all or substantially all of the consolidated assets of the Company and its Subsidiaries will not constitute a Change in Control under this prong of the definition if the outstanding voting securities representing more than 50% of the combined voting power of the acquiring Entity or its parent are owned by the IPO Entities; or</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:9.5pt;text-align:justify;text-indent:72pt;margin:0pt 0pt 12pt 0pt;"><b style="font-size:10pt;font-weight:bold;">(iv)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</b><font style="font-size:10pt;">individuals who, on the A&amp;R Effective Date, are members of the Board (the &#8220;</font><font style="font-size:10pt;font-style:italic;font-weight:bold;">Incumbent Board</font><font style="font-size:10pt;">&#8221;) cease for any reason to constitute at least a majority of the members of the Board; </font><i style="font-size:10pt;font-style:italic;">provided, however,</i><font style="font-size:10pt;"> that if the appointment or election (or nomination for election) of any new Board member was approved or recommended by a majority vote of the members of the Incumbent Board then still in office, such new member will, for purposes of this Plan, be considered as a member of the Incumbent Board.</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">Notwithstanding the foregoing definition or any other provision of this Plan, the term Change in Control will not include a sale of assets, merger or other transaction effected exclusively for the purpose of changing the domicile of the Company and the definition of Change in Control (or any analogous term) in an individual written agreement between the Company or any Affiliate and the Participant will supersede the foregoing definition with respect to Awards subject to such agreement; <i style="font-style:italic;">provided, however,</i> that if no definition of Change in Control or any analogous term is set forth in such an individual written agreement, the foregoing definition will apply.</p><p style="font-family:'Times New Roman','Times','serif';font-size:9.5pt;text-align:justify;text-indent:36pt;margin:0pt 0pt 12pt 0pt;"><b style="font-size:10pt;font-weight:bold;">(j)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</b><font style="font-size:10pt;">&#8220;</font><font style="font-size:10pt;font-style:italic;font-weight:bold;">Code</font><font style="font-size:10pt;">&#8221; means the Internal Revenue Code of 1986, as amended, including any applicable regulations and guidance thereunder.</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:9.5pt;text-align:justify;text-indent:36pt;margin:0pt 0pt 12pt 0pt;"><b style="font-size:10pt;font-weight:bold;">(k)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</b><font style="font-size:10pt;">&#8220;</font><font style="font-size:10pt;font-style:italic;font-weight:bold;">Committee</font><font style="font-size:10pt;">&#8221; means a committee of one or more Directors to whom authority has been delegated by the Board in accordance with Section 2(c).</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:9.5pt;text-align:justify;text-indent:36pt;margin:0pt 0pt 12pt 0pt;"><b style="font-size:10pt;font-weight:bold;">(l)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</b><font style="font-size:10pt;">&#8220;</font><font style="font-size:10pt;font-style:italic;font-weight:bold;">Common Stock</font><font style="font-size:10pt;">&#8221; means, as of the IPO Date, the common stock of the Company, having 1 vote per share.</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:9.5pt;text-align:justify;text-indent:36pt;margin:0pt 0pt 12pt 0pt;"><b style="font-size:10pt;font-weight:bold;">(m)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</b><font style="font-size:10pt;">&#8220;</font><font style="font-size:10pt;font-style:italic;font-weight:bold;">Company</font><font style="font-size:10pt;">&#8221; means GlycoMimetics, Inc., a Delaware corporation.</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:9.5pt;text-align:justify;text-indent:36pt;margin:0pt 0pt 12pt 0pt;"><b style="font-size:10pt;font-weight:bold;">(n)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</b><font style="font-size:10pt;">&#8220;</font><font style="font-size:10pt;font-style:italic;font-weight:bold;">Consultant</font><font style="font-size:10pt;">&#8221; means any person, including an advisor, who is (i) engaged by the Company or an Affiliate to render consulting or advisory services and is compensated for such services, or (ii) serving as a member of the board of directors of an Affiliate and is compensated for such services. However, service solely as a Director, or payment of a fee for such service, will not cause a Director to be considered a &#8220;</font><font style="font-size:10pt;font-style:italic;font-weight:bold;">Consultant</font><font style="font-size:10pt;">&#8221; for purposes of the Plan. Notwithstanding the foregoing, a person is treated as a Consultant under this Plan only if a Form S-8 Registration Statement under the Securities Act is available to register either the offer or the sale of the Company&#8217;s securities to such person.</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:9.5pt;text-align:justify;text-indent:36pt;margin:0pt 0pt 12pt 0pt;"><b style="font-size:10pt;font-weight:bold;">(o)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</b><font style="font-size:10pt;">&#8220;</font><font style="font-size:10pt;font-style:italic;font-weight:bold;">Continuous Service</font><font style="font-size:10pt;">&#8221; means that the Participant&#8217;s service with the Company or an Affiliate, whether as an Employee, Director or Consultant, is not interrupted or terminated. A change in the capacity in which the Participant renders service to the Company or an Affiliate as an Employee, Consultant or Director or a change in the entity for which the Participant renders such service, provided that there is no interruption or termination of the Participant&#8217;s service with the Company or an Affiliate, will not terminate a Participant&#8217;s Continuous Service &#894; </font><i style="font-size:10pt;font-style:italic;">provided, however,</i><font style="font-size:10pt;"> that if the Entity for which a Participant is rendering services ceases to qualify as an Affiliate, as determined by the Board, in its sole discretion, such Participant&#8217;s Continuous Service will be considered to have terminated on the date such Entity ceases to qualify as an Affiliate. To the extent permitted by law, the Board or the chief executive officer of the Company, in that party&#8217;s sole discretion, may determine whether Continuous Service will be considered interrupted in the case of (i) any leave of absence approved by the Board or chief executive officer, including sick leave, military leave or any other personal leave, or (ii) transfers between the Company, an Affiliate, or their successors. Notwithstanding the foregoing, a leave of absence will be treated as Continuous Service for purposes of vesting in an Award only to such extent as may be provided in the Company&#8217;s leave of absence policy, in the written terms of any leave of absence agreement or policy applicable to the Participant, or as otherwise required by law.</font></p></div><div style="clear:both;display:table;margin-bottom:27.35pt;min-height:44.65pt;width:100%;"><div style="display:table-cell;vertical-align:bottom;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;min-height:12.0pt;text-align:center;margin:24pt 0pt 0pt 0pt;">15</p></div></div></div><hr style="background-color:#000000;clear:both;color:#000000;height:2pt;line-height:0;margin-bottom:30pt;margin-left:11.76%;margin-right:11.76%;margin-top:30pt;page-break-after:always;width:76.47%;border-width:0;"><div style="max-width:100%;padding-left:11.76%;padding-right:11.76%;position:relative;"><div style="margin-top:27.35pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"><font style="font-weight:bold;visibility:hidden;">&#8203;</font></p></div><div style="clear:both;max-width:100%;position:relative;"><p style="font-family:'Times New Roman','Times','serif';font-size:9.5pt;text-align:justify;text-indent:36pt;margin:0pt 0pt 12pt 0pt;"><b style="font-size:10pt;font-weight:bold;">(p)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</b><font style="font-size:10pt;">&#8220;</font><font style="font-size:10pt;font-style:italic;font-weight:bold;">Corporate Transaction</font><font style="font-size:10pt;">&#8221; means the consummation, in a single transaction or in a series of related transactions, of any one or more of the following events:</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:9.5pt;text-align:justify;text-indent:72pt;margin:0pt 0pt 12pt 0pt;"><b style="font-size:10pt;font-weight:bold;">(i)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</b><font style="font-size:10pt;">a sale or other disposition of all or substantially all, as determined by the Board, in its sole discretion, of the consolidated assets of the Company and its Subsidiaries;</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:9.5pt;text-align:justify;text-indent:72pt;margin:0pt 0pt 12pt 0pt;"><b style="font-size:10pt;font-weight:bold;">(ii)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</b><font style="font-size:10pt;">a sale or other disposition of at least 90% of the outstanding securities of the Company;</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:9.5pt;text-align:justify;text-indent:72pt;margin:0pt 0pt 12pt 0pt;"><b style="font-size:10pt;font-weight:bold;">(iii)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</b><font style="font-size:10pt;">a merger, consolidation or similar transaction following which the Company is not the surviving corporation; or</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:9.5pt;text-align:justify;text-indent:72pt;margin:0pt 0pt 12pt 0pt;"><b style="font-size:10pt;font-weight:bold;">(iv)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</b><font style="font-size:10pt;">a merger, consolidation or similar transaction following which the Company is the surviving corporation but the shares of Common Stock outstanding immediately preceding the merger, consolidation or similar transaction are converted or exchanged by virtue of the merger, consolidation or similar transaction into other property, whether in the form of securities, cash or otherwise.</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:9.5pt;text-align:justify;text-indent:36pt;margin:0pt 0pt 12pt 0pt;"><b style="font-size:10pt;font-weight:bold;">(q)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</b><font style="font-size:10pt;">&#8220;</font><font style="font-size:10pt;font-style:italic;font-weight:bold;">Director</font><font style="font-size:10pt;">&#8221; means a member of the Board.</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:9.5pt;text-align:justify;text-indent:36pt;margin:0pt 0pt 12pt 0pt;"><b style="font-size:10pt;font-weight:bold;">(r)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</b><font style="font-size:10pt;">&#8220;</font><font style="font-size:10pt;font-style:italic;font-weight:bold;">Disability</font><font style="font-size:10pt;">&#8221; means, with respect to a Participant, the inability of such Participant to engage in any substantial gainful activity by reason of any medically determinable physical or mental impairment that can be expected to result in death or that has lasted or can be expected to last for a continuous period of not less than 12 months, as provided in Sections 22(e)(3) and 409A(a)(2)(c)(i) of the Code, and will be determined by the Board on the basis of such medical evidence as the Board deems warranted under the circumstances.</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:9.5pt;text-align:justify;text-indent:36pt;margin:0pt 0pt 12pt 0pt;"><b style="font-size:10pt;font-weight:bold;">(s)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</b><font style="font-size:10pt;">&#8220;</font><font style="font-size:10pt;font-style:italic;font-weight:bold;">Employee</font><font style="font-size:10pt;">&#8221; means any person employed by the Company or an Affiliate. However, service solely as a Director, or payment of a fee for such services, will not cause a Director to be considered an &#8220;Employee&#8221; for purposes of the Plan.</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:9.5pt;text-align:justify;text-indent:36pt;margin:0pt 0pt 12pt 0pt;"><b style="font-size:10pt;font-weight:bold;">(t)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</b><font style="font-size:10pt;">&#8220;</font><font style="font-size:10pt;font-style:italic;font-weight:bold;">Entity</font><font style="font-size:10pt;">&#8221; means a corporation, partnership, limited liability company or other entity.</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:9.5pt;text-align:justify;text-indent:36pt;margin:0pt 0pt 12pt 0pt;"><b style="font-size:10pt;font-weight:bold;">(u)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</b><font style="font-size:10pt;">&#8220;</font><font style="font-size:10pt;font-style:italic;font-weight:bold;">Exchange Act</font><font style="font-size:10pt;">&#8221; means the Securities Exchange Act of 1934, as amended, and the rules and regulations promulgated thereunder.</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:9.5pt;text-align:justify;text-indent:36pt;margin:0pt 0pt 12pt 0pt;"><b style="font-size:10pt;font-weight:bold;">(v)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</b><font style="font-size:10pt;">&#8220;</font><font style="font-size:10pt;font-style:italic;font-weight:bold;">Exchange Act Person</font><font style="font-size:10pt;">&#8221; means any natural person, Entity or &#8220;group&#8221; (within the meaning of Section 13(d) or 14(d) of the Exchange Act), except that &#8220;Exchange Act Person&#8221; will not include (i) the Company or any Subsidiary of the Company, (ii) any employee benefit plan of the Company or any Subsidiary of the Company or any trustee or other fiduciary holding securities under an employee benefit plan of the Company or any Subsidiary of the Company, (iii) an underwriter temporarily holding securities pursuant to a registered public offering of such securities, (iv) an Entity Owned, directly or indirectly, by the stockholders of the Company in substantially the same proportions as their Ownership of stock of the Company&#894; or (v) any natural person, Entity or &#8220;group&#8221; (within the meaning of Section 13(d) or 14(d) of the Exchange Act) that, as of the A&amp;R Effective Date, is the Owner, directly or indirectly, of securities of the Company representing more than 50% of the combined voting power of the Company&#8217;s then outstanding securities.</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:9.5pt;text-align:justify;text-indent:36pt;margin:0pt 0pt 12pt 0pt;"><b style="font-size:10pt;font-weight:bold;">(w)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</b><font style="font-size:10pt;">&#8220;</font><font style="font-size:10pt;font-style:italic;font-weight:bold;">Fair Market Value</font><font style="font-size:10pt;">&#8221; means, as of any date, the value of the Common Stock determined as follows:</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:9.5pt;text-align:justify;text-indent:72pt;margin:0pt 0pt 12pt 0pt;"><b style="font-size:10pt;font-weight:bold;">(i)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</b><font style="font-size:10pt;">If the Common Stock is listed on any established stock exchange or traded on any established market, the Fair Market Value of a share of Common Stock will be, unless otherwise determined by the Board, the closing sales price for such stock as quoted on such exchange or market (or the exchange or market with the greatest volume of trading in the Common Stock) on the date of determination, as reported in a source the Board deems reliable.</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:9.5pt;text-align:justify;text-indent:72pt;margin:0pt 0pt 12pt 0pt;"><b style="font-size:10pt;font-weight:bold;">(ii)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</b><font style="font-size:10pt;">Unless otherwise provided by the Board, if there is no closing sales price for the Common Stock on the date of determination, then the Fair Market Value will be the closing selling price on the last preceding date for which such quotation exists.</font></p></div><div style="clear:both;display:table;margin-bottom:27.35pt;min-height:44.65pt;width:100%;"><div style="display:table-cell;vertical-align:bottom;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;min-height:12.0pt;text-align:center;margin:24pt 0pt 0pt 0pt;">16</p></div></div></div><hr style="background-color:#000000;clear:both;color:#000000;height:2pt;line-height:0;margin-bottom:30pt;margin-left:11.76%;margin-right:11.76%;margin-top:30pt;page-break-after:always;width:76.47%;border-width:0;"><div style="max-width:100%;padding-left:11.76%;padding-right:11.76%;position:relative;"><div style="margin-top:27.35pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"><font style="font-weight:bold;visibility:hidden;">&#8203;</font></p></div><div style="clear:both;max-width:100%;position:relative;"><p style="font-family:'Times New Roman','Times','serif';font-size:9.5pt;text-align:justify;text-indent:72pt;margin:0pt 0pt 12pt 0pt;"><b style="font-size:10pt;font-weight:bold;">(iii)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</b><font style="font-size:10pt;">In the absence of such markets for the Common Stock, the Fair Market Value will be determined by the Board in good faith and in a manner that complies with Sections 409A and 422 of the Code.</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:9.5pt;text-align:justify;text-indent:36pt;margin:0pt 0pt 12pt 0pt;"><b style="font-size:10pt;font-weight:bold;">(x)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</b><font style="font-size:10pt;">&#8220;</font><font style="font-size:10pt;font-style:italic;font-weight:bold;">Incentive Stock Option</font><font style="font-size:10pt;">&#8221; means an option granted pursuant to Section 5 of the Plan that is intended to be, and qualifies as, an &#8220;incentive stock option&#8221; within the meaning of Section 422 of the Code.</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:9.5pt;text-align:justify;text-indent:36pt;margin:0pt 0pt 12pt 0pt;"><b style="font-size:10pt;font-weight:bold;">(y)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</b><font style="font-size:10pt;">&#8220;</font><font style="font-size:10pt;font-style:italic;font-weight:bold;">IPO Date</font><font style="font-size:10pt;">&#8221; means the date of the underwriting agreement between the Company and the underwriter(s) managing the initial public offering of the Common Stock, pursuant to which the Common Stock is priced for the initial public offering.</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:9.5pt;text-align:justify;text-indent:36pt;margin:0pt 0pt 12pt 0pt;"><b style="font-size:10pt;font-weight:bold;">(z)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</b><font style="font-size:10pt;">&#8220;</font><font style="font-size:10pt;font-style:italic;font-weight:bold;">Non-Employee Director</font><font style="font-size:10pt;">&#8221; means a Director who either (i) is not a current employee or officer of the Company or an Affiliate, does not receive compensation, either directly or indirectly, from the Company or an Affiliate for services rendered as a consultant or in any capacity other than as a Director (except for an amount as to which disclosure would not be required under Item 404(a) of Regulation S-K promulgated pursuant to the Securities Act (&#8220;</font><font style="font-size:10pt;font-style:italic;font-weight:bold;">Regulation S-K</font><font style="font-size:10pt;">&#8221;)), does not possess an interest in any other transaction for which disclosure would be required under Item 404(a) of Regulation S-K, and is not engaged in a business relationship for which disclosure would be required pursuant to Item 404(b) of Regulation S&#173;K&#894; or (ii) is otherwise considered a &#8220;non&#173;employee director&#8221; for purposes of Rule 16b&#172;3.</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:9.5pt;text-align:justify;text-indent:36pt;margin:0pt 0pt 12pt 0pt;"><b style="font-size:10pt;font-weight:bold;">(aa)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</b><font style="font-size:10pt;">&#8220;</font><font style="font-size:10pt;font-style:italic;font-weight:bold;">Nonstatutory Stock Option</font><font style="font-size:10pt;">&#8221; means any option granted pursuant to Section 5 of the Plan that does not qualify as an Incentive Stock Option.</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:9.5pt;text-align:justify;text-indent:36pt;margin:0pt 0pt 12pt 0pt;"><b style="font-size:10pt;font-weight:bold;">(bb)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</b><font style="font-size:10pt;">&#8220;</font><font style="font-size:10pt;font-style:italic;font-weight:bold;">Officer</font><font style="font-size:10pt;">&#8221; means a person who is an officer of the Company within the meaning of Section 16 of the Exchange Act.</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:9.5pt;text-align:justify;text-indent:36pt;margin:0pt 0pt 12pt 0pt;"><b style="font-size:10pt;font-weight:bold;">(cc)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</b><font style="font-size:10pt;">&#8220;</font><font style="font-size:10pt;font-style:italic;font-weight:bold;">Option</font><font style="font-size:10pt;">&#8221; means an Incentive Stock Option or a Nonstatutory Stock Option to purchase shares of Common Stock granted pursuant to the Plan.</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:9.5pt;text-align:justify;text-indent:36pt;margin:0pt 0pt 12pt 0pt;"><b style="font-size:10pt;font-weight:bold;">(dd)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</b><font style="font-size:10pt;">&#8220;</font><font style="font-size:10pt;font-style:italic;font-weight:bold;">Option Agreement</font><font style="font-size:10pt;">&#8221; means a written agreement between the Company and an Optionholder evidencing the terms and conditions of an Option grant. Each Option Agreement will be subject to the terms and conditions of the Plan.</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:9.5pt;text-align:justify;text-indent:36pt;margin:0pt 0pt 12pt 0pt;"><b style="font-size:10pt;font-weight:bold;">(ee)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</b><font style="font-size:10pt;">&#8220;</font><font style="font-size:10pt;font-style:italic;font-weight:bold;">Optionholder</font><font style="font-size:10pt;">&#8221; means a person to whom an Option is granted pursuant to the Plan or, if applicable, such other person who holds an outstanding Option.</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:9.5pt;text-align:justify;text-indent:36pt;margin:0pt 0pt 12pt 0pt;"><b style="font-size:10pt;font-weight:bold;">(ff)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</b><font style="font-size:10pt;">&#8220;</font><font style="font-size:10pt;font-style:italic;font-weight:bold;">Original Effective Date</font><font style="font-size:10pt;">&#8221; means September 19, 2013.</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:9.5pt;text-align:justify;text-indent:36pt;margin:0pt 0pt 12pt 0pt;"><b style="font-size:10pt;font-weight:bold;">(gg)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</b><font style="font-size:10pt;">&#8220;</font><font style="font-size:10pt;font-style:italic;font-weight:bold;">Other Award</font><font style="font-size:10pt;">&#8221; means an award valued in whole or in part by reference to, or otherwise based on, Common Stock, including the appreciation in value thereof (e.g., options or stock rights with an exercise price or strike price less than 100% of the Fair Market Value at the time of grant) that is not an Incentive Stock Option, Nonstatutory Stock Option, SAR, Restricted Stock Award, Restricted Stock Unit Award or Performance Award. </font></p><p style="font-family:'Times New Roman','Times','serif';font-size:9.5pt;text-align:justify;text-indent:36pt;margin:0pt 0pt 12pt 0pt;"><b style="font-size:10pt;font-weight:bold;">(hh)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</b><font style="font-size:10pt;">&#8220;</font><font style="font-size:10pt;font-style:italic;font-weight:bold;">Other Award Agreement</font><font style="font-size:10pt;">&#8221; means a written agreement between the Company and a holder of an Other Award evidencing the terms and conditions of an Other Award grant. Each Other Award Agreement will be subject to the terms and conditions of the Plan.</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:9.5pt;text-align:justify;text-indent:36pt;margin:0pt 0pt 12pt 0pt;"><b style="font-size:10pt;font-weight:bold;">(ii)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</b><font style="font-size:10pt;">&#8220;</font><font style="font-size:10pt;font-style:italic;font-weight:bold;">Own</font><font style="font-size:10pt;">,&#8221; &#8220;</font><font style="font-size:10pt;font-style:italic;font-weight:bold;">Owned</font><font style="font-size:10pt;">,&#8221; &#8220;</font><font style="font-size:10pt;font-style:italic;font-weight:bold;">Owner</font><font style="font-size:10pt;">,&#8221; &#8220;</font><font style="font-size:10pt;font-style:italic;font-weight:bold;">Ownership</font><font style="font-size:10pt;">&#8221; means a person or Entity will be deemed to &#8220;Own,&#8221; to have &#8220;Owned,&#8221; to be the &#8220;Owner&#8221; of, or to have acquired &#8220;Ownership&#8221; of securities if such person or Entity, directly or indirectly, through any contract, arrangement, understanding, relationship or otherwise, has or shares voting power, which includes the power to vote or to direct the voting, with respect to such securities.</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:9.5pt;text-align:justify;text-indent:36pt;margin:0pt 0pt 12pt 0pt;"><b style="font-size:10pt;font-weight:bold;">(jj)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</b><font style="font-size:10pt;">&#8220;</font><font style="font-size:10pt;font-style:italic;font-weight:bold;">Participant</font><font style="font-size:10pt;">&#8221; means a person to whom an Award is granted pursuant to the Plan or, if applicable, such other person who holds an outstanding Award.</font></p></div><div style="clear:both;display:table;margin-bottom:27.35pt;min-height:44.65pt;width:100%;"><div style="display:table-cell;vertical-align:bottom;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;min-height:12.0pt;text-align:center;margin:24pt 0pt 0pt 0pt;">17</p></div></div></div><hr style="background-color:#000000;clear:both;color:#000000;height:2pt;line-height:0;margin-bottom:30pt;margin-left:11.76%;margin-right:11.76%;margin-top:30pt;page-break-after:always;width:76.47%;border-width:0;"><div style="max-width:100%;padding-left:11.76%;padding-right:11.76%;position:relative;"><div style="margin-top:27.35pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"><font style="font-weight:bold;visibility:hidden;">&#8203;</font></p></div><div style="clear:both;max-width:100%;position:relative;"><p style="font-family:'Times New Roman','Times','serif';font-size:9.5pt;text-align:justify;text-indent:36pt;margin:0pt 0pt 12pt 0pt;"><b style="font-size:10pt;font-weight:bold;">(kk)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</b><font style="font-size:10pt;">&#8220;</font><font style="font-size:10pt;font-style:italic;font-weight:bold;">Performance Award</font><font style="font-size:10pt;">&#8221; means an Award that may vest or may be exercised or a cash award that may vest or become earned and paid contingent upon the attainment during a Performance Period of certain Performance Goals and which is granted under the terms and conditions of Section 6(c) pursuant to such terms as are approved by the Board. &#160;In addition, to the extent permitted by Applicable Law and set forth in the applicable Award Agreement, the Board may determine that cash or other property may be used in payment of Performance Awards. &#160;Performance Awards that are settled in cash or other property are not required to be valued in whole or in part by reference to, or otherwise based on, the Common Stock.</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:9.5pt;text-align:justify;text-indent:36pt;margin:0pt 0pt 12pt 0pt;"><b style="font-size:10pt;font-weight:bold;">(ll)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</b><font style="font-size:10pt;">&#8220;</font><font style="font-size:10pt;font-style:italic;font-weight:bold;">Performance Criteria</font><font style="font-size:10pt;">&#8221; means one or more criteria that the Board will select for purposes of establishing the Performance Goals for a Performance Period. The Performance Criteria that will be used to establish such Performance Goals may be based on any one of, or combination of, the following as determined by the Board: earnings (including earnings per share and net earnings); earnings before interest, taxes and depreciation; earnings before interest, taxes, depreciation and amortization; total stockholder return; return on equity or average stockholder&#8217;s equity; return on assets, investment, or capital employed; stock price; margin (including gross margin); income (before or after taxes); operating income; operating income after taxes; pre-tax profit; operating cash flow; sales or revenue targets; increases in revenue or product revenue; expenses and cost reduction goals; improvement in or attainment of working capital levels; economic value added (or an equivalent metric); market share; cash flow; cash flow per share; share price performance; debt reduction; customer satisfaction; stockholders&#8217; equity; capital expenditures; debt levels; operating profit or net operating profit; workforce diversity; growth of net income or operating income; billings; financing; regulatory milestones; stockholder liquidity; corporate governance and compliance; intellectual property; personnel matters; progress of internal research; progress of partnered programs; &#160;partner satisfaction; budget management; partner or collaborator achievements; internal controls, including those related to the Sarbanes-Oxley Act of 2002; investor relations, analysts and communication; implementation or completion of projects or processes; employee retention; number of users, including unique users; strategic partnership or transactions (including in-licensing and out-licensing of intellectual property); establishing relationships with respect to the marketing distribution and sale of the Company&#8217;s products; supply chain achievements; co-development, co-marketing, profit sharing, joint venture or other similar arrangements; individual performance goals; corporate development and planning goals; and other measures of performance selected by the Board or Committee whether or not listed herein.</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:9.5pt;text-align:justify;text-indent:36pt;margin:0pt 0pt 12pt 0pt;"><b style="font-size:10pt;font-weight:bold;">(mm)&#160;&#160;&#160;&#160;&#160;</b><font style="font-size:10pt;">&#8220;</font><font style="font-size:10pt;font-style:italic;font-weight:bold;">Performance Goals</font><font style="font-size:10pt;">&#8221; means, for a Performance Period, one or more goals established by the Board for the Performance Period based upon the Performance Criteria. Performance Goals may be based on a Company-wide basis, with respect to one or more business units, divisions, Affiliates, or business segments, and in either absolute terms or relative to the performance of one or more comparable companies or the performance of one or more relevant indices. Unless specified otherwise by the Board (i) in the Award Agreement at the time the Award is granted or (ii) in such other document setting forth the Performance Goals at the time the Performance Goals are established, the Board will appropriately make adjustments in the method of calculating the attainment of Performance Goals for a Performance Period as follows: (1) to exclude restructuring and/or other nonrecurring charges; (2) to exclude exchange rate effects; (3) to exclude the effects of changes to generally accepted accounting principles; (4) to exclude the effects of any statutory adjustments to corporate tax rates; (5) to exclude the effects of items that are &#8220;unusual&#8221; in nature or occur &#8220;infrequently&#8221; as determined under generally accepted accounting principles; (6) to exclude the dilutive effects of acquisitions or joint ventures; (7) to assume that any business divested by the Company achieved performance objectives at targeted levels during the balance of a Performance Period following such divestiture; (8) to exclude the effect of any change in the outstanding shares of Common Stock of the Company by reason of any stock dividend or split, stock repurchase, reorganization, recapitalization, merger, consolidation, spin-off, combination or exchange of shares or other similar corporate change, or any distributions to common stockholders other than regular cash dividends; (9) to exclude the effects of stock based compensation and the award of bonuses under the Company&#8217;s bonus plans; (10) to exclude costs incurred in connection with potential acquisitions or divestitures that are required to be expensed under generally accepted accounting principles; and (11) to exclude the goodwill and intangible asset impairment charges that are required to be recorded under generally accepted accounting principles. In addition, the Board may establish or provide for other adjustment items in the Award Agreement at the time the Award is granted or in such other document setting forth the Performance Goals at the time the Performance Goals are established. In addition, the Board retains the discretion to reduce or eliminate the compensation or economic benefit due upon attainment of Performance Goals and to define the manner of calculating the Performance Criteria it selects to use for such Performance Period. Partial achievement of the specified criteria may result in the payment or vesting corresponding to the degree of achievement as specified in the Award Agreement or the written terms of a Performance Award.</font></p></div><div style="clear:both;display:table;margin-bottom:27.35pt;min-height:44.65pt;width:100%;"><div style="display:table-cell;vertical-align:bottom;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;min-height:12.0pt;text-align:center;margin:24pt 0pt 0pt 0pt;">18</p></div></div></div><hr style="background-color:#000000;clear:both;color:#000000;height:2pt;line-height:0;margin-bottom:30pt;margin-left:11.76%;margin-right:11.76%;margin-top:30pt;page-break-after:always;width:76.47%;border-width:0;"><div style="max-width:100%;padding-left:11.76%;padding-right:11.76%;position:relative;"><div style="margin-top:27.35pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"><font style="font-weight:bold;visibility:hidden;">&#8203;</font></p></div><div style="clear:both;max-width:100%;position:relative;"><p style="font-family:'Times New Roman','Times','serif';font-size:9.5pt;text-align:justify;text-indent:36pt;margin:0pt 0pt 12pt 0pt;"><b style="font-size:10pt;font-weight:bold;">(nn)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</b><font style="font-size:10pt;">&#8220;</font><font style="font-size:10pt;font-style:italic;font-weight:bold;">Performance Period</font><font style="font-size:10pt;">&#8221; means the period of time selected by the Board over which the attainment of one or more Performance Goals will be measured for the purpose of determining a Participant&#8217;s right to vesting or exercise of an Award. &#160;Performance Periods may be of varying and overlapping duration, at the sole discretion of the Board.</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:9.5pt;text-align:justify;text-indent:36pt;margin:0pt 0pt 12pt 0pt;"><b style="font-size:10pt;font-weight:bold;">(oo)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</b><font style="font-size:10pt;">&#8220;</font><font style="font-size:10pt;font-style:italic;font-weight:bold;">Plan</font><font style="font-size:10pt;">&#8221; means this GlycoMimetics, Inc. Amended and Restated 2013 Equity Incentive Plan, as amended from time to time.</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:9.5pt;text-align:justify;text-indent:36pt;margin:0pt 0pt 12pt 0pt;"><b style="font-size:10pt;font-weight:bold;">(pp)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</b><font style="font-size:10pt;">&#8220;</font><font style="font-size:10pt;font-style:italic;font-weight:bold;">Restricted Stock Award</font><font style="font-size:10pt;">&#8221; means an award of shares of Common Stock which is granted pursuant to the terms and conditions of Section 6(a).</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:9.5pt;text-align:justify;text-indent:36pt;margin:0pt 0pt 12pt 0pt;"><b style="font-size:10pt;font-weight:bold;">(qq)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</b><font style="font-size:10pt;">&#8220;</font><font style="font-size:10pt;font-style:italic;font-weight:bold;">Restricted Stock Award Agreement</font><font style="font-size:10pt;">&#8221; means a written agreement between the Company and a holder of a Restricted Stock Award evidencing the terms and conditions of a Restricted Stock Award grant. Each Restricted Stock Award Agreement will be subject to the terms and conditions of the Plan.</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:9.5pt;text-align:justify;text-indent:36pt;margin:0pt 0pt 12pt 0pt;"><b style="font-size:10pt;font-weight:bold;">(rr)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</b><font style="font-size:10pt;">&#8220;</font><font style="font-size:10pt;font-style:italic;font-weight:bold;">Restricted Stock Unit Award</font><font style="font-size:10pt;">&#8221; means a right to receive shares of Common Stock which is granted pursuant to the terms and conditions of Section 6(b).</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:9.5pt;text-align:justify;text-indent:36pt;margin:0pt 0pt 12pt 0pt;"><b style="font-size:10pt;font-weight:bold;">(ss)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</b><font style="font-size:10pt;">&#8220;</font><font style="font-size:10pt;font-style:italic;font-weight:bold;">Restricted Stock Unit Award Agreement</font><font style="font-size:10pt;">&#8221; means a written agreement between the Company and a holder of a Restricted Stock Unit Award evidencing the terms and conditions of a Restricted Stock Unit Award grant. Each Restricted Stock Unit Award Agreement will be subject to the terms and conditions of the Plan.</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:9.5pt;text-align:justify;text-indent:36pt;margin:0pt 0pt 12pt 0pt;"><b style="font-size:10pt;font-weight:bold;">(tt)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</b><font style="font-size:10pt;">&#8220;</font><font style="font-size:10pt;font-style:italic;font-weight:bold;">Rule 16b-3</font><font style="font-size:10pt;">&#8221; means Rule 16b-3 promulgated under the Exchange Act or any successor to Rule 16b-3, as in effect from time to time.</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:9.5pt;text-align:justify;text-indent:36pt;margin:0pt 0pt 12pt 0pt;"><b style="font-size:10pt;font-weight:bold;">(uu)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</b><font style="font-size:10pt;">&#8220;</font><font style="font-size:10pt;font-style:italic;font-weight:bold;">Securities Act</font><font style="font-size:10pt;">&#8221; means the Securities Act of 1933, as amended.</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:9.5pt;text-align:justify;text-indent:36pt;margin:0pt 0pt 12pt 0pt;"><b style="font-size:10pt;font-weight:bold;">(vv)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</b><font style="font-size:10pt;">&#8220;</font><font style="font-size:10pt;font-style:italic;font-weight:bold;">Stock Appreciation Right</font><font style="font-size:10pt;">&#8221; or &#8220;</font><font style="font-size:10pt;font-style:italic;font-weight:bold;">SAR</font><font style="font-size:10pt;">&#8221; means a right to receive the appreciation on Common Stock that is granted pursuant to the terms and conditions of Section 5.</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:9.5pt;text-align:justify;text-indent:36pt;margin:0pt 0pt 12pt 0pt;"><b style="font-size:10pt;font-weight:bold;">(ww)&#160;&#160;&#160;&#160;&#160;&#160;</b><font style="font-size:10pt;">&#8220;</font><font style="font-size:10pt;font-style:italic;font-weight:bold;">Stock Appreciation Right Agreement</font><font style="font-size:10pt;">&#8221; means a written agreement between the Company and a holder of a Stock Appreciation Right evidencing the terms and conditions of a Stock Appreciation Right grant. Each Stock Appreciation Right Agreement will be subject to the terms and conditions of the Plan.</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:9.5pt;text-align:justify;text-indent:36pt;margin:0pt 0pt 12pt 0pt;"><b style="font-size:10pt;font-weight:bold;">(xx)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</b><font style="font-size:10pt;">&#8220;</font><font style="font-size:10pt;font-style:italic;font-weight:bold;">Subsidiary</font><font style="font-size:10pt;">&#8221; means, with respect to the Company, (i) any corporation of which more than 50% of the outstanding capital stock having ordinary voting power to elect a majority of the board of directors of such corporation (irrespective of whether, at the time, stock of any other class or classes of such corporation will have or might have voting power by reason of the happening of any contingency) is at the time, directly or indirectly, Owned by the Company, and (ii) any partnership, limited liability company or other entity in which the Company has a direct or indirect interest (whether in the form of voting or participation in profits or capital contribution) of more than 50%.</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:9.5pt;text-align:justify;text-indent:36pt;margin:0pt 0pt 12pt 0pt;"><b style="font-size:10pt;font-weight:bold;">(yy)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</b><font style="font-size:10pt;">&#8220;</font><font style="font-size:10pt;font-style:italic;font-weight:bold;">Ten Percent Stockholder</font><font style="font-size:10pt;">&#8221; means a person who Owns (or is deemed to Own pursuant to Section 424(d) of the Code) stock possessing more than ten percent of the total combined voting power of all classes of stock of the Company or any Affiliate.</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:0pt;margin:0pt;"><font style="margin-bottom:12pt;visibility:hidden;">&#8203;</font></p><p style="display:none;line-height:0pt;text-indent:0pt;margin:0pt;"><font style="font-family:'Times New Roman','Times','serif';font-size:0pt;margin-bottom:12pt;visibility:hidden;">&#8203;</font></p></div><div style="clear:both;display:table;margin-bottom:27.35pt;min-height:44.65pt;width:100%;"><div style="display:table-cell;vertical-align:bottom;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;min-height:12.0pt;text-align:center;margin:24pt 0pt 0pt 0pt;">19</p></div></div></div><hr style="background-color:#000000;clear:both;color:#000000;height:2pt;line-height:0;margin-bottom:30pt;margin-left:11.76%;margin-right:11.76%;margin-top:30pt;page-break-after:always;width:76.47%;border-width:0;"><div style="max-width:100%;padding-left:3.45%;padding-right:3.45%;position:relative;"><div style="margin-top:7.2pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></div><div style="clear:both;max-width:100%;position:relative;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p><div><table style="border-collapse:collapse;font-size:16pt;height:max-content;margin-left:auto;margin-right:auto;width:100%;" align="center"><tr style="height:1pt;"><td style="vertical-align:top;width:95.83%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="position:absolute;top:0pt;width:100%;"></div></div></td><td style="vertical-align:top;width:4.16%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="position:absolute;top:0pt;width:100%;"></div></div></td></tr><tr><td style="vertical-align:top;width:95.83%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><img src="tmb-20220518xdef14a013.jpg" alt="A picture containing text&#10;&#10;Description automatically generated" style="display:inline-block;height:900pt;left:0%;padding-bottom:0pt;position:relative;top:0pt;width:695.3pt;"></p></td><td style="vertical-align:top;width:4.16%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:1pt;text-align:justify;margin:0pt;"><font style="color:#ffffff;">VIEW MATERIALS &amp; VOTE w SCAN TO GLYCOMIMETICS, INC. 9708 MEDICAL CENTER DRIVE ROCKVILLE, MD 20850 VOTE BY INTERNET Before The Meeting - Go to www.proxyvote.com or scan the QR Barcode above Use the Internet to transmit your voting instructions and for electronic delivery of information. Vote by 11:59 P.M. ET on May 17, 2022. Have your proxy card in hand when you access the web site and follow the instructions to obtain your records and to create an electronic voting instruction form. During The Meeting - Go to www.virtualshareholdermeeting.com/GLYC2022 You may attend the meeting via the Internet and vote during the meeting. Have the information that is printed in the box marked by the arrow available and follow the instructions. VOTE BY PHONE - 1-800-690-6903 Use any touch-tone telephone to transmit your voting instructions. Vote by 11:59 P.M. ET on May 17, 2022. Have your proxy card in hand when you call and then follow the instructions. VOTE BY MAIL Mark, sign and date your proxy card and return it in the postage-paid envelope we have provided or return it to Vote Processing, c/o Broadridge, 51 Mercedes Way, Edgewood, NY 11717. TO VOTE, MARK BLOCKS BELOW IN BLUE OR BLACK INK AS FOLLOWS: D76425-P73165 KEEP THIS PORTION FOR YOUR RECORDS DETACH AND RETURN THIS PORTION ONLY THIS PROXY CARD IS VALID ONLY WHEN SIGNED AND DATED. GLYCOMIMETICS, INC. The Board of Directors recommends you vote FOR each of the following directors to hold office until the 2025 Annual Meeting: For Withhold For All AllAllExcept To withhold authority to vote for any individual nominee(s), mark &quot;For All Except&quot; and write the number(s) of the nominee(s) on the line below. ! ! ! 1. Election of Directors Nominees: 01) Scott Jackson 02) Scott Koenig M.D., Ph.D. 03) Harout Semerjian The Board of Directors recommends you vote FOR proposals 2, 3 and 4. For Against Abstain ! ! ! ! ! ! ! ! ! 2. To ratify the selection by the Audit Committee of the Board of Directors of Ernst &amp; Young LLP as the independent registered public accounting firm of GlycoMimetics, Inc. for its fiscal year ending December 31, 2022. To approve the Company&#39;s Amended and Restated Equity Incentive Plan. 3. 4. To approve, on an advisory basis, the compensation of the Company&#39;s named executive officers as disclosed in the proxy materials. NOTE: Such other business as may properly come before the meeting or any adjournment thereof. Please sign exactly as your name(s) appear(s) hereon. When signing as attorney, executor, administrator, or other fiduciary, please give full title as such. Joint owners should each sign personally. All holders must sign. If a corporation or partnership, please sign in full corporate or partnership name by authorized officer. Signature [PLEASE SIGN WITHIN BOX] Date Signature (Joint Owners) Date </font></p></td></tr></table></div><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;"><font style="font-size:1pt;visibility:hidden;">&#8203;</font></p></div><div style="clear:both;margin-bottom:14.4pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></div></div><hr style="background-color:#000000;clear:both;color:#000000;height:2pt;line-height:0;margin-bottom:30pt;margin-left:3.45%;margin-right:3.45%;margin-top:30pt;page-break-after:always;width:93.09%;border-width:0;"><div style="max-width:100%;padding-left:3.45%;padding-right:3.45%;position:relative;"><div style="margin-top:7.2pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></div><div style="clear:both;max-width:100%;position:relative;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;"><font style="font-size:1pt;visibility:hidden;">&#8203;</font></p><div><table style="border-collapse:collapse;font-size:16pt;height:max-content;margin-left:auto;margin-right:auto;width:100%;" align="center"><tr style="height:1pt;"><td style="vertical-align:top;width:95.83%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="position:absolute;top:0pt;width:100%;"></div></div></td><td style="vertical-align:top;width:4.16%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="position:absolute;top:0pt;width:100%;"></div></div></td></tr><tr><td style="vertical-align:top;width:95.83%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><img src="tmb-20220518xdef14a014.jpg" alt="Text, letter&#10;&#10;Description automatically generated" style="display:inline-block;height:900pt;left:0%;padding-bottom:0pt;position:relative;top:0pt;width:695.3pt;"></p></td><td style="vertical-align:top;width:4.16%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:1pt;text-align:justify;margin:0pt;"><font style="color:#ffffff;">Important Notice Regarding the Availability of Proxy Materials for the Annual Meeting: The Notice and Proxy Statement and Form 10-K are available at www.proxyvote.com. D76426-P73165 GLYCOMIMETICS, INC. Annual Meeting of Stockholders May 18, 2022 9:00 A.M., Eastern Daylight Time This proxy is solicited by the Board of Directors The stockholder(s) hereby appoint(s) Harout Semerjian and Brian Hahn, or either of them, as proxies, each with the power to appoint his substitute, and hereby authorize(s) them to represent and to vote, as designated on the reverse side of this ballot, all of the shares of Common Stock of GLYCOMIMETICS, INC. that the stockholder(s) is/are entitled to vote at the Annual Meeting of Stockholders to be held at 9:00 A.M., Eastern Daylight Time on Wednesday, May 18, 2022, via live audio webcast at www.virtualshareholdermeeting.com/GLYC2022 and any adjournment or postponement thereof. This proxy, when properly executed, will be voted in the manner directed herein. If no such direction is made, this proxy will be voted in accordance with the Board of Directors&#39; recommendations. Continued and to be signed on reverse side </font></p></td></tr></table></div><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></div><div style="clear:both;margin-bottom:14.4pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></div></div><hr style="background-color:#000000;clear:both;color:#000000;height:2pt;line-height:0;margin-left:3.45%;margin-right:3.45%;margin-top:30pt;page-break-after:avoid;width:93.09%;border-width:0;"></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>2
<FILENAME>tmb-20220518xdef14a001.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 tmb-20220518xdef14a001.jpg
M_]C_X  02D9)1@ ! @   0 !  #_VP!#  ," @," @,# P,$ P,$!0@%!00$
M!0H'!P8(# H,# L*"PL-#A(0#0X1#@L+$!80$1,4%145# \7&!84&!(4%13_
MVP!# 0,$! 4$!0D%!0D4#0L-%!04%!04%!04%!04%!04%!04%!04%!04%!04
M%!04%!04%!04%!04%!04%!04%!04%!3_P  1"  L -@# 2(  A$! Q$!_\0
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MM].U_P"'FJ6DTRNZ&VGBN,JN,G",3WKLO#WQW\+>(=6MM)\^?3M5N21%9:C
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MN,G.YBS%-V./NUT^D?LP^%],NH+]I]5EU9)5FDO/[1E0RL/[RJP7'MBO8Z*
M//\ QO\ #F^\<:UIT=UJDMOX<@4O/86S&-[F3/RAG'.T#L.M6_!OP=\(> KV
M^O-#T.VL+F^8/<2H,LY QU-=K10!PWC3XD1^"=4L].CT'5M7FN5+!M/M6D2/
M']YAP,UA2Z_\1O%#%=*T6Q\.0-P+C5)#.Y7U"(5P?KFO5#&I;<5!/K2[1Z4
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4M[584XCB C4'T P* +=%%% '_]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>3
<FILENAME>tmb-20220518xdef14a014.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 tmb-20220518xdef14a014.jpg
M_]C_X  02D9)1@ ! @   0 !  #_VP!#  ," @," @,# P,$ P,$!0@%!00$
M!0H'!P8(# H,# L*"PL-#A(0#0X1#@L+$!80$1,4%145# \7&!84&!(4%13_
MVP!# 0,$! 4$!0D%!0D4#0L-%!04%!04%!04%!04%!04%!04%!04%!04%!04
M%!04%!04%!04%!04%!04%!04%!04%!3_P  1" 2Y Z8# 2(  A$! Q$!_\0
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M32_+H*'OPC/:Z?\ [;_FW\GKI<^F=4\?^%]"%L=2\2:1IXN;=[R#[5?11>;
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M4AT+0-1V:Q=>'KFSMYHGM5U:VAA1KB")V #':K(0#U^4XS6M\9-"N?B=X4\
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MM+S_  :7X[K_ "U?H5%%%22%%%% !1110 4444 %%%% !1110 4444 %%%%
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M:7PUHMUX9TB_\2WT5TFLS&^F:.^NW"&U^R[ "XVY$YXYZ_+76VFJ>+_ FL^
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MGXC>+OA]/K'A2?Q"=;U_6=/T[_A%]4DM;=2US,ZVMPP1$"LL;E+@@@X64CD
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M,&0+--.TB*"!\JL%/((()R[4?A'X9U#Q9_PDOD:A8ZNTD<LTFEZO>645TT>
MAN(H94CGP !^]5N!CIQ79T4[N]PZ6Z'!#X'^#%\2?VV-,N/M'VO[?]D_M*Z^
MP?:=V[S_ +%YGV?S=WS;_+W;OFSGFM)OA=X8?27TPZ9FQ?5QKIB^T2_\?HN!
M<B7.[/\ K0&VYV]L8XKJZ*2?+:W3_@?Y+[D#UO?K_P '_-_>SFK_ .'F@:E=
M:O<S6DJW&KM;->RP7<T+2_9SF'E'&T ]0N P)#9!Q72T44 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !117D/Q=^)7Q6\&^)+:R\#?!
MK_A8>D26BS2ZI_PE-IIGE3%W#0^5,I9L*J-N'!WX_A- 'KU%?-7_  O;]HG_
M *-=_P#,@Z=_\17I7P:\=_$3QK_;'_"??"[_ (5M]F\G[%_Q4%MJOVW=O\S_
M %*CR]FU/O?>\SC[IH&>ET5\^>)OC/\ 'C2O$FK66C_LY?VYI-M=RPV>J?\
M"<V%O]LA5R(YO*9-T>]0&V'E<X/2LW_A>W[1/_1KO_F0=._^(H"Q]*T5S/\
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MX&S'<4 >NT5X=\1_BS\9_#/C/4-,\)_ ;_A,_#\'E_9M<_X3"RL/M.Z-6?\
M<2(73:Y9.3SLST-<W_PO;]HG_HUW_P R#IW_ ,10,^E:*X;P]XL\9ZC\)Y=?
MU3P%_8_C9;2ZF3P?_;$,^^9#(((?MBCRQYH6,[\83S.?NFO(_P#A>W[1/_1K
MO_F0=._^(H$?2M%?-7_"]OVB?^C7?_,@Z=_\17KGQ=\6>,_!OANVO? W@/\
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M;&S)^XC0.^YPJ<'C=D\ T >X45YI\9?'?Q$\$_V/_P (#\+O^%D_:O.^V_\
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M._'\)H ]>HKYJ_X7M^T3_P!&N_\ F0=._P#B*]<^$7BSQGXQ\-W-[XY\!?\
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M74R>#_[8AGWS(9!!#]L4>6/-"QG?C">9S]TUY'_PO;]HG_HUW_S(.G?_ !%
MCZ5HKY\\,_&?X\:IXDTFRUC]G+^P])N;N*&\U3_A.+"X^QP,X$DWE*FZ38I+
M;!RV,#K7I7Q=\6>,_!OANVO? W@/_A8>K27:PRZ7_;,.F>5 4<F;S905;#*B
M[!R=^>@- '<T5\U?\+V_:)_Z-=_\R#IW_P 17<?"+XE?%;QCXDN;+QS\&O\
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M_BH+;5?MN[?YG^I4>7LVI][[WF<?=- STNBBB@04444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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MG[.:%B44@A<\ F=LG'X#\A7W97PE^UE_RD!_9T_X#_Z/>@:/NVBBB@04444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !7Q'_P2]_Y%SXN?]C=-_P"@
M"OMROB/_ ()>_P#(N?%S_L;IO_0!0,^W****!!1110 4444 %?"7[67_ "D!
M_9T_X#_Z/>ONVOA+]K+_ )2 _LZ?\!_]'O0-'W;1110(**** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M2=-LO'_AMTL]4T:[AE-M#<F:-?N"0/L:.0.OS]^IQSX+XS_Y(+^V?_V.H_\
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MY1110(**** "BBB@ KX2_:R_Y2 _LZ?\!_\ 1[U]VU\)?M9?\I ?V=/^ _\
MH]Z!H^[:***!!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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MR0<E1R*V]2_:BU&[^*GB3PIX0^'NH^+]+\*%%\1:W;W\-N+1V7=Y<,3\W#@
MY4%3\I R<9N2<=_/Y6WOVM=;]UW1"=]5Y?.^UN][/;L^Q[]17EO[-OQO3]H?
MX4V/C6/1_P"PX[NXN(%LS<_:,"*5D#;]B==N<;>,XYKF?&7[2NKQ_$G6_ _P
MZ^'MW\1=;\/PQ3:TZZG#IUM9^8I9(Q)(#YDI49V@ ?[7!PI)Q?*]RDKW\M/Q
MM^9[Q17P]^U+^T[J_P 0/V/-:\2> =&O;"VFF?2M>N9[];2]T*9)XD>$Q $R
M%]Y3*LN%;/?%?0G[+'A+_A"O@QH^F_\ "%P^ B,RG28-4_M%6W ?OC+@<O\
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M'JK_ "W_ !Z?=N.:<&U+H[?/73\'^?5'T!1110(**** "BBB@ HHHH ****
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MV^I:C#;R2D] JNP))]JE-KEY7TBE_P!N/3\M2G)^]=;MM_--/Y69\U6_P_\
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M?XT3_&'PQX$@U]_%FA6MGKWA";6H;>[T^ZB V&.X;]U(H VL 1T)&>*Y6_\
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M,M1O7T[7=?TBX&K:A*GVB1+R[5FF=AN7>59\?>&=HYJ72_V4?[-\0_ W5/\
MA*?-'PRTR;3O)_L_']I>9;K#OSYO[G&W=C#]<9[UO!*E/D;VY=>[4:B;_P#
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M0N_/4BO,M0\2Z_XC_8R\!QOKEW=OIOQ2ATW1M<G;S)7MXWD$,H+?>VDD#/\
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M^T-XA\9ZFGV/3/B'X*.IF%N%.M6D0Q$/0L"![F2OHO\ 9!^&<_PL^ 7AJPU
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M=-_Z *!GVY1110(**** "BBB@ KX2_:R_P"4@/[.G_ ?_1[U]VU\)?M9?\I
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M\CL2[M@#EB37.?$3]F/X9?%CQ/#XA\6>%8=9U6.-(O,EN9TCD1"2BR1*X20
ML2 ZG&37J5%4W=IO<2T5D>>_$7X ?#WXKZ;IECXH\+6>H0:8OEV#1%[:6T3
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M110 4444 %%%% !1110 4444 %?$?_!+W_D7/BY_V-TW_H K[<KXC_X)>_\
M(N?%S_L;IO\ T 4#/MRBBB@04444 %%%% !7PE^UE_RD!_9T_P" _P#H]Z^[
M:^$OVLO^4@/[.G_ ?_1[T#1]VT444""BJU^]S'87#64,-Q>+&QAAN)3%&[X^
M56<*Q4$XR0K$#G!Z5Y'X=^*?Q%U?Q3XBT>\\%>%]/BT Q"^NX/%-S<$"2'S5
M,49T^/S,# (9TY[]ZF4E%-OIJ4DWL>RT5YG\%_C7H?Q/\)^&C)K^A2^,;W1K
M74M0T33[Q#-;&2)';]QO:1$!<8W9X(Y-=7H_Q"\*^(=?O]"TKQ+H^I:UI^?M
MFFV=_%+<VW./WD:L63GCD"M9P<).#W5_P,T[KF.AHK$\5^-O#O@+3!J/B;7]
M+\.Z>SB(7>K7D=K$7/1=\C 9.#QGM7+1?'WP'/\ $NT\"P^)M*EUVZLA>PQ1
MZA WF!MI2-1OW,[(PD"@<I\PXJ%J[+?_ (%_R*>BN]O^#;\ST2BN;TWXD^$=
M8\3W7ANP\4Z+>^(;0$W&D6VH0R7<('7?"K%UQD=1WKF/B3\;O#?A'0_%MKIG
MB7P_=>--'TF[U"+09;^-[G=% THWP*XDV_*"<8X[BI;25_F5&+G)06][?>>E
MT5YG\2/BP?!_PD\0:]97&FS>)].\//K::;.^[@1DJS1!P_EE@1G(Z$9S74^%
MOB%X9\9SWEKH?B/2-9O; A+VVTZ^BGDM7.?ED5&)0Y!&&QT-:.+3:9FI)I2[
M_P# _P SHZ*Y*P^*/A3Q#)K-EX?\4:'K>K:7$[W-C8:A%<2VY7/$B(Q9>1CG
M%8'@SXUZ)-\+_ GB+QCKVA>&M2\2Z;:W*0W5XEI'-/+$KM'"LKY;EN!DGIUJ
M5JF^UOQO;\F4]-'Y_A;_ #/3**\Q\%_&S1I/A1X=\7>-M<T+PN-44CS;R\2T
MMVDWL J&5^3A<XR376ZI\0O"NA2V46I>)='T^6^"-:I=7\41N [!4,89ANW,
M0!C.20!1UL&QT-%><Z/\9-%C\-WOBCQ-K6C^&/#,NHRVFEWFJ7:6JS1QL8][
M/(X4EW21E Q\FT\G-:>E^/!<^/VT&5[6>SO]-75M&O+5MRW,*E4F4G)#%2\3
M!A@%9AQ\I)%KHOZTO^0/3?\ K6WYG9T5YQX_^+%M\/?B!X8TW5[_ $K1_#NH
M:?J%W>:CJ<P@$+0&W$>)&<(H/G-G(.<#&.<]%??$KPCI?A6#Q/>>*=$M/#4X
M4Q:S/J,*6<@;A2LQ;8<]L'FETO\ UO;]"K/3S.EHKF-3^)W@_1-,L]1U'Q9H
M=AIU[$9[6[NM2ACBN(P5!='9@&4%T&02/F7U%2VWQ$\*WOBF;PS;>)M'G\20
MIYDFCQ7\37B+C.XPAMX&"#DCO3)Z7.BHKR[X1_''1/'NE:=9ZCK^@P>,;G[0
MS:';7B+<B..>1 P@9S)C:@)/3KVKO(O%.BSV%G?1:O8265[*(+6Y2Y0QSR$D
M!$8'#,2",#)R#0*YJT5C^*/&&@^!]*;4_$>MZ=X?TQ6"&\U2[CMH0QZ#>Y R
M?3-4;[XF>#],T.SUF\\5Z)::/>1--;:A/J,*6\\8&XNDA;:R@<D@X I7TN,Z
M:BN;/Q(\)+X?L]>/BC11H=X2MMJ?]H0_9IR%9B$EW;6^5'/!Z*3V-.T_XB^%
M-6\+2^);'Q/HUYX;A#-)K%OJ$4EF@7[Q,P;8,=^>*;TO?H';S.BHKCI/B3HN
MM^$/[?\ "OB+PWJ]A]JAMUU!M40V66F1&7SH]XWX;"KW<JO&<U9N_BEX,L-?
MMM#N?%V@VVMW,K00:;+J4*7,L@."BQEMS,#P0!FG9WMU#I?H=117F,/[1WP^
MF\3^+]!3Q+IK:AX7MC=7\27L+OL17:;8BN7)BV8<$#:2 :T=&^*NDV&F^'(/
M&6NZ'X;\3:[&)K71;J^C@G?>WR1(COND=0RHQ7@L#@#(%):[>7XWM^3!Z;^?
MX;_FOO.]HKDO GB^?Q%/K^F:C%%!K&B:@UG<I"I$;HRB6"5023AHG3/)PP<=
MJ?HWC?\ M?XA>)?"_P!B\K^QK6RN?M?FY\[[1YWR[-HV[?)ZY.=W;')_PXF[
M;G545Y]HGQGT&7PQJ^O>([[3O".F:?K-YHQN=4U".*%F@G>$,9'V %]F=O.,
MXR>M;%_\4_!>E:38ZI>^+]!L],OXC<6E[/J<*0W$0*@O&Y;:R@N@R"1\R^HH
M6NJ\OQU7X%---Q>ZNONT9U-%<U/\2O"-KXJA\,3>*M$B\2S*&BT9]1A6\<$9
M!6$MO((YX%:$OBC1;>PU"]EU>PCLM.=HKVY>Y01VKK@LLC9PA (R&QC(HW)-
M6BO/](^.G@O7/BGJOP^M-=L)?$NG6\4SVJWL):1F,FZ)$#ER\8BW.NT;0Z$]
M:E\>?$'4]!\2:+X9\.Z/::SXBU6WN+R*+4]0:PM4@@,2R%I5AF;=F9,*L9SR
M20!FCMYCZM=CNZ*Y34?B!I?@KPW8:CX]U70O!LT^(Y!=ZL@MA-_<CFE6+S/;
MY5)]!4OB#XE^#_"5K%<ZYXJT31K:6-)8YM0U&&!'1CA&!=@""> 1U[4>0'34
M5SVF?$'PMK7B"XT'3_$NCW^N6\0FFTRVOXI+F*,@$.T2L6"D$<D8Y'K3=+^(
MWA/7-;U'1M.\3Z-?ZOIH)O=/M=0BDN+4#J98U8LF/]H"@#HZ*XJU^*.@^(=4
MTFW\-^)O#&L13W7DW2Q:M&\V&MWFC$*Q[M[L%5]I(_=AW!..8V^+'AOPWX9T
M_5/%_BSPMH:7DLL45R=8B2TF978;8Y9"F]@ -P X.1VH:MN&[L=S17->(_B7
MX0\&VJ7.O^*M$T.VDC65)=2U&&W1D8X5@78 @G@'H:W;*]M]1LX;JTGBNK6=
M!)%/ X=)%(R&5AP01W% KEBBN;L/B1X2U7Q1<^&K+Q1HMYXCM03/H]OJ$+WD
M(&,[X0V]<9&<CO46G_%'P7JOB&/0+'Q=H-YKLD9E33+?4H9+ED&<L(@VXC@\
MXQQ0M;>8]KWZ'4T5Y=\6_CAHG@/2]0LM-U_0;CQA;-;$:'<7B-<^7)/'&S&!
M7$F-KD@],XKI?BIXWE^''P_UGQ'!8)JDUA$'CLY+@P+*Q95 ,@1]HRW7:?I2
MOI<#K**\W\._%#4X?$6IZ'XXTC2_"][9Z9_;'VJQU=KVQ-H'*.SS2P0&,J1D
MADQ@Y#'! V=/^(ND>(-?L[;0O$/AS5;$K=)=?9]422Y26(1$JB)D,%$@,F2"
MFZ/@[N'O_7]=5;U#K;^MK_D[G7T5RNA_%7P3XFM=5N='\8:!JMMI2E]0FL=3
M@F2S4 DF8JQ$8 5CEL=#Z58\/?$/PIXMU._TW0O$VCZUJ-@<7EGIU_%/+;<X
M_>(C$ISQR!0&VIT5%<GXS\=?\(CKO@W3OL7VO_A(M5;3/,\[9]GQ:SS[\;3N
M_P!1MQD?>SGC!;>>/X-/^(A\,W,$<%NFBR:S)J4LX1(U281E2I& ,'=NW<8Z
M=Z.R[W_!7?X()>ZKOR_%\J_'0ZZBO+O&?QQT1?A7XA\6>"-?T'Q2=*"*TEE>
M)>6Z.74%7,3\'#9QD5U6C_$WP=X@M-6N=+\5Z'J5MI&[^TIK/4894LMH);SB
MK$1X"DG=C&#Z4"6KLCIZ*YWP]\0_"GBW4[_3="\3:/K6HV!Q>6>G7\4\MMSC
M]XB,2G/'(%=%0,**YL?$CPC_ ,)9_P (M_PE.B_\)/C=_8O]H0_;<8SGR=V_
MISTZ5/:>.O#=_P"()-!MO$.E7&N1AR^F17L37*A" Y,0;<-I9<\<;AGK0M=@
M>FYNT5@>+/'WACP%#;3>)O$>D>'8;F3RH)-6OHK597_NH9&&X^PYKGO'OQ?T
M;X:6NNZOKVK:-;:#IFDIJ.P:@BWLC,T@51&Y5=LFQ5C.[YWW+@8Y5TM2E%MV
M7]:V/0**\;A_:3\*/XHTZ63Q3X;M?!%YH+:FFM3ZC$L7GBY6'RO/\SR^,L"O
M7<,9XQ7H>N_$+PKX7T"WUW6?$NCZ1HEQL\G4KZ_B@MI-PRNV1F"G(Y&#S56:
M5WYK[FU^:(33=E_6B?Y,Z&BN;U7XD^$="AL9=2\4Z+I\-]&)K1[K4(8EN(RR
M*'C+,-ZEI(UR,C+J.XK:U#4K31["XOKZZALK*W0R37-Q((XXD R69C@ #U-)
MZ*[&M=$6J*\X\4_'KP5HOPK\0>.M.\4:#K.CZ7;RL+FTU2!X)9U4E(!*K%=[
M-M4+G)+  5J?"OQ9)XK^'6F>(+WQ!H6O"ZA:=]2T%#%8XR<JN9I?N8*LV_JI
MX7H#N^UOQ#MYW_#?\_ZU.SHKPQOVJ?"GB72K6^\(Z[HNH0P^)H=$U$R7D4OD
MP-,\9N/W<GRHXC9HW;@KSBO4M"^(7A7Q/X?N-=T;Q+H^K:);[O.U.QOXIK:/
M:,OND5BHP.3D\4+5.71?Y)_DT#TER=?^"U^C.AHKF-+^)O@[7- _MS3?%FAZ
MAHGG"W_M*UU&&6V\TD*$\Q6*[B2!C.<D51A^-?P[N+/3[J+Q[X8EM=1N#:6<
MR:Q;E+F8$ QQG?AW!(^5<GD46>P>9VM%%<]XN^(7A;X?6]O/XH\2Z/X;@N7,
M<,FKW\5JLK <JID8!C["@#H:*YK7?B1X1\+W.EV^L^*=$TB?52!I\5]J,,#W
MA)  B#,#)DL/NYZCUK9U75K'0M/FO]2O;?3[&$9EN;J58HHQG&69B .2.M'F
M!<HKEM,^*?@O6K#5K[3O%^@W]CI&X:C<VVIPR1V6W);SF5B(\8.=V,8-5[_X
MQ^ -)T@:K>^./#=GI1N7LA?7&KV\<'GI]^+>7V[U[KG([B@#L:*S(_$ND37-
MI;1ZI9/<75LUY;PI<(7F@7:&E09RR#>F6' W#GD5CZ;X[TZ_O]2G36] GT"V
MT^WOX[NVU)7D6-S+F64?=2$B,;)-Q#;9.FWDVU8+78ZNBN4M/BOX(OO"MQXF
MMO&/A^X\-6[%)M8BU2!K.(Y (:8-L!R0.3W%;6@Z_I?BC2+;5=%U*SU?2[E=
M\%[83K/!*N<95U)5AD$<'M0!HT5FZ_XATKPII%QJFMZG9Z/I=NNZ:]O[A((8
MATRSN0%'U-9-U\4/!MCX4A\47/BW0K?PS,0(M9EU*%;-R3@;9BVPY(/0]J5Q
MV.HHKG[SX@>%].\*Q^)[KQ)I%KX;D19$UB:_B2S96^ZPF+;"#V.>:X!OVB_"
MUGX\N;>]\6>&+3P6=#M-2L]<EU*)(;B:6XN(F59S)Y;+B 8 YSNY/0/KR_UM
M?] 2O%R7]:I?J>OT5##=0W%JES#-'+;R()$F1@492,A@1P1CO68OC+P^UGI%
MVNN::;35W2+39Q>1^7>NREE6%LXD)520%SD GM1Y"Z7-FBN6U_QO8Z1J]C:C
M6-!MT6X>/4$O]16&>%!;R3#RTP=SX0.58KB,.^?EY\RB_:L\+>)=/\-ZIX8U
MO1KC2[CQ)+HNK27%W$YLX$CNV\XF.7$8<VP=&<X,;9QSP+7\/Q=AV>_J_N3?
MY)GNU%9'ACQ=H7C?24U3PYK6G:_I;LR+>Z7=1W,+,#@@.A()'<9KC]:^/7@W
M2?B++X";7M-3Q4-/>\2SEO80V\8*P[-^_P QE.\)MR5&:F3Y=_ZLK_D"5]OZ
MUM^9Z/17F?P7^->A_$_PGX:,FOZ%+XQO=&M=2U#1-/O$,UL9(D=OW&]I$0%Q
MC=G@CDUU>C_$+PKXAU^_T+2O$NCZEK6GY^V:;9W\4MS;<X_>1JQ9.>.0*UG!
MPDX/=7_ A.ZYCH:*Q_$?B[0O!UM%<:]K6G:);REECEU&ZCMT<JC.P!<@'"*S
M'T"D] :@M/'WAB_\+-XFM?$>DW/AM$:1M8AOHGLU1>&8S!MF!W.>*CI<KLC?
MHKF]#^)'A+Q-8V-[H_BG1=5L[^X-I:7%CJ$,T=Q,%+&*-E8AW"JQ*C)PI/8U
M?3Q3HKRZM$FKV#2:1@ZB@N4)LLIO'G#/[OY/F^;''/2AZ;@M=C5HKFKCXD^$
M;3Q!8:%/XIT2#6]0C66STR3485N;E",AHXBVYP0." :L6GCKPW?^()-!MO$.
ME7&N1AR^F17L37*A" Y,0;<-I9<\<;AGK1Y?UIN(W:*X#Q/\<_!?@_XCZ%X'
MU;7M/L=>UB)Y8()[V&,KAD5$96<-NE9\1@ [MCXZ5MCXD>$?^$L_X1;_ (2G
M1?\ A)\;O[%_M"'[;C&<^3NW].>G2A:I-=?TW&]-SI**** "OB/_ ()>_P#(
MN?%S_L;IO_0!7VY7Q'_P2]_Y%SXN?]C=-_Z *!GVY1110(**** "BBB@ KX2
M_:R_Y2 _LZ?\!_\ 1[U]VU\)?M9?\I ?V=/^ _\ H]Z!H^[:***!!7EGAW1[
M^W\??%RXDL;F.WOOL?V65H6"7&VR"MY9QAL-P<9P>*]3HJ)PYXN/=6*C+EDI
M=CYD\-_#[5=*^%/[.6GZ=HMWI5_IOEK?!+1T>P,FD72R-,,9CS,R!MV/G(!Y
MQ5/X"^!GL[WP!IFO:S\1%\0^%H7+:5?^'X(-)AF\AHI<7T>GQK-&V\LN+AF8
M[2V6!Q]3T5T2J.4Y3MN[_G_FR+>[&/96_P SRGX[+:V2:%J\<_B"Q\0Z=),^
MEWNA:!<:PJNR!7CGAABDQ&XP,G8>.'4USMI>>(6^(_A+5M;T._T;4=;\&MI\
MAT^QGN[:PU!I8Y#%+)$K+"HR<-(57Y2-V:]XK/TC5H]8AGDCM[NV$-Q+;%;R
MW:%F*,5+*& W(<95APP((X-8<JZ^?W-.+_\ 2OO2TWNWJON^]-27Y?=?4^;]
M T^\U'P-\,_ =CX6UK1_%_AO4+":_P!0N-)GCM+,P$&[F2]=!%/YZ^8G[MV9
MO/RP'S8?I\\^G?LZ>(_AO<^&?$$?C:'0-3@G,>@7<EM?W9AEW7$=VD1@=IV.
MX#?O)DVE0W%?2&IZO8Z);QSZA>064,DT=NCW$@16DD<)&@)ZLS,J@=22 *I^
M+_$UKX*\)ZSX@O8Y9;+2K*:^GCMU#2-'&A=@H) )PIQD@9[BJJ2YHSYMI7;]
M;+;LO+_@&E&\:D'!7:M;Y-_?N_ZO?YMO_".O:1^SU\2?!NI:!J>K>+M2\/SS
MC6K>SDF&L[H2B1_*#Y4L8Q&+?L "F06QU_Q2\ :U?^*](L?"EG)IA;P)K>D0
M7MO"4@MIF^QBVC9P,)R'*@_W6(Z&O;8]7BET1=32*9X6MQ<K$D9>4KMW8"KG
M+8[#/-3:?>+J%A;7:130I/$LHCN(S'(@8 X93RK#/(/(-7-MMW6NJ?S4H_DW
MY?+0RHR5/E<=;:K_ ,E?YI'SR3_PFDWPZTWPYX/UOP[<>%A*VH&^T:>RBL[?
M[#-"UI%*Z*EQOD>/B%G7Y-V>%SC_  MLKKX9V'A:^\5>%]=U"UO_ (?Z1HL%
MO::)<7LMK<1+*;FUFCC1C#O\R++2!4_=D,PVBOJ>BE*3DI)_:W^Z2T_\"_SO
M=W:T2BMDK+[TU?YK[NUD?&7@_P %:_X4\/?"W5-0'C7P9IMGX8GTQXO#>AQ:
MG=Z;.UP'\J6W>SN9%5T &^- /W0#'!%>E?#+X86>B?$;PM-:V>M7NDV/@ZYM
M[/5->L?(N(6FO%D,; 11K$^T\1A%*JH&T &O8]2\:66E^,]#\,RQ7#7VKVUU
M=02(J^4J0&(.&.<@GSEQ@'H<D<9Z"IWLW_>_'F3_ !D_ZU%*-UZV_!Q_^1/E
M_3K>V\.?"CP99O+XATWQAX)DN='M;G1- N-7"31+Y9%Q##%)B.>(QN&.PX<$
M.IKN?#MQK'C3XF^ [S5--32-3T+PU+=ZS:Q'<MM=7GDJEL&Z''DS,1DXVIZC
M/I\NJ:3INH:C%&T#ZJEL+VYM;50]T\0RJ.47YFSL95XY*D#I2:3JVDSW4:0>
M59ZGJ%NNHO92H(;IH\*F^2,X8$?(AW#C ':J4KMR>K>OSLT_U?R];N3^7_#I
M_E9?/T.&\:^&'U;X^_#35'TM[NSTO3]8;[88"\=K,XM53+XPK,OF 9()PV.A
MKQG5/!/B'2?$-AK32>*_#V@:;XF\0$R>&M&BO;J#[3)&T%PEM+:W!>-L3+OB
MB+#S<@[2U?7%4].U:QUB.:2QNX+R.&9[>5H) X25&VNA(Z,K @CJ""#4)---
M=$_Q:?\ P"W*\4GW_22_5OY'SUX(^&EG;>/_ (8W]E;^(M;TJVC\0Z@=1\2Z
M5]DGMKFXEM^7B$$*P%R9BBF-"06('6L'X9> )[/5M#\/>)=<^(D.L:7K\^II
M81>'K<Z1)*)I7$_]H1Z?]R1&)8-<^8=Y1O2OJ^BJV:MT_P [K[O0B7O1<7U_
M6]_S9\D>!M,N[KX;^%_ UKX-U[0_%5MXM75Y;FYT:>&VBB34VGDNC=E!%F2
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M+>&3:JOG]XK-AB0Q7%>D?'#PCJ5SK?B5-&T6ZFM;CX;ZMIR_8;5F22;='Y$
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M5T'Q%X<U#5]?N]-\-_$70[+3I)->O1<1V\[Z=(Z23B822[6FD*/(S,A(*L"
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MITUUW/'F^(5_8OX?'A-=<BFT_0_%"2:-JVK3:@[W]JUN%5YI))#/M<L$9F;
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M9WWN(W"_*I&Y",$E789YS5WQ3\%="\5GQ'Y\][:)KOAY?#4Z6CHJPVH,I#1
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M19Z/+I,MCI6GW$[IJ.O:EI<^I6VG($)4R0PRQ,%9N#(7")C+=:W_  5X)O\
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M)?&UXVX53]Y0U=SX:T:?0-&@L;G6+[7IX]Q?4-2\H3S$L3EA%'&@QG "HH
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M!*%H;B..0*P!PVW!P<$X->?:+\3KU?%_BFSU?Q#'9VEIXS72+&W;3C.T\/\
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MB\G^PTM'^T^;N\[ST=ON[1MV[,=3G/:O /&Q^'A\6_$0_%7^SQXH,Z_\(O\
MVCM^V_9/LD7E?V5GY_,\_P W/D_/YF,_PUD7*>)7\-^.!KOG_P!I_8_"1\2^
M1N\S[/\ +_:'W>?]5YV[';=0M4G?^7T][S_N_:[#;]Z,5UO^'^?3N?2R>-M_
MQ,F\(_8L>7I":K]L\WKNF:+R]FW_ &<[L]\8[UU-?#GBG_A%&\1^/U^"DVG0
MZ4/"NG?:9/#4/GZ<L7]I-]K\F.W= [>1O\Q865CTR&YJ;4/"?ARX^&'C"/PY
MXY\$ZWHEY<Z%:7.D?#K33IMK:2'4XOWS!+R<+,RDJ2-C?(I.2!3@G*,>[O\
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M#:"!D9KL+'0M03P'X4^(]Y87,\]WXI7Q?K%G! 9)UM)8)8(!Y8!9C;PO;,5
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M\5=?>M?0]3HKYSN?VJ-5F^._@[P=IO@36[KP_KNC#5/MP@@\TA_)*RK_ *0
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MX?7_ (KO]-\0:?%INN1>'M2TJXL5^W6-V[* )(U<AE =6S&SY'W0QXK4T?\
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MBK5?#7Q!TZ'4-'6?Q#X_M?%5JSS2A4M8Y+=F23$61)B%L  KR/F'./4/AO\
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M6!O8O/69H_,6,Q[MP8H"X7&2HSTK%17)&/2VGHX*/_I-OF4V^9RZW_%2<O\
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MN(7E[%$9(4V[Y%W,,HNY<L.!N&>HJ=%?U_17_!*_I<>]O3]6U^+=O6QXK=?
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M:OI.C77GV_BF2QE777169H@R!-@E4[!YOF'(7[H/-?2.H_$+PMH_B&VT&_\
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MP#\/]!^%_A6T\-^&+#^S-%M&D:&V\Z2787D:1_FD9F.6=CR>_''%.#Y)\_\
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M[RJY"YR<=*XCX-> ?$^EZE^R<U[X<U:T71= U>'5#/8RH+!W@0(D^5_=,Q!
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !7Q'_P2]_Y%SXN?]C=-_P"@"OMR
MOB/_ ()>_P#(N?%S_L;IO_0!0,^W****!!1110 4444 %?"7[67_ "D!_9T_
MX#_Z/>ONVOA+]K+_ )2 _LZ?\!_]'O0-'W;1110(**** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ KXC_X)>_\BY\7/^QNF_\ 0!7VY7Q'_P $O?\
MD7/BY_V-TW_H H&?;E%%% @HHHH **** "OA+]K+_E(#^SI_P'_T>]?=M?"7
M[67_ "D!_9T_X#_Z/>@:/NVBBB@04444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !7Q'_P $O?\ D7/BY_V-TW_H K[<KXC_
M ."7O_(N?%S_ +&Z;_T 4#/MRBBB@04444 %%%% !7PE^UE_RD!_9T_X#_Z/
M>ONVOA+]K+_E(#^SI_P'_P!'O0-'W;1110(**** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 5\1_\$O?^1<^+G_8W3?\ H K[<KXC_P""7O\ R+GQ<_[&Z;_T 4#/
MMRBBB@04444 %%%% !7PE^UE_P I ?V=/^ _^CWK[MKX2_:R_P"4@/[.G_ ?
M_1[T#1]VT444""BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M$%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 5\1_\$O?^1<^+G_8
MW3?^@"OMROB/_@E[_P BY\7/^QNF_P#0!0,^W****!!1110 4444 %?"7[67
M_*0']G3_ (#_ .CWK[MKX2_:R_Y2 _LZ?\!_]'O0-'W;1110(**** "BBB@
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MV^9@ZL,\C%>D^$/#(\(^'K?2AJFI:R82[-?ZM<>?<RLS%B6? '4X
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M.+PG=+83Z?'H6JW5QJ]PL:/,(9[>-X;8 L0HE+DX!.T$&NY?XW?$#Q%^T"?
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M (:3_:U_Z-YLO_ L_P#QV@+'VY17Q'_PTG^UK_T;S9?^!9_^.T?\-)_M:_\
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M]&\V7_@6?_CM 6/MRBOB/_AI/]K7_HWFR_\  L__ !VC_AI/]K7_ *-YLO\
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M_ L__':/^&D_VM?^C>;+_P "S_\ ': L?;E%?$?_  TG^UK_ -&\V7_@6?\
MX[1_PTG^UK_T;S9?^!9_^.T!8^W**^(_^&D_VM?^C>;+_P "S_\ ':/^&D_V
MM?\ HWFR_P# L_\ QV@+'VY17Q'_ ,-)_M:_]&\V7_@6?_CM'_#2?[6O_1O-
ME_X%G_X[0%C[<HKXC_X:3_:U_P"C>;+_ ,"S_P#':/\ AI/]K7_HWFR_\"S_
M /': L?;E%?$?_#2?[6O_1O-E_X%G_X[1_PTG^UK_P!&\V7_ (%G_P".T!8^
MW**^(_\ AI/]K7_HWFR_\"S_ /':/^&D_P!K7_HWFR_\"S_\=H"Q]N45\1_\
M-)_M:_\ 1O-E_P"!9_\ CM'_  TG^UK_ -&\V7_@6?\ X[0%C[<HKXC_ .&D
M_P!K7_HWFR_\"S_\=H_X:3_:U_Z-YLO_  +/_P =H"Q]N45\1_\ #2?[6O\
MT;S9?^!9_P#CM'_#2?[6O_1O-E_X%G_X[0%C[<HKXC_X:3_:U_Z-YLO_  +/
M_P =H_X:3_:U_P"C>;+_ ,"S_P#': L?;E%?$?\ PTG^UK_T;S9?^!9_^.T?
M\-)_M:_]&\V7_@6?_CM 6/MROB+_ ()=NLGAGXMNA#(WBZ8@@Y!&P=*P_&/Q
M*_;)^+>C2^%-,^%FG^ EU)3;W&M_:E#P1-PQ5VE.S@GE59O[N#BOI7]E+]G6
MP_9D^$EIX4@N5U#4IIFO=3OU4JL]RX4':#R$5550/1<GDF@#V2BBB@04444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
910 4444 %%%% !1110 4444 %%%% '__V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>4
<FILENAME>tmb-20220518xdef14a013.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 tmb-20220518xdef14a013.jpg
M_]C_X  02D9)1@ ! @   0 !  #_VP!#  ," @," @,# P,$ P,$!0@%!00$
M!0H'!P8(# H,# L*"PL-#A(0#0X1#@L+$!80$1,4%145# \7&!84&!(4%13_
MVP!# 0,$! 4$!0D%!0D4#0L-%!04%!04%!04%!04%!04%!04%!04%!04%!04
M%!04%!04%!04%!04%!04%!04%!04%!3_P  1" 2Y Z8# 2(  A$! Q$!_\0
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% 'QI^S9_R
M?Q^T?_URL/\ T!*^RZ^-/V;/^3^/VC_^N5A_Z E?9= !1110!\;?L2_\G)_M
M6_\ 8S6__HV]K[)KXV_8E_Y.3_:M_P"QFM__ $;>U]DT#845\/\ CW]HKXH^
M /%?BOX,'4GU#XE:SKMFG@K79-/AV_V7=,2\TB+&(F^S"*1&)49+9P0IJG\>
M?VB/B9\-[W]H33M+\6R%O!FC>'9=)N)=/M&>.:XD@2XE8>5M8R!W)!!5=WRA
M<# %C[LKYB^/G[%#?%GXC2>/_"OQ+\1_#?Q=-;1VLUUI3EHG1!M7"H\3@[2P
M/[S!XXZY\D\&?$G]H+6O@KX_\2P>*/&DNO:!;V.K6=MXL^'UEHT-Y OFM<PP
M,K2>>&C7)("LI6/;CS#B@W_!0SQ&OCL_$<:1=']G_P O^PPGV9//_M7[+]IW
M;]N_._\ <]=FWYL9H"S/9/V<OV$M)^"/Q"N?B!XA\7ZG\1/'4J2(FK:E&8Q&
M7&UY,,\CM(4^3<SG@MP,\5/C[_P3U\(?%_QH_C;PYKNH?#KQG*_G2ZCI*[XI
MIN\S1AD82'NR.N>2022:ZCX<^+?B-;_L?ZQXW\8:QYOC6ZT._P!?MB+2&-=/
M0P/):Q!%0!MBA&.\$Y8ALXKXYO\ ]O'X\I\ 8K5=+N;?QG;PIKMSXT-C;&W;
M1Y'"Q2",IY6]I7\KA. AXW9(!ZGT+X(_X)ZWMOXVT'Q+\1?C1XM^)$^@WL.H
M:?;7CO'$DL3ATW>;-.2-PZ*5Z]>M;?AW]@K29_VB?$_Q4\?ZY8_$,:QYQBT'
M4="06UL6*K%GS)9!((XE\M<J.QR,5Y1^V#^VOXI^&%UX"T#PKXJM-#UH:#'K
MVM37-@EP+UW1##: >4XC:3$C%AM #+\R]]'XM?%OXKZU+\*/&7@#XQ_V1X1^
M)^M6.E66C'PS97!T7SE5),S2 M.R2+)E3MYR < 4!J>Q_'G]A3X:?%[X>SZ!
MH7A[P_\ #[5C/%<6^MZ-H-NDL94_,K+'Y9=&4L-NX#.T\[17 _%W_@GMJ7QA
M^%GPM\(:I\3Q'<>!;6ZLDU,:"7-Y%)Y(B!C^TC88T@5<[FW=>._$?M!?%CXY
M_"OXO^$/AUIOQ$\2Z]<-X6_M*_O_  IX#L=3O+R<WEPOF?8V91&@C6-"5DP-
M@.,L:Y;]H?\ :B^-'P^\4:)I>E>,/$MC'#\/[37[U1X+L9+DWC,RL]]"Y_T)
M"2BR%7<1M@!&S0&I^@7Q/^&?A[XP>!M5\)>)[);[1]1B\N1!@/&W59(S@[74
MX8'L1^%>.?L>?L>K^R7#XMB3Q8?%":]);.N[3OLAMQ")0 ?WK[\^;U^7&WWX
MY_P/\>?&M[\;_AKI/B75;&ST75/AH/$NKVEHD+VWVO?\TRS %@H7LKE?KU/D
M/[-?[?VK?$/]I@Z+K_B*WN?"'BFYN[31='%DL,ND.KC[*))1$IE,R KC>V&8
M9V]*!:GZ&5\U?\,:_P#&9W_"_/\ A+_^Y>_LS_J'?8O^/CSO^!_ZO_9]ZUOV
M0OBCXG^*%A\4I/$VI_VF^B^.M2T:P/V>*+R;2(1>7'^[5=V-S?,V6.>2:\>^
M!OQK^+D7[1=KX8^,?BJ_\+7.HW%W'8>%I_"=NNE:@JJVP6>J))O9E^5OF4@_
M=R688 /K#XK?"?PQ\:O!%_X4\6:<NHZ1=@':#MDAD'W98V'*NN>#]0<@D'Y"
MC_X)EZ]H=K-H?AG]H'Q=H7@J5R7T%8I"C*QRX;R[B.,D^OE=>2#72?MV_M.>
M)_@[K_AO1/!FN?8;E[&[O=4%E:PW$UIG9'927#31O'%;-,Q#GY7('RD=_1/'
M'Q-\5>/?V9[WQ?\ "CQ':WGBG1 )I[C3[#S+'5);;'VR"W,\?[R)L2!)(\Y*
M@*_6@-3I?V<?V6_!/[,GAR?3_"]O+<:A>;3?ZO?$/<W1'0$@ *@R<(H &><G
M)/L%? /BG]N+QEXA\->-?BEX)_<?#_1=/T[1[&ROK9/)EUB[*--/-*4W[+99
M A5656;8>0373^*/&WQM^#'BKP%I&L_%S2/'D7Q'F_L:U>U\/6T$NBSS)B*^
MMQ&V+F*-W5CYG#*N,#=D 6/M>BOB?X/W7QY\2?M*>-_ NK?'/[=I7@2?2KB[
M_P"*1L(_[7AN(Q,\/RX:#Y04WAF/.X8QBN+_ &?/C]\:?B3\9Q;:EXG\:7?A
MJ#Q1<:=+%IW@&RN-'^SQOQ'-J2LCPG& <(Q4%3D[N +'Z&5\P?L#?\BA\5O^
MRCZU_.&OI^OF#]@;_D4/BM_V4?6OYPT ?3]<M\2_!OA'QUX.O],\<:=IVI>'
M-IEN$U0*(8@H/[S><;"H)PX(([$5Y9\6_P!K_P ,^ _$!\'>$].O/B7\1WRL
M7AGP[^\:%AU-S, 5@4?Q$Y*]2H'-<7IG[,?CSX_7L.M?M"^(1)I*NLUK\.O#
MD[0Z; 0<K]JD4YG<>QX.<.0=M 6/'?A!XS\7>%OC$GA;]FG4M4^*/PJM7\K4
M;;Q1N32=);@^7::B<OC!)"K&P P0)=Q(_0^,L8U+@*Y W*IR >^#@9_*J'AW
MPWI7A'1;32-$TVUTC2K1!';V5E"L442^BJH %:5 !1110(**** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH _.[PG^T'X#_9^_;H^/M[XZUIM&MM1^
MQPVKK9SW&]EC0L,1(Q& 1UQ7NW_#R7]GG_H>I?\ P2W_ /\ &*^%_P!MO]EW
MXK^)OVG?&VMZ)X#UK6]'U*:&XM;W3;5IXG7R(U/*YP0RL"#@\9Z$$^&?\,A_
M&O\ Z);XJ_\ !7+_ (4%V1^KK_\ !1[]GV.-';QM.J/G8S:)?@-C@X_<<TW_
M (>2_L\_]#U+_P""6_\ _C%?./[2WBKQ_P#'#]G;0OA]I7[./B[1M3LVM6:>
M73<V]EY2X(MMJ[OF^[R%PI/6OC+_ (9#^-?_ $2WQ5_X*Y?\*!)(_17_ ()[
M>+-*\>?&G]I?Q%H=R;O1]4UVTO+2<QM&9(G>]96VL PR#T(!K[AKX5_X):?
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M\>>&=(\2V7AV^\1:39>(+U!):Z3<7L4=U.I+ %(BP9@2CC(!^ZWH:HZ1\6O
MWB"W@GTKQGX>U*"XD\F&6SU2"59)-\,>Q2KG+;[FV7 YS/$.KKD$=917.0?$
M?PE<^*#X:A\4:++XC&[_ (DZ:A";OY=V[]R&W\;&SQQM/H:Z.@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M3+&R\7S);>)(;"!=3%A/:K;KJ9AC:6U2.2Y\Z,"20H)9E6$%2&FR#0/4^7O
MO[/?C&R^ 7BSPQJO@[6=/N/$&A^&&BM=(TFYA20+K(^UFY1@W^FQIM9CQ^Z
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MOW2"I/,R_MU?#VS@TZ:]T[Q!8PZEJ-K96+SVL.+J"=[A%OH]LQS;+]EE+/\
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M\=_M :)X4T_3-)/AW6#I\D%C+9W,=_%;7&C1ZC),UV7\AC&7V^2$#D$$=":
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MRT3Q-JGA::5[:VUZSLX?LMS<1P-/+#&'F60ND:2GE &,;*I9L*3QQ^WA\+_
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M]0!YQK/[/O@?Q%%*FIV&HWXFLK/3YFN-<OG>>*UN&N+;S&,V9'CE=V$C$O\
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M6IK/BG2] E,%Y<XNS9W%]'8V\;SW4\,&SS6BAC#22E?,C&U%))=0 20#J@Y
M(R ?48H \AO/V2?A5?P>3-X:F^RAIREM'JUZD,*3?ZZ*.-9@L<,G5H4 C8@9
M4X%=#HGP(\"^&]9LM6T[0_L]_9:E-J\$WVN=MEU+:+9R289R#F!%3:05&,@!
MN:[^B@#@-1^!/@?5O'B>,KG1G;Q$MY;ZA]I2^N(XVN8(7@AF:%9!&SK%(R;B
MI.T@'.!BEHO[.'P[\.:QI>J:7H+V%]IS2/!+!J%TH8O<27)$JB7$P$TTKJ)
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M901Z4 7J*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M_P#A&Y;C4+F>#4+%4MVW7"02VT9&8BOV*%5D"BO=O@M\)+?X6VOBF>2UT_\
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110!X[^T)\6?$WPL_X1N+P[I=EJ=QXCFDT.P6\
M20JFK2F,V9E*,,6X5;II.,X1<,,$-X;J_P"TC\0O$L&E?$'0([+1-(M/#OBC
M5DT;4[6X=;N&PCTP21S1K-'BX%T+V))#D(A/R.22WN_QY^+NL_"/4O!-S9Z;
M:7^@WMW??VR7E<72P6^FW5WBWC5&#N1;N1DC)1$Z2%X]/X8_%/5/%^MZOHNO
MZ#9:)J=CIMCK"#2M4;4H);6[-PL69/)B(D!M9,H%88*%6;)P#/#;O]J_Q]>Z
M_P"+]-TK2_#UL]AJD6FVD=^\+S6F_6K73XI9X([XW,B2PSR3AF@MU3$8!F5P
MY]6LOBSXG'P+\0^+9;.PO]=\-ZCJ-O>PVMM+'#>6^GZA+#<-#$9'='DMX)&1
M2[[79<[P,'F8OVI/$9TSPKK+^!--&@Z_H-]XKCFC\0N]S;Z5;1VTC,\7V/!N
M66Z0"%7*[@09<<USOCW]IT:Y\"]3U#Q!X!O8(KDW"3Z*]UK%E-?6$5M'<2SV
MTD>GK,8P)%B=Y$AA#!P92A#. :%G^TQXINM7\*":#0]/@UQ-+OK'2+B!_M^L
M6>H:G-"GV8F<;)+2S6WN)_W<G+G(A7!KJ?A9^T'=>//BDG@R=](%_:V_B&75
M+.U9OM-F;/5HK2R#J7.SS;=S(<CYLHR[58 \=J?[57B/P-X@\3Z(W@-->%GK
ML^GZ)I_AW[7-,]E;Z?9W+ I#:2$2D7<6T$+'ND9&D18A))Z-^T)^T'%\!](L
M-0.F1:PDD,]Y<VN^[6XCM(3&)9D2&UF7"F5 3,T* N@+C=P >3ZO^V#KEM\0
MO&_A_3QI-Q8:5O2/4KNQ6)-*\O5;6PN);Q4OI)'BB6Y><EX[7<D)8?(V];NL
M?M2:YH^G>,;JV\3^"-?FT*WA^PZ=I]KMGUJ*2*W=M4@+7^T6D33RJRY8?Z++
MNGCYV>D?#OX\ZAXT^(LWAR^\,6^DZ?-/KL.FZA#J9N)+C^R[^*SF:6$PH(@Y
MF5EP[]&!Q@%N%\2?M1Z[JUUJ]AHGAG4=&L[+Q%::5#XADM+AX)1'K]IIUU$[
M2VJP!I5DG\ORIIF"HY?RG4+0!FP_M2>+VM?"YN+KP18W&LZ)JUY"LM[;S)-/
M;"[:WGE>"_D6UM&CME=Y%-RBMYD32(0KMU6O_%SQ)XD_8P\3^/M UFS@\2V^
MC:C=1ZE;::! CVSRK)Y42W,Z' B95E6:6,G$@WH=AJ^$OVL]6\=QV::-\/[B
M*?6-2BL-"N-8GNK"QO%>&]G8R3R6?RND=@Y98%G3,T($ARQ2>?X_>/-+\::[
MH$GA#0=2N/\ A+K3PUIL<>MS0J@DT;^T9GE?[*Q8*JG&U,L9"NT>6&D .-;X
M]>-/ VK>.M7M[S3_ !YHEQJMU!IMG:03$O/#X7@U)'MI1/(HM96A<"%48[IB
MPD8G!]5^$WQ/\8?$KX*:[X@@MM%N/$<7VR'1YK6:WFL;YTCS"[+:WMRJ#S#L
M9!<%OD)RNX8Y./\ :QUB30]!O1X(L/M'BBUTW4/#T UYV26WO+ZVM$-ZXM3]
MFD4WD+%$68'$@5B4-,TG]J+5=;\766CZ;X<2;7M42WT^'2[[6%ATZWO4N-:C
MNOWZVC2X']CS /M8/^Y CB)=F //-"_;E\9^,-*\=ZCH_@^UBL]!\G5;:2XA
ME(ETB=/+AD9FDC02B8F5MS(GE03*2I'F"&']IWQK:^+AK5QK?AFVDNO"UG<V
MGAF65;I=?F75-1A5---O>R0Q7$T20[@'N"K&-3N"%J^BOB_\:IOA!9:&][H2
MW]QK,<UI9Q6]X0LVK[4-K8*QCR1.?. DQD>4/D;=\OF'BK]J[Q9'H6A7FB>$
M-(B/B-K6\T22]UB5S)9G5;&RE%W&ML#;2G[?#A5:4)F0DEHQ'( >G_%'XH7_
M (%^)/PXT2*[TJWTOQ%=3VES%/&)[^60>5Y0@B\^-A'\TGF2JDWE_N]R!2SK
M\SV'[4WCCP?I>FWLVHZ2UIJ?A'PO?6FFWL9<Z<MR+M;F[DFO-0B,ZB2%(V>:
M=/FN+<%]RDS>K^+/VI-3\$^-?&^F1>'!K5AX>:^U#4)KS5E@-K8VEGI,DWV6
M-+4F1C_:)8)*X)*/^] 9$3M?!7QSU'Q;\2K?P_)X;M;+1+\:X+#4UU-Y+EVT
MN^BLIQ+;&!5C#R2%D(E<[5Y"DX !5^('QJU/P=\ _#WC"[.G:'KVJPV(='$%
M_90SS('=/-:]MH3'PX65KE5/RX+%E4\-H/[2WC76KCPKJGV+1HM#NM*\)W6H
MZ?\ 8YC=R3:S<S6S>3/YX2-(FC1PK1N6!8;AP:OZM^U)J7A6TNY8_#O]MVEB
M_B?4-2N;_55@FM['2M46UD\A(K7;*VV4%(V*';& TKMEVTK[X_\ BV;X@Z'X
M<M?#6DZ:S^,GT"]MM0U"X^U&Q^RWLT5T%^S!!YJ6AE0H\JG;Y996+F( ROV5
M/B[KWQ=\>^-;[6-=TW4$7P_X?N/[)T@2I#HUQ-]O>>TE1Y9/])C(1)&&PGRT
MRB%=H\\T'X]^.?AOX6UN34_$.A7&IM>:[JD UV&[=_$-Q#J=S:KI6FH]X?(<
M"U3:B"0*+J$")R)'?TFR_:UU.'X;67BS6/!-KIZZAX.U'QE96=MK9G+P6QLQ
M%"[FW0+)*;P< ,%VK]XMA=#6OCOXWOOAIHGC'0/#&A6^FZSK^CV6GB_UB8SR
M6=W>I;NT\2VN()?GC78'DV;W)):(1N >4W/QN\6>#_&_AXMKZ6-A?ZCXSLKO
M4_$DLDVF:3%%K\,=O<7,8EC!6-!]GC_>*%,ZC<%SFQ\1/VU/&GP\\'Z'KA\/
M:1K=IJ!DDCO;*&80W-G9ZC-!?7L0\QOW<EN;&:$%CM$SL6E4#/>>#/VH]1U:
M75&'AXW>AZ1XN;POJ6H7VJ*M\D\^J-:6_P!GMH[54FA7S(/F+HP4.,S/&S/U
M_P  ?CSJ'QCC4:KX8@\-3W&@Z;XDM([;4S?![2]:X6,.3#%LD!MGRHW##*=V
M<@ %'XN^._&>B? &V\56VIZ;X4U9]5TZ>:XNK%I(;/3IM3B7$Z/(NTQVTB^>
MQ8#Y)MOEY5D\HMOVAO'OPZTCQ1=S-8^*].N+WQ7=Z3F*0W%G'9ZY#;*99I+@
M1R0+'=LX4>2$CMP/,P2RZ_@[]IOQKH_A3Q7J6NZ)9:Y<Z*^L:[J:OK*P)9:9
M;7]S:K!9;;)?M#J;*?"RE2?W;-*OG!(]WQ=^UGKWA;PQJ?B#_A!+"?3(->UG
M2;3S-?>.6>'3(;^:ZG=/LA\MB-/<)'ELEQN9 ,D V[WXLZYJ_P"R#XG\=WMM
M8G5X=$U2YC&F7P\B=8O.6*1);.ZD,9=$1B(KEFC9BHD)7=7#>(?VF/B!H/\
M;<\LW@VTLWN=>BTQ]0B:T6VCTW6;:QS/-/>1Q2O+%<.57= ID1 7 <[?=/A1
M\1]0\??\)+::QHEOH.KZ#J$=C<6UK?F]B826=O=HRR&*,YV7*JPV\,K8+#!/
M?4 ?)GAGX_\ C:_TSQ?=V_B30=1O;K7/"UMHMM>Z'+!]DL]3BT]7N6MA=^8T
M1:YEVJ9.)(I1YC#Y4=?_ +7.N6MQ/HZOX;&N6 U6/6"Z2;-'6'7[73H+NXB\
M[<L(M;A[J12PRJ!@\:'=7UC10!\F:A\9_$L/Q%N[*;QIX=\7:1<Q>#[C38-
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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MU*XAN;C3[V_MXEM-0CMV19FA99&? \Q#\Z)D$$9KT6@ HHHH **** "BBB@
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M!\#;L,GQP^ WB#XLWGB,:?\ #SQ=H>D>(A:2:AIU[8^'[]8KFW@^SQ7-H_\
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M,J;PNXK;L9'P6*CE?J.BB@04444 %%%% !1110 4444 %%%% !1110 4444
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MPO\ "/PYX/U*;4=-75C?SSK<3W5[KE]>23E8Y(T21IIG+QJLLA6)LHK$.%#
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M3/&QR%P!NR,  @CBNKHH Y_P%X)TWX<^#]+\-Z2)!8:?%Y:/,09)6)+/(Y4
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M\+,T,)0KC9&SL57&%+$@#)KH;&QMM+LK>RLK>*TL[>-88;>! D<2*,*JJ.
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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MTFD1W&EB=%U"$6XM&MC]@1'\W=,RQ_:+HL/O+$5V'/O_ !7J-O\ %+6OLGQ
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M4X>WD(_=RKZ,CA7'H5%?,MKKWQ-N[2/QUJMAXI\$W?B%'LKY-$T(:GJ-F;&
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M0 4444 %%%% &+9>$-*L/%.H^(XH)#K&H016T]Q+<22 11[MB1HS%8ERS$A
MH8G+9/-;5%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110!@:SXYT/P]XF\/>
M']0O?LVK>(&G338#$Y%PT,?F2+O"E5(3+ ,02 <9P:XC4/VHOACIFCZ3J<OB
M1I+355N);06VG74\KQ02M%+,8HXF=(5=2/-90A'(8@@UD_M7> ;[XA>!]%LO
M#GB'2?#/CNVUB&Z\.7>KW'DQR7(1Q)"" SL6MVG.U%).WD8!(Y&U^#NL>!/%
MFDI\+-6\):CJF@^#K3PCJVC:Y<NC6L09I;>ZQ$LC!G)E)1U42  [N,T >D6W
M[3'P[OO&NG>$[35KZ\UK48XI[-+71+^6"XADV;)DN%@,1B_>1YEW[!N&6%;'
MPK^-7A'XTZ?<7_A"]O=0L85C<W-SI-W912*^[:8VGB02#Y&SLW8XSC(SYO\
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M\9?&GQ3\>+93OX?B\.V.C_;;BZM;&8OJS-J&HVD-Q:N9RL4$B6,<ZAEE)67
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MR:[,/E7AA$1=V19EC,9B9V^60J689)^?]%^+GBV'5A>7^M:TVA:U'=_%&WN
MLLRVVC117BQV:1AE9HQMTB1H=R!S<2#C<2 0W3?A1^T@?!HCU_6M7OKO3=>G
M"0V6KDW&IZ=<1M,[-Y5]9\QW ME0?:82B).%W(WER?8'@"QU33/ OAVSUR]G
MU'6;?3K>*]O+J)(IIYEC4.[HCNBN6!)"NRY)PQ&#7S%X<_:Y\:ZSX1MK^'2-
M(U*XO?$,_@^SN[: &!]2EBM);"=A;WER@MPLMSYNR=\^6F'C)(KZSTS4[/6M
M-M-0TZ[@O]/NX4N+:ZM9%DBFB=0R.CJ2&4@@@@X((- %JBBB@04444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% 'C7[
M1?BCQ/H-Q\/=.\+W.N03:WKLMG=1>&X].:_FA33[N?;$=0!@7#PHS%B#M5@#
MD@'C-;_:6UO1?&^J7DVF*G@GP_H7BBY>)+E9+[5+C2I;.-VDC\E1;@,\P3;(
MP=9 [!0%KWKQ?X"\,_$#3XK#Q3X=TGQ+8PRB>.UUBQBNXDD *APLBD!L,PR.
M<$^M9DWPC\(K=:OJ&G>'=(T77M3L7T^;7+#2[47OE,@0 N\;!PH1,)(&3Y%!
M4@8H \6O/VOM<TC6KG0+OX<2WWB&RU6\L;NS\.W=WJJ>1;1:?))+"T-B69S_
M &E& DB1(#&P:5"55LOQ3^U;HFG_ !^L?#4_@::X\=6-OK&E:9,=2*1M<//$
M8+0X0@?:HH;2<NRGR@R@;QN->L^ ?V9OA[X"\-0:,OAW3=;CAU-]92?5-+L]
MR7C!5\Z..*&.*%@L<:CRHTX0=\D]P_@7PU)KXUQ_#VE-K8F^TC4C91&Y$OE>
M2)/,V[MWE?N\YSM^7IQ0/0\-T[]J_5M0/@^V7P59)J'CFSAU#PO'_;K&%X)!
MN_T^46O^B.$*D*JS!VRBL2*H>(?VF_$^N:;%!X?T.ST>XT_5M(M=>O)M1\W[
M/YWB&72I([5#;%;E7:RN1YC&$JDJ,!O!5?;4^#?@".RUFR3P/X;6TUJ19=4M
MUTBW$=^ZL75IUV8E(8E@6S@DGK3Y_A#X$NFT)I_!7AV5M!"KI+2:5 QTX*P9
M1;Y3]UA@"-F,$ ]J T.=_:3\1^)O"WPCO;SP=J%OI7B6;4M)L+.[NH%FBC:Y
MU*VMVWH0<J5E8' S@Y&#@UXS9?M$^.]5T[Q7XQTR..:VT3Q+;>&I?"%\L40B
MN;JST^$1F<)NW0:E,ZLV2#')-UVQX^E=(\!:%HWAX:+'8176FB]DU$PWH\_=
M<O=-=&4[\Y?SV,@;J&P1R!5EO"&@LMZ#HFG%;Z[CO[L&TC_TBYC*&.:3CYI%
M,415SDCRTP?E& #S[XPWWC'X?_LS>+-1T[Q+'+XST/P]/?'7;G3XV62:&(R2
M.(%VHI8(X4$%5)4L' (:6\\3^);?X^>"]&_M2$>&-7\+:E>2:>MJHE^V6\]D
M!*TIR=NRZP$4* =Q;=E0GI6I:;9ZQIUUI]_:P7UA=1-!<6MS&)(IHV!5D=6!
M#*02"",$$TUM(L'O[6^:RMFO;2*2"WN3$IDAC<H71&QE58QQD@<'8N>@H$?-
MFL^)_B%H7PF^/?B#1O'][JT?ARWGAT+4M>TVQD9)[*!I+YT6W@@1@9-\"^8&
M"26[,0PRK=Y\1+WQ*?B#\-;/0?&&J:?<ZO<K+>Z/%;64EF]A;+YMW-(7MVF!
M??!;Y250&GC( Y)].3PMHL>@W.B)I%@NBW*S)/IRVR"VE64L90T>-K!R[E@1
M\Q9LYR:L#1=/&IQ:D+"U&HQ6[6L=WY*^:D+,K-&'QD(2B$J#@E0>PH NT54T
MO2K+0],M-.TVSM]/TZTB6"WM+6)8HH8U "HB* %4    8 %6Z "BBB@ HHHH
M **** "BBB@ HHHH K:C8Q:II]S93-,D-Q$T+M;SO!*%8$$I(A#HV#PRD$'D
M$$9KFO#'PJ\,>$?)>PL)9KJ*ZDOA?:E>3W]VT[PK"TC3SN\C-Y2)'EF.$55&
M  *ZZB@ HHHH **** "BBB@ KE]#^'&A>'O%&I^([:*]FUG4%*2W-_J5S>>7
M&S[S'"LTCK!&6P?+B"+\J\?*N.HHH I1:/8P:O<ZK':Q)J-S!%:S72H!))%$
MTC1H3W"M-*0.QD;UJ[110 4444 %%%% !1110 4444 8'B+P-HOBS4=(O=6M
M'O9=*>62TC>XD$*O)&8F=H@P1VV,P5G4E=S;<9.=73=-M=&TZUL+&WCM+*UB
M2""")=J11J JJH[    >U6J* "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M_P I&Z/8Q+5]%67PE\#:;K.JZO:>#/#UKJVKQRQ:C?P:7 D]ZDK;I5FD";I
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M..NZ]>>#]2MO%FLV'@GQ#+XP.J:V'=GTO3!KD"6]R$<_NS&CQP+(5/V=)V?
M5&Q]N_\ "+:+_:?]H_V18?VC]I^V?:_LR>;Y_D^1YN_&=_D_NMV<[/ESCBH+
M'P3X=TQ@;/0-+M"$N(P8+.-,+<2"2X7A>DDBJ[C^)@"<D4!<X+X[^,W^%GP0
MO&T&6\N-6N((=&T1D,^H73W$V(HI!C?-<-&I,S?>=Q$QY)KQ/PWK7B/Q7\.%
MLCJ7B?7H?A]J=];:QI]YJE[X=US6-/V"2RO&E803>8L+J"DAC25@[%AM4'ZN
MM/">B6%EI%G:Z-I]O::.0VFV\5JBQV)$;1 PJ!B,B-W3Y<?*[#H2*Q_%'PA\
M">-]2&H>(_!7AW7[\*B_:]4TJ"YEVINV#>Z$X7<V/3<?4T >4?&SQ#_;ND?!
M9]"B\4ZMHFO:KO.G>'M8DTW4+^V.D7D\:M.US;GADCD8/*I/E\[CP>.UG4KJ
M3X:_%CQW/XK\0Z/XN\'W=Y;:7I;:W<>18?9E'V&WFM5E,5RUR/+9FE$C2&YP
MK<)CZIN-(L+N>QFGLK:::PD,MI))$K-;.4:,M&2,H2CNN1CY68=":Q=1^&'@
MW6/%5KXGO_">AWWB2UV>1K-SIL,EY#M^YLF*[UQDXP>* /$8O&&O/\($OGU6
M_COC\5AIS2_:G+K:_P#"5_9S;[LY\OR?W6W[NSY<8XK8UBU@\??%+XD6GB/Q
M=K7ANU\+6=H^FP:5K4^FI;V\EOYKZA((G43?O1(G[X/&HMB-OS/N]#O/@3\-
M+^\U6\NOAYX4N;O5BQU"XFT2V>2\)D65O.8IF3,B*YW9^90>H!IUS\#/AO>6
MFE6L_P /O"L]KI(9=.@DT6V9+(,^]A"I3$>7RQVXR>>M 'QU\1?BA\3[WX6:
MGI\'B74M-\5^*_"VD^-;&6T9HI;80:=))J$4 &#"C26-N3&#C-\PP=S5Z-%K
M?B3XU>#[/XNZ??:M?>#KJ%+B3PKI7B.XT:66UAM@))(98I$*S1W3W:LC.BRJ
ML6YQY:"OJ6\\.Z1J.I0ZA=:7975_#!):Q7<UNCRI#)M\R-7(R$;8NY0<':,]
M!6'K'PB\"^(=)TG2]5\%>'=3TS2%V:=97FE02PV2X Q"C(5C&%484#H/2@+E
MOP)JO]O>'K?4[>]CO-'OHH+K2SY4B3I:O;Q,BSM([,\A)=BWR\,H(R"S='5+
M3]&T_29+N2QL;:S>\F%Q<M;PK&9Y BQAW('S-LCC7)YVHHZ 5=H$%%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M\;?^%.C2/^*!\<>./[1\[_D3=&_M#[+Y>S_7?.NS=YGR]<[']* /2Z*^:O\
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M$\0V'B*TT7X=_$#P((;B*[N9_B!:3I<ZE-*I3>L\\TLDY1($4[F^5?* XP
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M)/#\TPMH]53483:/*7\L1B7=M+;_ )=H.=W'6M77O$.E>%=*GU/6M3L]'TV
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M/FP"Z$[@,$"Q]MZY\7_ ?ABPTF]UCQMX<TFRU=#)IUS?:M!#'>J-N6A9G D
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M:Y_X+_\ [?0&A^@M%?GU_P .F?\ JLVN?^"__P"WT?\ #IG_ *K-KG_@O_\
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M:Y_X+_\ [?0&A^@M%?GU_P .F?\ JLVN?^"__P"WT?\ #IG_ *K-KG_@O_\
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M? /3<V.IKH:!!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M>$/&]CXQN7M%N?AUX;M8M+U>Z#QJEA)']IF5[C]Z\F97";$D8E=ASNZ+XW\
M:7J=MXN\._!ZY&HZQ<#2M#UO3=*TR"YUW]W(2L#F=)%C$-K(^ZX\I3'&,9^4
M$ Q_BIXV\7^"_C?XOUB+6;2?1M!\,:5)IVCSK=0VT<U_>W%KYUR4N1'((WA\
MQF:+/EX5/+96D?0\/?&/XB:Q\9M.^'AG\+2/87^I1ZUJ\.G7 2ZM[:#2KA1;
M0_:3Y$A&J>4V]Y0K1[\$?)4NC_M+^!/'FLZNB>!=:N;%Y[#PSK6N7FG6@MHI
M;K:(;&XW3>:X66[,3*(W1'D?)"MO-#X=ZUXCUKP-X5U;X<_";PYX1-EXLO\
M1;VQOH;:+['I*WLD=W+:_9I=JR,T$8=<X:2)B%=!&[ '=_M ?$[7? .G:5:>
M%/(N/$E\+BXBLI]-6\62W@C#3.2][:1Q*F^/,C2G[P 1B>/*O"W[2GQ&\<6U
MAJFDVGAN*UUN]BT73-(N;&X^T07DWAL:O')-/]H"L@E(B,:QJ2ISO!'/MOQP
M'A"Q\$OK7C/PIIWBS3M)E2X2WU%+#; Y(7S5DOI(H8R ?O%U..!DD ^067[0
MGPVO?"3WOA?P1JMKH=CI\6MW/B'0M.TLQ>']PN-.%S\TK*\D*6DR;H4F'E1
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M_!/@K1]6FU?P]_97@_4U-G+I6M&:>&\NG!9)#%*7F,VPM(LI8.D;LX*JQ#_
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MEE;P1GA!\Q0MV+$  =Q110 4444 %%%% !1110 4444 %%%% !1110 4444
M?(O[77[?G_#*WQ)TWPG_ ,()_P )1]LTF/5/MG]L?9-F^::+R]GD29QY.<Y_
MBQCC)\/_ .'RG_5(/_+F_P#N2OTJHH'H?FK_ ,/E/^J0?^7-_P#<E'_#Y3_J
MD'_ES?\ W)7Z544!='YJ_P##Y3_JD'_ES?\ W)7->,O^"P?C"^^Q_P#")_#W
M0]$V;_M/]LWDVH^;G;LV>7]GV8PV<[LY&-N#G]3Z_-7_ (+*?\T@_P"XQ_[9
M4#5F?I511102%?!O_!*'_D6?BM_V,*_^@-7WE7P;_P $H?\ D6?BM_V,*_\
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M4KB:XM-69XUFM[BW>!RCHCG>F[>JD8)'WEKYVL_V!/$W_"NK#PV=8T+2+A/
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M %%%% !1110 4444 %?FK_P64_YI!_W&/_;*OTJK\U?^"RG_ #2#_N,?^V5
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M5_X+*?\ -(/^XQ_[95^E5?FK_P %E/\ FD'_ '&/_;*@:W/TJHHHH$%?!O\
MP2A_Y%GXK?\ 8PK_ .@-7WE7P;_P2A_Y%GXK?]C"O_H#4#Z'WE1110(****
M"BBB@ K\^OVPO^4AW[/7_;E_Z72U^@M?GU^V%_RD._9Z_P"W+_TNEH&C]!:*
M**!!1110 4444 %%<CJOQ6\*:'\1=%\"7VKQVOBO6;:2[T_3GBDS<11ABY5]
MNS("L=I;. 2!@5?\"^.=$^)7A+3/$_AN]_M+0]2C\VUNO*>+S$R5SL=58<@]
M0* -^BBL9/%NEOXOD\+B>3^VH[%-2:#[/($%NTC1AO-V["=R,-H;<."1@@D
MV:*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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MA[2>*ZLYK2XMYDQNCE@F1)(V (.&4$AE(X() .AHHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ KX-_X)0_\BS\5O^QA7_T!
MJ^\J^#?^"4/_ "+/Q6_[&%?_ $!J!]#[RHHHH$%%%% !1110 5^?7[87_*0[
M]GK_ +<O_2Z6OT%K\^OVPO\ E(=^SU_VY?\ I=+0-'Z"T444""BBB@ HHHH
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M] UV'Q5;ZA-J$6F33^1)]ECLR[+;$-<B$(MJ=K0F19002"#/I#P1X U7P_\
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "O@W_@E#_P BS\5O^QA7_P! :OO*O@W_ ()0
M_P#(L_%;_L85_P#0&H'T/O*BBB@04444 %%%% !7Y]?MA?\ *0[]GK_MR_\
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M5?:W(^6@#U&BN!^+OQ;A^#^A#5[GPOXB\1V*1S7%U)X?M(Y_L<,2AGDEWR(
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **\\\7_'WP/X%\>V'@K5]3NX_$U_;17<%C:Z5>77[F25
MHDD9X8G1%+HRY9AC&3@$&O0Z "BBN-U_XO>#_"_Q!\/>!]4UN&T\4^((Y9=-
MTYHW)G6,$L=X4HGW6QN(W$$+D\4 =E116-XE\7:7X0BTY]4GD@34+Z#3;;RK
M>2;=/,VV-2$5MH)ZLV%7J2!0!LT45EWWB;2=,US2]%NM0MX-6U19GLK)W EN
M%B ,I1>I"AER>VX>HH U***\PL/VE_AIJG@;Q3XPL_%,-SX<\,74EEJ][%;3
MM]FE0J&&S9O<?.N&0,IYP3@X /3Z**R].\3:3JVL:MI-GJ%O=:EI+1)?VL3A
MGM6D021AQ_"60A@#V(/<4 :E%8R>+=+?Q?)X7$\G]M1V*:DT'V>0(+=I&C#>
M;MV$[D8;0VX<$C!!.S0 5\&_\$H?^19^*W_8PK_Z U?>5?!O_!*'_D6?BM_V
M,*_^@-0/H?>5%%% @HHHH **** "OSZ_;"_Y2'?L]?\ ;E_Z72U^@M?GU^V%
M_P I#OV>O^W+_P!+I:!H_06BBB@05\NR_LK^(+WPUJ&DWESHES#=_%D^.9(I
M))&C?33=B9H6!BYF* C9C9DXWXYKZBHH ^*_B-^Q#XN\43:S<:3KNE:>EQXK
MUG5H--CE\N&2QO[.UMV5F>UE6.53!)PL3 K,V'4G->F?&_\ 9V\0>.?@5\/?
M!6@W=E=:AX7O])NI9-8U"XM1=1VD>UQ]HMX_,5WX^=%4C)8;2!7T110.Y\/Z
M;^P_XZT+0CY&I^%-4O;[2=:T6?3=3$\EIIL-_.)1-!,8VEN)DP07E"LXP"XQ
MFNF\1_LJ?$>\\=> #9^)]#N/!WA6[\/7 $\2PWUR+#RUF:5Q;.\CN$<H?/11
MNVE>2U?75% 7/CGPY^QAX@\$>!?@\FCV_@VZ\3>#H]2BU6SOTE_L_4VO(S&9
MFD6+>[QC&W<G(++E1@UU5K^R]XEB_97^'WP\?4])/B3PG?V6IE':233+][>Y
M,OD2DH',3 \G8<$#Y3BOIRB@+GRYX!_93U_PYXY\%>)M2N=">2R\5Z[XFU.Q
MM#(8;87UHT,5O:;HQO5'VN2PCY+,!GBNC^*WPJ^)MW\=+?Q_\/[GPM%GPG-X
M:?\ X2":X#0/)=+/YR1Q1,)-NQ1M+KG)].?H"B@+GQ7KO[!^M0^$&\+Z/J^D
MWNEKX0T?P]YFI/+$T\]OK1U"Y=D6-PL;HS!1N)W$ X'S4>*_V$=?U?XI:O=Z
M=XCM]*\$ZCK$>L10Z?+':W-@ZP"(1I&+-RRJ 54+/$ IQMSDG[4HH"Y\FP_L
MT^/K7X4?#SP^EAX&_MCX?ZQ87VGR12SI#J\-O!+"_P!I;R"T,C^8K':)!N4D
MGGCGW_8D\8MI5QH_]L>'_LFFZ9XIMM,U13,M]JLNKQ2HGV\^7A5B,F25,A;8
MI &,'[2HH"Y\NK^RCJV@^/\ X2ZUX270?"Z>&-.LM/UF[M)9=U]!&S//;BU\
MKRG$CD,)F974DM@D+CJ?B1^S>_Q'^,/B7Q3=RZ=!9ZAX#;PK87AC,M[I]V\U
MPS7$:E=J@),N&#AL@C ')]YHH$?$GA7]AWQGH/@MXKG6]'U#Q!:ZYHFK6]G>
MS>;IEXFG121+%*L=I$8@Z2C^&4CRH\EL9K5O?V1/'6MCQ%IMY-X/LM/\3^(K
M/Q)>ZO;-/)J>DO"82;6S8Q*&C'D[8W)38KL-AS7V-10.Y\67?[#>OW/@7PWI
M>[PN=6T[2/&5G<W1,F);C5"_V*0-Y.YA&K8<D K_  !JU6_8TUZZUZ;4;Q_#
METTOB+PEJ;/*TCNUIIEI##=1',/5V1]B_=8,-Q7)%?7U% 7/@W6?V!?'=SX>
MT*TM?$FE*8](U/0=1L(KGR8!;7.IW-VKQ2264QSLG164)&08EVR8 -=?>_L3
M:Y>Z1=V8U32H;RY\>'7VUD.[7@TPZ8;39O$0S,)&+[,A.<[@>*^PZ* N?#VE
M_L3^-+BS^Q>(-/\  UW86O@2+P=%#IM]>6CWTD5_;7,=S-*MON1ML#-\H?#X
MX96..]^*WPQ\2Z/^Q5_PB>OW-_XO\>V$*2V-]X?TZ6YE.HQSF:U(")N"J52-
MIF R-S-C<:^I** N?*-E^RSXHTOP3\)KVP?0]2\7>&SJ5_K.G>(]_P!BU"\U
M*(_:I'>-'):.1V"G:<KE<KG(X6;]ASXD>&/AGXJ\$^&O$GAS5+/Q/X;TS2;V
M_P!;>YBFMIK-Y6 B5$<&)A*5!8@J%7Y3BONBB@+GSU^U3^S=K7QQO/#%WX:U
M>TT.ZB$^CZW+<,ZFYT:ZV?:8TV*=T@\M2BMM7YFRP[\9XH_8\\1ZAJGBO1]+
MN_#D/A7Q'XEL_$1UR9)1K>E+ 8"+:V 0H5 @VHQ==BNPVG-?7%% 7/C'Q9^Q
MQX\U!]6CT;5]!L+>#QE?^*=+,<IC:YCO4F62&=9+6:.-H0X",$E!#OPAP:]#
M\:_LSZKK7[&]K\'-,O[9M2AMM.MQ<ZA=.8ML%Y#/(OFQQ!L;(V52$!^[G')'
MT710%SYVU/\ 9UU[X=_$'2_&'PCGTM+F+0I?#USIWB^_O;E#"UR;E)4G+2RE
MED9_D;@JV 5P*\IUS_@GA>:AHNFZ-'X@@DMM,\#W>CVU[]HGMY'UB:_-YYLD
M2 J]J2\JLCEN&'R$@,/M^B@+GS1^TMX*\8^(_ _P0L['P_IFK>(=,\8:5=W]
MI##++I<!BM+D2,Y6/=';AR%$A0;=R?+GBN*\#_L+ZM;>(M8U+Q/?:#(FKZ)K
ML(33HW<:-J%_=I+&]DKH,)#&'P^58,W"@'-?9E% 7/@#XJ_LG^/-,^$.NW$N
MGZ#>ZG;>&]#\(V.C>%;6>X34$@U:UF>\N8_+4Y"H244,%7S"7(KMH?V1/'L'
MQ-?XGAO!DGB!M6EN_P#A$':X_L00O8K:!Q)Y._SODWD^5@[F'?-?9-% 7/B_
MX:_L7>.OA7XG\'7OA[7]$TUM,MUCU;5/-N)SJ0'G.L)LG3RU2-Y=B2+*K"->
MF36=X;_8R^*2>-M"U_7]=\+W)L;[0+B5++$"+%87SSND44-E"@!1@$#9()*E
MR #7W#10%SY[_9R^ ?BCX/>-O%5Y=W6E:?X2U!2;'P[IMW->K!.TS223++-&
MCQ*V[_4@NN23NKCO"7PX^/W@7Q9XK\;W^D>"/%7C3Q'+:V2:A!JMRZ:;9"XC
M'DI!)%"%@CB,TA"R&1W"G#=*^M:* N>)?M5_"+Q'\;O T?A?1+?1I;2X6?[1
M-JFK7UBUO(T>R*1!; B8 /+F*7Y#\N<U/\2/A;XVU'X*>%_"OA37-(7Q%I/V
M&.XU+4K*)8YTACV2/$K0S)!(Q 93Y3A>0 .&'LU% CXH\%_L.>*-'\):[I^M
M77AK4]1N?A_J7A6QN69W$-Y<:C?W4<O, V1A+J')09#(P"X"DNTG]C+Q[H>L
MZ)!'=^$=0TFV\:Z/XQN-5NWN/[33[-'"D]K%^Z*E/W;>62PR#@A=V1]JT4#N
M?,O[3'[)&K_&74=6U_P_XTN=,UR\MK"P2QOHH&LH[>"\BN6"N8))8R60R?(0
M'=4#Y7@>[>!H?%%OIU[!XKETVYN8KV6.RN-/+DS68($,DX*J%G89+A!L!/R\
M5TE% @HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** /FGXH? ?QKXZ_:8O?%>A^(M8\%Z8O@6/2[76](N+;$E^M[/(()HI
M$D=HPKHY*JN>@?.17SQXH_9#^)OB#P1I6D:3X)?PQ?6NFVUGXGNH]?AE;Q9<
MB^LY#< ^9E2@AFF\R78_.Q0<#/Z.T4#N9/A3PKI7@?PYIV@:':"PTC3X1!:V
MRNSB*,=%!8DG\37QE\9_V=?C-\0_B=XV^).DVNB6FH:9?6*^%=-OV\R\DAL'
M$L<D,R3"*$3R/."LHSM8@A.M?<=% C\V[F'5KG]INTTUO#\6K?$5OB(=?:^7
M5%FDM]+^QLT-C.B%FBCA)12Y79E<H6W&M;P1^S3\7+3QEH=Y<> M/\,Z.FL^
M&]1NM/TB[ACMT:SOY'N)F#7DS32+$P/F\-(,#8&R*_0ZB@=SX M/V1/&6E>%
M/#@A\,ZK9ZGJ%AXGL_%,FA:U;07DR37BOIR;WEV,/+!8+]T98-M+5N?#?]F3
MQ5X?\4_!;Q/K_P --$GN/#U_J-I>Q::+.">UMI)(FL;N5!)Y1>)_/D98&;:9
M,H"2:^XZ* N<5\9Y?%47PI\4+X'L#J?BV6QD@TR 3QPXF<;%DWR,J@)NW\D9
MV8')%?$MW^Q]\7?AWX"\:>#-&T[1O$^E>)O",&FO)HCK9!;^TE4PR3+<S?,\
MD;RJ73"_*F0N.?T/HH"Y^=OBW]E?XB:Q%XCO=(^']WHVG3ZC:7>B>#)-6L+S
M3X)XK0Q7$]Y%++Y;I,[ AD8RJ4WE0QKH_$G[-GC/P_XM^(-SH_P?\-^(7\4M
MI5TUX9H391!((A?PB!KB"24M<@SA'=8W )9BP"M]WT4!<_.RW_94^+FH?#BX
MTG5?#KRWTGA;3]&"IJ=N,&'Q5->>4C>>2JI9&-E^;@ ("7&VOJ_]FKX9ZE\*
M;'X@Z1<Z;_9.B3>+KR]T"T6=9(TT^2&#9Y85F\M3()CL.""2<#(S[)10%PKX
M-_X)0_\ (L_%;_L85_\ 0&K[RKX-_P""4/\ R+/Q6_[&%?\ T!J Z'WE1110
M(**** "BBB@ K\^OVPO^4AW[/7_;E_Z72U^@M?GU^V%_RD._9Z_[<O\ TNEH
M&C]!:***!!15;4;MK#3KFY6WFNV@B:06]N 99< G8@) +'&!D@9/45R'P_\
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M)&S3^$_V@/AUXTT3PUJ>G^,M%$?B/"Z7;W%_#%<7,GRYA6,MN,JEE5D W*2
M0#0!Z%16+HOC/P]XDU/5=-TC7=,U34-*D$.H6EE>1S2V;G.$F123&WRMPP!X
M/I7.^+?CIX \$V/B:;4_%VC1S^&[4W>J6":A"UU;)\H4/%NW*SL\:J"!N:1
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MJWM?[>L=)NKZ\EM-*MM4O;>";5U20Q>?:Q&0O)$TBNJ-M!;82 5*D]/<^/\
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MEKJ\MK)IUBT'V&":V9I4W.\9B7#.L2E'\P2>=TG[9FAW%YXHM-2.HRRV^D>
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MD>!_#G@CQ?H'B[77\9:-<C3]#U."\F6&*Y6265DC9BJ(BDLYP!W/(KZAHHH
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MW@'PHVF6&IZY:7VHS:KK%I)>06\-MY0VK!'-"SN[3*,^8H4 G#=*SE\?>-O
MOQ:\$>$O%NH>'_$-GXN6^BM;G1=(GTV2TFMH?/.\275P)$9 PXV$$#J#P >S
M4444 %%%>;_&[XB:KX!TOPS:Z##9OK?B77K;0;.XU"-I+:U:19)&FDC1D:0*
MD+X4.N25Y S0!Z117AGCKQ[\1/@T?#6J>)=8\+^)M$U+7;+1+BUTO0+G3KB/
M[5((EF25[Z=3L9E)0H-PS\P->YT %%%% !17"?'+XD2?"+X3>)?%T%BNI7.F
M6P>"U=]BR2LZH@8]EW.N<<XSBN%^(WB3XN?"GX<:YXTU'Q#X)UN#0K%]1N]*
MM?#5Y:-<)&NZ2..X;4) A(#!6,3#.,K0![K15'1-5AU[1;#4X%=8+VWCN(U<
M88*ZA@#[X-7J "O@W_@E#_R+/Q6_[&%?_0&K[RKX-_X)0_\ (L_%;_L85_\
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M?*<C'*^'/V5+C1O GB?PS=^+(KV/5/!$7@6SNH]*\I[6UB%X(I7'G-YLFV\
M;'EAC%D!=V!]"44#/#? 7[,L?@;XIW'BG^WWU33C?7FJ6FGW;7Y>SN;E6$S1
MC[;]E"GS)0/]%# /C><9/4Z/\-_$GA#Q3J%QX:\3:;:^%]3U-M5O=&U/1Y+J
M9))&#7 MKA+F(1B1MS_/'+M=V(RN$'I-% CYZ\6_LJWOB_2M=T*Z\9I'X<N/
M[<GTJUCTG_2+*YU03><\TWG8G2/[5<;$"1G#KN9BN3U>H_ MKCQ'/K2ZTS.?
M%C>*DMC;=SHQTS[-NW\#GS=^.^W;_%7K5% 'R;X;_9,\7^(_ASX#B\8>*-+3
M6=!T"PTN+1I=#,U@L*+&T]I?HMWB]&^*$;D>)"8%.U@Q!Z?PI^R$GACX:^._
M"*>)H?*\4Z"^B^9:Z2MO#9;[K4K@R1P+*5V_\3':(P5 $(P0&POT710.YXW\
M$_A7/X6^(7Q+\87NG7.DCQ!J2KIVG7DD,CVULJF25QY3NJ>?=S74I4-D@QEL
M-\JVO /P<UWP-IGCA;?Q/IUKJ'B#=)9)I&C/:Z=I=P4<?:$M'N9=SN[AY,2(
MKE!PI+,?6J*!'S=J_P"Q-H$/AJWTOPMXDUG091H-]X=N;B^OKK4TFM;FW*D+
M%-/LA(G$,_[H*"8RN!N!7NM<^ \6M7GBF=M8\K^W?%6C^)F M<F(6 L0(,[Q
MNW_8?O\ &WS?NG;SZO10!\Y?##]D"/X=WWABXE\2C5F\/7MI+:SS0WDD\EI;
M6=];06SF>]FC0+]O9QY$<* A@(P&&RKXD_9#U>^\-^+M%T/QY;Z3;>+;6ZL=
M7>ZT,W3F&74K^^C\C%P@C9?[1FB8L'#!5("&OI>B@=SYGU/]C,:EK>KW,GBV
M26QDU2ZUS2(KE=0FDTN_FN6N1(J-?_9&197?*BV1F5B"^XESZ1X1^$^O:5H_
MQ"36_%T=YK?C"Y>X;4]%TXZ>+ _8H;1/)1IICN00*X8N>3[5ZA10%SYQ^%G[
M(8^'/CS3/%!UO1UFM)[::2ST+P__ &=#<^39:A;;I,W$K/(YU R-(Y9B8L="
M-C=#_9,U?PMX>TCP]I/CFVBT*-] GU6*XT,RSWD^EFW"-%(+E1 LBVD(92DF
M""0>2*^D** N>1?&;]GNR^,/B#2];FU&/3]2T;3;J#2+AK)9WL+][BTN(+Z,
MEAAHFM,%1C>LKKN4$YYBP_93?3?&GB#6_P"WK+5[749M1OK;3==M;^\MK6ZO
M8W2<FW_M!;9X3YLP,?D*Y1]OF<;J^A**!'SC!^REK5GH=_I]MX^6'^TM%71[
MP_V7*4$<5_<W<$<(^U;X[=1=R6YB9W+0JJB1"-U5-!_8S71(KZ.+Q#I>GP:I
M_:]OJ%GH?A\6%H+34+6R@FBMHEN#Y#J;"-UD)?[[;E8G=7TS10.Y\[>%?V5]
M6\)6FG7UIXQM9O&&F:A!>6FLWMGJ%[')'%:7-H(9XKG4I68>7>3D>3)"H9@=
MN!@Z<O[--Q<_L^V_PWO/$5AJMVFL?VU/J6I:*)K2[D.JG4&BELQ, T3$F-E\
MP94GZ5[M10(^7?BW^S/XOO/A;XML/!VK>';'4=7\*C0;O1=+\.BSM+I8);J6
MW2T5KO;9EOM<D;ES*IR& 0BKGC;]D76/&>E2Z _CRVL_"\=WKU[9V2:&S7$<
MFJ0WJ2&68W.)/*:_D*;8T^4;6R2''TM10.Y\V_&C]GC5_%UGXHTJPGEN[7Q=
MXFL-66ZM(H[>70E%M!9WTDDSSYE62TBE1%BB#!I2&)4[T[OXZ_ >'XS>%=+T
M.WU8>&X=/6\2)H+02JJSZ;=6("J'3:$%UO&.OEA>,Y'J]% CR#QQ\"+[Q%\2
M3X[T;Q+%H^O6_P#9S6(NM-^UV\;VT>I0OYJ"6-I%DBU2485HRK1JP8\BO.M7
M_8KO->/B);[QLD\6L_VC=X-OJ16QU"]MIH9KBW@.I&V10UQ,51H&<(Y7S"?G
MKZDHH \B\:? BZ\1_%"#QSIWB*+3-3M9M,FMX+C3S<0C[+'J43AP)4+"2/5)
M ,%=C1J?F!*UQUU^QEI>I:3X'TR^\273V.@^%V\-7\=O;B(ZF%M9;>VGSN/E
MM#]JNW5?G^:53D% 3]'44#N>2_ KX'7'PAEU6XU'7$\1W]Y;6MDM\QU S""#
MS2B.;N^NA@&9R!$(E!9OE.1CG])_9,T?PW\,?!'A/0M0@\.W?AZ3[1<ZUH^F
MQVUQJ%Q_9ES8&X;:WRR_Z3YN]BYS&!SG(]ZHH"Y\W_#?]CZ/P)XNTWQ ^LZ*
M)K2_L;Y[70_#W]GPSFVM-1M@SYN)6:5_[1,C2LS,3%CHPV>M?##P!>_#G3KO
M3&U:#4M+EO+V_B069BECFNK^ZNY,OYC!E N(XP-H.8F;)WA4[:B@04444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% 'S_\
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MWX>^*?#VGZ?X8\.:AI>MW$MI!J6J>))K#R)(K2XNY&F1;*54C$=LX#!R<D9
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MX$U/PG%K^HRZGH%K+J6H:>D6H:1=I*%LYC'-<.GE9C@4;"\K 1Q%]DC*ZLH
M/9**\OA_:%\)ZGX@&E:5=R7C0:Q=:)>R26%[$%N;>WNII8K=OLY2YD3[(X95
M< #G<2422B?VF?";^(([1#<V^F0:9JNHZI>:G9W-A/IOV);%V22UGA67+17Z
M2 X'RA<!MPP >O45F>'/$%KXIT6WU.SBOH;:XW;$U&PGL9QABIW0SHDB<@XW
M*,C!&00:TZ "BBB@ HHHH **** "BBB@ HHHH **** "BO*OB9\0_$=E\3/!
MW@'PHVF6&IZY:7VHS:KK%I)>06\-MY0VK!'-"SN[3*,^8H4 G#=*SE\?>-O
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M88*ZA@#[X-7J "O@W_@E#_R+/Q6_[&%?_0&K[RKX-_X)0_\ (L_%;_L85_\
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M>/A=/'<5[X8;5['79/[1TAIM2>ZAO;>\E)NEN%0K++ YP825\X_,0H%,U?\
M9IU/4Y;BVD\2Z-?^'H+[5-2TO1]9\.FZCCGOY)'N!=$7*?:(P+BY5$41%?,0
MLS[/F]\HH"Y\YZ?^R1<6OB+PIJM[XRFUG^S+>P@U"VOQ?B*\^QWLUW;,BQ7R
M*/+>8J@N1<A1''U.\OT'PH_9_P!9^'?B[P[J>H>,+;7-*\-^%W\*:1I\.CFU
MD2V,MLZ233>>XDE"VJ*2J(IZA5Y!]LHH$>$:E^R\-0TSQ)9_\).T2:SI7BK3
M"18Y$7]M7JW7F8\SYO(VE,<;\YRG2N[\>_#:Z\6W'@BZL=6@TVZ\-:D;W=<6
M;7"7$;V<]I+'M66,HQ2X8J^6"LHRK#BN\HH&?/?B7]DQ?$/@OP1H8\5SVMQX
M5\,P:#;WT-O)&TLT-SIMQ'<DQSHZ#?IB@JDBMB4E9$90U6/''P+UNW_9O3P'
MX<N;>77O[9L=0;4(UF*>9_;,-Y<7)6[NII'('FR%7G8N00#\P4>^44!<\+LO
MV97U+Q-JVO\ BKQ'%J^H:W::M::HNG:<;*%UO;;3K4>0K32M%Y<.FH/F9RS2
ML<J %K-\1?LNZS\0[."R\:^.8-4L%L8=%GBTK1C8M<Z:LBRS1.QN)")9I(;;
M=*FT!(W5(U,F]?H:B@1\^^"/@AK-K\=-)\2Z^]Q?Q^&?#D&EKJ\JPP1:S? 2
M(EXD$<CLCQV\T\+L^S<9OD78HQUTGP.67QBNO2:T7"^,AXN6V:UR!_Q)_P"S
M1;AM_P#VUWXZ_+M_BKU2B@#YIU#]CEK[7]*O7\465S:V6K#55COM%,\]LXUN
MXU0_8Y/M 6W:3[0()'V.72)?NC*T[Q1^Q_<^);."U?Q; +:"\UT"V:TOH8KC
M3]5NUNI[6X^RZA \K"12-VX1LIPT)*AA]*44#N>&ZY^S)_:OA6'1[3Q5<:3-
M%KFOZVE_:6NV:-M3AU"(*A\S*M#_ &@"'SEO)'"[LKB>!?V1CX)U;5-4BU7P
MV\U]:ZG;-I5OX8,.D#[9!IT)#6INF+IC3MSJ9,RF=R67O]&T4!<X3X1_#_5O
MAKX9MM#O=>M]:L;:-_)6.RD@,+O<3RE$+SR$0(DD44<9)*+#R[[@%[NBB@04
M444 %%%% !1110 4444 %%%% !1110!\_P#Q@UK3_ O[2GPP\5>(KVVT/PQ'
MHNLZ=+K.H3+!:0W$C6KQQR2L0J%EB?;N(W%2!DUF>)?'/AKXL_M*_!:3P3XB
MTGQ=%H+:S>:I)H=]%>)90R61AC:5HV8)ND=5 )&3G'0U])T4 %%%% !7AW[4
M\R:5:?##7[LB#1M#\;6-_J=\_$5E;>1<Q&:5NBH'EC!8\#=D\5[C10!\O?M#
M_$[P9\6](\#^'/!'B_0/%VNOXRT:Y&GZ'J<%Y,L,5RLDLK)&S%41%)9S@#N>
M17U#110 4444 >-_M@Z5>ZQ^S7XZMM/M)KZY%I',(+9"\C+'-'(^U1R2%1C@
M<\5QG[1OQ]^&?C?]GOQ[HWAWX@>&==UK5M#N;2PTO3=6@GN[F:6,K'&D",7+
MEF V[<COC%?2]% S$\$Z?/I'@S0+&Z3RKFUT^W@E3(.UUC4$9'N#6W110(*^
M#?\ @E#_ ,BS\5O^QA7_ - :OO*O@W_@E#_R+/Q6_P"QA7_T!J!]#[RHHHH$
M%%%% !1110 5^?7[87_*0[]GK_MR_P#2Z6OT%K\^OVPO^4AW[/7_ &Y?^ETM
M T?H+1110(***\"^&G[:OP]^*6F>$;_2H]4M8/$=[J%@GVZ*%#826=LUS+]I
MVRL$!B 92I;.Y<XYP >^T5X+H_[8GA;7'TXVWAGQ<EGK23MX>OKC34A@UYXT
M9Q%:L\HP\BH3&)A%OXP>:RX?VWO#Y\&>,/%-SX \=:?I'A:[_LZ^DN;.S!:\
M%U#:M;1A;HYD5YU)SA=JMR3@$ ^CJ*XSP-\3K+QD8[2ZTZ]\*:^\3W*^'=>D
MMTU+[,KA#<>3%+)^ZW,%WYQG@XXJAI7QET_5=7U^,:1J%GX<T*:XMK_Q7>S6
M<&FPRP?ZY3NG$P"G(+F()\I.[&"0#T*BL#Q!X^\,>$X;^77/$>D:-%81PRW<
MFH7T4"VR2LRQ-(78; [(ZJ3C<58#.#7.^#/CQX&\>^*-4\.Z3XBTZ;6+*5$C
MM/ML#27T36L%TMS;(KEI(#'<)B0#&5;L,D ]!HK!U#QWX9TCQ+8^'+[Q#I-E
MXAOXS+::3<7L4=W<(-V6CB+!W V/R ?NGT-><:;^UY\)M3N;%4\9Z3;Z=>#4
M1'JUW?V\-F)+.XAADB,C2##O]HCDC&/GC._H5R >RT5SE_\ $?PEI.J3:9>^
M*-%L]1AL&U26SGU"&.:.S4$M<,A;(B !RY&T8/-8_B3XU^#O#7@*U\:-K5GJ
M7A6XOK:Q&KZ==0RVJ&:Z6U\QIMX01QR/\[;OE"/P2,4 =W17,V7Q,\'ZCI,>
MJ6GBO1+K3)+2?4$O8-1A>%K6!@L\X<-M,<990[YPI(!(S5.]^+GA*WU&?3+7
M7]*U35[6[M;2ZTVSU.U^TVK7$R11F1'E4J-TB\?>;HBNQ52 =E17'Z/\8O /
MB&RU.\TKQOX<U.TTN!;F_GL]6MYH[.%@6625E<B-2 2&; (!I$^,?@&1-(9?
M''AMEUA'DTTC5K<B]5"0[0_/^\"D$$KG!!S0!V-%8.@>._#7BO0)-=T3Q#I.
MLZ'%OWZEI][%/;)L&7S(C%1M'7GCO678_&?X?:G!I<UGXZ\-7<.JW1L=/D@U
M>W=;RX!4&&$A_P!Y("Z?(N3\R\<B@#LJ*Y?Q'\4/!G@[5K?2]>\6Z%H>IW C
M,-EJ.I0V\THD9ECVH[ G<R.!@<E& Z&J'_"[_AS_ &/9ZM_PG_A?^RKVX:TM
M;[^V;;R)YEQF)'W[6<9&5!)Y% ';T5DP>+-$N;BUMX=9T^6>[FN+>WBCND9I
MI8&9)T0 Y9HV1E<#E2I!Q@UBI\8O ,FJZGI:>-_#C:EI<4\U_9KJUN9K..$D
M3/*F_,:QD'<6 "X.<4 =A17&6GQH^'M_<Z/;6WCOPS<7&LY&F11:Q;L]]B1H
MSY #YD_>(Z?+GYE(Z@BIK'XM^!M4U+5=.LO&?AZ[U#28Y9M1M(-5@>6R2)ML
MK3('S&$/#%@ #P<4 =;17FOC+]HOX;^"?!#^*KSQCH=UIKV5U?6*6>IVTDFI
MK;J3*EH#(!,X(VX4_>(!(S786/C+0M1^SBWUBPDDGNGL(XENHR[721M(]N #
MS*J([%/O!48D8!- &U17+ZE\4?!FBZU>Z/J'B[0K'5K&V-[=6%SJ4,<]O;A=
MQEDC9@RH 0=Q &#G-4I?C7\.[?3--U&3Q[X8CT[4S(MA=OK%N(KLHRHXB??A
MRK.BG:3@LH/)% ':T5QT/QC\ W'A^_UV+QQX;ET/3YA;7FIIJUN;:VE. (Y)
M=^U&^9?E)!Y'K4'C?XR^$_A[I?AG5=9U>UMM$\07JV5KJ[7,2V2;K::Y25YF
M<*(V2!@&!.2R8X.0 =Q17,R?$WP=!;Z#/)XKT..#7V":1(VHPA=18XP+<[L2
MD[EX3/4>M<;X6_:@^''BG2]>U=/%&DZ9X?TG4SI)UK4=6LH[2ZF ;_5,)B<'
M:VW>$+@;E#+AJ /6**Y'4?B[X%T:_P!2L;_QIX=L;W3+=;N^MKG58(Y+2!O+
MVRRJ7!1#YL6&; /F)S\PS7\8?&;P3X$\%6'B[5_$FFP^&[^>VM[34TNHV@G:
M=PL91]VUEP2Y8' 1'8\*2 #MJ*\]\ ?'OP)\2=2N=+T;Q'ILFM07EY:'2'OH
M#>/]FGDA>585<L8F,996QRI4\9Q73^&?&WAWQII]Q?>'M>TO7;&WE:":YTR\
MCN(HI% +(S(Q 8 @D'D9% &W17#:/\=?AMXAN[&TTKXA>%=3NKZ8VUI!9ZU;
M2O<2@*3'&JN2S ,I*C)^8>HK13XH^#))=>B3Q=H3R>'U+ZPBZE"3IJC.3<#=
M^Y VM]_'W3Z4 =117F7B#]H[X?:!J%IIX\2Z9J%_?:)<^(+&WM=1M@+NTA )
M:.625(_F&]E+.%*PRMN"QL1T5I\5_!&H>(+C0K7QCX?N=;MQ,9M,AU.![F(1
M,RR[H@VX;&1@V1\I4@XP: .KHKFO!OQ+\(?$1;H^%/%6B>)UM-GV@Z-J,-V(
M=V[9O\MFVYVMC/7:?0U3_P"%Q^ 1!K4W_"<>&Q#HCK%JLG]K6^VP=G\M5G._
M]T2_R@-C+<=: .QHKE]<^*/@SPQX>T[7M8\7:%I.A:D$:RU.^U*&&VN@Z;T,
M4K,%?<GS#:3D<CBJ]U\8O -CKSZ'<^-_#=OK2(9&TV75K=;E4$?FEC&7W "/
MY\X^[\W3F@#L**S;3Q'I.H.\=KJ=E<NEK%?,D-PCE;>7?Y4Q /$;^5)M;HWE
MM@G:<<Y;_&SX=WGAJZ\10>/?#$_A^TF6WN-6CUBW:UAE;&U'E#[58Y& 3GD4
M =K17F?@_P#:&\%>,-!U;78]5M=+\/Z;N,VK:E?VD5OM%Y<V8?<)B51I+1RC
MN%5PZ[22'5.LA^('A:?39=1B\2:1+I\-@FJR727T1B2S??LN2V[ B;RY,29V
MG8V#P: .@HKB-0^./PXTEM16^^('A:R;3;D6=ZMQK5M&;6<[\12Y?Y'_ '4O
MRM@_NWX^4X6\^-WPZTZ>P@NO'WA>UFU"U6]LXYM9MD:YMV!*S1@O\Z$*V&&0
M=IYXH [:BN2C^+G@671=-UA/&GAY](U.Z^Q6-^NJP&"[N,D>3%)OVN^01M4D
M\'BHS\8_ 0OM5L?^$V\.M?:3!/<ZA:KJL!FLXH6*SO*@?<BQL"K%@-I!!P:
M.QHKS2X_:*^'UE\*=#^(USXCLK;PEK3VT5I?33(H,DT@C"-EL!D;?Y@SF,12
MEL;&Q:\ ?'KP+\2KS4;#1?$>FR:K87-Y;S:6][ ;I4MKAX'G\I79O)9DW*Y
M!5E/&<4 >@T5Q5E\;/AWJ2Z:UIX]\,72ZG=&QL##K%NXN[@% 88L/\\@,L0*
M+D_O$X^89LR?%KP-!I6JZF_C/P_'IFD7/V/4;QM4@$-E/G;Y4S[\1OD@;6(.
M3TH ZRBO.)?C[X-;XC^$O!.GZI;:SJ_B6RGU*T;3[VU>)+:- PE;,H9Q("=@
MB5RP21L!$=AZ/0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 5\&_\$H?^19^*W_8PK_Z U?>5?!O_  2A_P"1
M9^*W_8PK_P"@-0/H?>5%%% @HHHH **** "OSZ_;"_Y2'?L]?]N7_I=+7Z"U
M^?7[87_*0[]GK_MR_P#2Z6@:/T%HHHH$%?#WP^_8"UWPMXA^&5U>ZSI@TO3]
M#OM,\5V=E/+_ *1/+9W5K%<6Q:(9;R[E48MLXB7AC7W#10!\P^$?V=OB+,GP
ML\->,=;\.3>"_AQ>07NGSZ1'.+_4WMH7@L_.1P$A"H^6"L^XCMUJIXN_97\6
M:[^S]\7_  /;WVB_VMXO\9W/B.PDFN9TMTMY-0@N529UBWJ^R)@=BL 2,-W'
MU310.YXO\$/AMXJ\!7]G%JWA[PEINFP:=/#]JT_5K_5=165[A76,7-V@<P%=
MS%2W#A<#'3F_BC\ O%'Q,USQ<;6T\/>#K76='U+2KG4].U&XGFUE9K=H;8WE
MM]GCC4QDH_F;Y7 38I"L:^C**!'S7J'P>^)^N_%!_B)>VOA"+5;.XTJ:PT%=
M5N9;65+:WU2"59;DVBLC?\3/S4<0OAH]I7C>>BTKX->)G\8VGB2_?2+*Y?QL
MGBBYM[.XDEV0?\(^=.:%9#"AD83LQ!95!CY^4G8/<J* /"_&GP6\2ZY\0=3N
M+$Z(WAW6M;T/7+R_NII5U"R;3I89!!#$(F219/LZ@,9(]GG2G:_0U_ 'P(U_
M0O%Z7>LKHL^E6</BFVMQ%.\TLZ:IJ<-[$[HT*B,JHFC=0SC[I#,&(7WRB@#X
ML3]C#QZWAZ\T6[\06-[;3^'_ "8G_M$1Q0ZI_P (W_8Q=T.GM--$?G;=]IC
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "O
M@W_@E#_R+/Q6_P"QA7_T!J^\J^#?^"4/_(L_%;_L85_] :@?0^\J***!!111
M0 4444 %?GU^V%_RD._9Z_[<O_2Z6OT%K\^OVPO^4AW[/7_;E_Z72T#1^@M%
M%% @HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "O@W_@E#_R+/Q6_P"QA7_T!J^\J^#?^"4/_(L_
M%;_L85_] :@?0^\J***!!1110 4444 %?GU^V%_RD._9Z_[<O_2Z6OT%K\^O
MVPO^4AW[/7_;E_Z72T#1^@M%%% @HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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MEW5?VH?AQHNGVUY=:Q?B.>"]N3%%H=_+/;1V9471N(4@+V_E%TW"54(W#UH
M]6HKS6T_:*\!7NE7M_'JEZL5I]ES!+HU['<SBY9EMFMX&A$MPLK(X1H5<-L;
M!.TXLZ)\>_ 7B.*S?3?$"77VO48-)AC6VF$C74UO]HCCV% P_=;F)(PACD5B
MK1N% /0:*R/%?BO2O!'A^[UK6KK['IMJ%\R01M(Q+,$1$1 6=V9E544%F9@
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MIH7PN\5>/='U2[\1Z':^'YH+W6='\1W%_=SV=I]IG,<=W]H+^8K33X82!@6
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MEN;>SM-&MK1%WBW19G$]N>T:[)"_RM^[KVNBB@04444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %?!O_!*'_D6?BM_V,*_^@-7WE7P;_P $H?\ D6?BM_V,*_\
MH#4#Z'WE1110(**** "BBB@ K\^OVPO^4AW[/7_;E_Z72U^@M?GU^V%_RD._
M9Z_[<O\ TNEH&C]!:***!!17#?'3Q)J/@WX)?$'7]'N/L>K:5X=U&^L[C8K^
M5-%;2/&VU@5;#*#@@@XY!%9W_"J/%'_19_''_@'H7_RLH ]*HKS7_A5'BC_H
ML_CC_P  ]"_^5E'_  JCQ1_T6?QQ_P" >A?_ "LH ]*HKS7_ (51XH_Z+/XX
M_P# /0O_ )64?\*H\4?]%G\<?^ >A?\ RLH ]*HKS7_A5'BC_HL_CC_P#T+_
M .5E'_"J/%'_ $6?QQ_X!Z%_\K* /2J*\U_X51XH_P"BS^./_ /0O_E91_PJ
MCQ1_T6?QQ_X!Z%_\K* /2J*\U_X51XH_Z+/XX_\  /0O_E91_P *H\4?]%G\
M<?\ @'H7_P K* /2J*\U_P"%4>*/^BS^./\ P#T+_P"5E'_"J/%'_19_''_@
M'H7_ ,K* /2J*\U_X51XH_Z+/XX_\ ]"_P#E91_PJCQ1_P!%G\<?^ >A?_*R
M@#TJBO-?^%4>*/\ HL_CC_P#T+_Y64?\*H\4?]%G\<?^ >A?_*R@#TJBO-?^
M%4>*/^BS^./_  #T+_Y64?\ "J/%'_19_''_ (!Z%_\ *R@#TJBO-?\ A5'B
MC_HL_CC_ , ]"_\ E91_PJCQ1_T6?QQ_X!Z%_P#*R@#TJBO-?^%4>*/^BS^.
M/_ /0O\ Y64?\*H\4?\ 19_''_@'H7_RLH ]*HKS7_A5'BC_ *+/XX_\ ]"_
M^5E'_"J/%'_19_''_@'H7_RLH ]*HKS7_A5'BC_HL_CC_P  ]"_^5E'_  JC
MQ1_T6?QQ_P" >A?_ "LH ]*HKP7XP>%O&GP^^$GC;Q1IWQB\83:AHFAWVI6T
M=U8Z&T3R0P/(@<+IP)4E1D @XSR*[#_A5'BC_HL_CC_P#T+_ .5E 'I5%>:_
M\*H\4?\ 19_''_@'H7_RLH_X51XH_P"BS^./_ /0O_E90!Z517FO_"J/%'_1
M9_''_@'H7_RLH_X51XH_Z+/XX_\  /0O_E90!Z517FO_  JCQ1_T6?QQ_P"
M>A?_ "LKF/'V@^+_ (<Z7H^M0?%7Q5J__%0Z)8RV.I6>C^1/#<ZI:VTR,8K"
M-QF.9\%74@X.>* /<:*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M_P *H\4?]%G\<?\ @'H7_P K*/\ A5'BC_HL_CC_ , ]"_\ E90!Z517FO\
MPJCQ1_T6?QQ_X!Z%_P#*RC_A5'BC_HL_CC_P#T+_ .5E 'I5%>:_\*H\4?\
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M1110(**** "BBB@ K\^OVPO^4AW[/7_;E_Z72U^@M?GU^V%_RD._9Z_[<O\
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M';(R"#6G_P *)_:)_P"CHO\ S'VG?_%T ?2M%?-7_"B?VB?^CHO_ #'VG?\
MQ='_  HG]HG_ *.B_P#,?:=_\70!]*T5\U?\*)_:)_Z.B_\ ,?:=_P#%T?\
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M/=(L_!&DSZ'_ &]%97>G7EC>30V>M+*[/;2R13'?<6BNC$RLLB-(@5ZZJ_\
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MM3C=RRG">E9/_#4'[7W_ $0"Q_[\S_\ Q^C_ (:@_:^_Z(!8_P#?F?\ ^/T
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M^C_AJ#]K[_H@%C_WYG_^/T"/O&BO@[_AJ#]K[_H@%C_WYG_^/T?\-0?M??\
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
7"BBB@ HHHH **** "BBB@ HHHH __]D!

end
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
